adult: M01.060.116
case-control studies: E05.318.760.500.500, N05.715.360.775.175.200, N06.850.520.450.500.500
adverse effects: 
female: 
humans: B01.050.150.900.649.801.400.112.400.400
etiology: 
male: 
occupational exposure: N06.850.460.350.600
ontario: Z01.107.567.176.639
risk assessment: E05.318.740.600.800.715, N04.452.871.715, N05.715.360.750.625.700.690, N06.850.505.715, N06.850.520.830.600.800.715
animals: B01.050
dibutyl phthalate: D02.241.223.805.225
toxicity: 
dose-response relationship, drug: G07.690.220
embryo implantation: G08.686.785.760.170.104.500
drug effects: 
chemically induced: 
organ size: E01.370.600.115.100.660, E05.041.124.715, G07.100.100.660, G07.700.320.249.690
ovary: A05.360.319.114.630, A05.360.576.497, A06.407.312.497
anatomy &amp; histology: 
pregnancy: G08.686.785.760.769
blood: A12.207.152, A15.145
progesterone: D04.808.745.745.654.829, D06.472.334.734.623, D06.472.334.851.687.750
physiopathology: 
rats: B01.050.150.900.649.865.635.505.700
rats, wistar: B01.050.150.900.649.865.635.505.700.900
teratogens: D27.888.569.864
physiology: H01.158.782
adenosine triphosphate: D03.438.759.646.138.236, D13.695.667.138.236, D13.695.827.068.236
metabolism: G03.495
biological transport: G03.495.166
brain: A08.186.211
chlorides: D01.210.450.150, D01.248.497.158.215
maneb: D02.241.081.251.869.265.441, D02.691.600, D02.886.706.250.500
pharmacology: H01.158.703, H02.628
pesticides: D27.720.031.700, D27.720.723, D27.888.723
rats, sprague-dawley: B01.050.150.900.649.865.635.505.700.750
zineb: D02.241.081.251.869.265.908, D02.691.975, D02.886.706.250.950
caprylates: D02.241.081.222, D10.251.122
analysis: 
chromatography, gas: E05.196.181.349
decanoic acids: D10.251.175
pharmacokinetics: G02.111.325.500, G03.787, G07.690.725
fluorocarbons: D02.455.526.510.435
liver: A03.620
chemistry: H01.181
tissue distribution: G03.787.917, G07.690.725.949
aerosols: D20.280.055, D26.255.165.055, D27.720.280.165.055
bronchoalveolar lavage fluid: E05.927.100.500
carcinogens: D27.888.569.100
dust: D20.633.222
erythrocytes: A11.118.290, A11.443.240, A15.145.229.334
enzymology: 
macrophages, alveolar: A11.329.372.600, A11.627.482.600, A11.733.397.600, A15.382.680.397.600, A15.382.812.522.600
particle size: G02.842.680
reactive oxygen species: D01.339.431, D01.650.775
titanium: D01.268.557.800, D01.268.956.878, D01.552.547.800
chromium compounds: D01.220
urine: A12.207.927
dna damage: G05.355.180
sister chromatid exchange: G05.355.760.615.750
body weight: C23.888.144, E01.370.600.115.100.160.120, E05.041.124.160.750, G07.100.100.160.120, G07.700.320.249.314.120
cerebrovascular disorders: C10.228.140.300, C14.907.253
pathology: H02.403.650
prevention &amp; control: 
drug interactions: G07.690.812.240, G07.700.680.240
hemodynamics: G09.330.190.400, G09.330.380
hypertension: C14.907.489
genetics: H01.158.273.343
sodium, dietary: D01.857.700
benzene: D02.455.426.559.389.023
lymphoma: C04.557.386, C15.604.515.569, C20.683.515.761
time factors: G01.910.857
cathartics: D27.505.954.483.396
cell division: G04.299.134.220, G04.299.233.750.500, G05.355.105, G07.700.320.249.410.750.500
colonic neoplasms: C04.588.274.476.411.307.180, C06.301.371.411.307.180, C06.405.249.411.307.180, C06.405.469.158.356.180, C06.405.469.491.307.180
epithelial cells: A11.436
precancerous conditions: C04.834
abnormalities, drug-induced: C16.131.042
administration, oral: E02.319.267.100
amniotic fluid: A12.098, A16.378.149
area under curve: E05.318.740.200, G03.787.101, G07.690.725.064, N06.850.520.830.200
embryo, mammalian: A16.254
maternal-fetal exchange: G08.686.785.760.769.455
metabolic clearance rate: E01.370.225.843, E05.200.843, G03.490, G03.495.244.640, G07.690.595, G07.690.725.513, G07.690.812.097.595, G07.700.680.097.595
toxicity tests: E05.940
environmental exposure: N06.850.460.350
environmental monitoring: N06.850.460.350.080, N06.850.780.375
gas chromatography-mass spectrometry: E05.196.181.349.500, E05.196.566.500
halogenated diphenyl ethers: D02.355.726.601, D02.455.426.559.389.657.654.601
prenatal exposure delayed effects: C13.703.824.500
cells, cultured: A11.251
kidney: A05.810.453
carbaryl: D02.241.081.251.150, D02.455.426.559.847.638.162, D04.615.638.162
cholinesterase inhibitors: D27.505.519.389.275, D27.505.519.625.120.300, D27.505.696.577.120.300
copper: D01.268.556.195, D01.268.956.170, D01.552.544.195
down-regulation: G02.111.087.225, G02.149.115.225, G05.355.315.200, G07.690.812.230, G07.700.680.230
fishes: B01.050.150.900.493
insecticides: D27.720.031.700.491, D27.720.723.491, D27.888.723.491
oncorhynchus mykiss: B01.050.150.900.493.817.750.825.580.600
permethrin: D02.455.849.575.812.636
phenols: D02.455.426.559.389.657
pyrethrins: D02.455.849.575.812
species specificity: G16.824
temperature: G01.906.595, G16.500.275.063.725.710, G16.500.750.775.710, N06.230.150.450, N06.230.300.100.725.710
carbofuran: D02.241.081.251.583.166
diet: G07.610.240
sensitivity and specificity: E05.318.740.872, E05.318.780.800, G17.800, N05.715.360.750.725, N05.715.360.780.700, N06.850.520.445.800, N06.850.520.830.872
glycine: D12.125.481
analogs &amp; derivatives: 
herbicides: D27.720.031.700.366, D27.720.723.366, D27.888.723.366
algorithms: G17.035, L01.224.050
hot temperature: G01.906.595.543, G16.500.275.063.725.710.380, G16.500.750.775.710.380, N06.230.300.100.725.232, N06.230.300.100.725.710.380
magnetics: H01.671.493
radiation effects: G01.750.745, N06.850.810.300
biological markers: D23.101
cholesterol: D04.808.247.222.284, D04.808.247.808.197, D10.570.938.208, D10.851.208
endothelium, vascular: A07.231.330, A10.272.491.355
intercellular adhesion molecule-1: D12.776.395.550.200.450, D12.776.543.550.200.450, D23.050.301.264.035.400, D23.050.301.350.450, D23.101.100.110.400
administration &amp; dosage: 
vascular cell adhesion molecule-1: D12.776.395.550.200.920, D12.776.543.550.200.920, D23.050.301.264.035.920, D23.050.301.350.920, D23.101.100.110.970
animals, newborn: B01.050.050.282
fetus: A16.378
fungicides, industrial: D27.720.031.700.288, D27.720.723.288, D27.888.723.288
manganese: D01.268.556.484, D01.268.956.374, D01.552.544.484
zinc: D01.268.556.940, D01.268.956.906, D01.552.544.940
aryl hydrocarbon hydroxylases: D08.244.453.040, D08.811.682.690.708.170.040, D12.776.422.220.453.040
chlorobenzenes: D02.455.426.559.389.261, D02.455.526.439.202
cytochrome p-450 cyp3a: D08.244.453.040.986, D08.811.682.662.582.353, D08.811.682.690.708.170.040.888, D12.776.422.220.453.040.972
cytochrome p-450 enzyme system: D08.244.453, D08.811.682.690.708.170, D12.776.422.220.453
antagonists &amp; inhibitors: 
mice: B01.050.150.900.649.865.635.505.500
microsomes, liver: A11.284.835.540.541
oxidation-reduction: G02.149.767.650, G02.842.750.650, G03.495.335.531
sex factors: N05.715.350.675, N06.850.490.875
solvents: D27.720.844
cadmium: D01.268.556.137, D01.268.956.061, D01.552.544.137
hypertrophy, left ventricular: C14.280.195.400, C23.300.775.250.400
norepinephrine: D02.033.100.291.502, D02.092.063.480, D02.092.211.215.311.560, D02.092.311.461.484
sodium chloride, dietary: D01.857.650.705, D01.857.700.705
daphnia: B01.050.500.131.365.150.200
hydrogen-ion concentration: G02.300
lipids: D10
nanotubes, carbon: D01.268.150.250.500, J01.637.512.850.500
organic chemicals: D02
reproduction: G08.686.785.760
water: D01.455.900, D01.650.550.925
water pollutants, chemical: D27.888.284.903.655
coloring agents: D27.720.233, D27.720.470.330
glutathione transferase: D08.811.913.225.500
l-lactate dehydrogenase: D08.811.682.047.551.400, D08.811.682.047.820.493
oxidative stress: G03.495.710, G07.700.830.750
carcinogens, environmental: D27.888.569.100.125
chromium: D01.268.556.175, D01.268.956.124, D01.552.544.175
fertility: G08.686.210
lactation: G08.686.702.500, G08.686.785.420
mice, inbred balb c: B01.050.050.157.520.338, B01.050.050.199.520.520.338, B01.050.150.900.649.865.635.505.500.400.338
embryonic and fetal development: G07.700.320.500.325, G08.686.785.760.170
estrogens: D27.505.696.399.472.277
embryology: H01.158.100.529, H01.158.273.200.350
hydrocarbons: D02.455
trachea: A04.889
ovarian neoplasms: C04.588.322.455, C13.351.500.056.630.705, C13.351.937.418.685, C19.344.410, C19.391.630.705
powders: D26.255.779, D27.720.280.779
acetylcholinesterase: D08.811.277.352.100.170.176
growth &amp; development: 
catalase: D08.811.682.732.332
chlorpyrifos: D02.705.400.625.100, D02.705.539.345.100, D02.886.300.692.100
glutathione peroxidase: D08.811.682.732.500
hydrogen peroxide: D01.248.497.158.685.750.424, D01.339.431.374.424, D01.650.550.750.400
nadp: D03.438.759.646.138.749, D08.211.625, D13.695.667.138.749, D13.695.827.068.749
rats, long-evans: B01.050.150.900.649.865.635.505.700.500
disease outbreaks: N06.850.290
lung diseases: C08.381
water supply: H01.158.273.248.875.500
aging: G07.700.320.124
animals, suckling: B01.050.050.293
muscarinic antagonists: D27.505.519.625.120.200.500, D27.505.696.577.120.200.500
lung neoplasms: C04.588.894.797.520, C08.381.540, C08.785.520
polycyclic compounds: D04
silicon dioxide: D01.578.750, D01.650.550.825, D01.837.725
blood pressure: E01.370.600.875.249, G09.330.380.076
cell communication: G04.299.122
dna: D13.444.308
biosynthesis: 
mice, inbred strains: B01.050.050.157.520, B01.050.050.199.520.520, B01.050.150.900.649.865.635.505.500.400
phthalic acids: D02.241.223.805
rats, inbred f344: B01.050.050.157.760.200, B01.050.050.199.520.760.200, B01.050.150.900.649.865.635.505.700.400.200
environmental pollutants: D27.888.284
environmental pollution: N06.850.460
flame retardants: D27.720.361
hydrocarbons, brominated: D02.455.526.368
stereoisomerism: G02.607.500.682
analysis of variance: E05.318.740.150, N05.715.360.750.125, N06.850.520.830.150
diethylhexyl phthalate: D02.241.223.805.250
magnetic resonance spectroscopy: E05.196.867.519
peroxisome proliferators: D27.888.569.100.675
pyrimidines: D03.383.742
amino acids: D12.125
therapeutic use: 
drug therapy: E02.319
disease models, animal: C22.232, E05.598.500, E05.599.395.080
drug combinations: D26.310
drug evaluation, preclinical: E05.295.750, E05.337.550
drug synergism: G07.690.812.240.477, G07.700.680.240.477
sodium chloride: D01.210.450.150.875, D01.857.650
administration, inhalation: E02.319.267.050
axons: A08.663.542.145, A11.284.180.075, A11.671.137
ultrastructure: 
microscopy, electron: E01.370.350.515.402, E05.595.402
nerve degeneration: C23.550.737
cytology: 
tyrosine 3-monooxygenase: D08.811.682.690.708.923, D12.776.556.579.374.925
dogs: B01.050.150.900.649.147.153.200
life tables: E05.318.308.985.475, E05.318.740.100.500, L01.280.975.475, N01.224.935.530, N06.850.505.400.975.475, N06.850.520.308.985.475
cadmium compounds: D01.142
mercuric chloride: D01.210.450.150.525, D01.538.500
nitrates: D01.248.497.158.606, D01.625.525.550, D02.583
organ specificity: G07.650
spleen: A10.549.700, A15.382.520.604.700
water pollutants: D27.888.284.903
adipose tissue: A10.165.114
body temperature: E01.370.600.875.374, G07.110
dietary sucrose: D09.301.325, D09.698.629.305.770.200, J02.500.362.325
mitochondria, liver: A11.284.430.214.190.875.564.461, A11.284.835.626.461
obesity: C18.654.726.500, C23.888.144.699.500, E01.370.600.115.100.160.120.699.500, G07.100.100.160.120.699.500
endocrine system: A06
hormones: D06.472, D27.505.696.399.472
radioimmunoassay: E01.370.384.700, E05.478.566.639, E05.601.495.639
agonists: 
steroids: D04.808
testosterone: D04.808.054.079.429.824, D06.472.334.851.968.984
estrogens, non-steroidal: D27.505.696.399.472.277.540
receptors, estrogen: D12.776.260.698.750.350, D12.776.826.750.350, D12.776.930.669.750.350
vagina: A05.360.319.779
breast neoplasms: C04.588.180, C17.800.090.500
estradiol: D04.808.365.415.248, D06.472.334.851.437.500
epididymis: A05.360.444.371
sperm motility: E01.370.225.992.812, E05.200.992.812, G04.299.283.750
spermatozoa: A05.360.490.890, A11.497.760
testis: A05.360.444.849, A05.360.576.782, A06.407.312.782
atrazine: D03.383.931.247
larva: B05.500.500, G07.700.320.500.550.500.500
lethal dose 50: E05.940.402, G07.690.520
sex ratio: G05.815, I01.240.800.815, N01.224.803.815, N06.850.505.400.850.815
chromatography, high pressure liquid: E05.196.181.400.300
skin: A17.815
skin absorption: G03.495.023.750, G13.750.829.820
triclosan: D02.355.726.900, D02.455.426.559.389.657.654.900
androgen antagonists: D06.347.065, D27.505.696.399.450.065
base sequence: G02.111.570.080, G05.360.080, L01.453.245.667.080
estrogen antagonists: D06.347.360.315, D27.505.696.399.450.360.315
gene expression: G05.355.310
immunohistochemistry: E01.370.225.500.607.512, E01.370.225.750.551.512, E05.200.500.607.512, E05.200.750.551.512, E05.478.583, H01.158.100.656.234.512, H01.158.201.344.512, H01.158.201.486.512, H01.181.122.573.512, H01.181.122.605.512
perciformes: B01.050.150.900.493.602
rna, messenger: D13.444.735.544
reverse transcriptase polymerase chain reaction: E05.393.620.500.725
vitellogenins: D12.776.092.500.925, D12.776.290.812.500, D12.776.744.925
nitric oxide: D01.339.387, D01.625.550.500, D01.625.700.500, D01.650.550.587.600
vasoconstrictor agents: D27.505.954.411.793
gene expression regulation: G05.355.315
isoenzymes: D08.811.348, D12.776.800.300
mixed function oxygenases: D08.811.682.690.708
neural conduction: G07.265.337.600, G07.700.240.600, G11.561.600.620
organometallic compounds: D02.691
diagnostic use: 
sodium-potassium-exchanging atpase: D08.811.277.040.025.810, D12.776.157.530.450.162.780, D12.776.157.530.450.250.880, D12.776.543.585.450.162.800, D12.776.543.585.450.250.890
cell differentiation: G04.299.151
cerebellum: A08.186.211.132.810.428.200, A08.186.211.865.428.200
neurons: A08.663, A11.671
neurotoxins: D27.888.569.504
protein binding: G02.111.087.680, G02.149.115.680, G03.495.800
transcription factors: D12.776.930
soil: D20.721, G01.311.820, G16.500.275.815, N06.230.600
soil pollutants: D27.888.284.756
plasticizers: D27.720.760
stomach neoplasms: C04.588.274.476.767, C06.301.371.767, C06.405.249.767, C06.405.748.789
diazinon: D02.705.400.625.200, D02.705.539.345.200, D02.886.300.692.200
ecosystem: G16.500.275.157, N06.230.124
sex characteristics: G08.686.815
methods: E05.581
cytochrome p-450 cyp1a1: D08.244.453.040.555, D08.811.682.690.708.170.040.332, D12.776.422.220.453.040.332
enzyme induction: G05.355.315.320.200
fatty acids: D10.251
hydrocarbons, fluorinated: D02.455.526.510
oxidoreductases: D08.811.682
antioxidants: D27.505.519.217, D27.505.696.706.125, D27.720.799.047
cataract: C11.510.245
cattle: B01.050.150.900.649.077.380.271
fructose: D09.546.359.250, D09.546.465.354
superoxide dismutase: D08.811.682.881
abnormalities: 
embryonic development: G07.700.320.500.325.180, G08.686.785.760.170.104
endosulfan: D02.886.092.408, D03.438.197.408
eye abnormalities: C11.250, C16.131.384
cricetinae: B01.050.150.900.649.865.635.150
diethylstilbestrol: D02.455.426.559.389.150.700.175
lung: A04.411
united states: Z01.107.567.875
actins: D05.750.078.730.250, D12.776.210.500.100, D12.776.220.525.255
cell count: E01.370.225.500.195, E05.200.500.195, E05.242.195, G04.170
chick embryo: A13.350.150, A16.331.200
endothelium: A10.272.491
trichloroethylene: D02.455.526.439.939
apoptosis: G04.299.139.160
eye: A01.456.505.420, A09.371
metals: D01.552
alkaline phosphatase: D08.811.277.352.650.035
instrumentation: 
cobalt: D01.268.556.185, D01.268.956.155, D01.552.544.185
edetic acid: D02.092.782.258.368.250, D02.241.081.018.253
electrophoresis, polyacrylamide gel: E05.196.401.402, E05.301.300.319
kidney neoplasms: C04.588.945.947.535, C12.758.820.750, C12.777.419.473, C13.351.937.820.535, C13.351.968.419.473
air pollutants, occupational: D27.888.284.101.268
heart rate: E01.370.600.875.500, G09.330.380.500
rats, inbred wky: B01.050.050.157.760.390, B01.050.050.199.520.760.390, B01.050.150.900.649.865.635.505.700.400.390
reflex: E01.370.376.550.650, E01.370.600.550.650, F02.830.702, G11.561.600.765
tumor markers, biological: D23.101.840
acrylamide: D02.065.122.015, D02.241.081.069.094.015
cell nucleus: A11.284.430.106, A11.284.430.214.190.875.117
micronucleus tests: E05.393.560.598
mutagenicity tests: E05.393.560, E05.940.560
mutagens: D27.888.569.468
salmonella typhimurium: B03.440.450.425.800.200.825, B03.660.250.150.710.160.760
classification: L01.100, L01.453.245.275
leukemia, radiation-induced: C04.557.337.650, C04.682.512, C26.733.345
pituitary gland: A06.407.747, A06.688.357.750, A08.186.211.730.317.357.352.435.500, A08.713.357.750
prostate: A05.360.444.575, A10.336.707
microscopy, electron, scanning: E01.370.350.515.402.541, E05.595.402.541
catecholamines: D02.092.211.215.311, D02.092.311
epinephrine: D02.033.100.291.310, D02.092.063.291.310, D02.092.211.215.311.461, D02.092.311.461
flow cytometry: E01.370.225.500.363.342, E01.370.225.500.386.350, E05.196.712.516.600.240.350, E05.200.500.363.342, E05.200.500.386.350, E05.242.363.342, E05.242.386.350
mitogens: D27.505.519.593.624
t-lymphocytes: A11.118.637.555.567.569, A15.145.229.637.555.567.569, A15.382.490.555.567.569
immunology: 
imidazoles: D03.383.129.308
mice, inbred c57bl: B01.050.050.157.520.420, B01.050.050.199.520.520.420, B01.050.150.900.649.865.635.505.500.400.420
survival rate: E05.318.308.985.550.900, L01.280.975.550.900, N01.224.935.698.826, N06.850.505.400.975.550.900, N06.850.520.308.985.550.900
disinfectants: D27.505.954.122.425, D27.720.274
electric stimulation: E05.723.402
electrophysiology: H01.158.344.528, H01.158.782.236
evoked potentials: G07.265.500, G11.561.270
hippocampus: A08.186.211.464.405, A08.186.211.730.885.287.500.345
hexachlorobenzene: D02.455.426.559.389.261.400, D02.455.526.439.202.400
inflammation: C23.550.470
random allocation: E05.318.780.700, E05.581.500.805, N05.715.360.780.675, N06.850.520.445.700
skin diseases: C17.800
dimethoate: D02.705.400.625.220, D02.705.539.345.220, D02.886.300.692.220
acetates: D02.241.081.018, D10.251.400.045
ethylene glycols: D02.033.455.250
rats, inbred strains: B01.050.050.157.760, B01.050.050.199.520.760, B01.050.150.900.649.865.635.505.700.400
sertoli cells: A05.360.444.849.789, A11.382.952, A11.436.837
dna primers: D13.695.578.424.450.275, D27.720.470.530.600.223.600
densitometry: E05.196.712.224
indicators and reagents: D27.720.470.410
milk: A12.200.455, J02.200.700, J02.500.350.525
electrochemistry: H01.181.529.307
microscopy, confocal: E01.370.350.515.395, E05.595.395
butyrylcholinesterase: D08.811.277.352.100.170.250
pyridones: D03.383.725.791
tritium: D01.435.719, D01.496.749.925
maternal exposure: N06.850.460.350.145
epoxy compounds: D02.355.291.411
spermatogenesis: G04.299.151.650.624, G08.686.785.760.310.760
statistics, nonparametric: E05.318.740.995, N05.715.360.750.760, N06.850.520.830.995
blood supply: 
heart ventricles: A07.541.560
epithelium: A10.272
methylmethacrylate: D02.241.081.069.800.550.450, D05.750.716.822.111.650.605.450, D25.720.716.822.111.650.605.450, J01.637.051.720.716.822.111.650.605.450
permeability: G02.685, G02.842.700
acetone: D02.522.064, D02.522.585.342
nasal mucosa: A04.531.520, A04.760.600, A10.615.550.760.600
vinyl compounds: D02.455.326.271.884
methanol: D02.033.623
acute disease: C23.550.291.125
mercury: D01.268.556.504, D01.268.956.437, D01.552.544.504
pneumonia: C08.381.677, C08.730.610
volatilization: G01.595.680.750, G02.149.767.680.933, G02.842.750.680.933
blotting, western: E05.196.401.143, E05.301.300.096, E05.393.525.262, E05.478.566.320.200, E05.601.495.320.200
glutathione: D12.644.456.448
dose-response relationship, radiation: E05.799.513.500, G01.750.740.500, G04.299.680.500, G07.225, G07.700.760.500, N06.850.810.250.180
forecasting: I01.320
canada: Z01.107.567.176
corpus striatum: A08.186.211.730.885.287.249.487
nitriles: D02.626
trialkyltin compounds: D02.691.850.900
carcinogenicity tests: E05.940.150
liver neoplasms: C04.588.274.623, C06.301.623, C06.552.697
cytochrome p-450 cyp2e1: D08.244.453.040.972, D08.811.682.662.582.338, D08.811.682.690.708.170.040.777, D12.776.422.220.453.040.944
membrane proteins: D12.776.543
microbodies: A11.284.430.214.190.500.585, A11.284.430.214.190.875.190.190.755
bronchi: A04.411.125
coal: D20.345.108, N06.230.132.258.108
pulmonary alveoli: A04.411.715
genetic predisposition to disease: C23.550.291.687.500, G05.380.355
agriculture: J01.040
central nervous system: A08.186
culture techniques: E05.240
mitosis: G04.299.134.220.220.781, G05.355.105.220.781
chloroform: D02.455.526.439.224, D02.455.526.913.810
carcinoma, squamous cell: C04.557.470.200.400, C04.557.470.700.400
kidney diseases: C12.777.419, C13.351.968.419
carboxylic ester hydrolases: D08.811.277.352.100
genes, p53: G05.360.340.024.340.375.249.385, G05.360.340.024.340.415.400.385
mice, inbred cba: B01.050.050.157.520.440, B01.050.050.199.520.520.440, B01.050.150.900.649.865.635.505.500.400.440
mice, knockout: B01.050.050.136.500.500, B01.050.150.900.649.865.635.505.500.550.455, B01.050.150.900.649.865.635.505.500.800.500
cell proliferation: G04.299.233.750, G07.700.320.249.410.750
butadienes: D02.455.326.271.665.146.240
kidney tubules, proximal: A05.810.453.736.560.570
potassium dichromate: D01.220.150.650, D01.745.650
lead: D01.268.556.435, D01.552.544.435
formaldehyde: D02.047.407
lymphocyte activation: E01.370.225.812.482, E05.200.812.482, E05.478.594.530, G12.425.747, G12.450.050.400.545
polymers: D05.750, D25.720, J01.637.051.720
dopamine: D02.092.211.215.311.342, D02.092.311.342
nerve tissue proteins: D12.776.641
predictive value of tests: E05.318.780.800.650, N05.715.360.780.700.640, N06.850.520.445.800.650
nervous system: A08
chromosome aberrations: C23.550.210, G05.365.590.175
hypoxanthine phosphoribosyltransferase: D08.811.913.400.725.450
mutation: G05.365.590
membrane potential, mitochondrial: G03.495.335.770.500, G04.580.550, G07.265.750.550
microscopy, fluorescence: E01.370.350.515.458, E05.595.458
heart: A07.541
oxides: D01.248.497.158.685, D01.650.550
acrolein: D02.047.122
liver neoplasms, experimental: C04.588.274.623.460, C04.619.540, C06.301.623.460, C06.552.697.580, E05.598.500.496.750
organophosphates: D02.705.400
cardiovascular system: A07
adenoma: C04.557.470.035
dna methylation: G02.111.087.029.538.161, G02.111.087.218, G02.149.115.029.538.161, G02.149.115.218, G03.495.130.538.161, G05.355.190
trichloroacetic acid: D02.241.081.018.214.750, D02.455.526.439.196.750
acrylamides: D02.065.122, D02.241.081.069.094
rna: D13.444.735
gases: D01.362
albuminuria: C12.777.934.734.269, C13.351.968.934.734.269, C23.888.942.750.269
alpha-globulins: D12.776.124.790.106, D12.776.377.715.085
immunoglobulin g: D12.776.124.486.485.114.619.393, D12.776.124.790.651.114.619.393, D12.776.377.715.548.114.619.393
transferrin: D12.776.124.050.800, D12.776.124.790.223.839, D12.776.157.427.750.500, D12.776.377.715.182.839, D12.776.556.579.750.500
protein biosynthesis: G02.111.087.675.871, G02.149.115.675.871, G03.495.770.871, G05.355.310.670
diet, sodium-restricted: E02.642.249.290, G07.610.240.290
kidney cortex: A05.810.453.324
transcription, genetic: G02.111.087.847, G02.149.115.847, G05.355.310.700
up-regulation: G02.111.087.880, G02.149.115.880, G05.355.315.850, G07.690.812.925, G07.700.680.925
structure-activity relationship: G02.111.830, G07.690.830
epichlorohydrin: D02.355.291.411.400
ethylene dibromide: D02.455.526.368.225
methylmercury compounds: D02.691.750.100.738
polychlorinated biphenyls: D02.455.426.559.389.185.698, D02.455.526.439.773
propane: D02.455.326.146.800
infertility, female: C13.351.500.365.700
pentachlorophenol: D02.455.426.559.389.657.190.633
geologic sediments: G01.311.330, G16.500.320
acetylcysteine: D02.886.030.230.259, D12.125.166.230.259
cysteine: D02.886.030.230, D02.886.489.155, D12.125.154.299, D12.125.166.230
arrhythmias, cardiac: C14.280.067, C23.550.073
growth hormone: D06.472.699.631.525.425, D12.644.548.691.525.425
food additives: D27.720.368, J02.500.512
parkinson disease: C10.228.140.079.862.500, C10.228.662.600.400, C10.574.812
radiation dosage: E05.799.513, G01.750.740, N06.850.810.250
ethanol: D02.033.375
porphyrins: D03.383.129.578.840.500, D03.549.909.500, D04.345.783.500, D23.767.727
enzyme-linked immunosorbent assay: E05.478.566.350.170, E05.478.566.380.360, E05.478.583.400.170, E05.601.495.350.170, E05.601.495.380.360
gasoline: D20.345.630.540, N06.230.132.258.630.540
vehicle emissions: D20.832
respiratory hypersensitivity: C08.674, C20.543.480.680
pleura: A04.716, A10.615.789.736
industrial waste: D20.944.420, N06.850.460.710.420
tanning: J01.576.852
cerebral cortex: A08.186.211.730.885.287.500
ultraviolet rays: G01.358.500.505.650.891, G01.590.540.891, G01.750.250.650.891, G01.750.750.659, G01.750.770.578.891, G16.500.275.063.725.525.600, G16.500.750.775.525.600, N06.230.300.100.725.525.600
lipid metabolism: G03.495.520
alkanesulfonic acids: D02.455.326.146.100, D02.886.645.600.055
neutrophils: A11.118.637.415.583, A11.627.340.583, A11.733.689, A15.145.229.637.415.583, A15.382.490.315.583, A15.382.680.689
surface-active agents: D27.720.877
caproates: D02.241.081.193, D10.251.400.326
hexanols: D02.033.415.510, D02.033.480, D10.289.510
metallothionein: D12.776.556.670
dichloroethylenes: D02.455.326.271.367.300, D02.455.526.439.350
hydrocarbons, chlorinated: D02.455.526.439
rabbits: B01.050.150.900.649.521.700
leukocyte count: E01.370.225.500.195.107.595, E01.370.225.625.107.595, E05.200.500.195.107.595, E05.200.625.107.595, E05.242.195.107.595, G04.170.107.595, G09.188.105.595
neurons, afferent: A08.663.650, A11.671.650
organophosphorus compounds: D02.705
cell membrane: A11.284.149
vanadium: D01.268.556.920, D01.268.956.886, D01.552.544.920
selenium: D01.268.185.850, D01.578.700
lactates: D02.241.511.459
pyruvates: D02.241.755.812
nickel: D01.268.556.607, D01.268.956.625, D01.552.544.607
mammary neoplasms, experimental: C04.588.531.500, C04.619.590, E05.598.500.496.843
reproducibility of results: E05.318.780.725, E05.337.851, N05.715.360.780.685, N06.850.520.445.725
exons: G05.360.340.024.340.137.232
polymerase chain reaction: E05.393.620.500
sequence analysis, dna: E05.393.760.700
flavonoids: D03.438.150.266.450, D03.830.219.266.450
malondialdehyde: D02.047.700
plant extracts: D20.215.784.500, D26.667
stomach: A03.556.875.875
endotoxins: D23.946.123.329
humidity: G16.500.275.063.725.310, G16.500.750.775.310, N06.230.150.372, N06.230.300.100.725.310
image processing, computer-assisted: L01.224.308
neuroglia: A08.637, A11.650
kinetics: G01.374.661, G02.111.325
bronchodilator agents: D27.505.696.663.050.110, D27.505.954.796.050.100
aloe: B01.650.940.800.575.100.027
benzimidazoles: D03.438.103
molecular structure: G02.111.570, G02.575, G02.842.575
plants, medicinal: B01.650.560
maximum allowable concentration: N06.850.460.350.210, N06.850.460.350.600.615
atmosphere exposure chambers: E07.079
body burden: E05.799.638.231, N06.850.460.200
methylnitronitrosoguanidine: D02.078.370.649.400, D02.654.567.400
antihypertensive agents: D27.505.954.411.162
collagen: D05.750.078.280, D12.776.860.300.250
dietary carbohydrates: D09.301, J02.500.362
dna fragmentation: G05.355.180.230
uterine neoplasms: C04.588.945.418.948, C13.351.500.852.762, C13.351.937.418.875
neoplasms, radiation-induced: C04.682, C26.733.476
fruit: A18.024.500, J02.500.562
fertilization in vitro: E02.875.800.750, E05.820.800.750
dietary proteins: D12.776.256, J02.500.428
biological assay: E05.091
neoplasms, experimental: C04.619, E05.598.500.496
thymus gland: A10.549.750, A15.382.520.604.750
food contamination: J01.576.423.850.730.500.249, N06.850.460.400, N06.850.601.500.249
muscle, skeletal: A02.633.567, A10.690.552.500
spectrophotometry, atomic: E05.196.712.726.551, E05.196.867.826.551
benzoates: D02.241.223.100, D02.455.426.559.389.127
food preservatives: D27.720.368.385, J02.500.512.700
mice, inbred icr: B01.050.050.157.520.510, B01.050.050.199.520.520.510, B01.050.150.900.649.865.635.505.500.400.510
skin tests: E01.370.225.812.871, E05.200.812.871, E05.478.594.890
photosensitizing agents: D27.505.954.444.600, D27.505.954.600.710
proteins: D12.776
age factors: N05.715.350.075, N06.850.490.250
manganese poisoning: C10.720.475.500, C25.723.618
statistics as topic: E05.318.740, H01.548.832, N05.715.360.750, N06.850.520.830
iron: D01.268.556.412, D01.268.956.287, D01.552.544.412
ascorbic acid: D02.241.081.844.107, D02.241.511.902.107, D09.811.100
dna adducts: D13.444.308.135, G05.355.180.104
deoxyguanosine: D03.438.759.590.454.240, D13.570.230.360, D13.570.583.454.240
ketones: D02.522
guinea pigs: B01.050.150.900.649.865.550
hypersensitivity: C20.543
benzene derivatives: D02.455.426.559.389
chlorophenols: D02.455.426.559.389.261.190, D02.455.426.559.389.657.190
hazardous substances: D27.888.426
norway: Z01.542.808.618
evaluation studies as topic: E05.337, N05.715.360.335
thyroid neoplasms: C04.588.322.894, C04.588.443.915, C19.344.894, C19.874.788
follicle stimulating hormone: D06.472.699.322.576.288, D06.472.699.631.525.343.288, D12.644.548.691.525.343.288
secretion: 
dna modification methylases: D08.811.150.240, D08.811.913.555.500.350
epigenesis, genetic: G05.355.315.203
isolation &amp; purification: 
pathogenicity: 
mycotoxins: D23.946.587
dna, neoplasm: D13.444.308.425
intermediate filaments: A11.284.430.214.190.750.410
gastric mucosa: A03.556.875.875.440, A10.615.550.291
polybrominated biphenyls: D02.455.426.559.389.185.680, D02.455.526.368.700
atrophy: C23.300.070
aspartame: D12.644.456.345.190
organothiophosphorus compounds: D02.705.539, D02.886.300
tandem mass spectrometry: E05.196.566.880
macrophages: A11.329.372, A11.627.482, A11.733.397, A15.382.680.397, A15.382.812.522
hemoglobins: D12.776.124.400, D12.776.422.316.762
1-propanol: D02.033.755.600
models, neurological: E05.599.395.642
calcium: D01.268.552.100, D01.552.539.288, D23.119.100
dinoprostone: D10.251.355.255.100.637.250.200, D10.251.355.255.550.250.200, D23.469.050.175.725.780.200
parathyroid hormone: D06.472.699.590, D12.644.548.587
hypolipidemic agents: D27.505.519.186.071, D27.505.954.557.500
probability: E05.318.740.600, G17.680, N05.715.360.750.625, N06.850.520.830.600
diabetes mellitus, type 2: C18.452.394.750.149, C19.246.300
eggs: J02.500.470
standards: 
united states environmental protection agency: I01.409.137.500.937, N03.540.348.500.500.937
oocytes: A05.360.490.690.680, A11.497.497.600
flutamide: D02.065.199.420
receptors, androgen: D12.776.260.698.750.150, D12.776.826.750.150, D12.776.930.669.750.150
dichlorodiphenyl dichloroethylene: D02.455.526.439.292
gonadal steroid hormones: D06.472.334.851
oxazoles: D03.383.129.462
xenobiotics: D26.969
homeostasis: G07.700.345
perfusion: E05.680
creatinine: D03.383.129.308.207
heart diseases: C14.280
aldehydes: D02.047
necrosis: C23.550.717, G04.299.139.638
xenopus laevis: B01.050.150.900.090.180.610.500.562
methylation: G02.111.087.029.538, G02.149.115.029.538, G02.149.465.040.538, G02.607.750.040.538, G03.495.130.538
sulfhydryl compounds: D02.886.489
meat: J02.500.600
polymorphism, genetic: G05.365.795
naphthalenes: D02.455.426.559.847.638, D04.615.638
phenobarbital: D03.383.742.698.253.650
acetylcholine: D02.092.211.111
systole: G09.330.190.541.880, G11.427.590.540.570.880
enzyme inhibitors: D27.505.519.389
myelin sheath: A08.637.600.500, A08.637.800.500, A08.663.542.512.560, A08.800.800.690.500, A10.755.503, A11.284.149.165.600, A11.650.600.500, A11.650.800.500, A11.671.514.553
bone and bones: A02.835.232, A10.165.265
plant oils: D10.627.700, D20.215.784.750
irritants: D27.720.400, D27.720.821.498, D27.888.569.300, D27.888.569.734.498
ethylene chlorohydrin: D02.033.260.350, D02.033.375.310
binding sites: G02.111.570.120
neuroprotective agents: D27.505.696.706.548, D27.505.954.427.575
caffeine: D03.132.960.175, D03.438.759.758.824.175
intestinal absorption: G03.495.023.500, G07.610.593.431, G07.700.620.431, G10.261.326.430
mass spectrometry: E05.196.566
carbon radioisotopes: D01.496.123.328, D01.496.749.154
dialysis: E05.196.353, G02.149.767.540, G02.842.750.540
biotransformation: G03.495.244, G07.690.812.097, G07.700.680.097
bone marrow: A15.382.216
chromates: D01.220.150, D01.248.497.158.235
potassium compounds: D01.745
oxygen: D01.268.185.550, D01.362.670
polycyclic hydrocarbons, aromatic: D02.455.426.559.847, D04.615
chlordan: D02.455.526.439.180
phenotype: G05.695
receptor, epidermal growth factor: D08.811.913.696.620.682.725.400.100, D12.776.543.750.060.249, D12.776.543.750.750.360.300, D12.776.543.750.750.400.340
leukemia, lymphocytic, chronic, b-cell: C04.557.337.428.080.125, C15.604.515.560.080.125, C20.683.515.528.080.125
nasal cavity: A04.531.449
specimen handling: E01.370.225.998, E05.200.998
cluster analysis: E05.318.740.250, N05.715.360.750.200, N06.850.520.830.250
data interpretation, statistical: E05.245.380, E05.318.740.300, L01.700.508.190.380, N05.715.360.750.300, N06.850.520.830.300
likelihood functions: E05.318.740.500.475, E05.318.740.600.400, E05.599.835.500, N05.715.360.750.530.450, N05.715.360.750.625.450, N06.850.520.830.500.475, N06.850.520.830.600.400
models, statistical: E05.318.740.500, E05.599.835, N05.715.360.750.530, N06.850.520.830.500
drug therapy, combination: E02.319.310
muscle contraction: G11.427.590.540
porphyrias: C16.320.565.708, C17.800.849.617, C18.452.648.708, C18.452.811, C18.452.880.617
oryzias: B01.050.150.900.493.850.139.650
tetrachlorodibenzodioxin: D03.383.231.900
fluorescent antibody technique: E01.370.225.500.607.512.240, E01.370.225.750.551.512.240, E05.200.500.607.512.240, E05.200.750.551.512.240, E05.478.412, E05.478.583.375
gene expression regulation, developmental: G05.355.315.310
atrial natriuretic factor: D06.472.699.584.500, D12.644.548.585.500
stroke: C10.228.140.300.775, C14.907.253.855
carbamates: D02.241.081.251
action potentials: G04.580.100, G07.265.750.100, G11.561.570.100
cyclic amp: D03.438.759.646.138.395, D13.695.462.200, D13.695.667.138.395, D13.695.827.068.395
thyrotropin: D06.472.699.631.525.883, D12.644.548.691.525.883
endocrine disruptors: D27.505.696.353, D27.888.141
body size: E01.370.600.115.100.160, E05.041.124.160, G07.100.100.160, G07.700.320.249.314
hepatocytes: A11.436.348
adrenergic alpha-antagonists: D27.505.519.625.050.200.100, D27.505.696.577.050.200.100
angiotensin ii: D06.472.699.094.078, D12.644.400.070.078, D12.644.456.073.041, D12.644.548.058.078, D12.776.641.650.070.078, D23.469.050.050.050
mitochondria: A11.284.430.214.190.875.564, A11.284.835.626
nf-kappa b: D12.776.260.600, D12.776.660.600, D12.776.930.600
injections, subcutaneous: E02.319.267.530.620
parabens: D02.241.223.100.300.460, D02.241.511.390.460, D02.455.426.559.389.127.281.460, D02.455.426.559.389.657.410.460
india: Z01.252.245.393
lindane: D02.455.526.439.600
pesticide residues: D27.888.723.697, N06.850.460.200.700
movement: G07.700.560, G11.427.590.530
adrenal glands: A06.407.071
genistein: D03.438.150.266.450.400.375, D03.830.219.266.450.400.375
proteomics: H01.158.201.843, H01.158.273.180.350.700, H01.158.273.343.350.700, H01.181.122.738
signal transduction: G02.111.087.800, G02.149.115.800, G04.299.880
cell transformation, neoplastic: C04.697.098.500, C23.550.727.098.500
anti-infective agents: D27.505.954.122
metal nanoparticles: J01.637.512.600.500
povidone: D02.455.326.271.884.533.699, D03.383.773.812.615, D05.750.716.721.838, D25.720.716.721.838, J01.637.051.720.716.721.838
silver: D01.268.556.812, D01.268.956.843, D01.552.544.812
quality control: J01.897.608
genomics: H01.158.273.180.350, H01.158.273.343.350
chromatography, liquid: E05.196.181.400
cytokines: D12.644.276.374, D12.776.467.374, D23.529.374
light: G01.358.500.505.650, G01.590.540, G01.750.250.650, G01.750.770.578
zirconium: D01.268.556.950, D01.268.956.937, D01.552.544.950
sulfonic acids: D01.029.260.877.740, D01.875.800.740, D02.886.645.600
germ cells: A05.360.490, A11.497
mesothelioma: C04.557.470.035.510, C04.557.470.660.510
phagocytosis: G04.299.482.350, G09.188.124.780, G12.425.899, G12.450.564.809
spectrometry, mass, electrospray ionization: E05.196.566.600
genotype: G05.380
benzhydryl compounds: D02.455.426.559.389.115
trichothecenes: D02.455.849.765.850, D04.345.891, D23.946.587.933
drinking water: D01.455.900.300, D01.650.550.925.199, J02.200.418
synaptic transmission: G02.111.087.800.850, G02.149.115.800.850, G04.299.880.850, G07.265.337.900, G07.700.240.900, G11.561.600.835
nanoparticles: J01.637.512.600
neural pathways: A08.612
particulate matter: D20.633
zinc oxide: D01.650.550.975, D01.975.975
myocardial contraction: G09.330.190.541, G11.427.590.540.570
metals, heavy: D01.268.556, D01.552.544
greenland: Z01.107.567.403, Z01.639.400
estrogen receptor alpha: D12.776.260.698.750.350.174, D12.776.826.750.350.174, D12.776.930.669.750.350.174
insect control: N06.850.780.200.650.425
fetal development: G07.700.320.500.325.235, G08.686.785.760.170.157
cytoskeleton: A11.284.430.214.190.750
cerium: D01.268.477.249, D01.268.558.362.249, D01.552.550.399.249
gold: D01.268.556.322, D01.268.956.186, D01.552.544.322
peroxisome proliferator-activated receptors: D12.776.260.698.239, D12.776.826.239, D12.776.930.669.239
estrogen receptor beta: D12.776.260.698.750.350.262, D12.776.826.750.350.262, D12.776.930.669.750.350.262
caspase 3: D08.811.277.656.262.500.126.350.300, D08.811.277.656.300.200.126.350.300, D12.644.360.075.405.350.300, D12.776.476.075.405.350.300
blood cells: A11.118, A15.145.229
chromatin: A11.284.430.106.279.345.190.160.180, D12.776.664.224, G05.360.160.180
swine: B01.050.150.900.649.077.880
oligonucleotide array sequence analysis: E05.196.630.570.660, E05.393.525.640, E05.393.661.640, E05.393.760.640, E05.588.570.660, E05.601.640
real-time polymerase chain reaction: E05.393.620.500.706
chelating agents: D27.505.519.914.500, D27.720.832.500
colon: A03.556.124.526.356, A03.556.249.249.356
pancreas: A03.734
arylsulfotransferase: D08.811.913.817.400.300
helicobacter infections: C01.252.400.466
helicobacter pylori: B03.440.500.550, B03.660.150.280.550
sulfotransferases: D08.811.913.817.400
poaceae: B01.650.940.800.575.100.822
korea: Z01.252.474.557, Z01.586.407
in situ nick-end labeling: E05.393.475
neurotoxicity syndromes: C10.720, C25.723.705
nerve tissue: A08.561, A10.755
surface properties: G02.842.850
food preferences: F01.145.407.516
intestines: A03.556.124
consumer product safety: N06.850.210
micronuclei, chromosome-defective: A11.284.430.106.570, A11.284.430.214.190.875.117.570, C23.550.210.570, G05.365.590.175.570
plant leaves: A18.024.812
bivalvia: B01.050.500.644.080
geography: H01.277.500
complex mixtures: D20
gamma rays: G01.358.500.505.300, G01.750.250.300, G01.750.750.400
central nervous system diseases: C10.228
models, theoretical: E05.599
glucose: D09.546.359.448
drugs, chinese herbal: D20.215.784.500.350, D26.335
endometrium: A05.360.319.679.490
hydrocarbons, halogenated: D02.455.526
karyotyping: E01.370.225.500.385.315, E05.200.500.385.315, E05.242.385.315, E05.393.285.475
cholesterol side-chain cleavage enzyme: D08.244.453.915.212, D08.811.682.690.708.170.915.212, D08.811.682.690.708.783.212, D12.776.422.220.453.915.212
ovulation: G08.686.785.760.690
preservatives, pharmaceutical: D26.650.702, D27.720.744.771
glucosephosphate dehydrogenase: D08.811.682.047.150.300
rivers: G01.311.750, G16.500.275.280.650, N06.230.232.650
pregnancy complications: C13.703
enzymes: D08.811
linear models: E05.318.740.500.500, E05.318.740.750.425, E05.599.835.750, N05.715.360.750.530.460, N05.715.360.750.695.460, N06.850.520.830.500.500, N06.850.520.830.750.425
thymidine: D03.383.742.680.705, D13.570.230.855, D13.570.685.705
anti-bacterial agents: D27.505.954.122.085
imaging, three-dimensional: E01.370.350.400, L01.224.308.410
retinal vessels: A07.231.611
sodium: D01.268.549.750, D01.552.528.850
metabolic syndrome x: C18.452.394.968.500.570, C18.452.625
microscopy, electron, transmission: E01.370.350.515.402.580, E05.595.402.580
adipates: D02.241.081.337.052
reference values: E05.978.810
trace elements: D27.505.696.377.605.555, J02.500.631.555
pulmonary disease, chronic obstructive: C08.381.495.389
phenol: D02.455.426.559.389.657.595
blood-brain barrier: A07.035, A08.186.211.035
microwaves: G01.358.500.505.810.500, G01.750.250.810.500, G01.750.770.721.500
hip joint: A02.835.583.411
dinoprost: D10.251.355.255.100.637.400.200, D10.251.355.255.550.400.200, D23.469.050.175.725.790.185
carbon dioxide: D01.200.200, D01.362.150, D01.650.550.200
respiration: G09.772.770.755
calcium-binding protein, vitamin d-dependent: 
tubulin: D05.750.078.734.800, D12.776.220.600.800, D12.776.641.920
glycols: D02.033.455
toxicology: H01.158.703.795, H02.628.795
membrane glycoproteins: D12.776.395.550, D12.776.543.550
seasons: G01.910.645.661, G16.500.275.071.590, N06.230.300.100.250.525
aspartic acid: D12.125.067.500, D12.125.119.170, D12.125.427.040
triazoles: D03.383.129.799
simazine: D03.383.931.819
estradiol congeners: D06.472.334.851.437
guidelines as topic: N04.761.700.350, N05.700.350
principal component analysis: E05.318.740.562
spain: Z01.542.846
muscles: A02.633, A10.690
luciferases: D08.811.682.517, D12.776.532.510
paraquat: D03.383.725.762.621
gamma-aminobutyric acid: D02.241.081.114.500.350, D12.125.190.350
adenocarcinoma: C04.557.470.200.025
microbiology: H01.158.273.540
bromine: D01.268.380.112
evoked potentials, visual: G07.265.500.425, G11.561.270.425, G14.330
nanotechnology: H01.603, J01.897.520.600
x-ray diffraction: E05.196.309.742, E05.196.822.950, G01.595.861.950, G02.149.767.915, G02.842.750.915
skin neoplasms: C04.588.805, C17.800.882
urea: D02.948
cities: G16.500.275.069, N06.230.069, Z01.433
spectrometry, x-ray emission: E05.196.867.800, E05.799.830
phenylalanine: D12.125.072.050.685, D12.125.142.666
prefrontal cortex: A08.186.211.730.885.287.500.270.700
sweetening agents: D27.720.364.609, D27.720.888, J02.500.512.400.700
meiosis: G04.299.134.220.220.687, G05.355.105.220.687
diazepam: D03.438.079.080.070.216
diacetyl: D02.522.296.400
acetylglucosaminidase: D08.811.277.450.483.180.500
free radicals: D01.339, D02.389
homovanillic acid: D02.241.223.601.521
benzofurans: D03.438.127
tyrosine: D12.125.072.050.875
lanthanum: D01.268.477.500, D01.268.558.362.500, D01.552.550.399.500
computer terminals: L01.224.230.260.115.500
hormone antagonists: D06.347, D27.505.696.399.450
body constitution: E01.370.600.115, G07.100
physical exertion: G11.427.590.780
leukocytes: A11.118.637, A15.145.229.637, A15.382.490
fatty acids, unsaturated: D10.251.355
membrane transport proteins: D12.776.157.530, D12.776.543.585
plastics: D05.750.716, D25.720.716, J01.637.051.720.716
uric acid: D03.132.960.877, D03.438.759.758.824.877
immunoblotting: E05.478.566.320, E05.601.495.320
ions: D01.248.497
virginia: Z01.107.567.875.075.837, Z01.107.567.875.750.870
osteocalcin: D12.776.157.125.700
creatine kinase: D08.811.913.696.640.150
tin: D01.268.556.875, D01.552.544.875
prolactin: D06.472.699.322.576.773, D06.472.699.631.525.525, D12.644.548.691.525.525
republic of korea: Z01.252.474.557.750
anoxia: C23.888.852.079
myocytes, cardiac: A07.541.704.570, A10.690.552.750.570, A11.620.500
isomerism: G02.575.249, G02.607.500
adenosine diphosphate: D03.438.759.646.138.124, D13.695.667.138.124, D13.695.827.068.124
sulfides: D01.248.497.158.874, D01.875.350.850, D02.886.520
ethylene oxide: D02.355.291.411.417
leydig cell tumor: C04.557.475.750.847.249, C04.588.322.762.500.249, C04.588.945.440.915.500.249, C12.294.260.937.500.249, C12.758.409.937.500.249, C19.344.762.500.249, C19.391.829.782.500.249
testicular neoplasms: C04.588.322.762, C04.588.945.440.915, C12.294.260.937, C12.758.409.937, C19.344.762, C19.391.829.782
methylene chloride: D02.455.526.439.642
renal insufficiency: C12.777.419.780, C13.351.968.419.780
cell separation: E01.370.225.500.363, E05.200.500.363, E05.242.363
ferric compounds: D01.490.100, D02.691.550.100
chemical synthesis: 
fertilizers: D27.720.031.400
gene frequency: G05.330
bilirubin: D03.383.129.578.840.249.184, D03.549.909.249.184, D04.345.783.249.184, D23.767.193.184
polyvinyl chloride: D02.455.326.271.884.533.565, D05.750.716.721.812, D25.720.327.811, D25.720.716.721.812, J01.637.051.720.716.721.812
xylenes: D02.455.426.559.389.948
limit of detection: E05.318.740.872.374, N05.715.360.750.725.500, N06.850.520.830.872.500
abnormalities, multiple: C16.131.077
crystallization: E05.196.300, G02.149.767.505, G02.842.750.505
dopamine plasma membrane transport proteins: D12.776.157.530.450.625.124, D12.776.157.530.562.374.500.500, D12.776.543.585.450.625.124, D12.776.543.585.562.374.500.500
oxygen consumption: G03.730
mercury poisoning, nervous system: C10.720.475.600, C25.723.647.500
peritoneal neoplasms: C04.588.033.513, C04.588.274.780, C06.301.780, C06.844.620
ozone: D01.362.670.600
urinalysis: E01.370.225.124.810, E01.370.390.810, E05.200.124.810
osmolar concentration: G02.640, G02.842.640
digestive system: A03
pulmonary emphysema: C08.381.495.389.750
aluminum: D01.268.557.050, D01.552.547.050
phosphates: D01.029.260.700.675.374, D01.248.497.158.730, D01.695.625.675.650
pulmonary fibrosis: C08.381.765
alpha-tocopherol: D03.438.150.909.750.249, D03.830.219.909.750.249
molybdenum: D01.268.556.555, D01.268.956.500, D01.552.544.555
solanum tuberosum: B01.650.940.800.575.100.905.725.777, J02.500.850.790
sodium compounds: D01.857
muscle, smooth: A02.633.570, A10.690.467
sorbitol: D02.033.800.813, D09.853.813
drug resistance: G07.690.320
heart defects, congenital: C14.240.400, C14.280.400, C16.131.240.400
stress, physiological: G07.700.830
air: G16.500.275.063.150, N06.230.300.100.150
staining and labeling: E01.370.225.500.620.670, E01.370.225.750.600.670, E05.200.500.620.670, E05.200.750.600.670
radioisotopes: D01.496.749
azo compounds: D02.172
dna, mitochondrial: D13.444.308.283.225
indomethacin: D03.438.473.420
dipeptides: D12.644.456.345
household articles: J01.494
washington: Z01.107.567.875.560.900, Z01.107.567.875.580.900
adrenal cortex hormones: D06.472.040
dinitrobenzenes: D02.455.426.559.389.565.225, D02.640.529.240
vinyl chloride: D02.455.326.271.884.750, D02.455.526.439.975
sleep: F02.830.855, G11.561.600.815
dioxins: D03.383.231
pyrazoles: D03.383.129.539
spectrophotometry: E05.196.712.726, E05.196.867.826
vascular endothelial growth factor a: D12.644.276.100.800.200, D12.776.467.100.800.200, D23.529.100.800.200
cross-linking reagents: D27.720.470.410.210
adiponectin: D06.472.699.042.249, D12.644.276.024.249, D12.644.548.011.249, D12.776.467.024.249, D23.529.024.249
depression, chemical: G07.690.812.210, G07.700.680.210
magnesium: D01.268.552.437, D01.268.557.500, D01.552.547.500
potassium: D01.268.549.550, D01.552.528.652
yeasts: B01.300.930
spores, fungal: A11.870.710, A19.374.500, B05.775.710
inhalation: G09.772.770.755.700.390
acrylates: D02.241.081.069
antibodies: D12.776.124.486.485.114, D12.776.124.790.651.114, D12.776.377.715.548.114
household products: J01.516
economics: I01.261, N03.219
biological transport, active: G03.495.166.310
cyclic gmp: D03.438.759.646.454.160, D13.695.462.275, D13.695.667.454.160, D13.695.827.426.160
nitrogen: D01.268.604, D01.362.625
detergents: D27.720.877.265, J01.516.381
arachidonic acid: D10.251.355.096.100, D10.251.355.255.100.100, D10.251.355.310.166.100
phenanthrenes: D02.455.426.559.847.723, D04.615.723
vitamins: D27.505.696.377.605.600, J02.500.631.600
chemical phenomena: G02
alleles: G05.360.340.024.340.030
chromium alloys: D01.220.175, D01.552.033.182, D25.058.224, D25.339.208.224, J01.637.051.058.224, J01.637.051.339.208.224
nad(p)h dehydrogenase (quinone): D08.811.682.608.800.500
hungary: Z01.542.248.495
pharmaceutical vehicles: D26.650.700, D27.720.744.770, E02.319.300.754
silicones: D02.715.650.700, D05.750.900.850, D25.720.900.850, J01.637.051.720.900.850
electron probe microanalysis: E01.370.350.515.402.250, E05.196.867.800.360, E05.595.402.250, E05.799.830.360
antibody specificity: G12.100
fluorescein: D02.455.426.559.847.885.347.390, D03.494.953.275.390, D04.615.885.347.390
calibration: E05.140, E05.978.155
electromagnetic phenomena: G01.358.500
creatine: D02.078.370.280, D12.125.373
lens, crystalline: A09.371.060.500
alkanes: D02.455.326.146
glutamates: D12.125.067.625, D12.125.119.409
histamine: D02.092.211.215.501, D02.092.471.440, D03.383.129.308.373, D23.469.050.300
chromatography, thin layer: E05.196.181.400.537
antigens, cd: D23.050.301.264.035, D23.101.100.110
milk proteins: D12.776.256.626, J02.500.350.525.520, J02.500.428.626
nitrobenzenes: D02.455.426.559.389.565, D02.640.529
smoke: D20.633.937
atropine: D02.145.074.722.229.199, D03.132.760.180.572.199, D03.132.889.180.648.199, D03.605.869.229.199, D04.075.080.875.099.722.229.199
genetic markers: D23.101.387, G05.695.450
cholinesterase reactivators: D27.505.519.405.347, D27.505.519.625.120.400, D27.505.696.577.120.400
antigens: D23.050
thromboxane b2: D10.251.355.255.100.825.810, D23.469.050.175.800.810
basement membrane: A10.272.220, A10.615.179
epilepsy: C10.228.140.490
research: H01.770.644
succinates: D02.241.081.337.759
ethylenes: D02.455.326.271.367
platelet aggregation: G09.188.124.552.624, G09.188.124.560.600.640
chlorohydrins: D02.033.260
senna extract: D02.455.426.559.847.117.159.750, D02.806.100.750, D20.215.784.500.860
alveolar: 
macrophages: A11.329.372, A11.627.482, A11.733.397, A15.382.680.397, A15.382.812.522
cells: A11
chromium: D01.268.556.175, D01.268.956.124, D01.552.544.175
crvi: 
cell: 
regulation: 
bone: 
formation: 
engineered: 
nanoparticles: J01.637.512.600
steroid: 
skin: A17.815
samples: 
induction: 
estrogens: D27.505.696.399.472.277
linked: 
cytotoxic: 
elucidated: 
increases: 
epithelial: 
cultured: 
quantitative: 
vitro: 
gas: 
bisphenol-a: 
mcf-7: 
phenolic: 
materials: 
cd2+: 
ni2+: 
ions: D01.248.497
isolated: 
waste: 
dna: D13.444.308
oxidative: 
microsomal: 
biotransformation: G03.495.244, G07.690.812.097, G07.700.680.097
primary: 
might: 
carcinoma: C04.557.470.200
receptors: 
arthroplasty: E04.555.110
titanium: D01.268.557.800, D01.268.956.878, D01.552.547.800
bottles: 
well-known: 
activation: 
nanomaterials: 
brominated: 
line: 
physicochemical: 
sertoli: 
cytotoxicity: 
presence: 
nongenomic: 
cultures: 
prepared: 
essive: 
thereby: 
culture: I01.076.201.450, I01.880.143
proliferation: 
liquid: 
avalent: 
hamster: 
a549: 
absence: 
apoptosis: G04.299.139.160
activities: 
upon: 
electromagnetic fields: G01.358.500.260, G01.358.750.500
leukemia: C04.557.337
epidemiology: H02.403.720.500
occupational diseases: C24
mineral fibers: D01.578.500
electroplating: E05.301.250.348
risk factors: E05.318.740.600.800.725, N05.715.350.200.700, N05.715.360.750.625.700.700, N06.850.490.625.750, N06.850.520.830.600.800.725
smoking: F01.145.466.349.750, F01.145.928.500
taiwan: Z01.252.474.872, Z01.639.850
diuretics: D27.505.696.560.500
complications: 
medical record linkage: E05.318.308.940.968.500, L01.280.900.968.500, N04.452.859.564.550, N05.715.360.300.715.500.500, N06.850.520.308.940.968.500
middle aged: M01.060.116.630
multiple myeloma: C04.557.595.500, C14.907.454.460, C15.378.147.780.650, C15.378.463.515.460, C20.683.515.845, C20.683.780.650
naval medicine: H02.403.560
petroleum: D20.345.630, N06.230.132.258.630
air pollutants: D27.888.284.101
air pollution, indoor: N06.850.460.100.080
statistics &amp; numerical data: 
denmark: Z01.542.808.224
adolescent: M01.060.057
child: M01.060.406
electric power supplies: E07.305.124
electricity: G01.358.500.249
epidemiologic studies: E05.318.760.500, N05.715.360.775.175, N06.850.520.450.500
antiporters: D12.776.157.530.450.162, D12.776.543.550.190, D12.776.543.585.450.162
cross-over studies: E05.318.780.150, N05.715.360.780.150, N06.850.520.445.150
double-blind method: E05.318.780.300, E05.581.500.300, N05.715.360.780.320, N06.850.520.445.300
selectins: D12.776.395.550.200.700, D12.776.503.843, D12.776.543.550.200.700, D23.050.301.264.035.912, D23.050.301.350.700, D23.101.100.110.918
sodium-potassium-chloride symporters: D12.776.157.530.450.625.750, D12.776.543.585.450.625.750
von willebrand factor: D12.776.124.125.920, D23.119.985
attention: F02.830.104.214
memory: F02.463.425.540
perception: F02.463.593
color vision defects: C10.597.751.941.256, C11.966.256, C23.888.592.763.941.256
diagnosis: E01
follow-up studies: E05.318.760.500.750.500.350, N05.715.360.775.175.250.350, N06.850.520.450.500.750.350
italy: Z01.542.489
tetrachloroethylene: D02.455.526.439.880
alcohol drinking: F01.145.317.269
body mass index: E01.370.600.115.100.125, E05.041.124.125, G07.100.100.125, N06.850.505.200.100.175
confounding factors (epidemiology): N05.715.350.240, N06.850.490.718
cross-sectional studies: E05.318.760.500.875, N05.715.360.775.175.275, N06.850.520.450.500.875
hygiene: E02.547, N06.850.670
logistic models: E05.318.740.500.525, E05.318.740.600.800.450, E05.318.740.750.450, E05.599.835.875, N05.715.360.750.530.480, N05.715.360.750.625.700.450, N05.715.360.750.695.470, N06.850.520.830.500.525, N06.850.520.830.600.800.450, N06.850.520.830.750.450
socioeconomic factors: I01.880.840, N01.824
talc: D01.524.500.850, D01.578.725.500.800, D01.837.725.700.760.535.800
hemosiderosis: C18.452.565.500.500
infant: M01.060.703
ohio: Z01.107.567.875.075.512, Z01.107.567.875.350.540, Z01.107.567.875.510.540
autonomic nervous system diseases: C10.177
parasympathetic nervous system: A08.800.050.600
aged: M01.060.116.100
alloys: D01.552.033, D25.058, J01.637.051.058
cohort studies: E05.318.760.500.750, N05.715.360.775.175.250, N06.850.520.450.500.750
france: Z01.542.286
metallurgy: J01.576.370.400
odds ratio: E05.318.740.600.600, G17.680.500, N05.715.360.750.625.590, N06.850.520.830.600.600
steel: D01.490.800, D01.552.033.847, D25.058.807, J01.637.051.058.807
germany: Z01.542.315, Z01.586.315
mortality: E05.318.308.985.550, L01.280.975.550, N01.224.935.698, N06.850.505.400.975.550, N06.850.520.308.985.550
child, preschool: M01.060.406.448
incidence: E05.318.308.985.525.375, L01.280.975.525.375, N01.224.935.597.500, N06.850.505.400.975.525.375, N06.850.520.308.985.525.375
infant, newborn: M01.060.703.520
leukemia, myeloid, acute: C04.557.337.539.275
tobacco smoke pollution: D20.633.937.680, N06.850.460.100.555
nervous system diseases: C10
pest control: N06.850.780.200.650
diabetes mellitus: C18.452.394.750, C19.246
israel: Z01.252.245.500.375, Z01.586.500.375
dermatitis, allergic contact: C17.800.174.255.100, C17.800.815.255.100, C20.543.418.150
dermatitis, occupational: C17.800.174.255.700, C17.800.815.255.700, C24.270
ear, external: A09.246.272
asthma: C08.127.108, C08.381.495.108, C08.674.095, C20.543.480.680.095
forced expiratory volume: E01.370.386.700.660.230, G09.772.650.430
longitudinal studies: E05.318.760.500.750.500, N05.715.360.775.175.250.450, N06.850.520.450.500.750.500
toluene 2,4-diisocyanate: D02.455.426.559.389.832.500, D02.500.800
vital capacity: E01.370.386.700.485.750.900, G09.772.850.970
poisoning: C25.723
paresthesia: C10.597.751.791.875, C23.888.592.763.770.875
peripheral nervous system diseases: C10.668.829
suicide, attempted: F01.145.126.980.875.600, I01.880.735.856.600
china: Z01.252.474.164
fetal blood: A12.207.152.200, A15.145.300, A16.378.200
milk, human: A12.200.467, J02.200.700.500, J02.500.350.525.500
parturition: G08.686.785.760.769.490
dietary fiber: J02.500.400
esophageal neoplasms: C04.588.274.476.205, C04.588.443.353, C06.301.371.205, C06.405.117.430, C06.405.249.205
japan: Z01.252.474.463, Z01.639.595
rectal neoplasms: C04.588.274.476.411.307.790, C06.301.371.411.307.790, C06.405.249.411.307.790, C06.405.469.491.307.790, C06.405.469.860.180.500
infertility: C12.294.365, C13.351.500.365
diabetes complications: C19.246.099
nurses: M01.526.485.650, N02.360.650
perineum: A01.719
proportional hazards models: E05.318.740.500.700, E05.318.740.600.700, E05.318.740.750.725, E05.318.740.998.825, E05.599.835.900, N05.715.360.750.530.650, N05.715.360.750.625.650, N05.715.360.750.695.650, N05.715.360.750.795.825, N06.850.520.830.500.700, N06.850.520.830.600.700, N06.850.520.830.750.725
prospective studies: E05.318.760.500.750.500.650, N05.715.360.775.175.250.630, N06.850.520.450.500.750.650
risk: E05.318.740.600.800, G17.680.750, N05.715.360.750.625.700, N06.850.520.830.600.800
arsenic: D01.268.067, D01.268.513.249
cosmetics: D27.720.269, J01.516.213
mental processes: F02.463
radiation monitoring: E05.799.638, N06.850.780.375.700, N06.850.810.370
tungsten compounds: D01.940
carcinoma, renal cell: C04.557.470.200.025.390, C04.588.945.947.535.160, C12.758.820.750.160, C12.777.419.473.160, C13.351.937.820.535.160, C13.351.968.419.473.160
gamma-globulins: D12.776.124.486.485.397, D12.776.124.790.651.397, D12.776.377.715.548.397
hypotension: C14.907.514
confidence intervals: E05.318.740.275, N05.715.360.750.220, N06.850.520.830.275
registries: E05.318.308.970, L01.280.950, N04.452.859.819, N05.715.360.300.715.700, N06.850.520.308.970
retrospective studies: E05.318.760.500.500.500, E05.318.760.500.750.750, N05.715.360.775.175.200.710, N05.715.360.775.175.250.815, N06.850.520.450.500.500.500, N06.850.520.450.500.750.825
sweden: Z01.542.808.843
adaptation, physiological: G07.700.062, G16.100.057.500
radiation tolerance: G04.299.680, G07.700.760
workplace: N01.824.245.925, N04.452.677.975
epidemiologic research design: E05.318.780, N05.715.360.780, N06.850.520.445
residence characteristics: N01.224.791, N06.850.505.400.800
styrene: D02.455.426.559.389.150.750.800
fluorescent antibody technique, direct: E01.370.225.500.607.512.240.300, E01.370.225.750.551.512.240.300, E05.200.500.607.512.240.300, E05.200.750.551.512.240.300, E05.478.412.300, E05.478.583.375.300
tremor: C10.597.350.850, C23.888.592.350.850
cardiovascular diseases: C14
cause of death: E05.318.308.985.550.250, L01.280.975.550.250, N01.224.935.698.100, N06.850.505.400.975.550.250, N06.850.520.308.985.550.250
energy intake: G07.610.240.340
health surveys: E05.318.308.250, N05.715.360.300.375, N06.850.520.308.250
hearing loss: C09.218.458.341, C10.597.751.418.341, C23.888.592.763.393.341
toluene: D02.455.426.559.389.832
arthroplasty, replacement, hip: E04.555.110.110.110, E04.650.110.110
hip prosthesis: E07.695.400.400
live birth: G08.686.785.760.769.530.249
pregnancy complications, hematologic: C13.703.667, C15.378.785
pregnancy trimester, first: G08.686.707.408
prosthesis design: E05.320.550, E07.695.680
dioxolanes: D03.383.246.238
nitroparaffins: D02.455.326.146.672, D02.640.720
polyradiculoneuropathy: C10.114.750, C10.314.750, C10.668.829.800.750, C20.111.258.750
health status: I01.240.425, N01.224.425, N06.850.505.400.425
dental technicians: M01.526.485.067.105.503, N02.360.067.105.503
methylmethacrylates: D02.241.081.069.800.550, D05.750.716.822.111.650.605, D25.720.716.822.111.650.605, J01.637.051.720.716.822.111.650.605
ventilation: N06.230.150.520
eye diseases: C11
bias (epidemiology): N05.715.350.150, N06.850.490.500
diet surveys: E05.318.308.250.600.350, E05.318.308.585.550.350, N05.715.360.300.375.560.300, N05.715.360.300.560.565.300, N06.850.520.308.250.600.350, N06.850.520.308.585.550.350
neoplasms: C04
questionnaires: E05.318.308.750, L01.280.800, N05.715.360.300.695, N06.850.520.308.750
regression analysis: E05.318.740.750, N05.715.360.750.695, N06.850.520.830.750
antimony: D01.268.513.124, D01.268.556.050, D01.552.544.050
chemical industry: J01.576.207
kyrgyzstan: Z01.252.100.450, Z01.586.200.450, Z01.586.950.450
menstruation: G08.686.605.428, G08.686.785.560
blood pressure determination: E01.370.370.140, E01.370.600.100
bronchial provocation tests: E01.370.386.700.125
bronchoconstrictor agents: D27.505.696.663.050.100, D27.505.954.796.170
methacholine chloride: D02.092.877.883.555.500, D02.675.276.534.500
resins, synthetic: D05.750.716.822, D25.339.816, D25.720.716.822, J01.637.051.339.816, J01.637.051.720.716.822
respiratory function tests: E01.370.386.700
age distribution: I01.240.050, N01.224.033, N06.850.505.400.050
epidemiological monitoring: E05.318.375, N06.850.520.460
hearing loss, high-frequency: C09.218.458.341.812, C10.597.751.418.341.812, C23.888.592.763.393.341.812
industry: J01.576
akathisia, drug-induced: C10.228.662.037, C10.720.075, C23.888.592.350.600.500, C25.100.249, C25.723.705.100
dyspnea: C08.618.326, C23.888.852.371
industrial oils: J01.637.450
irritable mood: F01.470.047.110
median nerve: A08.800.800.720.050.500
mercury poisoning: C25.723.647
psychomotor performance: F02.808, G11.427.700, G11.561.623
sensation disorders: C10.597.751, C23.888.592.763
ships: J01.937.817
housing: N01.224.791.400, N06.230.150.360, N06.850.505.400.800.400
los angeles: Z01.107.567.875.580.200.450, Z01.107.567.875.760.200.450, Z01.433.565
multivariate analysis: E05.318.740.150.500, N05.715.360.750.125.500, N06.850.520.830.150.500
power plants: E07.305.437, J01.780
brain neoplasms: C04.588.614.250.195, C10.228.140.211, C10.551.240.250
epidemiologic methods: E05.318, N06.850.520
molecular epidemiology: E05.318.416, E05.393.522, H01.158.201.636.475.500, H01.158.273.343.595.475.500, H01.181.122.650.475.550, H02.403.720.500.300, N06.850.520.470
prevalence: E05.318.308.985.525.750, L01.280.975.525.750, N01.224.935.597.750, N06.850.505.400.975.525.750, N06.850.520.308.985.525.750
rural population: N01.600.725
sex distribution: I01.240.800, N01.224.803, N06.850.505.400.850
ukraine: Z01.542.248.960, Z01.586.200.960, Z01.586.950.960
continental population groups: M01.686.508
diabetes, gestational: C13.703.170, C18.452.394.750.448, C19.246.200
educational status: N01.824.196
iowa: Z01.107.567.875.510.370
maternal age: G08.686.560, N05.715.350.075.550, N06.850.490.250.550
north carolina: Z01.107.567.875.075.475, Z01.107.567.875.750.530
parity: G08.686.677, G08.686.785.760.769.472, N06.850.490.812.600
blindness: C10.597.751.941.162, C11.966.075, C23.888.592.763.941.162
magnetic resonance imaging: E01.370.350.500, E01.370.350.825.500
optic neuritis: C10.292.700.550, C11.640.576
phosphenes: F02.830.816.964.500, G11.561.600.810.964.500, G14.640.816.500
cadmium poisoning: C25.723.165
neoplasms, multiple primary: C04.651
brain diseases: C10.228.140
child behavior: F01.145.179
intelligence: F01.752.543
neurologic examination: E01.370.376.550, E01.370.600.550
visual acuity: E01.370.380.850.950, F02.463.593.932.901, G14.940
occupational medicine: H02.403.720.750.510
ussr: Z01.586.950
construction materials: J01.637.241
granuloma, foreign-body: C23.550.382.437, C26.392.560.325
sarcoidosis: C15.604.515.827
electroretinography: E01.370.380.225, E01.370.405.270
glyoxylates: D02.241.152.367
mandelic acids: D02.241.223.475, D02.241.511.536
behavior: F01.145
psychology: F04.096.628
neuropsychological tests: F04.711.513
psychometrics: F04.711.780
verbal learning: F02.463.425.952
evoked potentials, somatosensory: G07.265.500.400, G11.561.270.400
oropharynx: A04.623.603, A14.724.603
mining: J01.576.370.500
anthropometry: E01.370.600.024, E05.041, N06.850.505.200.100
echocardiography: E01.370.350.130.750, E01.370.350.850.220, E01.370.370.380.220
ultrasonography: E01.370.350.850
prognosis: E01.789
affect: F01.470.047
cognition: F02.463.188
dental amalgam: D25.339.208.291, J01.637.051.339.208.291
dental assistants: M01.526.485.067.105.250, N02.360.067.105.250
dentists: M01.526.485.330, N02.360.330
protease inhibitors: D27.505.519.389.745
retinol-binding proteins: D12.776.157.700
beta 2-microglobulin: D12.776.124.790.223.100, D12.776.377.715.182.100
aged, 80 and over: M01.060.116.100.080
carbon disulfide: D01.200.210, D01.875.350.850.074
chlorofluorocarbons, methane: D02.455.526.439.220.300, D02.455.526.510.140.300
formamides: D02.065.463, D02.241.081.420.500
anti-inflammatory agents, non-steroidal: D27.505.696.663.850.014.040.500, D27.505.954.158.030, D27.505.954.329.030
benzophenones: D02.455.426.559.389.115.124, D02.522.223
ketoprofen: D02.241.223.701.480
patch tests: E01.370.225.812.871.610, E05.200.812.871.610, E05.478.594.890.610
photosensitivity disorders: C17.800.600
sunscreening agents: D27.505.696.706.776.800, D27.505.954.444.695, D27.720.269.800, D27.720.799.763.764
new zealand: Z01.639.760.747, Z01.678.100.747
cross reactions: G12.425.143.281
dermatitis, photoallergic: C17.800.174.255.100.600, C17.800.600.325, C17.800.815.255.100.600, C20.543.418.150.600
propionates: D02.241.081.751, D10.251.400.706
radiography: E01.370.350.700
lung diseases, interstitial: C08.381.483
ion transport: G03.495.166.500
amphotericin b: D02.540.505.050
antimony sodium gluconate: D02.241.081.844.322.060, D02.241.511.902.322.060, D02.691.080, D09.811.308.060
antiprotozoal agents: D27.505.954.122.250.100
electrocardiography: E01.370.370.380.240, E01.370.405.240
leishmaniasis, visceral: C03.752.300.500.510
africa, western: Z01.058.290.190
chronic disease: C23.550.291.500
immunoglobulin e: D12.776.124.486.485.114.619.312, D12.776.124.790.651.114.619.312, D12.776.377.715.548.114.619.312
isocyanates: D02.500
radioallergosorbent test: E01.370.225.812.735.830, E05.200.812.735.830, E05.478.566.380.810, E05.478.566.639.810, E05.478.594.760.830, E05.601.495.380.810, E05.601.495.639.810
respiratory tract diseases: C08
alzheimer disease: C10.228.140.380.100, C10.574.945.249, F03.087.400.100
amyotrophic lateral sclerosis: C10.228.854.139, C10.574.562.250, C10.574.950.050, C10.668.467.250, C18.452.845.800.050
neurodegenerative diseases: C10.574
new south wales: Z01.338.480
poisson distribution: E05.318.740.994.750, G17.820.750, N05.715.360.750.750.620, N06.850.520.830.994.750
population surveillance: E05.318.308.250.700, N05.715.360.300.375.625, N06.850.520.308.250.700, N06.850.780.675
precursor cell lymphoblastic leukemia-lymphoma: C04.557.337.428.600, C15.604.515.560.600, C20.683.515.528.600
radio waves: G01.358.500.505.810, G01.750.250.810, G01.750.770.721
small-area analysis: E05.318.740.250.675, N05.715.360.750.200.750, N06.850.520.830.250.675
television: J01.897.280.500.898, L01.178.590.875, L01.178.820.090.898, L01.178.847.823
urban health: N01.400.800
allergens: D23.050.063
england: Z01.542.363.300, Z01.639.280.300
nose diseases: C08.460, C09.603
ulcer: C23.550.891
aviation: J01.937.285
myocardial ischemia: C14.280.647, C14.907.585
utah: Z01.107.567.875.760.800
diagnosis, differential: E01.171
facial dermatoses: C17.800.271
hand dermatoses: C17.800.338
neck: A01.598
pleural diseases: C08.528
pleurodesis: E02.319.694
tomography, x-ray computed: E01.370.350.350.810, E01.370.350.600.350.700.810, E01.370.350.700.700.810, E01.370.350.700.810.810, E01.370.350.825.810.810
water microbiology: H01.158.273.540.274.777, N06.850.425.450
reaction time: F02.830.650, F04.669.817, G11.561.677
styrenes: D02.455.426.559.389.150.750
electromyography: E01.370.405.255, E01.370.530.255
homicide: I01.198.240.470, I01.880.735.344
severity of illness index: E05.318.308.250.475.456.500, N05.715.360.300.375.375.364.500, N06.850.520.308.250.475.364.500
suicide: F01.145.126.980.875, I01.880.735.856
eosinophils: A11.118.637.415.345, A11.627.340.345, A15.145.229.637.415.345, A15.382.490.315.251
mast cells: A11.329.427, A15.382.652
endopeptidase k: D08.811.277.656.300.760.247, D08.811.277.656.959.350.247
research design: E05.581.500, H01.770.644.728
pilot projects: E05.318.760.750, E05.337.737, N05.715.360.775.625, N06.850.520.450.720
multicenter studies as topic: E05.318.760.535.500, E05.337.250.500, N05.715.360.775.235.545, N06.850.520.450.535.500
urticaria: C17.800.862.945, C20.543.480.904
erythema multiforme: C17.800.229.400, C17.800.865.475
california: Z01.107.567.875.580.200, Z01.107.567.875.760.200
glioma: C04.557.465.625.600.380, C04.557.470.670.380, C04.557.580.625.600.380
esophageal diseases: C06.405.117
esophagoscopy: E01.370.372.250.250.275, E01.370.388.250.250.250.260, E04.210.240.250.260, E04.800.250.250.250.260
abortion, spontaneous: C13.703.039
pregnancy outcome: E01.789.700, G08.686.785.760.769.530
stainless steel: D01.490.800.900, D01.552.033.847.681, D25.058.807.681, J01.637.051.058.807.681
welding: J01.576.370.400.900
globus pallidus: A08.186.211.730.885.287.249.487.397
parkinson disease, secondary: C10.228.140.079.862.800, C10.228.662.600.700
child day care centers: I01.880.787.293.392
fatigue: C23.888.369
glucans: D05.750.078.562, D09.698.365
sick building syndrome: C20.543.312.750, C21.223.750
sleep stages: F02.830.855.796, G11.561.600.815.754
albuterol: D02.033.100.291.057, D02.092.063.291.057, D02.092.471.683.061
occupations: N01.824.547
emphysema: C23.550.325
hazardous waste: D20.944.380, D27.888.426.500, N06.850.460.710.380
hearing disorders: C09.218.458, C10.597.751.418, C23.888.592.763.393
speech disorders: C10.597.606.150.500.800, C23.888.592.604.150.500.800
urologic diseases: C12.777, C13.351.968
phenylmercury compounds: D02.691.750.740
genes, tumor suppressor: G05.360.340.024.340.375.249, G05.360.340.024.340.415.400
communication: F01.145.209, L01.143
environmental health: H02.229
environmental microbiology: H01.158.273.540.274, N06.850.425
finland: Z01.542.267
schools: I02.233.659, I02.783
cocaine: D02.145.074.722.388, D03.132.889.354, D03.605.869.388, D04.075.080.875.099.722.388
odors: G16.500.275.640, N06.230.480
treatment outcome: E01.789.800, N04.761.559.590.800, N05.715.360.575.575.800
coccidioidomycosis: C01.703.203
sclerosis: C23.550.823
silicosis: C08.381.483.581.760, C08.381.520.702.760, C24.800.834
polyneuropathies: C10.668.829.800
railroads: J01.937.690
age of onset: N05.715.350.075.100, N06.850.490.250.100
ethnic groups: M01.686.754, N01.224.317
income: N01.824.417
electroencephalography: E01.370.376.300, E01.370.405.245
young adult: M01.060.116.815
seafood: J02.500.600.875
abortion, induced: E04.520.050
anesthesia, obstetrical: E03.155.364
bulgaria: Z01.542.248.180
attention deficit disorder with hyperactivity: F03.550.150.150
diet therapy: E02.642.249
benzoic acid: D02.241.223.100.120, D02.455.426.559.389.127.117
food coloring agents: D27.720.233.674, D27.720.368.355
food hypersensitivity: C20.543.480.370
personality assessment: F04.513
tartrazine: D02.172.950
data collection: E05.318.308, L01.280, N05.715.360.300, N06.850.520.308
fungi: B01.300
hypersensitivity, immediate: C20.543.480
memory disorders: C10.597.606.525, C23.888.592.604.529, F01.700.625
mississippi: Z01.107.567.875.750.500
movement disorders: C10.228.662
chalcones: D02.522.818.222, D03.438.150.266.450.221, D03.830.219.266.450.221
respiratory mechanics: G09.772.770.755.700
astrocytoma: C04.557.465.625.600.380.080, C04.557.470.670.380.080, C04.557.580.625.600.380.080
cerebellar neoplasms: C04.588.614.250.195.411.211, C10.228.140.211.500.200, C10.228.140.252.200, C10.551.240.250.400.300
ependymoma: C04.557.465.625.600.380.290, C04.557.470.670.380.290, C04.557.580.625.600.380.290
frontal lobe: A08.186.211.730.885.287.500.270
glioblastoma: C04.557.465.625.600.380.080.335, C04.557.470.670.380.080.335, C04.557.580.625.600.380.080.335
meningeal neoplasms: C04.588.614.250.580, C10.551.240.500
meningioma: C04.557.580.520, C04.557.645.520, C04.588.614.250.580.500, C10.551.240.500.500
neuroma, acoustic: C04.557.465.625.650.595.610, C04.557.580.600.610.595.610, C04.557.580.625.650.595.610, C04.588.614.596.240.015, C09.218.807.800.675, C09.647.675, C10.292.225.750, C10.292.910.600
occipital lobe: A08.186.211.730.885.287.500.571
oligodendroglioma: C04.557.465.625.600.380.590, C04.557.470.670.380.590, C04.557.580.625.600.380.590
parietal lobe: A08.186.211.730.885.287.500.670
telephone: L01.178.847.698
temporal lobe: A08.186.211.730.885.287.500.863
australia: Z01.338, Z01.639.100, Z01.678.100.373
amines: D02.092
germany, west: Z01.542.315.440, Z01.586.315.440
hydrocarbons, aromatic: D02.455.426.559
infant, small for gestational age: M01.060.703.520.460.560
sampling studies: E05.318.760.875, N05.715.360.775.700, N06.850.520.450.875
women's health: N01.400.900
central nervous system neoplasms: C04.588.614.250, C10.551.240
minnesota: Z01.107.567.875.350.510, Z01.107.567.875.510.510
ceruloplasmin: D08.811.682.226, D12.776.124.050.130, D12.776.124.790.106.214, D12.776.157.160, D12.776.377.715.085.214, D12.776.556.151
cockroaches: B01.050.500.131.617.140
sentinel surveillance: E05.318.308.250.700.650, E05.318.650, N05.715.360.300.375.625.650, N06.850.520.308.250.700.650, N06.850.520.699, N06.850.780.675.650
loss of heterozygosity: G05.365.590.029.530
von hippel-lindau disease: C10.562.925, C14.907.077.925
cranial nerves: A08.800.800.120
terpenes: D02.455.849
fumigation: N06.850.780.200.300
chewing gum: D05.750.078.739.249, D09.698.700.249, D20.215.721.249.249, J02.500.140.200
migraine disorders: C10.228.140.546.399.750
drug eruptions: C17.800.174.600, C20.543.206.380, C25.100.468.380
atmospheric pressure: G16.500.750.274, N06.230.300.100.185
ethylenethiourea: D02.948.898.323, D03.383.129.308.432.500
phosphoramides: D01.029.260.700.675.374.425, D01.695.625.675.650.425, D02.705.672
scandinavia: Z01.542.808
sensory thresholds: F02.463.593.710
greece: Z01.542.383, Z01.586.035.450
colorectal neoplasms: C04.588.274.476.411.307, C06.301.371.411.307, C06.405.249.411.307, C06.405.469.158.356, C06.405.469.491.307, C06.405.469.860.180
massachusetts: Z01.107.567.875.550.510
pancreatic neoplasms: C04.588.274.761, C04.588.322.475, C06.301.761, C06.689.667, C19.344.421
achievement: F01.658.059, F02.784.629.054
benchmarking: N04.452.500.150, N04.761.685.150, N04.761.700.150, N05.700.150, N05.715.360.650.150
hair: A17.360
psychological tests: F04.711
ossification of posterior longitudinal ligament: C05.116.900.480, C23.550.751.500
liver function tests: E01.370.372.460
seychelles: Z01.639.520.750
butanones: D02.522.296
cyclohexanones: D02.455.426.392.368.367.340, D02.522.400
electric wiring: E07.305.245
patient selection: E05.581.500.653, N04.590.731
agricultural workers' diseases: C24.080
conjunctivitis: C11.187.183
dermatitis, irritant: C17.800.174.255.400, C17.800.815.255.400
ecuador: Z01.107.757.362
pigmentation disorders: C17.800.621
quebec: Z01.107.567.176.791
hematologic neoplasms: C04.588.448, C15.378.400
asbestos, amosite: D01.524.500.040, D01.578.725.050.050.050, D01.578.725.500.040, D01.837.725.700.760.070.050.060, D01.837.725.700.760.535.040
asbestosis: C08.381.483.581.125, C08.381.520.702.125, C24.800.127
microscopy, electron, scanning transmission: E01.370.350.515.402.580.480, E05.595.402.580.480
rural health: N01.400.650
bone density: G11.427.100
calcium, dietary: D01.146.315
dental prosthesis: E06.780.345, E07.695.190
drug hypersensitivity: C20.543.206, C25.100.468
eyelid diseases: C11.338
lip diseases: C07.465.409
disease progression: C23.550.291.656
leukemia, myeloid: C04.557.337.539
appendicitis: C01.539.463.099, C06.405.205.099, C06.405.469.110.207
syndrome: C23.550.288.500
kidney function tests: E01.370.390.400
oryza sativa: B01.650.940.800.575.100.822.616, J02.500.200.700
electrocardiography, ambulatory: E01.370.370.380.240.230, E01.370.405.240.230, E01.370.520.500.230
monitoring, physiologic: E01.370.520
poland: Z01.542.248.679
cotinine: D03.383.773.812.180
infant, premature: M01.060.703.520.520
respiratory sounds: C23.888.852.779, E01.370.386.720, G09.772.775
ethylene glycol: D02.033.455.250.268
biopsy: E01.370.225.500.384.100, E01.370.225.998.054, E01.370.388.100, E04.074, E05.200.500.384.100, E05.200.998.054, E05.242.384.100
colonic diseases: C06.405.469.158
colonoscopy: E01.370.372.250.250.200, E01.370.388.250.250.250.160, E04.210.240.250.160, E04.800.250.250.250.160
melanosis: C17.800.621.430.530
cellular phone: L01.178.847.698.300
aerospace medicine: H02.403.029
colostrum: A12.200.194
liver diseases: C06.552
thyroid diseases: C19.874
west virginia: Z01.107.567.875.075.900, Z01.107.567.875.750.900
respiratory distress syndrome, adult: C08.381.840, C08.618.840
therapy: 
serum: A12.207.152.846, A15.145.846
quality of life: I01.800, K01.752.400.750
radiometry: E05.799
nutrition surveys: E05.318.308.250.600, E05.318.308.585.550, N05.715.360.300.375.560, N05.715.360.300.560.565, N06.850.520.308.250.600, N06.850.520.308.585.550
developed countries: I01.615.500.250
hodgkin disease: C04.557.386.355, C15.604.515.569.355, C20.683.515.761.355
lymphoma, non-hodgkin: C04.557.386.480, C15.604.515.569.480, C20.683.515.761.480
leukemia, lymphoid: C04.557.337.428, C15.604.515.560, C20.683.515.528
colombia: Z01.107.757.284
hepatitis c: C02.440.440, C02.782.350.350, C06.552.380.705.440
cheilitis: C07.465.409.215
lip: A01.456.505.631.515, A14.549.336
nephritis: C12.777.419.570, C13.351.968.419.570
paternal age: G08.686.700
phosphorus, dietary: D01.695.635
chi-square distribution: E05.318.740.994.300, G17.820.300, N05.715.360.750.750.200, N06.850.520.830.994.300
chromosomes, human, pair 7: A11.284.187.520.300.325.335, G05.360.162.520.300.325.335
chromosomes, human, pair 8: A11.284.187.520.300.325.340, G05.360.162.520.300.325.340
monosomy: C23.550.210.050.500, G05.365.590.175.050.500, G05.700.131.500
myelodysplastic syndromes: C15.378.190.625
trisomy: C23.550.210.050.750, C23.550.210.182.500, G05.365.590.175.050.750, G05.365.590.175.183.500, G05.700.131.750
asia: Z01.252
mathematical computing: L01.224.680
repetitive sequences, nucleic acid: G02.111.570.080.708, G05.360.080.708
asbestos: D01.578.725.050, D01.837.725.700.760.070
air pollution: N06.850.460.100
affective symptoms: F01.145.126.100
behavioral symptoms: F01.145.126
chlorine: D01.268.380.150, D01.362.225
electrolysis: E05.301.250
noise, occupational: N06.230.400.500, N06.850.460.610.526
task performance and analysis: F02.784.412.846, F02.784.692.746, F02.808.600
rhinitis: C08.460.799, C08.730.674, C09.603.799
intelligence tests: F04.711.141.493
new york city: Z01.107.567.875.350.530.530, Z01.107.567.875.500.530.530, Z01.433.741
trends: 
abruptio placentae: C13.703.420.078, C13.703.590.132
birth certificates: E05.318.308.940.250, L01.280.900.250, N04.452.859.132, N05.715.360.300.715.175, N06.850.520.308.940.250
birth rate: E05.318.308.985.775.500, L01.280.975.775.500, N01.224.935.849.500, N06.850.505.400.975.775.500, N06.850.520.308.985.775.500
infertility, male: C12.294.365.700
new york: Z01.107.567.875.075.437, Z01.107.567.875.350.530, Z01.107.567.875.500.530
african americans: M01.686.508.100.100, M01.686.754.100
health education: I02.233.332, N02.421.143.827.407, N02.421.726.407
hispanic americans: M01.686.754.441
anovulation: C13.351.500.056.630.050, C19.391.630.050, G08.686.785.760.690.080
menstrual cycle: G08.686.605
premenopause: G08.686.157.500.812, G08.686.785.880.249.500.812
semen: A12.200.732
sri lanka: Z01.252.245.840, Z01.639.520.875
radiation injuries: C26.733, N06.850.810.300.360
european continental ancestry group: M01.686.508.400
ethnology: I01.076.201.450.457
dental staff: M01.526.485.290, N02.360.290
michigan: Z01.107.567.875.350.500, Z01.107.567.875.510.500
aldosterone: D04.808.745.745.654.062, D06.472.040.585.353.118
postmenopause: G08.686.157.500.625, G08.686.785.880.249.500.625
manufactured materials: J01.637
utilization: 
ganglioglioma: C04.557.465.625.600.380.350, C04.557.470.670.380.350, C04.557.580.625.600.380.350
wisconsin: Z01.107.567.875.350.900, Z01.107.567.875.510.900
asperger syndrome: F03.550.325.100
autistic disorder: F03.550.325.125
child development disorders, pervasive: F03.550.325
ethylmercuric chloride: D02.691.750.100.347.417
immunization: E02.095.465.425.400, E05.478.550, N02.421.726.758.310, N06.850.780.200.425, N06.850.780.680.310
immunization schedule: E02.095.465.425.400.470, E05.478.550.545
measles-mumps-rubella vaccine: D20.215.894.815.500, D20.215.894.899.390, D20.215.894.899.404.500, D20.215.894.899.488.500, D20.215.894.899.779.500
thimerosal: D02.691.750.100.347.850
surgery: 
succimer: D02.241.081.337.759.500, D02.886.489.750
unithiol: D02.886.489.180.900
developmental disabilities: F03.550.362
diphtheria-tetanus-pertussis vaccine: D20.215.894.135.300, D20.215.894.135.535.300, D20.215.894.691.263.300, D20.215.894.691.824.300, D20.215.894.815.300
haemophilus vaccines: D20.215.894.135.450
vaccination: E02.095.465.425.400.530.890, E05.478.550.600.890, N02.421.726.758.310.890, N06.850.780.200.425.900, N06.850.780.680.310.890
food habits: F01.145.407.432, F01.145.466.349
mexico: Z01.107.567.589
motor skills: F02.808.260
hla-dp antigens: D12.776.395.550.509.400.420, D12.776.543.550.423.400.420, D23.050.301.500.400.400.420, D23.050.301.500.450.400.420, D23.050.705.552.410.400.420, D23.050.705.552.450.400.420
hla-dp beta-chains: D12.776.395.550.509.400.420.750, D12.776.543.550.423.400.420.750, D23.050.301.500.400.400.420.750, D23.050.301.500.450.400.420.750, D23.050.705.552.410.400.420.750, D23.050.705.552.450.400.420.750
hla-dr antigens: D12.776.395.550.509.400.440, D12.776.543.550.423.400.440, D23.050.301.500.400.400.440, D23.050.301.500.450.400.440, D23.050.705.552.410.400.440, D23.050.705.552.450.400.440
hla-drb1 chains: D12.776.395.550.509.400.440.200.010, D12.776.543.550.423.400.440.200.010, D23.050.301.500.400.400.440.200.010, D23.050.301.500.450.400.440.333.500, D23.050.705.552.410.400.440.200.010, D23.050.705.552.450.400.440.333.500
haplotypes: G05.380.360
peripheral nervous system: A08.800
image interpretation, computer-assisted: E01.158.600, E01.370.350.350, L01.700.508.100.158.600
lead poisoning: C25.723.589
arthralgia: C05.550.091, C23.888.646.130, F02.830.816.444.350, G11.561.600.810.444.350
chelation therapy: E02.319.155
prosthesis failure: C23.550.767.865, E05.325.771
reoperation: E04.690
vision disorders: C10.597.751.941, C11.966, C23.888.592.763.941
metaplasia: C23.550.589
nasopharyngeal neoplasms: C04.588.443.665.710.650, C07.550.350.650, C07.550.745.650, C09.647.710.650, C09.775.350.650, C09.775.549.650
ulnar nerve: A08.800.800.720.050.850
spouses: F01.829.263.500.660, I01.880.225.500.670, M01.816
brazil: Z01.107.757.176
autoantibodies: D12.776.124.486.485.114.323, D12.776.124.790.651.114.323, D12.776.377.715.548.114.323
idaho: Z01.107.567.875.560.380
infant, low birth weight: M01.060.703.520.460
neonatal screening: E01.370.225.910, E01.370.500.580, E05.200.910, E05.318.308.250.580.580, N02.421.143.827.233.443.816, N05.715.360.300.375.500.575, N06.850.520.308.250.580.580, N06.850.780.500.580
premature birth: C13.703.420.491.500
asian continental ancestry group: M01.686.508.200
fractures, bone: C26.404
osteoporosis: C05.116.198.579
life style: F01.829.458
diffusion magnetic resonance imaging: E01.370.350.500.150, E01.370.350.825.500.150
single-blind method: E05.318.780.850, N05.715.360.780.730, N06.850.520.445.850
nitrogen dioxide: D01.362.635.600, D01.625.550.525, D01.650.550.587.625
brca2 protein: D12.776.313.249, D12.776.624.776.101, D12.776.660.105
connecticut: Z01.107.567.875.550.200
lymphoma, follicular: C04.557.386.480.350, C15.604.515.569.480.350, C20.683.515.761.480.350
lymphoma, large b-cell, diffuse: C04.557.386.480.150.585, C15.604.515.569.480.150.585, C20.683.515.761.480.150.585
polymorphism, single nucleotide: G05.365.795.598
employment: N01.824.245
job description: N04.452.677.410
caudate nucleus: A08.186.211.730.885.287.249.487.550.184
radionuclide imaging: E01.370.350.710, E01.370.384.730
dihydroxyphenylalanine: D02.092.311.200, D12.125.072.050.685.400, D12.125.072.050.875.130
end stage liver disease: C06.552.308.500.177
hepatitis b: C02.256.430.400, C02.440.435, C06.552.380.705.437
liver cirrhosis, alcoholic: C06.552.630.380, C06.552.645.590, C25.775.100.087.645.550
putamen: A08.186.211.730.885.287.249.487.550.784
radiopharmaceuticals: D27.505.259.843, D27.505.519.871, D27.720.470.410.650
sperm tail: A05.360.490.890.840, A11.284.180.290.835, A11.497.760.500
folic acid: D03.438.733.631.400
folic acid deficiency: C18.654.521.500.133.699.308
homocysteine: D02.886.030.498, D12.125.166.498
arterioles: A07.231.114.060, A07.231.461.080
laser-doppler flowmetry: E01.370.370.475, E05.830.500
coffee: D20.215.784.249, J02.200.325
diterpenes: D02.455.849.291
depression: F01.145.126.350
corpus callosum: A08.186.211.730.885.362
metabolic diseases: C18.452
hemolysin proteins: D12.776.543.695.444
emigrants and immigrants: M01.189
west indies: Z01.107.084.900, Z01.639.880
carbohydrates: D09
belgium: Z01.542.115
baltimore: Z01.107.567.875.500.500.100, Z01.433.100
connective tissue: A10.165
femur head necrosis: C05.116.852.175, C23.550.717.732.368
granuloma, plasma cell: C23.550.382.875
prosthesis-related infections: C01.539.685, C23.550.767.868
functional laterality: F02.830.297.425, G11.561.225.425
mental disorders: F03
self concept: F01.752.747.792
monte carlo method: E05.318.740.525, L01.906.575.422, N05.715.360.750.540, N06.850.520.830.525
neoplasms, hormone-dependent: C04.626
netherlands: Z01.542.651
absorptiometry, photon: E01.370.350.700.024, E05.196.712.224.187
menopause: G08.686.157.500, G08.686.785.880.249.500
femur head: A02.835.232.043.650.247.343
hip dislocation: C26.289.384, C26.531.500
polyethylene: D02.455.326.271.665.550.500, D05.750.716.507.500, D25.720.716.507.500, J01.637.051.720.716.507.500
prosthesis fitting: E02.794
range of motion, articular: E01.370.600.700, G11.427.760
solid phase extraction: E05.196.155.800
cooking: J01.576.423.200.200
slovenia: Z01.542.248.820, Z01.586.980.820
uterine cervical neoplasms: C04.588.945.418.948.850, C13.351.500.852.593.131, C13.351.500.852.762.850, C13.351.937.418.875.850
alabama: Z01.107.567.875.075.100, Z01.107.567.875.750.100
episode of care: E02.760.300, N02.421.585.300
fluorides: D01.248.497.158.380, D01.303.350.300
petroleum pollution: N06.850.460.660
demography: I01.240, N01.224, N06.850.505.400
urban population: N01.600.900
vietnam: Z01.252.145.945
paint: J01.637.597
parkinsonian disorders: C10.228.140.079.862, C10.228.662.600
effect modifier, epidemiologic: N05.715.350.350, N06.850.490.734
psychomotor disorders: C10.597.606.881, C23.888.592.604.882, F01.700.875
hemiterpenes: D02.455.849.486
pentanes: D02.455.326.146.770
europe: Z01.542
diphtheria toxoid: D20.215.894.691.263
immune tolerance: G12.425.746.425
immunity, humoral: G12.450.050.420
tetanus toxoid: D20.215.894.691.824
mongolia: Z01.252.474.651
cognition disorders: F03.087.250
headache: C10.597.617.470, C23.888.592.612.441, C23.888.646.487
sleep disorders: C10.886, C23.888.592.796, F03.870
african continental ancestry group: M01.686.508.100
dominican republic: Z01.107.084.900.300, Z01.639.880.300
poverty: I01.880.735.634, I01.880.840.535, N01.824.600
history: K01.400
comorbidity: N05.715.350.225, N06.850.490.687
history, 20th century: K01.400.504.968
beverages: J02.200
sucrose: D09.698.629.305.770
ultrasonography, prenatal: E01.370.350.850.865, E01.370.378.630.865
fixatives: D27.720.355
funeral rites: I01.076.201.450.550
kidney transplantation: E02.870.500, E04.936.450.485, E04.950.774.400
living donors: M01.898.656
fever: C23.888.119.344
heart septal defects, ventricular: C14.240.400.560.540, C14.280.400.560.540, C16.131.240.400.560.540
child development: F01.525.200, G07.700.320.374.750
meconium: A12.459.529, A16.378.529
new jersey: Z01.107.567.875.500.525
waist circumference: E01.370.600.115.100.160.560, E05.041.124.160.875, G07.100.100.160.560
giant cells: A11.500
radiation protection: N06.850.810.425
whole-body counting: E05.799.950
child behavior disorders: F03.550.300
mental recall: F02.463.425.540.641
health behavior: F01.145.488
protective clothing: E07.700.600, J01.637.215.600, J01.637.708.600
texas: Z01.107.567.875.760.750
akinetic mutism: C10.228.140.042
fatal outcome: E05.318.308.985.550.325, L01.280.975.550.325, N01.224.935.698.201, N06.850.505.400.975.550.325, N06.850.520.308.985.550.325
leukocytosis: C15.378.553.475, C23.550.526
bronchiolitis obliterans: C08.127.446.135.140, C08.381.495.146.135.140
joint diseases: C05.550
ointments: D26.255.640, D27.720.280.640
anatomy: H01.158.100
bronchoconstriction: G09.772.770.755.700.080
students, medical: I02.851.686.602, M01.848.769.602
confusion: C10.597.606.337, C23.888.592.604.339, F01.700.250
kidney failure, chronic: C12.777.419.780.750.500, C13.351.968.419.780.750.500
renal dialysis: E02.870.300, E02.912.800
radiation, nonionizing: G01.750.770
hepatitis: C06.552.380
nonprescription drugs: D26.530
reproductive history: E01.370.510.700, N05.715.350.575, N06.850.490.812
military personnel: M01.526.625
hydronephrosis: C12.777.419.307, C13.351.968.419.307
ureteral calculi: C12.777.725.938.500, C12.777.967.374.500, C12.777.967.500.851, C13.351.968.725.938.500, C13.351.968.967.374.500, C13.351.968.967.500.851, C23.300.175.850.750
ureteroscopy: E01.370.388.250.920, E01.370.390.800, E04.800.250.920, E04.950.774.840
alveolitis, extrinsic allergic: C08.381.483.125, C08.674.055, C20.543.480.680.075
biopsy, needle: E01.370.225.500.384.100.119, E01.370.225.998.054.119, E01.370.388.100.100, E04.074.119, E04.665.100, E05.200.500.384.100.119, E05.200.998.054.119, E05.242.384.100.119
volatile organic compounds: D02.974
natriuresis: G08.852.796.241.557
head and neck neoplasms: C04.588.443
south africa: Z01.058.290.175.735
forearm: A01.378.800.585
cellulose: D05.750.078.562.180, D09.698.365.180, D25.720.099.500, J01.637.051.720.099.500
costa rica: Z01.107.169.238
respiration disorders: C08.618
naphthols: D02.455.426.559.847.638.638, D04.615.638.638
peak expiratory flow rate: E01.370.386.700.660.225.600, G09.772.650.300.790
cd4 lymphocyte count: E01.370.225.500.195.107.595.500.150, E01.370.225.625.107.595.500.150, E05.200.500.195.107.595.500.150, E05.200.625.107.595.500.150, E05.242.195.107.595.500.150, G04.170.107.595.500.150, G09.188.105.595.500.150
bleaching agents: D27.720.642.315
family: F01.829.263, I01.880.225
skin pigmentation: E01.370.600.620.750, G13.750.829.833, G16.690.890
endometrial neoplasms: C04.588.945.418.948.585, C13.351.500.852.762.200, C13.351.937.418.875.200
diet, vegetarian: E02.642.249.300, G07.610.240.300
hong kong: Z01.252.474.164.450
uteroglobin: D12.776.861.500
flavoring agents: D27.720.364, J02.500.512.400
food industry: J01.576.423
scalp: A01.456.810
dermatitis, contact: C17.800.174.255, C17.800.815.255
lidocaine: D02.065.199.092.500
prilocaine: D02.065.199.750
gels: D20.280.320, D26.255.165.320, D27.720.280.165.320
baths: E02.056.110, E02.779.249.110
acrodynia: C10.668.829.025, C10.720.475.600.150, C25.723.647.500.100
antidotes: D27.505.696.706.037, D27.720.799.037
penicillamine: D02.886.030.786, D12.125.166.786
georgia: Z01.107.567.875.075.250, Z01.107.567.875.750.370
body height: E01.370.600.115.100.160.100, E05.041.124.160.500, G07.100.100.160.100, G07.700.320.249.314.100
obstetric labor, premature: C13.703.420.491
carbon monoxide poisoning: C25.723.455.245
cough: C08.618.248, C23.888.852.293
dizziness: C10.597.751.237, C23.888.592.763.237
nursing assessment: N04.590.233.508.480
patient care planning: N04.590.233.624
school nursing: H02.478.676.824, N02.421.143.827.809.742, N02.421.726.809.742
education: I02
analgesics, non-narcotic: D27.505.696.663.850.014.040, D27.505.954.427.040.100
indians, south american: M01.686.508.150.625
paper: J01.576.154.600, J01.637.650
dermatitis: C17.800.174
lung diseases, obstructive: C08.381.495
pre-eclampsia: C13.703.395.249
porosity: G01.374.710
databases, factual: L01.470.750.750, L01.700.508.300.188.400
antineoplastic combined chemotherapy protocols: E02.183.750.500, E02.319.077.500, E02.319.310.037
breast neoplasms, male: C04.588.180.260, C17.800.090.500.260
hypokalemia: C18.452.950.565
cholestasis: C06.130.120.135
fat emulsions, intravenous: D26.255.165.260.270, D26.776.708.733.500, D27.505.954.578.733.500, D27.720.280.775.733.500
infant, premature, diseases: C16.614.521
intensive care units, neonatal: N02.278.388.493.390.380
parenteral nutrition, total: E02.421.505.575, E02.642.500.505.750
mothers: F01.829.263.500.320.200, I01.880.225.500.340.270, M01.620.630
great britain: Z01.542.363, Z01.639.280
breech presentation: C13.703.420.183, G08.686.520.150, G08.686.785.760.769.326.520.150
causality: N05.715.350.200, N06.850.490.625
cesarean section: E04.520.252.500
labor, obstetric: G08.686.785.760.769.326
obstetric labor complications: C13.703.420
boron: D01.268.108, D01.268.513.500
body fat distribution: E01.370.600.115.100.062, G02.111.097.134, G03.180.134, G07.100.049.134
outcome assessment (health care): H01.770.644.145.431, N04.761.559.590, N05.715.360.575.575
analgesics, opioid: D27.505.696.277.600.500, D27.505.696.663.850.014.760.500, D27.505.954.427.040.550.500, D27.505.954.427.210.600.500
cyclohexanecarboxylic acids: D02.241.223.268, D02.455.426.392.368.367.218
pain: C10.597.617, C23.888.592.612, C23.888.646, F02.830.816.444, G11.561.600.810.444
tramadol: D02.033.480.300.802, D02.092.668.387.750
acetic acid: D02.241.081.018.165, D10.251.400.045.500
nitrogen oxides: D01.362.635, D01.625.550, D01.650.550.587
sulfur dioxide: D01.362.810, D01.650.550.850.925, D01.875.825.925
missouri: Z01.107.567.875.510.515
multiple sclerosis: C10.114.375.500, C10.314.350.500, C20.111.258.250.500
anemia, neonatal: C15.378.071.363, C16.614.053
blood safety: E02.792.833.230.500, E05.760.833.230.500, N06.850.780.200.450.325
blood transfusion: E02.095.135
infant, extremely low birth weight: M01.060.703.520.460.600.500
respiratory tract neoplasms: C04.588.894.797, C08.785
hospitals, teaching: N02.278.020.300, N02.278.421.639
nigeria: Z01.058.290.190.565
nutrition assessment: E05.318.308.585, N05.715.360.300.560, N06.850.505.557, N06.850.520.308.585
optic nerve diseases: C10.292.700, C11.640
tanzania: Z01.058.290.120.840
vitamin b 12: D03.383.129.578.840.437.777, D03.549.909.437.777, D04.345.783.437.777
insurance, physician services: N03.219.521.576.343.616
regression (psychology): F01.393.784
pica: F03.375.600, F03.550.400.600
food-processing industry: J01.576.423.200.400
gastritis, atrophic: C06.405.205.697.394, C06.405.748.398.394
interviews as topic: E05.318.308.420, L01.280.520, N05.715.360.300.400, N06.850.520.308.420
coma: C10.597.606.358.800.200, C23.888.592.604.359.800.200
pennsylvania: Z01.107.567.875.075.550, Z01.107.567.875.350.550, Z01.107.567.875.500.550
basal ganglia diseases: C10.228.140.079
sterilization, reproductive: E02.875.194.910, E04.950.599
4-butyrolactone: D02.540.150, D03.383.312.150
lignans: D02.455.426.559.389.140.450
genetic variation: G05.365
awareness: F02.463.188.150
iran: Z01.252.245.500.350, Z01.586.500.350
french guiana: Z01.107.757.435
vision, ocular: F02.830.816.964, G02.111.087.800.480.900, G02.149.115.800.480.900, G04.299.880.480.900, G11.561.600.810.964, G14.640.816
switzerland: Z01.542.883
heroin: D03.132.577.249.562.445, D03.549.686.607.490, D03.605.497.607.490, D04.615.723.795.576.445
national institutes of health (u.s.): I01.409.137.500.600.480, N03.540.348.500.500.600.480
organization &amp; administration: 
publication bias: L01.737.813
exercise: G11.427.590.530.698.277, I03.350
vegetables: B01.650.510.956, J02.500.850
adenocarcinoma, clear cell: C04.557.470.200.025.045
adenocarcinoma, mucinous: C04.557.470.200.025.075, C04.557.470.590.075
carcinoma, endometrioid: C04.557.470.200.025.240, C04.588.945.418.948.585.124, C13.351.500.056.630.705.331, C13.351.937.418.685.331, C13.351.937.418.875.200.124, C19.391.630.705.331
cystadenocarcinoma, serous: C04.557.470.200.025.480.240, C04.557.470.590.480.240
colorado: Z01.107.567.875.760.210
international classification of diseases: L01.453.245.945.400
administrative personnel: M01.526.070
food services: J01.576.423.500
guideline adherence: N04.761.337, N05.715.360.395
child welfare: I01.880.787.293
ethylmercury compounds: D02.691.750.100.347
evidence-based medicine: H02.249.750, H02.403.200.400
hepatitis b vaccines: D20.215.894.899.955.400
vaccines: D20.215.894
boston: Z01.107.567.875.550.510.210, Z01.433.210
spirometry: E01.370.386.700.750
databases as topic: L01.470.750, L01.700.508.300.188
bedding and linens: E07.325.137, J01.494.221
heating: N06.230.150.300
tissue donors: M01.898
world health: N01.400.910
color vision: F02.830.816.964.124, G11.561.600.810.964.124, G14.640.816.124
postpartum period: G08.686.702
mexican americans: M01.686.754.441.500
laryngeal neoplasms: C04.588.443.665.481, C08.360.369, C08.785.481, C09.400.369, C09.647.481
rubber: D25.720.099.750, D25.720.327.840, J01.637.051.720.099.750, J01.637.051.720.327.840, J01.637.412.767
textile industry: J01.576.885
wood: A18.700.888, J01.637.241.900
cacao: B01.650.940.800.575.100.915.144
candy: J02.500.140
prehypertension: C14.907.653
pakistan: Z01.252.245.723
hyperhidrosis: C17.800.946.350
neuralgia: C10.597.617.682, C10.668.829.600, C23.888.592.612.664, C23.888.646.508
siblings: F01.829.263.500.490, I01.880.225.500.505, M01.781
marriage: F01.829.263.315.500.500, I01.240.361.500.500, I01.880.225.423.500.500, N01.224.361.500.500, N01.824.308.500.500
medical records: E05.318.308.940.968, L01.280.900.968, N04.452.859.564, N05.715.360.300.715.500, N06.850.520.308.940.968
sample size: E05.318.780.762, E05.581.500.902, N05.715.360.780.692, N06.850.520.445.762
gout: C05.550.114.423, C05.799.414, C16.320.565.798.368, C18.452.648.798.368
safety: N06.850.135.060.075
climate: G16.500.275.071, N06.230.300.100.250
students: I02.233.748, I02.851, M01.848
adhesives: D27.720.013, J01.637.016
breast feeding: F01.145.407.199, G07.610.220.500.500, G07.610.593.185, G07.700.620.185
child health services: N02.421.143.130
social work: I01.880.792, N02.421.849
adrenergic fibers: A08.663.542.075
angiotensinogen: D12.644.456.073.070, D12.644.822.750.020, D12.644.861.020, D12.776.645.750.020, D12.776.811.070, D12.776.872.020
genetic association studies: E05.393.385
kallikreins: D08.811.277.656.300.760.442, D08.811.277.656.959.350.442, D12.776.124.125.597, D23.119.597
linkage disequilibrium: G05.540.500
receptors, adrenergic, beta-2: D12.776.543.750.070.300.300.340.725, D12.776.543.750.100.150.300.340.725, D12.776.543.750.720.300.300.300.340.200
tachycardia: C14.280.067.845, C23.550.073.845
autonomic nervous system: A08.800.050
posture: G11.427.695
tilt-table test: E01.370.370.750
analgesia, epidural: E03.091.080
analgesia, obstetrical: E03.091.110
dysarthria: C10.597.606.150.500.800.150.200, C23.888.592.604.150.500.800.150.200
fluid therapy: E02.319.360
nausea: C23.888.821.712
street drugs: D26.878
substance-related disorders: C25.775, F03.900
virus diseases: C02
transmission: 
spectrum analysis: E05.196.867
capsules: D26.255.150, D27.720.280.150
meglumine: D02.033.800.813.550, D09.067.342.600, D09.853.813.550
poisons: D27.720.777, D27.888.569.612
asthma, occupational: C08.127.108.495, C08.674.095.495, C20.543.480.680.095.495, C24.102
phenylenediamines: D02.092.146.651, D02.092.782.258.651
polyurethanes: D02.241.081.251.944.750, D05.750.716.650, D25.720.327.782, D25.720.716.650, J01.637.051.720.327.782, J01.637.051.720.716.650, J01.637.412.700
dermatitis, atopic: C16.320.850.210, C17.800.174.193, C17.800.815.193, C17.800.827.210, C20.543.480.343
photons: G01.249.705, G01.358.500.505.650.782, G01.590.540.782, G01.750.250.650.782, G01.750.770.578.782
psoriasis: C17.800.859.675
surgical tape: E07.858.690.800
water loss, insensible: G02.111.635.500.750, G03.615.500.750, G07.700.345.810.500.750
organotechnetium compounds: D02.691.825
tomography, emission-computed, single-photon: E01.370.350.350.800.800, E01.370.350.600.350.800.800, E01.370.350.710.800.800, E01.370.350.825.800.800, E01.370.384.730.800.800
tropanes: D02.145.074.722, D03.132.889, D03.605.869, D04.075.080.875.099.722
hand: A01.378.800.667
hand disinfection: N06.850.780.200.412.500
potassium, dietary: D01.745.660
diskectomy: E04.555.200
intervertebral disc: A02.165.308.410, A02.835.232.834.432
intervertebral disc degeneration: C05.116.900.153
joint prosthesis: E07.695.400
lumbar vertebrae: A02.835.232.834.519
prosthesis implantation: E04.650
overweight: C23.888.144.699, E01.370.600.115.100.160.120.699, G07.100.100.160.120.699
videotape recording: J01.897.280.500.846.734, J01.897.280.500.898.840, L01.178.590.875.840, L01.178.820.090.846.734, L01.178.820.090.898.840, L01.240.940.840, L01.240.960.880
blood circulation: G09.330.190.163
constipation: C23.888.821.150
laxatives: D27.505.954.483.620
sigmoid diseases: C06.405.469.158.850
fracture fixation, internal: E04.555.300.300
internal fixators: E07.695.350, E07.858.442.660.460, E07.858.690.650.460
postoperative complications: C23.550.767
health status indicators: E05.318.308.250.475, N05.715.360.300.375.375, N06.850.520.308.250.475
false negative reactions: E01.354.340
vibration: G01.374.676.930, G01.595.540.930
laundering: J01.576.549
meta-analysis as topic: E05.318.780.500, E05.581.500.501, N05.715.360.780.515, N06.850.520.445.500
semen analysis: E01.370.225.992, E05.200.992
anesthetics: D27.505.696.277.100, D27.505.954.427.210.100
chlordecone: D02.455.526.439.190
contraceptives, oral, hormonal: D27.505.696.875.360.276.210.277, D27.505.954.705.360.276.210.277
mood disorders: F03.600
psychiatric status rating scales: F04.586
diphtheria-tetanus vaccine: D20.215.894.135.310, D20.215.894.691.263.310, D20.215.894.691.824.310, D20.215.894.815.320
language disorders: C10.597.606.150.500, C23.888.592.604.150.500
tics: C10.597.350.700, C23.888.592.350.700
family health: N01.400.300
penicillium: B01.300.381.662
carbonated beverages: J02.200.300
amenorrhea: C23.550.568.500
menstruation disturbances: C23.550.568
occupational health: N01.400.525
infant, newborn, diseases: C16.614
public health: H02.403.720, N01.400.550, N06.850
turkey: Z01.252.245.500.850, Z01.586.500.850
rh-hr blood-group system: D23.050.301.290.775, D23.050.705.230.775
rho(d) immune globulin: D12.776.124.486.485.114.619.393.700, D12.776.124.790.651.114.619.393.700, D12.776.377.715.548.114.619.393.700
cytogenetic analysis: E01.370.225.500.385, E05.200.500.385, E05.242.385, E05.393.285
foreign-body reaction: C23.550.470.251, C26.392.560
public health practice: N06.850.780
louisiana: Z01.107.567.875.750.480
mouth neoplasms: C04.588.443.591, C07.465.565
anti-infective agents, urinary: D27.505.954.122.237, D27.505.954.613.056
observation: E05.581.249
amniocentesis: E01.370.225.500.384.050, E01.370.225.998.329.309, E01.370.378.630.050, E04.665.600.309, E05.200.500.384.050, E05.200.998.329.309, E05.242.384.050
environmental illness: C20.543.312, C21.223
mycoses: C01.703
microscopy, polarization: E01.370.350.515.624, E05.595.624
pulmonary embolism: C08.381.746, C14.907.355.350.700
heart failure: C14.280.434
blood coagulation disorders: C15.378.100
anaphylaxis: C20.543.480.099
eclampsia: C13.703.395.124
history, 19th century: K01.400.504.937
wales: Z01.542.363.914, Z01.639.280.914
casts, surgical: E07.858.442.660.414, E07.858.690.650.414
orthopedic equipment: E07.858.442
intrauterine devices: E07.190.250.520
intrauterine devices, copper: E07.190.250.520.520.300
menorrhagia: C13.351.500.852.691.449, C23.550.568.875
gastrointestinal diseases: C06.405
water-electrolyte imbalance: C18.452.950
relative biological effectiveness: N06.850.810.250.275
developing countries: I01.615.500.300
geographic information systems: L01.470.750.750.462, L01.700.508.300.314
medicare: N03.219.521.346.506.564.663, N03.219.521.576.343.840, N03.706.615.696
multiple pulmonary nodules: C04.588.894.797.520.237, C08.381.540.148, C08.785.520.148
pneumoconiosis: C08.381.483.581, C08.381.520.702, C24.800
pulmonary artery: A07.231.114.715
morbidity: E05.318.308.985.525, L01.280.975.525, N01.224.935.597, N06.850.505.400.975.525, N06.850.520.308.985.525
glass: J01.637.241.400, J01.637.437
eosinophilia: C15.378.553.231
sputum: A12.200.808
cannabis: B01.650.940.800.575.100.175.500
wechsler scales: F04.711.141.493.822
allyl compounds: D02.455.326.271.122
death certificates: E05.318.308.940.350, L01.280.900.350, N04.452.859.264, N05.715.360.300.715.315, N06.850.520.308.940.350
wakefulness: F02.830.104.821, G11.561.600.042.738
brain damage, chronic: C10.228.140.140
expert testimony: I01.880.604.583.232, N03.706.535.253
legislation &amp; jurisprudence: 
liability, legal: I01.880.604.583.490, N03.706.535.547
coal mining: J01.576.370.500.500
cyanates: D02.262
disability evaluation: E01.370.400
orthopedics: H02.403.810.494
appendectomy: E04.210.078
diagnostic errors: E01.354, N02.421.450.280
breath tests: E01.370.100
least-squares analysis: E05.318.740.750.400, N05.715.360.750.695.440, N06.850.520.830.750.400
spectrum analysis, raman: E05.196.822.860, E05.196.867.890
von hippel-lindau tumor suppressor protein: D08.811.464.938.750.875, D12.776.624.776.865
pneumothorax: C08.528.778
national cancer institute (u.s.): I01.409.137.500.600.480.150, N03.540.348.500.500.600.480.150
reference standards: E05.978.808
activation analysis: E05.196.039
faculty, medical: I02.463.373, M01.526.339.373, M01.526.485.375, N02.360.375
maximal midexpiratory flow rate: E01.370.386.700.660.225.510, G09.772.650.300.670
schools, medical: I02.783.660.552, N02.278.020.578
lighting: N06.230.150.410
color perception: F02.463.593.932.217
bone cements: D05.750.716.822.300, D25.720.716.822.300, D27.720.102.158, J01.637.051.720.716.822.300
gingival neoplasms: C04.588.443.591.402, C07.465.565.402, C07.465.714.258.409
histiocytoma, benign fibrous: C04.557.450.565.590.425.350
neoplasms, second primary: C04.692
mass screening: E01.370.500, E05.318.308.250.580, N02.421.143.827.233.443, N02.421.726.233.443, N05.715.360.300.375.500, N06.850.520.308.250.580, N06.850.780.500
southeastern united states: Z01.107.567.875.750
veterans: M01.930
pattern recognition, visual: F02.463.593.524.500, F02.463.593.932.622, F02.463.593.932.869.435.673
national institute for occupational safety and health (u.s.): I01.409.137.500.600.650.225.520, N03.540.348.500.500.600.650.225.520
chondroitin sulfates: D09.698.373.200.300
g(m1) ganglioside: D09.400.410.420.025.475.390, D10.390.470.025.475.390, D10.570.877.360.025.475.390
immunoglobulin a: D12.776.124.486.485.114.619.026, D12.776.124.790.651.114.619.026, D12.776.377.715.548.114.619.026
myelin proteins: D12.776.543.620, D12.776.641.580
neurofilament proteins: D05.750.078.593.630, D12.776.220.475.630, D12.776.641.630
sulfoglycosphingolipids: D09.400.410.420.025.837, D10.390.470.025.837, D10.570.877.360.025.837
mouth mucosa: A10.615.550.599, A14.549.512
dimethyldithiocarbamate: D02.241.081.251.869.210, D02.886.706.175
carbolines: D03.383.725.150, D03.438.473.155, D03.494.154
halogens: D01.268.380
chromosomes, human, pair 18: A11.284.187.520.300.415.430, G05.360.162.520.300.415.430
dna probes: D13.444.600.223, D27.505.259.750.600.223, D27.720.470.530.600.223
sex chromosomes: A11.284.187.865, G05.360.162.865
inhibition (psychology): F01.145.544, F02.463.425.475, F02.739.794.405
inuits: M01.686.508.150.675, M01.686.754.520
electronic waste: N06.850.460.710.189
electronics: H01.671.293
furosemide: D02.065.884.725.300, D02.092.146.807.300, D02.886.590.700.725.300
hypokinesia: C10.597.350.400, C23.888.592.350.400
paraparesis, spastic: C10.597.636.500.500, C23.888.592.643.500.500
motor skills disorders: F03.550.650
polonium: D01.268.185.600, D01.268.271.680, D01.268.513.875
supranuclear palsy, progressive: C10.228.140.079.882, C10.228.662.700, C10.292.562.750.500, C10.574.945.500, C10.597.622.447.690, C11.590.472.500, C23.888.592.636.447.690
prostatic neoplasms: C04.588.945.440.770, C12.294.260.750, C12.294.565.625, C12.758.409.750
radiation: G01.750
personality inventory: F04.711.647.513
carbidopa: D02.092.311.200.538.200, D02.442.200
milk hypersensitivity: C20.543.480.370.500
theophylline: D03.132.960.751, D03.438.759.758.824.751
heart arrest: C14.280.383
intraoperative complications: C23.550.505
glaucoma: C11.525.381
coated materials, biocompatible: D25.130.420, J01.637.051.130.420
suture techniques: E04.987.775
sutures: E07.858.690.820
travel: I03.883
audiometry, pure-tone: E01.370.382.375.060.055
auditory perception: F02.463.593.071
hearing loss, sensorineural: C09.218.458.341.887, C10.597.751.418.341.887, C23.888.592.763.393.341.887
time perception: F02.463.593.857
psychophysiologic disorders: C23.888.592.700
cephalometry: E01.370.600.024.250, E05.041.250, N06.850.505.200.100.300
gait disorders, neurologic: C10.597.404, C23.888.592.413
choice behavior: F02.463.785.373.346
dental auxiliaries: M01.526.485.067.105, N02.360.067.105
dentistry: E06, H02.163
dentists, women: M01.526.485.330.310, M01.975.310, N02.360.330.310
food preservation: J01.576.423.850.700
aspirin: D02.455.426.559.389.657.410.595.176
urination: G08.852.796.877
diamond: D01.268.150.200
medical history taking: E01.370.510
nasal lavage fluid: E05.927.573.500
nasal provocation tests: E01.370.386.550
antibodies, bacterial: D12.776.124.486.485.114.107, D12.776.124.790.651.114.125, D12.776.377.715.548.114.125
pulmonary edema: C08.381.742
health promotion: N02.370, N02.421.726.507
patient compliance: F01.145.488.500, N05.300.150.600.600
potassium deficiency: C18.654.521.500.617
recurrence: C23.550.291.937
spinal cord diseases: C10.228.854
leukemia, myelogenous, chronic, bcr-abl positive: C04.557.337.539.250, C15.378.190.636.370
lymphoproliferative disorders: C15.604.515, C20.683.515
aminobutyrates: D02.241.081.114.500, D12.125.190
food, genetically modified: J02.500.518
phosphoric acids: D01.029.260.700.675, D01.695.625.675
phenothiazines: D02.886.369, D03.494.741
electromagnetic radiation: G01.358.500.505, G01.750.250
stillbirth: G08.686.785.760.769.530.500
foot: A01.378.610.250
polynesia: Z01.639.760.815
tobacco, smokeless: J01.637.836.500
arylamine n-acetyltransferase: D08.811.913.050.134.138
neoplasm invasiveness: C04.697.645, C23.550.727.645
new hampshire: Z01.107.567.875.550.580
adverse drug reaction reporting systems: E05.337.800.120, L01.453.270.120, N02.421.668.320.120
diphtheria-tetanus-acellular pertussis vaccines: D20.215.894.135.290, D20.215.894.135.535.295, D20.215.894.691.263.290, D20.215.894.691.824.290, D20.215.894.815.149, D20.215.894.860.900.267
united states food and drug administration: I01.409.137.500.600.650.760, N03.540.348.500.500.600.650.760
diterpenes, abietane: D02.455.426.559.847.723.590, D02.455.849.291.206, D04.615.723.590
bithionol: D02.455.426.559.389.657.120
salicylanilides: D02.065.199.860, D02.065.793.650
psychotic disorders: F03.700.675
minority groups: I01.880.371
manpower: 
dichlorodiphenyldichloroethane: D02.455.526.439.294
radial artery: A07.231.114.740
vascular stiffness: G09.330.940
extraction and processing industry: J01.576.370
acetabulum: A02.835.232.043.825.108
london: Z01.433.553, Z01.542.363.300.553
community-based participatory research: H01.770.644.193, N05.425.104
medication adherence: F01.145.488.500.500, N05.300.150.600.600.500
patient education as topic: I02.233.332.500, N02.421.143.827.407.680, N02.421.726.407.680
poverty areas: I01.880.840.535.550, N01.824.600.550
exhumation: I01.198.780.937.422
forensic pathology: H02.403.330.300, H02.403.650.249, I01.198.780.937.460
forensic toxicology: H01.158.703.795.424, H02.628.795.424, I01.198.780.968
meperidine: D03.066.399.450, D03.383.621.349.450
sodium cyanide: D01.625.400.100.875, D01.857.660
erythema: C17.800.229
hyperaldosteronism: C19.053.800.604
pregnancy trimester, second: G08.686.707.490
hepatic encephalopathy: C06.552.308.500.356, C10.228.140.163.360, C18.452.132.360
corrosion: G02.149.200
weather: G16.500.275.063.725, G16.500.750.775, N06.230.300.100.725
biological agents: 
intestinal neoplasms: C04.588.274.476.411, C06.301.371.411, C06.405.249.411, C06.405.469.491
umbilical cord: A16.378.693
asymptomatic diseases: C23.550.291.187
nystagmus, optokinetic: G14.640.260.378.500
nystagmus, physiologic: G14.640.260.378
pursuit, smooth: G14.640.260.453
saccades: G14.640.260.500
vestibular diseases: C09.218.568.900
vestibular function tests: E01.370.382.900
vestibule, labyrinth: A09.246.631.909
contrast sensitivity: E01.370.380.850.950.500, F02.463.593.932.869.435.110, F02.463.593.932.901.500, G14.940.500
blood gas analysis: E01.370.225.124.100.100, E01.370.386.700.100, E05.200.124.100.100
delaware: Z01.107.567.875.500.200
fluorescence: G01.358.500.505.650.665.500, G01.590.540.665.500
toothpastes: D25.376.711, J01.637.051.376.711
ceramics: D25.264, J01.637.051.264, J01.637.153
health personnel: M01.526.485, N02.360
housekeeping: N02.508
elastomers: D25.720.327, J01.637.051.720.327, J01.637.412
acid-base equilibrium: G02.111.029, G02.300.176, G03.030, G07.700.345.110, G09.188.050
head-down tilt: G11.427.695.300
anemia, iron-deficiency: C15.378.071.196.300, C18.452.565.100
musculoskeletal diseases: C05
mycotoxicosis: C25.723.680
physical examination: E01.370.600
lung diseases, fungal: C01.703.534, C08.381.472, C08.730.435
truth disclosure: F01.829.401.046.800, I01.880.604.583.080.134.800
arm injuries: C26.088
egypt: Z01.058.266.317, Z01.586.035.200, Z01.586.500.300
malaysia: Z01.252.145.487
antibodies, fungal: D12.776.124.486.485.114.179, D12.776.124.790.651.114.179, D12.776.377.715.548.114.179
aspergillus: B01.300.381.081
basidiomycota: B01.300.179
cladosporium: B01.300.381.200
spores, bacterial: A11.870.700, B05.775.700
streptomyces: B03.300.390.400.810.768, B03.510.024.049.775.775, B03.510.415.400.810.768, B03.510.460.410.810.768
trichoderma: B01.300.381.910
osteoarthritis, hip: C05.550.114.606.400, C05.799.613.400
executive function: F02.463.217
nails: A17.600
intensive care: E02.760.190.400, N02.421.585.190.400
length of stay: E02.760.400.480, N02.421.585.400.480
farmer's lung: C08.381.483.125.365, C08.674.055.365, C20.543.480.680.075.365, C24.080.365
forestry: J01.576.430
gardening: I03.450.642.378, J01.040.413
microscopy, fluorescence, multiphoton: E01.370.350.515.458.500, E05.595.458.500
tomography: E01.370.350.825
trichloroethanes: D02.455.526.439.927
arthroplasty, replacement, knee: E04.555.110.110.115, E04.650.110.115
knee joint: A02.835.583.475
knee prosthesis: E07.695.400.410
niobium: D01.268.556.615, D01.268.956.687, D01.552.544.615
osteoarthritis, knee: C05.550.114.606.500, C05.799.613.500
osteolysis: C05.116.264.579, G11.427.590.195.150.570
ataxia: C10.597.350.090, C23.888.592.350.090
cranial nerve diseases: C10.292
taste perception: F02.463.593.817
taste threshold: F02.463.593.710.790, G11.561.600.810.724.880, G11.561.840
child nutritional physiological phenomena: G07.610.220
nutritional requirements: G07.610.620
nutritive value: G07.610.660, J01.576.423.850.730.750, N06.850.601.750
australian capital territory: Z01.338.240
radiation, ionizing: G01.750.750
medical laboratory personnel: M01.526.485.510, M01.526.502.500, N02.360.510
nutritional status: G07.610.650, N01.224.425.525
threshold limit values: N03.706.615.917, N06.850.460.350.600.807
heart conduction system: A07.541.409
lupus erythematosus, systemic: C17.300.480, C20.111.590
new mexico: Z01.107.567.875.760.560
sulfur compounds: D01.875, D02.886
thailand: Z01.252.145.841
cranial nerve neoplasms: C04.588.614.300, C04.588.614.596.240, C10.292.225, C10.551.360
facial nerve: A08.800.050.050.275, A08.800.050.600.149, A08.800.800.060.275, A08.800.800.120.250
temporal muscle: A02.633.567.600.850, A14.530.940
lead poisoning, nervous system, adult: C10.720.475.400.350, C25.723.589.500.400
pedigree: E05.393.673
rome: Z01.433.850, Z01.542.489.569
potassium citrate: D02.241.081.901.434.249.750
audiometry: E01.370.382.375.060
rehabilitation: E02.831, H02.403.680.600, N02.421.784
needs assessment: I02.594, N03.349.380.565, N05.300.537
skin irritancy tests: E05.940.790.500
september 11 terrorist attacks: I01.198.240.856.800.750, K01.400.504.984.500
dental equipment: E06.186, E07.222
equipment failure: E05.325
pulse: E01.370.370.380.650, E01.370.600.650, G09.330.380.750
rest: I03.450.769.647
alpha rhythm: E01.370.376.300.150.374, E01.370.405.245.287.374, G07.265.087.500, G11.561.127.500
color perception tests: E01.370.380.850.150
refrigeration: E02.792.643, E05.760.643
lymphocyte subsets: A11.118.637.555.567.550, A15.145.229.637.555.567.550, A15.382.490.555.567.550
child language: F01.525.200.310.250
dental restoration, permanent: E06.323.428, E06.780.345.737, E07.695.190.190
visual perception: F02.463.593.932
communicable diseases: C01.539.221
accidents: N06.850.135
cholesterol, ldl: D10.532.515.500, D10.570.938.208.275, D12.776.521.550.500
waist-hip ratio: E01.370.600.115.100.960, E05.041.124.946, G07.100.100.960
galvanic skin response: F02.830.702.315, F04.669.332, G07.265.337.249, G07.700.240.249, G13.750.829.320
skin temperature: G07.110.753, G13.750.844
toxaphene: D02.455.526.439.913, D02.455.849.575.781.795
beta carotene: D02.455.326.271.665.202.123, D02.455.426.392.368.367.379.249.050, D02.455.849.131.123, D23.767.261.050
saudi arabia: Z01.252.245.500.750, Z01.586.500.750
cementation: E05.170, E06.095.170
wounds and injuries: C26
clothing: J01.637.215
vasomotor system: A08.800.050.800.900
adolescent health services: N02.421.044
architecture as topic: J01.086
mitosporic fungi: B01.300.381
water-electrolyte balance: G02.111.635.500, G03.615.500, G07.700.345.810.500
ultrasonography, doppler, transcranial: E01.370.350.578.937.260.850, E01.370.350.700.560.260.850, E01.370.350.850.260.850, E01.370.350.850.850.870, E01.370.376.537.750.260.850, E05.629.937.260.850
anticoagulants: D27.505.954.502.119
senna plant: B01.650.940.800.575.100.401.718
thrombolytic therapy: E02.319.913
treatment failure: E01.789.800.760, N04.761.559.590.800.760, N05.715.360.575.575.800.760
ultrasonography, doppler, color: E01.370.350.850.850.850.850
venous thrombosis: C14.907.355.830.925
history, 21st century: K01.400.504.984
device approval: E05.337.275, N06.850.210.275
equipment failure analysis: E05.325.192
equipment safety: E05.330
practice guidelines as topic: N04.761.700.350.650, N05.700.350.650
kidney calculi: C12.777.419.600.500, C12.777.967.249.500, C12.777.967.500.503, C13.351.968.419.600.500, C13.351.968.967.249.500, C13.351.968.967.500.503, C23.300.175.850.550
oxalates: D02.241.081.337.593
contraceptive devices, female: E07.190.250
neoplasm staging: E01.789.625
immunoglobulins: D12.776.124.486.485, D12.776.124.790.651, D12.776.377.715.548
otorhinolaryngologic neoplasms: C04.588.443.665, C09.647
glomerulonephritis, iga: C12.777.419.570.363.608, C13.351.968.419.570.363.608, C20.111.525
purpura, schoenlein-henoch: C14.907.940.777, C15.378.100.802.375, C15.378.463.515.580, C20.543.520.600, C23.550.414.950.375, C23.888.885.687.375
cyprus: Z01.542.580.500.300, Z01.639.640.300
depressive disorder: F03.600.300
headache disorders: C10.228.140.546
differential threshold: F02.463.593.230, F02.463.593.710.370
hydrochloric acid: D01.029.260.326, D01.210.450
cinnamates: D02.241.223.200
paranasal sinus neoplasms: C04.588.443.665.650.693, C08.460.669.693, C08.460.692.503, C08.785.600.693, C09.603.669.693, C09.603.692.503, C09.647.685.693
antigens, cd8: D23.050.301.264.035.108, D23.050.301.264.894.108, D23.101.100.110.109, D23.101.100.894.108
community health services: N02.421.143
community-institutional relations: N04.452.822.210
intervention studies: E05.318.760.565, N05.715.360.775.390, N06.850.520.450.565
program evaluation: E05.337.820, N04.761.685, N05.715.360.650
acetylation: G02.111.087.019.052, G02.149.115.019.052, G02.149.465.030.052, G02.607.750.030.052, G03.495.095.052
healthy worker effect: N05.715.350.350.375, N06.850.490.734.750
endoscopy: E01.370.388.250, E04.800.250
pepsinogen a: D08.622.509.700
ureter: A05.810.776
diuresis: G08.852.796.241
shoes: J01.637.215.800
tinnitus: C09.218.458.670, C10.597.751.418.670, C23.888.592.763.393.670
bronchial neoplasms: C04.588.894.797.520.109, C08.127.265, C08.785.520.100
sjogren's syndrome: C05.550.114.154.774, C05.799.114.774, C07.465.815.929.669, C11.496.260.719, C17.300.775.099.774, C20.111.199.774
tungsten: D01.268.556.887, D01.268.956.882, D01.552.544.887
cyclamates: D02.455.426.392.368.367.204
thiazines: D02.886.665, D03.383.855
fats: D10.212
emotions: F01.470
calcaneus: A02.835.232.043.300.710.300
leukopenia: C15.378.553.546
lymphoma, t-cell: C04.557.386.480.750, C15.604.515.569.480.750, C20.683.515.761.480.750
romania: Z01.542.248.764
gene dosage: G05.380.350
long interspersed nucleotide elements: G02.111.570.080.708.330.800.400, G05.360.080.708.330.800.400, G05.360.340.024.425.800.400
sexual partners: M01.778
climacteric: G08.686.157, G08.686.785.880.249
vision screening: E01.370.380.850.900, E05.318.308.250.580.925, N05.715.360.300.375.500.825, N06.850.520.308.250.580.925, N06.850.780.500.950
congenital: 
aircraft: J01.937.285.100
urologic neoplasms: C04.588.945.947, C12.758.820, C13.351.937.820
social class: I01.880.552, I01.880.840.755, N01.824.782
parents: F01.829.263.500.320, I01.880.225.500.340, M01.620
creatine kinase, mm form: D08.811.913.696.640.150.875
evoked potentials, motor: G07.265.500.385, G11.561.270.385
autopsy: E01.370.060, E05.070, I01.198.780.937.120
granuloma: C15.604.515.292, C23.550.382
self administration: E02.319.890, E02.900.890
adolescent behavior: F01.145.022
adolescent development: F01.525.049, G07.700.320.374.500
adolescent nutritional physiological phenomena: G07.610.220.060
fluorodeoxyglucose f18: D09.254.229.500
accidents, occupational: N06.850.135.240
russia: Z01.252.122.500, Z01.542.248.775, Z01.586.200.775, Z01.586.950.775
tobacco: B01.650.940.800.575.100.905.900
calcinosis: C18.452.174.130
sleep initiation and maintenance disorders: C10.886.425.800.800, F03.870.400.800.800
bentonite: D01.056.050.075.100, D01.578.725.025.100, D01.650.550.050.075.100, D01.837.725.700.760.050.100
incidental findings: E01.410
silicates: D01.578.725, D01.837.725.700.760
antigens, differentiation, t-lymphocyte: D23.050.301.264.894, D23.101.100.894
binding sites, antibody: G02.111.570.060.425.079, G02.111.570.120.408, G12.125, G12.425.143.232
bone plates: E07.695.125, E07.858.442.660.110, E07.858.690.650.110
femoral fractures: C26.404.061, C26.558.276
district of columbia: Z01.107.567.875.500.210, Z01.433.429
women, working: M01.975.825
urinary bladder neoplasms: C04.588.945.947.960, C12.758.820.968, C12.777.829.813, C13.351.937.820.945, C13.351.968.829.707
disease: C23.550.288
space-time clustering: E05.318.740.250.700, N05.715.360.750.200.775, N06.850.520.830.250.700
dermatologic agents: D27.505.954.444
eligibility determination: N04.452.264
insurance, accident: N03.219.521.576.343.409
meniere disease: C09.218.568.217.500
neuroma: C04.557.580.600.610
arsenic poisoning: C10.720.475.150, C25.723.097
composite resins: D05.750.716.822.308, D25.339.816.500, D25.720.716.822.308, J01.637.051.339.816.500, J01.637.051.720.716.822.308
maine: Z01.107.567.875.550.500
pelvic inflammatory disease: C01.539.635.500, C13.351.500.056.750
visual fields: F02.463.593.932.934, G14.950
levodopa: D02.092.311.200.480, D12.125.072.050.685.400.500, D12.125.072.050.875.130.500
psychophysics: E01.370.685, F04.096.753, F04.732
antimetabolites, antineoplastic: D27.505.519.186.144, D27.505.954.248.144, D27.888.569.042.030
trigeminal nerve: A08.800.800.120.760
libraries: L01.346.596
cholecalciferol: D04.808.247.222.159, D04.808.247.808.146, D04.808.812.768.196, D10.570.938.146
world health organization: N03.540.514.718.800
deafness: C09.218.458.341.186, C10.597.751.418.341.186, C23.888.592.763.393.341.186
austria: Z01.542.088
benzalkonium compounds: D02.092.877.096.040, D02.675.276.080
emollients: D27.505.954.444.200
equipment design: E05.320
habits: F01.145.466
inorganic chemicals: D01
anticonvulsants: D27.505.954.427.080
clonazepam: D03.438.079.080.070.150
fire extinguishing systems: N06.230.216.500
myoclonus: C10.597.350.500, C23.888.592.350.500
epilepsy, tonic-clonic: C10.228.140.490.375.290
fires: N06.230.216
ophthalmoscopy: E01.370.380.560
methyl chloride: D02.455.526.439.632
heterotrimeric gtp-binding proteins: D08.811.277.040.330.300.200, D12.644.360.375, D12.776.157.325.332, D12.776.476.375, D12.776.543.325
polymorphism, restriction fragment length: G05.365.795.595
antiparkinson agents: D27.505.954.427.090.050
benserazide: D02.442.175
western australia: Z01.338.800
tomography, emission-computed: E01.370.350.350.800, E01.370.350.600.350.800, E01.370.350.710.800, E01.370.350.825.800, E01.370.384.730.800
labor unions: N03.540.571
online systems: L01.700.508.300.742
cerebellar diseases: C10.228.140.252
randomized controlled trials as topic: E05.318.760.535.365.500, E05.337.250.365.500, N05.715.360.775.235.387.500, N06.850.520.450.535.365.500
defoliants, chemical: D27.720.031.700.366.181, D27.720.723.366.181, D27.888.723.366.181
drug and narcotic control: I01.880.604.605.250, N03.706.615.402.250, N04.452.706.310
incubators, infant: E07.325.569, E07.461.487
tennessee: Z01.107.567.875.075.775
decision making: F02.463.785.373
malingering: F01.145.126.925
viral hepatitis vaccines: D20.215.894.899.955
alkalies: D01.045
hypoproteinemia: C15.378.147.607
adaptation, psychological: F01.058
language development: F01.525.200.310
hip: A01.378.610.400
arthritis: C05.550.114
body composition: G02.111.097, G03.180, G07.100.049
tea: D20.215.784.875, J02.200.900
confined spaces: G16.500.275.074, N06.230.074
occupational health services: N02.421.143.740
preventive health services: N02.421.143.827, N02.421.726
iodides: D01.248.497.158.490, D01.475.410
perchloric acid: 
pyrenes: D02.455.426.559.847.799, D04.615.799
coronary artery disease: C14.280.647.250.260, C14.907.137.126.339, C14.907.585.250.260
academies and institutes: N03.540.052
fish products: J02.500.600.875.400
diabetic ketoacidosis: C18.452.076.176.652.500, C18.452.394.750.535, C19.246.099.812
hypernatremia: C18.452.950.452
acidosis: C18.452.076.176
liver failure, acute: C06.552.308.500.750
urodynamics: G08.852.898
charcoal: D01.268.150.150
factor analysis, statistical: E05.318.740.400, N05.715.360.750.350, N06.850.520.830.400
seer program: E05.318.308.970.725, L01.280.950.725, N04.452.859.819.725, N05.715.360.300.715.700.725, N06.850.520.308.970.725
neutron activation analysis: E05.196.039.564
anti-arrhythmia agents: D27.505.954.411.097
eye manifestations: C11.300, C23.888.307
gastric lavage: E05.927.441
hyperventilation: C08.618.501, C23.888.852.591
neurologic manifestations: C10.597, C23.888.592
skin manifestations: C23.888.885
uremia: C12.777.419.936, C13.351.968.419.936
nitrous oxide: D01.362.635.625, D01.625.550.550, D01.650.550.587.650
motor neuron disease: C10.574.562, C10.668.467
cytarabine: D03.383.742.680.245.453, D13.570.065.300, D13.570.685.245.453
blepharoptosis: C11.338.204
arrhythmia, sinus: C14.280.067.093, C23.550.073.093
pain measurement: E01.370.600.550.324
adult children: F01.829.263.065, I01.880.225.281, M01.055
schizophrenia: F03.700.750
work: I03.946
renal plasma flow, effective: G08.852.796.700.750, G09.330.190.163.812.750
metal ceramic alloys: D01.552.033.690, D25.058.520, D25.339.208.720, J01.637.051.058.520, J01.637.051.339.208.720
vision, low: C10.597.751.941.905, C11.966.905, C23.888.592.763.941.848
air movements: G16.500.240.135.249, G16.500.275.063.725.154, N06.230.300.100.150.185
lung volume measurements: E01.370.386.700.485
fingers: A01.378.800.667.430
carcinoma, ductal, breast: C04.557.470.200.025.232.500, C04.557.470.615.132.500, C04.588.180.390, C17.800.090.500.390
carcinoma, lobular: C04.557.470.200.025.305, C04.557.470.615.305
touch: F02.830.816.850, G11.561.600.810.850
acclimatization: G07.700.062.133, G16.100.057.500.133
cadaver: C23.550.260.224
embalming: I01.076.201.450.550.250
physical therapy modalities: E02.779
sneezing: C23.888.852.889, G09.772.770.820
students, health occupations: I02.851.686, M01.848.769
uterine contraction: G08.686.785.760.769.326.700, G11.427.590.540.890
maternal nutritional physiological phenomena: G07.610.566
carcinoma, papillary: C04.557.470.200.360, C04.557.470.700.360
microtubule-associated proteins: D12.776.220.600.450, D12.776.641.560
bronchoscopy: E01.370.386.105, E01.370.388.250.100, E04.800.250.100, E04.928.600.080
radiography, thoracic: E01.370.350.700.730
eczema, dyshidrotic: C17.800.174.620.300, C17.800.815.620.300, C17.800.865.385
cardiac complexes, premature: C14.280.067.325, C23.550.073.325
epilepsies, myoclonic: C10.228.140.490.250
atrial premature complexes: C14.280.067.325.250, C23.550.073.325.050
bradycardia: C14.280.067.319, C23.550.073.300
bundle-branch block: C14.280.067.558.323, C23.550.073.425.100
leishmaniasis, cutaneous: C03.752.300.500.400, C03.858.560.400, C17.800.838.775.560.400
ventricular premature complexes: C14.280.067.325.500, C23.550.073.325.800
burning mouth syndrome: C07.465.114
iraq: Z01.252.245.500.360, Z01.586.500.360
gastrointestinal neoplasms: C04.588.274.476, C06.301.371, C06.405.249
inhibitor of apoptosis proteins: D12.644.360.075.437, D12.776.476.075.437
printing: L01.737.787
phosgene: D02.522.741
nephrotic syndrome: C12.777.419.630.643, C13.351.968.419.630.643
resins, plant: D05.750.078.840, D20.215.721.500
medical audit: N04.761.700.250.500, N05.700.175.500
sural nerve: A08.800.800.720.450.760.820.820
floors and floorcoverings: J01.086.339.140
placebos: D26.660, E02.785
medical records systems, computerized: E05.318.308.940.968.625, L01.280.900.968.775, L01.700.508.300.695, N04.452.859.564.650, N05.715.360.300.715.500.530, N06.850.520.308.940.968.625
fathers: F01.829.263.500.320.100, I01.880.225.500.340.210, M01.620.390
diastole: G09.330.190.541.295, G11.427.590.540.554.250, G11.427.590.540.570.295
ventricular function, left: G09.330.190.962.800
omega-n-methylarginine: D12.125.068.050.650, D12.125.095.104.650, D12.125.142.087.500
blood specimen collection: E01.370.225.998.110, E04.665.150, E05.200.998.110
cardiac catheterization: E01.370.370.380.140, E02.148.442
embolism: C14.907.355.350
hepatic artery: A07.231.114.407
iatrogenic disease: C23.550.291.875
intracranial embolism and thrombosis: C10.228.140.300.525, C14.907.253.566, C14.907.355.590.213, C14.907.355.830.850.213
geriatrics: H02.403.355
ireland: Z01.542.467, Z01.639.587
pleural neoplasms: C04.588.894.797.640, C08.528.694, C08.785.640
sarcoma: C04.557.450.795
ventricular fibrillation: C14.280.067.922, C23.550.073.922
neuritis: C10.668.829.650
polycythemia vera: C15.378.190.636.753
schistosomiasis: C03.335.865.859
hallucinations: C10.597.606.762.300, C23.888.592.604.764.300, F01.700.750.300
placebo effect: N05.715.350.350.625, N06.850.490.734.875
set (psychology): F02.463.425.838
asbestos, amphibole: D01.578.725.050.050, D01.837.725.700.760.070.050
energy-generating resources: N06.230.132
automobiles: J01.937.500.100
workers' compensation: N03.219.521.346.866, N03.219.521.576.300.900
thallium: D01.268.556.847, D01.552.544.847
endometriosis: C13.351.500.163
polycystic ovary syndrome: C04.182.612.765, C13.351.500.056.630.580.765, C19.391.630.580.765
carbon monoxide: D01.200.250, D01.362.200, D01.650.550.250
complement c3: D12.776.124.050.140, D12.776.124.486.274.250
atrial fibrillation: C14.280.067.198, C23.550.073.198
serotonin receptor agonists: D27.505.519.625.850.800, D27.505.696.577.850.800
tryptamines: D02.092.211.215.801, D03.438.473.914
radio: J01.897.280.500.739, L01.178.590.700, L01.178.820.090.739, L01.178.847.514
mass media: L01.178.590
blood pressure monitoring, ambulatory: E01.370.370.140.100, E01.370.520.500.100
plethysmography: E01.370.370.610, E01.370.610
nadolol: D02.033.100.624.698.601, D02.033.755.624.698.601, D02.092.063.624.698.601
quinidine: D03.132.206.636, D03.438.810.699, D03.605.687.637
epidemiologic factors: N05.715.350, N06.850.490
leiomyoma: C04.557.450.590.450
sexually transmitted diseases: C01.539.778, C02.800, C12.294.668, C13.351.500.711
nervous system neoplasms: C04.588.614, C10.551
salivary gland neoplasms: C04.588.443.591.824, C07.465.565.824, C07.465.815.718
phosphorus metabolism disorders: C18.452.750
antigens, dermatophagoides: D23.050.181
arthropod proteins: D12.776.092
cysteine endopeptidases: D08.811.277.656.262.500, D08.811.277.656.300.200
dermatophagoides pteronyssinus: B01.050.500.131.166.132.419.600.215
eosinophil cationic protein: D08.811.277.352.700.350.262, D12.776.124.486.379.249
carbon tetrachloride poisoning: C25.723.177
barbiturates: D03.383.742.698.253
silicon: D01.268.513.937
vision tests: E01.370.380.850
respiratory insufficiency: C08.618.846
peroneal nerve: A08.800.800.720.450.760.640
myopia: C11.744.636
methacholine compounds: D02.092.877.883.555, D02.675.276.534
electrooculography: E01.370.380.230.285, E01.370.405.265
eye movements: G11.427.590.530.140, G14.640.260
anterior chamber: A09.371.060.067
corneal opacity: C11.204.299
entropion: C11.338.443
eye burns: C26.200.503, C26.260.275.250.250
keratoconjunctivitis: C11.187.183.394, C11.204.564.585
medication errors: E02.319.529, N02.421.450.500
suppuration: C01.539.830, C23.550.470.756
delirium, dementia, amnestic, cognitive disorders: F03.087
parenteral nutrition: E02.421.505, E02.642.500.505
xylitol: D02.033.800.936, D09.853.936
sensation: F02.830.816, G11.561.600.810
digitalis glycosides: D04.808.155.580.130.500, D09.408.180.261
intermittent positive-pressure breathing: E02.041.625.790.520, E02.880.820.790.520
methenamine: D02.092.782.500, D02.455.426.100.050.392
oxygen inhalation therapy: E02.880.690
quaternary ammonium compounds: D01.625.062.500, D02.092.877, D02.675.276
tracheotomy: E04.580.907, E04.928.790
boron compounds: D01.132, D02.203
hydrogen sulfide: D01.029.260.340, D01.362.350, D01.875.350
positive-pressure respiration: E02.041.625.790, E02.880.820.790
coal tar: D20.749.354
ethiopia: Z01.058.290.120.310
computers: L01.224.230.260
maps as topic: J01.897.280.500.426, L01.178.820.090.426
gonadal hormones: D06.472.334
gas poisoning: C25.723.455
antipyrine: D03.383.129.539.850.088
heroin dependence: C25.775.675.400, F03.900.675.400
medline: L01.470.750.500.650.500, L01.700.508.280.710.500, L01.700.508.280.750.500, L01.700.508.300.188.300.650.500, L01.700.508.300.710.500, L01.700.508.300.742.650.500
kaolin: D01.056.050.075.350, D01.578.725.025.350, D01.650.550.050.075.350, D01.837.725.700.760.050.400
clinical trials as topic: E05.318.760.535, E05.337.250, N05.715.360.775.235, N06.850.520.450.535
pertussis toxin: D08.811.913.400.725.115.680, D23.946.123.946.690, D23.946.896.980.690
altitude: G16.500.275.058, N06.230.058
building codes: N02.278.200.100
blood volume: G09.188.130, G09.330.380.092
hypertension, pulmonary: C08.381.423
perceptual disorders: C10.597.606.762, C23.888.592.604.764, F01.700.750
natriuretic agents: D27.505.696.560, D27.505.954.411.455
physicians: M01.526.485.810, N02.360.810
thermoluminescent dosimetry: E05.799.638.785, N06.850.810.370.420
smoking cessation: F01.145.928.968.700, F01.145.940.700
pregnancy trimester, third: G08.686.707.520
histamine release: G12.425.431
beds: E07.325.220
coumarins: D03.438.150.446, D03.830.219.446
selection bias: N05.715.350.150.775, N06.850.490.500.500
ambulatory care: E02.760.106, N02.421.585.106
anxiety disorders: F03.080
desipramine: D03.494.240.281
panic: F01.470.361.585
hospitalization: E02.760.400, N02.421.585.400
neuropsychology: F04.096.795.600, H01.158.782.795.110
matched-pair analysis: E05.318.740.475, E05.318.780.485, N05.715.360.750.500, N05.715.360.780.500, N06.850.520.445.485, N06.850.520.830.475
hospital design and construction: J01.086.339.250, N02.278.200.403
hospitals: N02.278.421
personnel, hospital: M01.526.485.740, N02.360.740
anemia, aplastic: C15.378.071.085, C15.378.190.196
lipoproteins: D10.532, D12.776.521
consanguinity: G05.180, G05.355.090.403.180
arizona: Z01.107.567.875.760.100
calcium oxalate: D02.241.081.337.593.750.500
outpatient clinics, hospital: N02.278.035.380, N02.278.354.422.527, N04.452.442.422.527
vomiting: C23.888.821.937
air ionization: G02.149.060, G02.149.767.040, G02.842.750.040, G16.500.240.070, N06.230.300.100.150.100
hexanes: D02.455.326.146.500
drug evaluation: E05.337.425
emulsions: D20.280.260, D26.255.165.260
skin care: E02.547.800
reflex, vestibulo-ocular: G11.561.600.765.795
personality disorders: F03.675
equipment reuse: E05.328, N06.850.585
glomerulonephritis, membranous: C12.777.419.570.363.625, C13.351.968.419.570.363.625, C20.111.535
hobbies: I03.450.642.469
olfaction disorders: C10.597.751.600, C23.888.592.763.550
flour: J02.500.484
deodorants: D27.720.269.385
soaps: D27.720.877.265.861, J01.516.872
diplopia: C10.597.751.941.339, C11.966.339, C23.888.592.763.941.339
facial paralysis: C07.465.327, C10.597.622.214, C23.888.592.636.214
keratitis: C11.204.564
nystagmus, pathologic: C10.292.562.675, C11.590.400
optic atrophy: C10.292.700.225, C11.640.451
papilledema: C10.292.700.900, C11.640.710
barium: D01.268.552.050, D01.268.556.062, D01.552.539.124, D01.552.544.062
beryllium: D01.268.552.075, D01.268.557.080, D01.552.547.080
carcinoma, bronchogenic: C04.588.894.797.520.109.220, C08.381.540.140, C08.785.520.100.220
pneumonia, lipid: C08.381.677.529.612, C08.730.610.529.612
tuberculosis, pulmonary: C01.252.410.040.552.846.899, C08.381.922, C08.730.939
bronchial spasm: C08.127.321
ether, ethyl: 
halothane: D02.455.526.340
methoxyflurane: D02.355.417.600, D02.355.601.620
flicker fusion: E01.370.380.245, F02.463.593.932.458, G14.370
cerebellar ataxia: C10.228.140.252.190, C10.597.350.090.500, C23.888.592.350.090.200
platinum: D01.268.556.690, D01.268.956.734, D01.552.544.690
tuberculosis: C01.252.410.040.552.846
ballistocardiography: E01.370.370.380.100
thorax: A01.923.761, A02.835.232.904
amobarbital: D03.383.742.698.253.077
dimercaprol: D02.886.489.180
benzenesulfonates: D02.455.426.559.389.097, D02.886.645.600.080.050.100
blood sedimentation: E01.370.225.625.125, E05.200.625.125
cerebrospinal fluid proteins: D12.776.178
femur neck: A02.835.232.043.650.247.510
family characteristics: F01.829.263.315, I01.240.361, I01.880.225.423, N01.224.361, N01.824.308, N06.850.505.400.400
synkinesis: C10.597.350.675, C23.888.592.350.675
glutaral: D02.047.532
latex: D05.750.078.625, D20.215.721.124, D25.720.099.625, D25.720.099.750.500, D25.720.327.840.239, J01.637.051.720.099.625, J01.637.051.720.540
isoptera: B01.050.500.131.617.485
mosquito control: N06.850.780.200.650.425.500
philippines: Z01.252.145.671, Z01.639.790
hydrolases: D08.811.277
iodine isotopes: D01.496.448
melanoma: C04.557.465.625.650.510, C04.557.580.625.650.510, C04.557.665.510
pneumoencephalography: E01.370.350.578.937.620, E01.370.350.700.560.620, E01.370.350.700.625.620, E01.370.376.537.750.620, E05.629.937.620
hardness: G01.374.647
blinking: G11.561.600.765.127, G14.640.182
intradermal tests: E01.370.225.812.871.300, E05.200.812.871.300, E05.478.594.890.300
knee: A01.378.610.450
bolivia: Z01.107.757.136
infant behavior: F01.145.179.500
uzbekistan: Z01.252.100.975, Z01.586.200.975, Z01.586.950.975
formates: D02.241.081.420
patient admission: E02.760.400.600, N02.421.585.400.600
meat products: J02.500.600.500
oligomenorrhea: C23.550.568.937
analgesics: D27.505.696.663.850.014, D27.505.954.427.040
arachidonic acids: D10.251.355.096, D10.251.355.255.100, D10.251.355.310.166
complement activation: G12.425.255
bone diseases: C05.116
foodborne diseases: C25.723.415
4-aminobenzoic acid: D02.241.223.100.050.500.640, D02.455.426.559.389.127.020.937.640
angioedema: C14.907.079, C17.800.862.945.066, C20.543.480.904.066
salicylates: D02.241.223.100.300.595, D02.241.511.390.595, D02.455.426.559.389.127.281.595, D02.455.426.559.389.657.410.595
abortion, legal: E04.520.050.055
iceland: Z01.542.433, Z01.639.490
leukemia, monocytic, acute: C04.557.337.539.275.484
transportation: J01.937
torsades de pointes: C14.280.067.845.940.700, C23.550.073.845.940.700
lithium: D01.268.549.450, D01.552.528.480
renal blood flow, effective: G08.852.796.700.700, G09.330.190.163.812.700
hypopharyngeal neoplasms: C04.588.443.665.710.485, C07.550.745.436, C09.647.710.485, C09.775.549.485
neoplasms, squamous cell: C04.557.470.700
digestive system diseases: C06
noise, transportation: N06.230.400.550, N06.850.460.610.680
pulmonary diffusing capacity: E01.370.386.700.650.650, G09.772.600
sinusitis: C08.460.692.752, C08.730.749, C09.603.692.752
microclimate: G16.500.275.071.450, N06.230.300.100.250.450
neuromuscular diseases: C10.668
cross-cultural comparison: I01.076.201.450.281, I01.880.143.257
phenolphthalein: D02.455.426.559.389.657.625.555
phenolphthaleins: D02.455.426.559.389.657.625
victoria: Z01.338.740
sex hormone-binding globulin: D12.776.124.790.223.800, D12.776.157.762, D12.776.377.715.182.800
catchment area (health): N01.224.791.200, N03.349.650.095, N06.850.505.400.800.200
trigeminal neuralgia: C10.292.775.700
anesthesia, general: E03.155.197
leishmaniasis: C03.752.300.500, C03.858.560, C17.800.838.775.560
water softening: N06.850.860.510.910
heart block: C14.280.067.558, C23.550.073.425
latvia: Z01.542.248.136.560, Z01.586.950.140.560
infant mortality: E05.318.308.985.550.475, L01.280.975.550.475, N01.224.935.698.489, N06.850.505.400.975.550.475, N06.850.520.308.985.550.475
tylosin: D02.540.505.905
engineering: J01.293
extracorporeal membrane oxygenation: E02.880.301, E04.292.451
hyperbilirubinemia: C23.550.429
football: I03.450.642.845.300
asthenia: C23.888.089
carrier state: N06.850.160
hepatitis c, chronic: C02.440.440.120, C02.782.350.350.120, C06.552.380.350.120, C06.552.380.705.440.120
refractive errors: C11.744
catheters: E07.132
bipolar disorder: F03.600.150.150
venezuela: Z01.107.757.943
diet records: N04.452.859.360
liver cirrhosis: C06.552.630
calcium hydroxide: D01.146.335, D01.455.275
seminoma: C04.557.465.330.800
illinois: Z01.107.567.875.350.350, Z01.107.567.875.510.350
food, fortified: J02.500.525.400
electrodiagnosis: E01.370.405
elbow: A01.378.800.420
tantalum: D01.268.556.837, D01.268.956.859, D01.552.544.837
erythrocytes, abnormal: A11.118.290.330, A11.443.240.330, A15.145.229.334.330
methadone: D02.522.675
methylphenidate: D02.241.223.601.600, D03.383.621.460
phenmetrazine: D03.383.533.640.650
maximal expiratory flow rate: E01.370.386.700.660.225.500, G09.772.650.300.590
amaranth dye: D02.172.025, D02.455.426.559.847.638.555.200, D02.886.645.600.080.050.650.012, D04.615.638.555.200
erythrosine: D02.455.426.559.847.885.347.350, D03.494.953.275.350, D04.615.885.347.350
naphthalenesulfonates: D02.455.426.559.847.638.555, D02.886.645.600.080.050.650, D04.615.638.555
burns, chemical: C26.200.156
hysterectomy: E04.950.300.399
menarche: G08.686.760.410, G08.686.785.880.374.410
sterilization, tubal: E04.950.300.766, E04.950.599.683
soft tissue neoplasms: C04.588.839
acquired immunodeficiency syndrome: C02.782.815.616.400.040, C02.800.801.400.040, C02.839.040, C20.673.480.040
back pain: C10.597.617.232, C23.888.592.612.107, C23.888.646.172
eye injuries: C11.297, C26.260.275.250
foot diseases: C05.360, C17.800.321
herpes simplex: C02.256.466.382, C02.825.320, C17.800.838.790.320
myotonia: C10.597.613.700, C23.888.592.608.700
nursing: H02.478, N04.452.758.377
peptic ulcer: C06.405.469.275.800, C06.405.608, C06.405.748.586
antidepressive agents, tricyclic: D27.505.954.427.700.122.055
imipramine: D03.494.240.485
pharmaceutic aids: D26.650, D27.720.744
acne vulgaris: C17.800.030.150, C17.800.271.125.200, C17.800.794.111
interpersonal relations: F01.829.401
vertigo: C09.218.568.900.883, C10.597.951, C23.888.592.958
fasting: F01.145.407.400, G07.610.240.587
lactose tolerance test: E01.370.225.124.100.450, E01.370.372.450, E05.200.124.100.450
adams-stokes syndrome: C14.280.067.558.137, C23.550.073.425.025
emergencies: C23.550.291.781, N06.230.100.083, N06.850.376
pacemaker, artificial: E07.305.250.750
anesthesia, intratracheal: E03.155.253
benperidol: D02.522.352.155
brain abscess: C01.252.200.100, C01.323, C01.539.830.025.160, C10.228.140.116, C10.228.228.090, C10.228.228.180.100
cerebral hemorrhage: C10.228.140.300.535.200, C14.907.253.573.200, C23.550.414.913.100
fentanyl: D03.383.621.265
intracranial pressure: G11.561.170.505
isonipecotic acids: D03.066.399, D03.383.621.349
phenoperidine: D03.066.399.600, D03.383.621.349.683
abducens nerve: A08.800.800.120.030
demyelinating diseases: C10.314
carbohydrate metabolism, inborn errors: C16.320.565.202, C18.452.648.202
femoral neck fractures: C26.404.061.425.500, C26.558.276.425.500
cyanoacrylates: D02.241.081.069.366, D02.626.290, D05.750.259, D25.720.259, D25.919.367, J01.637.051.720.259, J01.637.051.919.367
dermatitis, exfoliative: C17.800.174.318, C17.800.815.318
operating room nursing: H02.478.676.650.625, N02.421.533.710.625
mathematics: H01.548
bronchial diseases: C08.127
whales, pilot: B01.050.150.900.649.189.267.920
allied health personnel: M01.526.485.067, N02.360.067
histology: H01.158.100.656
phenylketonurias: C10.228.140.163.100.687, C16.320.565.100.766, C16.320.565.189.687, C18.452.132.100.687, C18.452.648.100.766, C18.452.648.189.687
wind: G16.500.240.135.249.200, G16.500.275.063.725.154.200, G16.500.750.775.780, N06.230.132.644.875, N06.230.300.100.150.185.200, N06.230.300.100.725.780
hydroxybenzoates: D02.241.223.100.300, D02.241.511.390, D02.455.426.559.389.127.281, D02.455.426.559.389.657.410
cross infection: C01.539.248
skinfold thickness: E01.370.600.115.100.803, E05.041.124.803, G07.100.100.803
mental fatigue: C23.888.369.500, F01.145.126.937
periodicity: G01.910.645, G07.180.562
chloroprene: D02.455.326.271.665.146.280
pulmonary heart disease: C14.280.832
forensic medicine: H02.403.330, I01.198.780.937
psychoses, substance-induced: C25.723.809, C25.775.746, F03.700.675.600, F03.900.746
beauty culture: J01.576.112
histiocytic disorders, malignant: C04.557.227, C15.604.250.390
platelet activation: G09.188.124.560.600
zimbabwe: Z01.058.290.175.960
beta-thromboglobulin: D12.644.276.374.200.070, D12.776.124.125.050, D12.776.124.790.223.160, D12.776.377.715.182.160, D12.776.467.374.200.070, D23.119.050, D23.125.300.070, D23.469.200.070, D23.529.374.200.070
lymphatic diseases: C15.604
hallux: A01.378.610.250.300.792.380
hair dyes: D27.720.233.688, D27.720.269.430.430
tranquilizing agents: D27.505.696.277.950, D27.505.954.427.210.950, D27.505.954.427.700.872
camphor: D02.455.849.575.781.234.326, D02.522.376
facility design and construction: J01.086.339, N02.278.200
bicarbonates: D01.200.275.150.100, D01.248.497.158.165.100
thermometers: E07.900
coronary disease: C14.280.647.250, C14.907.585.250
emetics: D27.505.696.329, D27.505.696.663.050.225, D27.505.954.427.270, D27.505.954.483.560
background radiation: G01.750.750.115
pharyngeal neoplasms: C04.588.443.665.710, C07.550.745, C09.647.710, C09.775.549
metacarpus: A01.378.800.667.572
hawaii: Z01.107.567.875.580.375, Z01.639.760.815.482
physical fitness: G11.427.685, I03.450.642.845.054.800, N01.400.545
thromboembolism: C14.907.355.590, C14.907.355.830.850
eyelids: A01.456.505.420.504, A09.371.337
scotland: Z01.542.363.766, Z01.639.280.766
radar: L01.178.847.500
glycyrrhiza: B01.650.940.800.575.100.401.300
discriminant analysis: E05.318.740.350, N05.715.360.750.325, N06.850.520.830.350
substance abuse, intravenous: C25.775.793, F03.900.793
cold climate: G16.500.275.071.275, N06.230.300.100.250.275
skin ulcer: C17.800.893
midwestern united states: Z01.107.567.875.510
chlorine compounds: D01.210
duodenal diseases: C06.405.469.275
bangladesh: Z01.252.245.131
polymerization: G02.149.883
saralasin: D12.644.456.073.041.800, D23.469.050.050.050.700
yugoslavia: Z01.586.980
foreign bodies: C26.392
blepharitis: C11.338.133
ophthalmic solutions: D26.255.775.645, D26.776.708.645, D27.505.954.578.645, D27.720.280.775.645
pigments, biological: D23.767
pilocarpine: D03.132.672
sulfathiazoles: D02.065.884.725.935, D02.092.146.807.935, D02.886.590.700.725.935, D02.886.675.725, D03.383.129.708.725
sodium glutamate: D12.125.067.625.349.850, D12.125.119.409.349.575
drug compounding: E05.916.270
amphetamines: D02.092.471.683.152
enzyme multiplied immunoassay technique: E05.478.566.350.180, E05.478.583.400.180, E05.601.495.350.180
radioactive hazard release: N06.850.135.848
vermont: Z01.107.567.875.550.880
prednisone: D04.808.745.432.719.702
sulfuric acids: D01.029.260.877.800, D01.875.800.800, D02.886.645.655
diseases in twins: C23.550.291.750
mmpi: F04.711.647.513.607
yeast, dried: J02.500.456.933
maryland: Z01.107.567.875.075.418, Z01.107.567.875.500.500
clinical protocols: E02.183, N05.715.360.775.225
leukemia, hairy cell: C04.557.337.415, C15.604.515.553, C20.683.515.517
alcoholic intoxication: C25.775.100.175, F03.900.100.300
bulbar palsy, progressive: C10.574.562.300, C10.668.467.300
benzamides: D02.065.277, D02.241.223.100.100, D02.455.426.559.389.127.085
respiratory distress syndrome, newborn: C08.381.842, C08.618.842, C16.614.521.563
gluconates: D02.241.081.844.322, D02.241.511.902.322, D09.811.308
urinary tract infections: C01.539.895, C12.777.892, C13.351.968.892
calculi: C23.300.175
histiocytes: A11.329.372.385, A11.627.482.385, A11.733.397.385, A15.382.680.397.385, A15.382.812.522.385
rhinitis, allergic, seasonal: C08.460.799.633, C08.674.815, C09.603.799.633, C20.543.480.680.795
synovial membrane: A02.835.583.443.800
follicular fluid: A05.360.319.114.630.535.150, A06.407.312.497.535.150, A12.207.270.340
azerbaijan: Z01.542.900.120, Z01.586.200.120, Z01.586.950.120
bone diseases, metabolic: C05.116.198
pancytopenia: C15.378.700
diagnosis, computer-assisted: E01.158, L01.700.508.100.158
government agencies: I01.409.418, N03.540.400
legislation, drug: I01.880.604.605, N03.706.615.402
glycosuria: C12.777.934.363, C13.351.968.934.363, C18.452.394.937
histiocytosis, sinus: C15.604.250.410.450
pelvis: A01.923.600
corneal diseases: C11.204
hypesthesia: C10.597.751.791.500, C23.888.592.763.770.500
pseudotumor cerebri: C10.228.140.631.750
cerebral palsy: C10.228.140.140.254
intellectual disability: C10.597.606.643, C23.888.592.604.646, F01.700.687, F03.550.600
visual field tests: E01.370.380.850.962
antidepressive agents: D27.505.954.427.700.122
morphinans: D03.132.577.249, D03.549.686, D03.605.497, D04.615.723.795
vascular diseases: C14.907
paraldehyde: D02.047.064.586
goiter: C19.874.283
technology, radiologic: E05.920, H02.010.850, J01.897.891
diabetic coma: C19.246.099.750
eating disorders: F03.375
muscle cramp: C05.651.475, C10.597.613.500, C23.888.592.608.500
syncope: C10.597.606.358.800.600, C23.888.592.604.359.800.600
beer: J02.200.100.200
cyanosis: C23.888.248
thiamine: D02.886.675.900, D03.383.129.708.900, D03.383.742.795
bleeding time: E01.370.225.625.625.100, E05.200.625.625.100, G09.188.087
cromolyn sodium: D03.438.150.266.300, D03.830.219.266.300
radium: D01.268.271.770, D01.268.552.775, D01.268.556.775, D01.552.539.745, D01.552.544.775
water pollutants, radioactive: D20.693.903, D27.888.284.903.821
mass behavior: F01.145.813.527
judgment: F02.463.785.626
laboratories, hospital: N02.278.354.422.420, N02.278.487.410, N04.452.442.422.420
bicycling: I03.450.642.845.140
colitis, ulcerative: C06.405.205.265.231, C06.405.205.731.249, C06.405.469.158.188.231, C06.405.469.432.249
cardiac tamponade: C14.280.155
hyponatremia: C18.452.950.620
renal insufficiency, chronic: C12.777.419.780.750, C13.351.968.419.780.750
peripheral arterial disease: C14.907.137.126.307.500, C14.907.617.671
biliary tract neoplasms: C04.588.274.120, C06.130.320, C06.301.120
product surveillance, postmarketing: E05.337.800
abattoirs: J01.576.423.200.700.100
poultry: B01.050.050.116.625, B01.050.150.900.248.617, J02.500.600.750
reye syndrome: C06.552.241.649, C10.228.140.163.780, C18.452.132.780
status epilepticus: C10.228.140.490.690
hemodialysis, home: E02.870.300.300, E02.912.800.300, N02.421.143.524.337
hospital units: N02.278.388
kidneys, artificial: E07.858.082.585
cassia: B01.650.940.800.575.100.401.100
plantago: B01.650.940.800.575.100.818
film dosimetry: E05.799.638.420, N06.850.810.370.310
maximal expiratory flow-volume curves: E01.370.386.700.660.225.505, G09.772.650.300.630
positron-emission tomography: E01.370.350.350.800.700, E01.370.350.600.350.800.399, E01.370.350.710.800.399, E01.370.350.825.800.399, E01.370.384.730.800.399
orosomucoid: D12.776.124.050.600, D12.776.124.790.106.640, D12.776.377.715.085.640, D12.776.395.560.742
tracheal neoplasms: C04.588.443.925, C04.588.894.797.760, C08.785.760, C08.907.563
air conditioning: N06.230.150.050
airway obstruction: C08.618.846.185
nylons: D05.750.716.392, D25.720.716.392, J01.576.885.800.600, J01.637.051.720.716.392, J01.637.548
personality: F01.752
northern ireland: Z01.542.363.602, Z01.639.280.602
intubation: E02.585, E05.497
hyperesthesia: C10.597.751.791.450, C23.888.592.763.770.450
paranoid disorders: F03.700.450
denture bases: E06.780.345.760.281, E07.695.190.200.200
plants, toxic: B01.650.660
vitamin d: D04.808.812.768
eosinophilic granuloma: C05.116.391, C08.381.483.375.500, C15.378.553.231.348, C15.604.250.400.360, C23.550.382.250
langerhans cells: A11.066.270.500, A11.436.270.545, A15.382.066.270.500, A15.382.812.260.500
lymphangiomyoma: C04.557.375.460, C15.604.515.562, C20.683.515.710
perfume: D27.720.269.700
methylprednisolone: D04.808.745.432.769.795.539
germany, east: Z01.542.315.315, Z01.586.315.315
bronchiectasis: C08.127.384
alcoholism: C25.775.100.250, F03.900.100.350
tablets: D26.255.830, D27.720.280.830
citrus: B01.650.940.800.575.100.875.177
intensive care units: N02.278.388.493
dentures: E06.780.345.760, E07.695.190.200
polyethylenes: D02.455.326.271.665.550, D05.750.716.507, D25.720.716.507, J01.637.051.720.716.507
forced expiratory flow rates: E01.370.386.700.660.225, G09.772.650.300
accidents, home: N06.850.135.217
hiv infections: C02.782.815.616.400, C02.800.801.400, C20.673.480
kidney concentrating ability: G08.852.536
jewelry: J01.637.502
scleroderma, systemic: C17.300.799, C17.800.784
candidiasis: C01.703.160
penicillins: D02.065.589.099.750, D02.886.108.750, D03.438.260.825, D03.605.084.737, D04.075.080.875.099.221.750
malawi: Z01.058.290.175.500
plasmodium malariae: B01.043.075.380.611.661
delivery, obstetric: E04.520.252
gynecomastia: C17.800.090.875
raynaud disease: C14.907.617.812
protective devices: E07.700, J01.637.708
castor bean: B01.650.940.800.575.100.350.650.300
contraceptives, oral: D27.505.696.875.360.276.210, D27.505.954.705.360.276.210
lipoproteins, hdl: D10.532.432, D12.776.521.479
lipoproteins, ldl: D10.532.515, D12.776.521.550
brachial artery: A07.231.114.139
hyperemia: C14.907.474
manometry: E05.559
postprandial period: G10.261.700
fractional flow reserve, myocardial: G09.330.190.163.324.500
twins: M01.438.873
eczema: C17.800.174.620, C17.800.815.620
respiration, artificial: E02.041.625, E02.365.647.729, E02.880.820
clinical enzyme tests: E01.370.225.124.200, E05.196.427.200, E05.200.124.200
universities: I02.783.850
self report: E05.318.308.750.500, L01.280.800.655, N05.715.360.300.695.500, N06.850.520.308.750.500
embryo loss: C13.703.039.711, C23.550.260.440
pregnancy, animal: G08.686.785.760.769.498
pseudopregnancy: G08.686.785.760.769.887
uterus: A05.360.319.679
glutamic acid: D12.125.067.625.349, D12.125.119.409.349, D12.125.427.300
thiocarbamates: D02.241.081.251.869, D02.886.706
injections, intraperitoneal: E02.319.267.530.490
lipid peroxidation: G02.111.087.520, G02.149.115.520, G03.495.335.531.587
macrophage activation: G12.425.270.500
angiotensin-converting enzyme inhibitors: D27.505.519.389.745.085
indans: D02.455.426.559.847.486.487, D04.615.486.487
indapamide: D02.065.884.540, D02.886.590.700.540, D03.438.473.391
longevity: G07.540, G07.700.320.124.519
rats, inbred shr: B01.050.050.157.760.300, B01.050.050.199.520.760.300, B01.050.150.900.649.865.635.505.700.400.300
cleft palate: C05.500.460.185, C05.660.207.540.460.185, C07.320.440.185, C07.465.525.185, C07.650.500.460.185, C07.650.525.185, C16.131.621.207.540.460.185, C16.131.850.500.460.185, C16.131.850.525.185
placenta: A16.710
cell size: G04.325
cyprinidae: B01.050.150.900.493.200.244
receptors, muscarinic: D12.776.543.750.100.475, D12.776.543.750.720.360.500
birds: B01.050.150.900.248
cholinesterases: D08.811.277.352.100.170
feeding behavior: F01.145.113.547, F01.145.407
fenthion: D02.705.400.625.320, D02.705.539.345.320, D02.886.300.692.320
strigiformes: B01.050.150.900.248.815.550, B01.050.150.900.248.870
cdc2 protein kinase: D08.811.913.696.620.682.700.200.067.249, D08.811.913.696.620.682.700.200.580.500, D12.644.360.250.067.249, D12.644.360.250.580.500, D12.776.167.200.067.249, D12.776.167.200.580.500, D12.776.476.250.067.249, D12.776.476.250.580.500, D12.776.744.360
cyclin b: D12.644.360.262.120, D12.776.167.218.120, D12.776.476.262.120
embryo, nonmammalian: A13.350, A16.331
ovum: A05.360.490.690, A11.497.497, A16.690
sea urchins: B01.050.500.408.578
endothelin-1: D12.644.276.400.225, D12.776.467.400.225, D23.529.400.225
noise: G01.750.770.776.567, G16.500.275.600, N06.230.400, N06.850.460.610
bone morphogenetic proteins: D12.644.276.954.200, D12.776.467.942.200, D23.529.942.200
cartilage: A02.165, A10.165.382
adrenergic agents: D27.505.519.625.050, D27.505.696.577.050
myocardium: A02.633.580, A07.541.704, A10.690.552.750
nerve growth factors: D12.644.276.860, D12.776.467.860, D12.776.641.600, D23.529.850
neuropeptide y: D12.644.400.500, D12.776.641.650.500
rats, inbred dahl: B01.050.050.157.760.165, B01.050.050.199.520.760.165, B01.050.150.900.649.865.635.505.700.400.165
sympathetic nervous system: A08.800.050.800
suspensions: D20.280.810, D26.255.165.810, D27.720.280.165.810
toxicity tests, acute: E05.940.790
toxicity tests, chronic: E05.940.800
drinking: G07.610.593.260.249, G07.700.620.260.249, G10.261.326.240.249
sexual maturation: G07.700.320.750.750, G08.686.785.880.750
genitalia, male: A05.360.444
inhalation exposure: N06.850.460.350.112
hemorrhage: C23.550.414
stachybotrys: B01.300.381.840
bicyclo compounds, heterocyclic: D02.455.426.100.080.085, D03.438.260, D03.605.084, D04.075.080.875
nicotinic agonists: D27.505.519.625.120.140.700, D27.505.696.577.120.140.700
no-observed-adverse-effect level: E05.940.600, G07.690.620
pyridines: D03.383.725
quinuclidinyl benzilate: D02.241.223.601.238.306.740, D02.241.511.085.740, D03.605.687.800
receptors, nicotinic: D12.776.157.530.400.400.100.500, D12.776.543.550.425.500.100.500, D12.776.543.585.400.500.100.500, D12.776.543.750.051.687, D12.776.543.750.720.360.550
cardiomegaly: C14.280.195, C23.300.775.250
physical conditioning, animal: G11.427.590.530.698.277.280
dna replication: G02.111.087.222, G02.149.115.222, G05.355.200
peroxisomes: A11.284.430.214.190.500.585.600, A11.284.430.214.190.875.190.190.755.600
charadriiformes: B01.050.150.900.248.150
phosphatidylcholines: D10.570.755.375.760.400.800
phosphatidylethanolamines: D10.570.755.375.760.400.840
brain edema: C10.228.140.187
magnesium sulfate: D01.524.550, D01.875.800.800.850.500
nootropic agents: D27.505.954.427.637
potassium chloride: D01.210.450.150.750, D01.745.625
denervation: E04.525.210
nadph dehydrogenase: D08.811.682.608.550
nerve regeneration: G11.561.600.615, G16.100.856.611
nitric oxide synthase: D08.811.682.664.500.772
nitric oxide synthase type i: D08.811.682.664.500.772.249
olfactory bulb: A08.186.211.464.699.573, A08.186.211.730.885.600.573
olfactory mucosa: A04.531.520.573, A04.760.600.640, A09.531.623, A10.615.550.760.600.640
olfactory receptor neurons: A04.531.520.573.580, A04.760.600.640.640, A08.663.650.915.500.540, A08.800.950.500.540, A09.531.623.580, A10.615.550.760.600.640.640, A11.671.650.915.500.540
copper sulfate: D01.875.800.800.850.150
muramidase: D08.811.277.450.642
dietary fats: D10.212.302, J02.500.375
hepatomegaly: C06.552.416, C23.300.775.525
hyperplasia: C23.550.444
iodide peroxidase: D08.811.682.732.525
islets of langerhans: A03.734.414, A06.407.414
muridae: B01.050.150.900.649.865.635
pancreatic diseases: C06.689
rupture, spontaneous: C23.300.909
triiodothyronine: D06.472.931.740.385, D12.125.072.050.767.741.894
weight gain: C23.888.144.243.926, G07.700.320.249.314.120.200.926
methyl ethers: D02.355.601
receptors, cell surface: D12.776.543.750
receptors, dopamine: D12.776.543.750.070.300.400, D12.776.543.750.100.150.400, D12.776.543.750.720.300.300.400
thyroid function tests: E01.370.374.750
estrus: G08.686.195.500
methoxychlor: D02.455.526.439.610
ovariectomy: E04.270.282.685, E04.950.165.685, E04.950.300.680
receptors, progesterone: D12.776.260.698.750.765, D12.776.826.750.765, D12.776.930.669.750.765
biphenyl compounds: D02.455.426.559.389.185
sperm count: E01.370.225.500.195.870, E01.370.225.992.624, E05.200.500.195.870, E05.200.992.624, E05.242.195.870, G04.170.870
benzo(a)pyrene: D02.455.426.559.847.799.306.300, D04.615.799.306.300
copepoda: B01.050.500.131.365.160
administration, cutaneous: E02.319.267.120.060
anti-infective agents, local: D27.505.954.122.187
feces: A12.459
amino acid sequence: G02.111.570.060, L01.453.245.667.060
blotting, northern: E05.196.401.095, E05.301.300.074, E05.393.525.100, E05.601.140
molecular sequence data: L01.453.245.667
veterinary: 
sequence alignment: E05.393.751
ubiquitin thiolesterase: D08.811.277.352.897.850
arginine: D12.125.068.050, D12.125.095.104, D12.125.142.087
carotid arteries: A07.231.114.186
free radical scavengers: D27.505.519.217.500
phenylephrine: D02.033.100.291.617, D02.092.063.291.617
serotonin: D02.092.211.215.801.852, D03.438.473.914.814, D23.469.050.650
cos cells: A11.251.210.172.500, A11.329.228.220
genes, reporter: G05.360.340.024.340.435
receptors, cytoplasmic and nuclear: D12.776.260.698, D12.776.826, D12.776.930.669
receptors, steroid: D12.776.260.698.750, D12.776.826.750, D12.776.930.669.750
stimulation, chemical: G07.690.812.850, G07.700.680.850
ouabain: D04.808.155.160.861.600, D04.808.155.580.130.750.600, D09.408.180.810.600
sciatic nerve: A08.800.800.720.450.760
prosencephalon: A08.186.211.730
avoidance learning: F02.463.425.097
behavior, animal: F01.145.113
fullerenes: D01.268.150.250, J01.637.512.600.612.350
oligochaeta: B01.050.500.091.657
carps: B01.050.150.900.493.200.244.248
chlorfenvinphos: D02.705.400.120
gonads: A05.360.576, A06.407.312
water movements: G16.500.240.960, N06.230.132.644.750, N06.230.850
biocompatible materials: D25.130, D27.720.102.130, J01.637.051.130
cytochrome p-450 cyp2b1: D08.244.453.040.888, D08.811.682.690.708.170.040.499, D12.776.422.220.453.040.777
nadph-ferrihemoprotein reductase: D08.811.682.608.191.500
siloxanes: D01.837.800, D02.715.650, D05.750.900, D25.720.900, J01.637.051.720.900
steroid hydroxylases: D08.244.453.915, D08.811.682.690.708.170.915, D08.811.682.690.708.783, D12.776.422.220.453.915
acyl-coa oxidase: D08.811.682.660.150.200, D12.776.331.149
heptanoic acids: D10.251.450
orchiectomy: E04.270.282.679, E04.950.165.679, E04.950.774.860.618
gelatinases: D08.811.277.656.300.480.252, D08.811.277.656.675.374.252
matrix metalloproteinase 3: D08.811.277.656.300.480.525.700.200, D08.811.277.656.675.374.525.700.200
crystallins: D12.776.306.366
pentetic acid: D02.092.782.590, D02.241.081.018.639
bufonidae: B01.050.150.900.090.180.210
forelimb: A13.395
hindlimb: A13.473
ranidae: B01.050.150.900.090.180.708
survival analysis: E05.318.740.998, N05.715.360.750.795, N06.850.520.830.998
aneuploidy: C23.550.210.050, G05.365.590.175.050, G05.700.131
mitotic index: E01.370.225.500.385.500, E05.200.500.385.500, E05.242.385.500
endocardial cushion defects: C14.240.400.560.350, C14.280.400.560.350, C16.131.240.400.560.350
mesoderm: A16.504.660
transforming growth factor beta: D12.644.276.374.687, D12.644.276.954.800.720, D12.644.276.963.720, D12.776.467.374.687, D12.776.467.942.800.720, D12.776.467.960.720, D23.529.374.687, D23.529.942.800.720, D23.529.960.720
alanine transaminase: D08.811.913.477.700.100
aspartate aminotransferases: D08.811.913.477.700.225
hypoglycemic agents: D27.505.696.422
injections, intravenous: E02.319.267.082.750, E02.319.267.530.540
lumbosacral plexus: A08.800.800.720.450
metformin: D02.078.370.141.450
drinking behavior: F01.145.317
motor activity: F01.145.632, G11.427.590.530.698
luteinizing hormone: D06.472.699.322.576.463, D06.472.699.631.525.343.463, D12.644.548.691.525.343.463
seminal vesicles: A05.360.444.713
cochlea: A09.246.631.246
injuries: 
evoked potentials, auditory: G07.265.500.370, G11.561.270.370
hair cells, auditory, outer: A08.663.650.250.315, A08.663.650.915.750.600.350.365, A08.800.950.750.600.350.365, A09.246.631.246.577.325.380, A11.671.650.250.315, A11.671.650.915.750.600.350.365
hearing: F02.830.816.263, G11.561.600.810.263
hearing loss, noise-induced: C09.218.458.341.887.460, C10.597.751.418.341.887.460, C23.888.592.763.393.341.887.460
organ of corti: A09.246.631.246.577
biodegradation, environmental: N06.850.460.375.500, N06.850.860.510.900.299
humic substances: D02.241.444, D02.455.426.559.389.657.377, D20.721.500
adjuvants, immunologic: D27.505.696.477.067
lymphocyte count: E01.370.225.500.195.107.595.500, E01.370.225.625.107.595.500, E05.200.500.195.107.595.500, E05.200.625.107.595.500, E05.242.195.107.595.500, G04.170.107.595.500, G09.188.105.595.500
t-lymphocyte subsets: A11.118.637.555.567.550.500, A11.118.637.555.567.569.500, A15.145.229.637.555.567.550.500, A15.145.229.637.555.567.569.500, A15.382.490.555.567.550.500, A15.382.490.555.567.569.500
t-lymphocytes, regulatory: A11.118.637.555.567.550.500.700, A11.118.637.555.567.569.200.700, A11.118.637.555.567.569.500.700, A15.145.229.637.555.567.550.500.700, A15.145.229.637.555.567.569.200.700, A15.145.229.637.555.567.569.500.700, A15.382.490.555.567.550.500.700, A15.382.490.555.567.569.200.700, A15.382.490.555.567.569.500.700
animal feed: J02.500.300.100
seizures: C10.228.140.490.631, C10.597.742, C23.888.592.742
excitatory postsynaptic potentials: G04.580.887.249, G07.265.337.900.750.199, G07.265.750.887.249, G07.700.240.900.750.199, G11.561.570.918.249, G11.561.600.835.750.199
neuronal plasticity: G11.561.600.635
heterozygote: G05.380.383
rats, nude: B01.050.150.900.649.865.635.505.700.550.508
specific pathogen-free organisms: G06.320.676
thymectomy: E04.928.770
estrous cycle: G08.686.195
hypertrophy: C23.300.775
ovarian follicle: A05.360.319.114.630.535, A06.407.312.497.535
fibrosis: C23.550.355
platelet-derived growth factor: D12.644.276.910, D12.776.124.625, D12.776.467.910, D23.529.910
procollagen: D12.776.811.690, D12.776.860.300.250.600
receptors, platelet-derived growth factor: D08.811.913.696.620.682.725.400.900, D12.776.543.750.060.625, D12.776.543.750.750.400.630
acoustic stimulation: E02.037, E02.190.888.030, E05.723.136
auditory threshold: F02.463.593.071.173, F02.463.593.710.190
n-methylscopolamine: D02.145.074.722.822.550, D03.132.889.601.550, D03.605.869.822.550, D04.075.080.875.099.722.822.550
parasympatholytics: D27.505.696.663.050.650
synaptosomes: A11.284.835.859
gestational age: G07.700.320.500.325.235.968, G08.686.320
methane: D02.455.326.146.571
remission induction: E02.860
litter size: G08.686.530, G08.686.785.760.769.498.300
ciliary body: A09.371.060.160, A09.371.894.280
disseminated intravascular coagulation: C15.378.100.220, C15.378.463.250, C15.378.925.220
limbus corneae: A09.371.060.217.659
photoreceptor cells, vertebrate: A08.663.650.850.625.670, A08.663.650.915.937.670, A08.800.950.937.670, A09.371.729.831.625.670, A11.671.650.850.625.670, A11.671.650.915.937.670
retinal degeneration: C11.768.585
retinal hemorrhage: C11.290.807, C11.768.710, C23.550.414.756.775
thrombosis: C14.907.355.830
energy metabolism: G03.495.335
circadian rhythm: G07.180.562.190
telemetry: E01.370.520.750, E05.925, L01.178.847.675
mucus: A12.200.503
bronchial hyperreactivity: C08.127.210
ethyl ethers: D02.355.417
egg proteins: D12.776.290
salmo salar: B01.050.150.900.493.817.750.705.790
biogenic monoamines: D02.092.211.215
hypothalamus: A08.186.211.464.482, A08.186.211.730.317.357
locomotion: G07.700.560.500, G11.427.590.530.568
sexual behavior, animal: F01.145.113.252.748
vas deferens: A05.360.444.930
organogenesis: G07.700.320.500.325.377, G08.686.785.760.170.450
palaemonidae: B01.050.500.131.365.190.615
pigmentation: E01.370.600.620, G16.690
palmitoyl coenzyme a: D03.438.759.646.138.382.300.700, D08.211.211.300.700, D10.251.694.600.500, D13.695.667.138.382.300.700, D13.695.827.068.382.300.700
peroxisomal disorders: C10.228.140.163.100.680, C16.320.565.189.680, C16.320.565.663, C18.452.132.100.680, C18.452.648.189.680, C18.452.648.663
alkane 1-monooxygenase: D08.811.682.690.708.170.035
callithrix: B01.050.150.900.649.801.400.600.150.150.114
cell fractionation: E05.242.251
clofibrate: D02.241.081.114.968.500.500.195, D02.355.726.305.500.195, D02.455.426.559.389.657.654.305.500.195
salivary glands: A03.556.500.760, A10.336.779, A14.549.760
image cytometry: E01.370.225.500.386.400, E05.196.712.516.600.240.400, E05.200.500.386.400, E05.242.386.400
quartz: D01.578.750.600, D01.650.550.825.600, D01.837.725.600
eating: G07.610.593.260, G07.700.620.260, G10.261.326.240
carboxylesterase: D08.811.277.352.100.100
esterases: D08.811.277.352
metabolic detoxication, drug: G03.495.244.820, G07.690.812.097.600, G07.700.680.097.600
mice, transgenic: B01.050.050.136.500, B01.050.150.900.649.865.635.505.500.800
protein-serine-threonine kinases: D08.811.913.696.620.682.700
proto-oncogene proteins: D12.776.624.664.700
proto-oncogene proteins c-pim-1: D08.811.913.696.620.682.700.776, D12.776.624.664.700.191
ki-67 antigen: D12.776.660.625.500, D23.050.290.500, D23.101.840.400
octamer transcription factor-3: D12.776.260.655.500.300, D12.776.930.632.500.300
retinoblastoma protein: D12.776.260.704, D12.776.624.776.745, D12.776.660.807, D12.776.744.770
nephrons: A05.810.453.736
transaminases: D08.811.913.477.700
genital diseases, female: C13.351.500
brain chemistry: G02.111.100, G03.200
maze learning: F02.463.425.507
neurotransmitter agents: D27.505.519.625, D27.505.696.577
avidin: D12.776.034.614.300, D12.776.256.317.663.300, D12.776.290.663.100, D12.776.395.175
fluorescein-5-isothiocyanate: D02.455.426.559.847.885.347.400, D02.500.375.250, D02.886.250.250, D03.494.953.275.400, D04.615.885.347.400
motor neurons: A08.663.655.500, A11.671.655.500
nucleic acids: D13.444
spinal cord: A08.186.854
ca(2+) mg(2+)-atpase: D08.811.277.040.025.095
dna, single-stranded: D13.444.308.497, G02.111.570.790.486.437, G05.360.580.437
genetic vectors: G05.360.337
5-methylcytosine: D03.383.742.698.421.500
cytosine: D03.383.742.698.421
dichloroacetic acid: D02.241.081.018.214.500, D02.455.526.439.196.500
rubidium: D01.268.549.650, D01.268.556.800, D01.552.528.759, D01.552.544.800
tibial nerve: A08.800.800.720.450.760.820
ganglia, spinal: A08.340.390.340, A08.800.350.340, A08.800.800.720.725.350
nerve fibers: A08.663.542
spinal nerve roots: A08.800.800.720.725
tissue fixation: E01.370.225.500.620.760.720, E01.370.225.750.600.760.720, E05.200.500.620.760.720, E05.200.750.600.760.720
adrenomedullin: D06.472.699.077, D12.644.548.017
kidney glomerulus: A05.810.453.324.359, A05.810.453.736.520
kidney medulla: A05.810.453.466
kidney tubules, collecting: A05.810.453.736.560.510
peptides: D12.644
receptors, adrenomedullin: D12.776.543.750.100.041, D12.776.543.750.750.049
receptors, peptide: D12.776.543.750.750
renal circulation: G08.852.796.700, G09.330.190.163.812
ribonucleases: D08.811.277.352.700
clofibric acid: D02.241.081.114.968.500.500, D02.355.726.305.500, D02.455.426.559.389.657.654.305.500
fibric acids: D02.241.081.114.968.500, D02.355.726.305, D02.455.426.559.389.657.654.305
gerbillinae: B01.050.150.900.649.865.635.300
azinphosmethyl: D02.705.400.625.060, D02.705.539.345.060, D02.886.300.692.060
paracentrotus: B01.050.500.408.578.600
water pollution, chemical: N06.850.460.790.410
porphyrias, hepatic: C06.552.830, C16.320.565.708.400, C16.320.850.742, C17.800.827.742, C17.800.849.617.400, C18.452.648.708.400, C18.452.811.400, C18.452.880.617.400
uroporphyrins: D03.383.129.578.840.500.880, D03.549.909.500.880, D04.345.783.500.880, D23.767.727.880
aminooxyacetic acid: D02.092.570.050, D02.241.081.018.207
probenecid: D02.065.884.625, D02.886.590.700.625
renal agents: D27.505.954.613
birth weight: C23.888.144.186, E01.370.600.115.100.160.120.186, E05.041.124.160.750.149, G07.100.100.160.120.186, G07.700.320.249.314.120.186
growth: G07.700.320.249
urogenital system: A05
butylated hydroxyanisole: D02.355.601.200.324, D02.355.726.158.324, D02.455.426.559.389.657.654.158.324
rats, inbred lew: B01.050.050.157.760.280, B01.050.050.199.520.760.280, B01.050.150.900.649.865.635.505.700.400.280
luminescent measurements: E05.196.712.516
porphyria cutanea tarda: C06.552.830.250, C16.320.565.708.400.250, C16.320.850.742.250, C17.800.827.742.250, C17.800.849.617.400.250, C18.452.648.708.400.250, C18.452.811.400.250, C18.452.880.617.400.250
antibody formation: G12.425.071
blood cell count: E01.370.225.500.195.107, E01.370.225.625.107, E05.200.500.195.107, E05.200.625.107, E05.242.195.107, G04.170.107, G09.188.105
blood chemical analysis: E01.370.225.124.100, E05.200.124.100
glial fibrillary acidic protein: D05.750.078.593.400, D12.776.220.475.400
2,4-dichlorophenoxyacetic acid: D02.241.081.018.386.682.224, D02.241.511.316.682.149
agrochemicals: D27.720.031
drug-induced liver injury: C06.552.195, C25.100.562, C25.723.260
phospholipids: D10.570.755, D10.695
sphingomyelins: D09.400.410.420.525.870, D10.390.470.675.870, D10.570.755.893, D10.570.877.360.612.870
crown-rump length: E01.370.600.115.100.160.100.500, E05.041.124.160.500.500, G07.100.100.160.100.500, G07.100.100.250, N06.850.505.200.100.400
encephalocele: C10.500.680.488, C16.131.666.680.488, C23.300.707.186
hydrocephalus: C10.228.140.602, C10.228.140.631.450
valproic acid: D02.241.081.944.509.900, D10.251.400.895.593.900
hypersensitivity, delayed: C20.543.418
immunity, cellular: G12.450.050.400
interferon-gamma: D12.644.276.374.440.893, D12.644.276.374.480.350, D12.644.276.374.480.615.350, D12.644.276.718.550, D12.776.467.374.440.893, D12.776.467.374.480.350, D12.776.467.374.480.615.350, D12.776.467.718.550, D23.529.374.440.893, D23.529.374.480.350, D23.529.374.480.615.350, D23.529.718.550
interleukin-2: D12.644.276.374.465.502, D12.644.276.374.480.372, D12.776.467.374.465.502, D12.776.467.374.480.372, D23.529.374.465.502, D23.529.374.480.372
killer cells, natural: A11.118.637.555.567.537, A15.145.229.637.555.567.537, A15.382.490.555.567.537
superoxides: D01.248.497.158.685.750.850, D01.339.431.374.850, D01.339.431.750, D01.650.550.750.800
tibia: A02.835.232.043.650.883
antibody-producing cells: A11.063, A15.382.032
interleukin-6: D12.644.276.374.465.506, D12.776.467.374.465.506, D23.529.374.465.506
suppressor factors, immunologic: D12.644.276.374.480.700, D12.776.467.374.480.700, D23.529.374.480.700
cytosol: A11.284.430.214.200, A11.284.430.429.200, A11.284.835.450.200
angiosperms: B01.650.940.800.575.100
blood glucose: D09.546.359.448.500
hemoglobin a, glycosylated: D09.408.375, D12.776.124.400.405.440, D12.776.422.316.762.380.440
insulin: D06.472.699.587.200.500.625, D12.644.548.586.200.500.625
phytotherapy: E02.190.755
starch: D05.750.078.562.855, D09.698.365.855
thiobarbituric acid reactive substances: D02.047.700.700, D27.720.470.410.750
piperonyl butoxide: D03.383.246.118.600, D03.438.115.600
myometrium: A02.633.570.500, A05.360.319.679.690, A10.690.467.500
salmonidae: B01.050.150.900.493.817.750
mucous membrane: A10.615.550
conditioning, operant: F02.463.425.179.509
motivation: F01.658, F01.752.543.500.750
reinforcement schedule: F02.463.425.770.644
polyvinyls: D02.455.326.271.665.616, D02.455.326.271.884.533, D05.750.716.721, D25.720.716.721, J01.637.051.720.716.721
epoxide hydrolases: D08.811.277.340
glucuronosyltransferase: D08.811.913.400.450.480
9,10-dimethyl-1,2-benzanthracene: D02.455.426.559.847.149.301, D04.615.149.301
melatonin: D03.438.473.914.481, D06.472.506
peptidyl-dipeptidase a: D08.811.277.656.350.350.687, D23.050.301.264.035.585, D23.101.100.110.585
brain stem: A08.186.211.132
electrodes, implanted: E07.305.250.319, E07.695.202
hand strength: E01.370.600.425.500, G11.427.560.500
ethinyl estradiol: D04.808.668.651.568.291, D06.472.334.851.437.968.500
genitalia: A05.360
adenoma, liver cell: C04.557.470.035.120, C04.588.274.623.040, C06.301.623.040, C06.552.697.040
carcinoma, hepatocellular: C04.557.470.200.025.255, C04.588.274.623.160, C06.301.623.160, C06.552.697.160
polymorphism, single-stranded conformational: G05.365.795.600
trans-activators: D12.776.260.755, D12.776.930.900, D12.776.964.925.984
beta catenin: D12.776.091.249, D12.776.220.145.500, D12.776.930.130
chemoprevention: E02.319.162
curcuma: B01.650.940.800.575.100.975.900.166
curcumin: D02.455.326.146.485.222.222, D02.455.426.559.389.657.166.200, D02.455.426.559.694.222
garcinia kola: B01.650.940.800.575.100.928.249.333.400
testicular diseases: C12.294.829, C19.391.829
gamma-glutamyltransferase: D08.811.913.050.200.500
duodenum: A03.556.124.684.124, A03.556.875.249
esophagus: A03.556.875.500
paternal exposure: N06.850.460.350.700
substantia nigra: A08.186.211.132.659.822.731, A08.186.211.653.822.731
copulation: F01.145.113.252.748.200
preoptic area: A08.186.211.730.317.357.342.450
choline o-acetyltransferase: D08.811.913.050.134.180
hemicholinium 3: D02.092.877.435, D02.675.276.435
synapses: A08.850, A11.284.149.165.420.780
olfactory nerve: A08.800.800.120.640
electrophoresis, agar gel: E05.196.401.153, E05.301.300.100
ppar alpha: D12.776.260.698.239.500, D12.776.826.239.500, D12.776.930.669.239.500
deficiency: 
half-life: G01.910.405
absorption: G02.149.023, G02.149.767.019, G02.842.750.019, G03.495.023
proto-oncogene proteins c-myc: D12.776.260.676, D12.776.624.664.700.189, D12.776.660.765
tetradecanoylphorbol acetate: D02.455.849.291.500.510.850
anticarcinogenic agents: D27.505.696.706.018, D27.505.954.248.125, D27.720.799.018
soybeans: B01.650.940.800.575.100.401.750, J02.500.300.100.900, J02.500.850.500.700
bone development: G07.700.320.500.325.377.625.100, G11.427.590.560.100
limb deformities, congenital: C05.660.585, C16.131.621.585
pesticide synergists: D27.720.031.700.748, D27.720.723.748, D27.888.723.748
dihydropyridines: D03.383.725.203
fibronectins: D12.776.377.715.390, D12.776.395.550.350, D12.776.543.550.350, D12.776.860.300.450
fear: F01.470.361
multiple chemical sensitivity: C20.543.312.500, C21.223.500
glomerulosclerosis, focal segmental: C12.777.419.570.363.660, C13.351.968.419.570.363.640
glucose intolerance: C18.452.394.952.500
renin-angiotensin system: G03.495.805, G09.330.190.400.750
fatty acids, nonesterified: D10.251.310
lipoxygenase inhibitors: D27.505.519.389.480
nordihydroguaiaretic acid: 
triglycerides: D10.351.801
chromatography: E05.196.181
proto-oncogenes: G05.360.340.024.340.375.500.791
phyllanthus: B01.650.940.800.575.100.350.622
protective agents: D27.505.696.706, D27.720.799
renin: D08.811.277.656.074.500.780, D08.811.277.656.300.048.780, D08.811.277.656.837.750
population dynamics: I01.240.600, N01.224.625, N06.850.505.400.700
anisoles: D02.355.601.200, D02.355.726.158, D02.455.426.559.389.657.654.158
benzodioxoles: D03.383.246.118, D03.438.115
caffeic acids: D02.241.223.200.054
catechols: D02.455.426.559.389.657.166
nucleic acid hybridization: E05.393.661, G02.111.087.620, G02.149.115.620
receptors, cytokine: D12.776.543.750.705.852
receptors, interleukin-2: D12.776.543.750.705.852.420.320
congenital abnormalities: C16.131
death: C23.550.260
bass: B01.050.150.900.493.602.105
environmental policy: I01.655.500.608.180, I01.880.604.825.608.180, N03.623.500.608.180, N06.230.204
european union: I01.615.500.250.300, Z01.586.300
organomercury compounds: D02.691.750
portugal: Z01.542.727
seawater: G16.500.275.810, N06.230.580
drug residues: N06.850.460.200.250
mites: B01.050.500.131.166.132.419
instillation, drug: E02.319.267.641
antimetabolites: D27.505.519.186, D27.888.569.042
buthionine sulfoximine: D02.886.030.676.620.125, D12.125.166.676.620.125
rats, mutant strains: B01.050.150.900.649.865.635.505.700.550
injections, intradermal: E02.319.267.530.620.410
autoradiography: E01.370.225.750.132, E05.200.750.132, E05.799.256
respiratory system: A04
disease susceptibility: C23.550.291.687, G07.100.250
radiation injuries, experimental: C26.733.720, E05.598.500.750, N06.850.810.300.360.285
whole-body irradiation: E02.815.814, E05.980
carcinoma, medullary: C04.557.465.625.650.240.315, C04.557.470.200.025.370.315, C04.557.470.615.315, C04.557.580.625.650.240.315
fibroadenoma: C04.557.450.565.590.595.350, C04.557.470.625.350
mammary neoplasms, animal: C04.588.531, C22.520
parathion: D02.705.400.625.600, D02.705.539.345.600, D02.886.300.692.600
pituitary gland, anterior: A06.407.747.500, A06.688.357.750.500, A08.186.211.730.317.357.352.435.500.500, A08.713.357.750.500
acetylthiocholine: D02.092.877.883.333.800.030, D02.675.276.232.800.030, D02.886.489.789.030
benzenaminium, 4,4'-(3-oxo-1,5-pentanediyl)bis(n,n-dimethyl-n-2-propenyl-), dibromide: D02.092.146.290
physostigmine: D02.241.081.251.583.682, D03.132.436.545, D03.438.473.402.545
gonadal dysgenesis: C12.706.316.309, C13.351.875.253.309, C16.131.939.316.309, C19.391.119.309
cocarcinogenesis: C04.697.098.875, C23.550.727.098.750
palpation: E01.370.600.600
anisotropy: G01.590.040, G02.842.050
microscopy: E01.370.350.515, E05.595, H01.671.617.562
nerve fibers, myelinated: A08.663.542.512, A11.671.514
optic nerve: A08.800.800.120.680
protons: D01.248.497.300.459.700, D01.435.550, G01.249.765
blastocyst: A16.254.500
monoterpenes: D02.455.849.575
aortic diseases: C14.907.109
arteriosclerosis: C14.907.137.126
hypercholesterolemia: C18.452.584.500.500.396
hyperinsulinism: C18.452.394.968
insulin resistance: C18.452.394.968.500, G07.690.320.617
receptors, ldl: D12.776.543.750.710.450
medulla oblongata: A08.186.211.132.810.406, A08.186.211.865.467.500
pons: A08.186.211.132.810.428.600, A08.186.211.865.428.600
immunosuppressive agents: D27.505.696.477.656
organotin compounds: D02.691.850
mice, mutant strains: B01.050.150.900.649.865.635.505.500.550
wallerian degeneration: C23.550.737.750
sheep: B01.050.150.900.649.077.380.791
iodine radioisotopes: D01.496.448.496, D01.496.749.474
thyroid gland: A06.407.900
thyroxine: D06.472.931.812, D12.125.072.050.767
chironomidae: B01.050.500.131.617.289.260
bromodeoxyuridine: D03.383.742.680.852.300.150, D13.570.230.430.196, D13.570.685.852.300.150
proliferating cell nuclear antigen: D12.776.660.740, D23.050.290.750, D23.101.840.600
seminiferous tubules: A05.360.444.849.700
trigeminal ganglion: A08.340.390.850, A08.800.350.850, A08.800.800.120.760.825
cyclohexenes: D02.455.426.392.368.367.379
smell: F02.830.816.643, G11.561.600.810.643
astringents: D27.505.696.207, D27.505.954.444.100
fetal death: C13.703.243, C23.550.260.460
acid phosphatase: D08.811.277.352.650.025
cattle diseases: C22.196
horse diseases: C22.488
kentucky: Z01.107.567.875.075.400, Z01.107.567.875.510.400
osteochondritis: C05.116.791, C05.182.520, C17.300.182.520
leukemia, experimental: C04.557.337.372, C04.619.531, E05.598.500.496.500
rana ridibunda: B01.050.150.900.090.180.708.360
dietary supplements: J02.500.456
fish oils: D10.627.430
catalepsy: C10.597.350.200, C23.888.592.350.200
exploratory behavior: F01.145.387, F01.658.370
hindlimb suspension: E05.472.760.370, E05.977.400, N06.230.150.440.950.400
breeding: E05.820.150, G05.355.090
chickens: B01.050.150.900.248.350.150, B01.050.150.900.248.617.192
water pollution: N06.850.460.790
cyclohexanes: D02.455.426.392.368.367
sperm-ovum interactions: G08.686.785.760.277.800
polychaeta: B01.050.500.091.700
zygote: A05.360.490.690.970, A11.497.497.950, A16.950
androgens: D27.505.696.399.472.161
cryptorchidism: C12.294.829.258, C12.706.258, C16.131.939.258, C19.391.829.258
sex differentiation: G07.700.320.500.325.377.843, G07.700.320.750.500, G08.686.785.880.500
alligators and crocodiles: B01.050.150.900.833.100
aminoimidazole carboxamide: D03.383.129.308.030
bicyclo compounds: D02.455.426.100.080, D04.075.080
hydantoins: D03.383.129.308.432.555
ketoconazole: D03.383.606.560
linuron: D02.455.426.559.389.703.515, D02.948.681.515
dentate gyrus: A08.186.211.464.405.200, A08.186.211.730.885.287.500.345.200
long-term potentiation: G11.561.600.635.350
dietary fats, unsaturated: D10.212.302.380, J02.500.375.400
linoleic acid: D10.251.355.310.515.500, D10.251.355.343.500.500
bradykinin: D12.644.276.812.169, D12.644.400.090, D12.644.456.193, D12.776.467.812.169, D12.776.641.650.090, D23.469.050.375.110, D23.529.812.169
receptors, bradykinin: D12.776.543.750.100.080, D12.776.543.750.720.600.220, D12.776.543.750.750.555.220
anti-inflammatory agents: D27.505.954.158
cysteine proteinase inhibitors: D27.505.519.389.745.325
gadolinium: D01.268.477.484, D01.268.558.362.484, D01.552.550.399.484
kupffer cells: A11.329.372.588, A11.627.482.588, A11.733.397.588, A15.382.680.397.588, A15.382.812.522.588
vacuoles: A11.284.430.214.190.875.190.920
endocrine glands: A06.407
cyclophosphamide: D02.455.526.728.650.730.243, D02.705.672.500.243
nitrosamines: D02.654.442
adenosine: D03.438.759.590.138, D13.570.583.138, D13.570.800.096
methyltransferases: D08.811.913.555.500
s-adenosylhomocysteine: D02.886.030.498.050, D03.438.759.590.138.240, D12.125.166.498.050, D13.570.583.138.240, D13.570.800.096.262
s-adenosylmethionine: D02.886.030.676.180, D03.438.759.590.138.264, D12.125.166.676.180, D13.570.583.138.264, D13.570.800.096.264
aniline compounds: D02.092.146
carbon tetrachloride: D02.455.526.439.150
drug antagonism: G07.690.812.240.310, G07.700.680.240.310
drug toxicity: 
electrophoresis: E05.196.401, E05.301.300
interleukin-1: D12.644.276.374.465.501, D12.644.276.374.500.400, D12.776.467.374.465.501, D12.776.467.374.500.400, D23.529.374.465.501, D23.529.374.500.400
rana esculenta: B01.050.150.900.090.180.708.240
second messenger systems: G02.111.087.800.800, G02.149.115.800.800, G04.299.880.800
aorta: A07.231.114.056
muscle relaxation: G11.427.590.540.554
muscle, smooth, vascular: A02.633.570.491, A07.231.491, A10.690.467.491
vasodilation: G09.330.190.400.925
conditioning (psychology): F02.463.425.179
learning disorders: C10.597.606.150.550, C23.888.592.604.150.550, F03.550.350.500, F03.550.450
chloral hydrate: D02.033.455.250.130
chloroacetates: D02.241.081.018.214, D02.455.526.439.196
subcellular fractions: A11.284.835
conflict (psychology): F01.658.209
postural balance: G11.427.690, G11.561.600.810.541.595
mesenteric arteries: A07.231.114.565
ng-nitroarginine methyl ester: D12.125.068.050.525, D12.125.095.104.525
proteinuria: C12.777.934.734, C13.351.968.934.734, C23.888.942.750
methylnitrosourea: D02.654.692.480, D02.948.594.490
proto-oncogene proteins c-jun: D12.776.260.108.820, D12.776.624.664.700.182, D12.776.660.763, D12.776.930.127.820
transforming growth factor alpha: D12.644.276.963.700, D12.776.467.960.700, D23.529.960.700
gait: E01.370.600.250, G11.427.590.530.389
thiazolidinediones: D02.886.675.933, D03.383.129.708.933
sarcoplasmic reticulum: A10.690.552.500.500.850, A11.284.430.214.190.875.248.310.800
drug administration schedule: E02.319.283
life cycle stages: B05.500, G07.700.320.500.550.500
nose neoplasms: C04.588.149.721.600, C04.588.443.665.650, C05.116.231.754.600, C08.460.669, C08.785.600, C09.603.669, C09.647.685
papilloma: C04.557.470.700.600
gaba modulators: D27.505.519.625.240.500, D27.505.696.577.240.500
heparin: D09.698.373.400
lipoprotein lipase: D08.811.277.352.100.430
nifedipine: D03.383.725.203.540
phenethylamines: D02.092.471.683
vasodilator agents: D27.505.954.411.918
fatty liver: C06.552.241
soybean oil: D10.212.302.380.800, D10.212.507.800, D10.627.700.880, D20.215.784.750.880, J02.500.375.400.750
alpha-linolenic acid: D10.212.302.380.410.100, D10.251.355.310.640.400, D10.251.355.337.100, D10.251.355.450.400
immunoenzyme techniques: E05.478.566.350, E05.478.583.400, E05.601.495.350
microsomes: A11.284.835.540
dizocilpine maleate: D02.455.426.559.847.181.384.380, D04.615.181.384.380
receptors, n-methyl-d-aspartate: D12.776.157.530.400.400.500.500, D12.776.543.550.425.500.200.500, D12.776.543.585.400.500.200.500, D12.776.543.750.720.200.450.400.500
aromatase: D08.244.453.915.099, D08.811.682.690.708.170.915.099, D08.811.682.690.708.783.099, D12.776.422.220.453.915.099
central nervous system stimulants: D27.505.696.282, D27.505.954.427.220
chromatography, gel: E05.196.181.400.250
isotope labeling: E05.522
uroporphyrinogen decarboxylase: D08.811.520.224.125.900
edema: C23.888.277
antibody-dependent cell cytotoxicity: G12.425.270.070
cytotoxicity, immunologic: G12.425.270
esters: D02.241.400
1-octanol: D02.033.415.600.600, D10.289.600.610
alcohols: D02.033
octanols: D02.033.415.600, D10.289.600
flounder: B01.050.150.900.493.418.438
quinones: D02.806
crosses, genetic: E05.393.281
diethylnitrosamine: D02.654.442.200
mice, inbred c3h: B01.050.050.157.520.388, B01.050.050.199.520.520.388, B01.050.150.900.649.865.635.505.500.400.388
mesocricetus: B01.050.150.900.649.865.635.150.500
biometry: E05.318.740.225, N06.850.505.200
adrenergic beta-antagonists: D27.505.519.625.050.200.200, D27.505.696.577.050.200.200
calcium channel blockers: D27.505.519.562.249, D27.505.954.411.192
felodipine: D03.383.725.203.250
metoprolol: D02.033.100.624.698.573, D02.033.755.624.550, D02.033.755.624.698.573, D02.092.063.624.698.573
coproporphyrins: D03.383.129.578.840.500.250, D03.549.909.500.250, D04.345.783.500.250, D23.767.727.250
chorion: A10.615.284.473, A16.254.750.473
fish diseases: C22.362
gastrula: A16.331.600
microinjections: E02.319.267.530.690, E05.591.570
vitelline membrane: A16.690.886
zebrafish: B01.050.150.900.493.200.244.828
colchicine: D03.132.225
l-iditol 2-dehydrogenase: D08.811.682.047.150.700.475
liver regeneration: G10.261.326.520, G16.100.856.468
s phase: G02.111.087.222.880, G02.149.115.222.880, G04.299.134.500.800, G05.355.200.880
cercopithecus aethiops: B01.050.150.900.649.801.400.112.199.120.126.110
neocortex: A08.186.211.730.885.287.500.420
thyroid hormones: D06.472.931
angiotensin ii type 2 receptor blockers: D27.505.519.162.750
collagen type i: D05.750.078.280.300.100, D12.776.860.300.250.300.100
matrix metalloproteinase 2: D08.811.277.656.300.480.205.352, D08.811.277.656.300.480.252.420, D08.811.277.656.300.480.525.700.150, D08.811.277.656.675.374.205.352, D08.811.277.656.675.374.252.420, D08.811.277.656.675.374.525.700.150
mutation, missense: G05.365.590.650
natriuretic peptide, brain: D06.472.699.584.625, D12.644.548.585.625, D12.776.641.590
receptor, angiotensin, type 1: D12.776.543.750.100.047.625, D12.776.543.750.720.600.150.625, D12.776.543.750.750.130.750, D12.776.543.750.750.555.150.750
receptor, angiotensin, type 2: D12.776.543.750.100.047.687, D12.776.543.750.720.600.150.687, D12.776.543.750.750.130.875, D12.776.543.750.750.555.150.875
receptors, atrial natriuretic factor: D08.811.520.650.600.500.500, D12.776.543.750.120.500, D12.776.543.750.720.600.170, D12.776.543.750.750.160, D12.776.543.750.750.555.170
transforming growth factor beta1: D12.644.276.374.687.100, D12.644.276.954.800.720.100, D12.644.276.963.720.100, D12.776.467.374.687.100, D12.776.467.942.800.720.100, D12.776.467.960.720.100, D23.529.374.687.100, D23.529.942.800.720.100, D23.529.960.720.100
cholesterol, hdl: D10.532.432.400, D10.570.938.208.270, D12.776.521.479.470
pan troglodytes: B01.050.150.900.649.801.400.112.400.620
allethrin: D02.455.849.575.812.272
innervation: 
neural inhibition: G07.265.337.615, G07.700.240.615, G11.561.600.625
reflex, abnormal: C10.597.704, C23.888.592.717, E01.370.376.550.650.655, E01.370.600.550.650.655, G11.561.600.765.587
sulfates: D01.248.497.158.845, D01.875.800.800.850
retinal horizontal cells: A08.663.650.850.937, A09.371.729.831.937, A11.671.650.850.937
forskolin: 
rana pipiens: B01.050.150.900.090.180.708.310
falconiformes: B01.050.150.900.248.250, B01.050.150.900.248.815.350
phenyl ethers: D02.355.726, D02.455.426.559.389.657.654
cell enlargement: G04.299.233.500, G07.700.320.249.410.500
endocrine system diseases: C19
muscle strength: E01.370.600.425, G11.427.560
salivation: G07.610.593.220.800, G07.700.620.220.800, G10.261.326.222.800
glucose tolerance test: E01.370.225.124.100.355, E01.370.374.355, E05.200.124.100.355
locus coeruleus: A08.186.211.132.659.473, A08.186.211.132.810.428.600.500, A08.186.211.653.473, A08.186.211.865.428.600.500
prazosin: D03.438.786.750
spermatids: A05.360.490.890.860, A11.497.760.600
hypertension, renal: C12.777.419.331, C13.351.968.419.331, C14.907.489.631
chorionic gonadotropin: D06.472.699.322.326, D06.472.699.649.367, D12.644.548.726.367, D12.776.780.400
macaca fascicularis: B01.050.150.900.649.801.400.112.199.120.510.520
chlorella: B01.650.940.150.469
population density: N01.224.600, N06.850.505.400.600
population growth: I01.240.600.660, N01.224.625.660, N06.850.505.400.700.660
rotifera: B01.050.500.500.770
vaginal smears: E01.370.225.500.384.100.800, E01.370.225.998.054.800, E01.370.378.900, E04.074.800, E05.200.500.384.100.800, E05.200.998.054.800, E05.242.384.100.800
coumestrol: D03.438.150.266.450.400.187, D03.438.150.446.350, D03.830.219.266.450.400.187, D03.830.219.446.350
catfishes: B01.050.150.900.493.080
ddt: D02.455.526.439.255
animal nutritional physiological phenomena: G07.610.161
phosphorus: D01.268.666
molting: G07.700.320.500.550.750
animal fins: A13.077
xenopus: B01.050.150.900.090.180.610.500
mammary glands, animal: A10.336.482, A13.589
proteome: D12.776.817
puberty: G08.686.760, G08.686.785.880.374
soy foods: J02.500.850.500.700.500
phosphoric monoester hydrolases: D08.811.277.352.650
albumins: D12.776.034
tail: A13.895
citric acid: D02.241.081.901.434.249
excipients: D26.650.700.419, D27.720.744.770.419
gills: A13.421
gum arabic: D05.750.078.739.500, D09.698.700.500, D20.215.721.249.500
vitellogenesis: G04.299.151.650.249.880, G08.686.785.760.310.500.880
genes, dominant: G05.360.340.024.340.240, G05.420.320
genes, lethal: G05.360.340.024.340.350
translocation, genetic: C23.550.210.870, G05.355.600.860, G05.365.590.175.870
anura: B01.050.150.900.090.180
predatory behavior: F01.145.113.111.600, F01.145.113.252.520
salamandridae: B01.050.150.900.090.608.700
wetlands: G16.500.275.960, N06.230.124.625
nanofibers: J01.637.512.300
pleurisy: C08.528.735, C08.730.582
transforming growth factor beta2: D12.644.276.374.687.200, D12.644.276.954.800.720.200, D12.644.276.963.720.200, D12.776.467.374.687.200, D12.776.467.942.800.720.200, D12.776.467.960.720.200, D23.529.374.687.200, D23.529.942.800.720.200, D23.529.960.720.200
electrodes: E07.305.250
glucuronides: D02.241.081.844.915.162.500, D02.241.152.811.162.750, D02.241.511.902.915.162.750, D09.811.922.162.750
administration, intranasal: E02.319.267.080, E02.319.267.120.080
histocytochemistry: E01.370.225.500.607, E01.370.225.750.551, E05.200.500.607, E05.200.750.551, H01.158.100.656.234, H01.158.201.344, H01.181.122.573
macaca mulatta: B01.050.150.900.649.801.400.112.199.120.510.550
neutrophil infiltration: G12.425.898
azoxymethane: D02.172.080
colitis: C06.405.205.265, C06.405.469.158.188
dextran sulfate: D09.698.365.272.300
electrophoresis, gel, two-dimensional: E05.196.401.250, E05.196.401.402.250, E05.301.300.230, E05.301.300.319.450
wnt signaling pathway: G02.149.115.800.925
nervous system malformations: C10.500, C16.131.666
olfactory marker protein: D12.644.360.543, D12.776.476.543, D12.776.641.652
optical imaging: E01.370.350.589, E05.642
animals, wild: B01.050.050.300
rodentia: B01.050.150.900.649.865
slovakia: Z01.542.248.797, Z01.586.250.750
peritoneum: A01.923.047.025.600, A10.615.789.596
nf-e2-related factor 2: D12.776.260.108.737, D12.776.930.127.737
pneumocytes: A04.411.715.512, A11.436.714
aldehyde reductase: D08.811.682.047.150.700.075, D08.811.682.047.820.275
alpha-glucosidases: D08.811.277.450.420.050
carnivora: B01.050.150.900.649.147
ferrets: B01.050.150.900.649.147.550.350
mink: B01.050.150.900.649.147.550.500
cypriniformes: B01.050.150.900.493.200
genitalia, female: A05.360.319
penis: A05.360.444.492
ursidae: B01.050.150.900.649.147.890
caenorhabditis elegans: B01.050.500.500.294.700.700.660.250.250
caenorhabditis elegans proteins: D12.776.419.500
glutathione reductase: D08.811.682.667.092
chromosome painting: E01.370.225.500.620.670.325.350.125, E01.370.225.750.600.670.325.350.125, E05.200.500.620.670.325.350.125, E05.200.750.600.670.325.350.125, E05.393.285.350.125, E05.393.661.475.350.125
ducks: B01.050.150.900.248.050.200, B01.050.150.900.248.617.345
learning: F02.463.425, F02.784.629.529
nipples: A01.236.500
leydig cells: A05.360.444.849.513, A06.407.312.782.513, A11.382.906, A11.436.513
spermatogonia: A05.360.490.890.900, A11.497.760.800
nicotine: D03.132.760.570, D03.383.725.518
cyprinodontiformes: B01.050.150.900.493.850.280
growth and development: G07.700.320
ovoviviparity: G08.686.655
macromolecular substances: D05
gonadotropins, equine: D06.472.699.322.451, D06.472.699.649.451, D12.644.548.726.451, D12.776.780.451
ovulation induction: E02.875.800.984, E05.820.800.984
corticosterone: D04.808.745.745.654.237, D06.472.040.585.353.237
trees: B01.650.915
endpoint determination: E05.315
biomass: G16.500.275.157.100, N06.230.124.100
insects: B01.050.500.131.617
vimentin: D05.750.078.593.900, D12.776.220.475.900
ethyl methanesulfonate: D02.455.326.146.100.050.500.300, D02.886.645.600.055.050.510.300
fetal resorption: C13.703.243.300, C23.550.260.460.260
mutagenesis: G05.355.600
alaska: Z01.107.567.875.580.100
ecological and environmental processes: G16.500.240
food chain: G16.500.275.157.250, N06.230.124.250
atherosclerosis: C14.907.137.126.307
hematocrit: E01.370.225.625.400, E05.200.625.400, G09.188.370.374
conditioning, classical: F02.463.425.179.308
interleukin-1beta: D12.644.276.374.465.501.600, D12.644.276.374.500.400.600, D12.776.467.374.465.501.600, D12.776.467.374.500.400.600, D23.529.374.465.501.600, D23.529.374.500.400.600
neurogenic inflammation: C10.597.609, C23.550.470.448
neuroimmunomodulation: G07.265.337.620, G07.700.240.620, G11.561.600.630, G12.425.746.575
dna glycosylases: D08.811.074.249, D08.811.277.450.430.099
reticulocytes: A11.118.290.760, A11.148.790, A11.443.240.665, A15.145.229.334.760, A15.378.316.790
maximum tolerated dose: E05.940.481, G07.690.570
nanostructures: J01.637.512
myocardial infarction: C14.280.647.500, C14.907.585.500
zearalenone: D02.455.426.559.389.657.852.900, D02.540.950, D23.946.587.989
brain-derived neurotrophic factor: D12.644.276.860.100, D12.776.467.860.100, D12.776.641.600.100, D23.529.850.100
cyclic amp response element-binding protein: D12.776.260.108.184, D12.776.930.127.184
neurogenesis: G04.299.151.912, G07.700.320.500.325.377.687, G08.686.785.760.170.450.500
bacillus cereus: B03.300.390.400.158.218.252, B03.510.100.100.218.252, B03.510.415.400.158.218.252, B03.510.460.410.158.218.252
depsipeptides: D04.345.566.297, D12.644.641.297
enterotoxins: D23.946.330
food microbiology: H01.158.273.540.274.332, J01.576.423.850.730.500.249.300, N06.850.425.200, N06.850.460.400.300, N06.850.601.500.249.300
staphylococcus aureus: B03.300.390.400.800.750.100, B03.510.100.750.750.100, B03.510.400.790.750.100
gene expression profiling: E05.393.332
cyproterone acetate: D04.808.745.432.219.150, D04.808.883.419.150
disorders of sex development: C12.706.316, C13.351.875.253, C16.131.939.316, C19.391.119, F03.800.399
feminization: C23.888.378
metamorphosis, biological: G07.700.320.500.550
biological factors: D23
vasoconstriction: G09.330.190.400.920
tretinoin: D02.455.326.271.665.202.495.818.500, D02.455.426.392.368.367.379.249.700.860.500, D02.455.849.131.495.818.800, D23.767.261.700.780
abdominal fat: A10.165.114.830.500
diglycerides: D10.351.303
oils: D10.627
viscera: A01.960
flatfishes: B01.050.150.900.493.418
nitrophenols: D02.455.426.559.389.657.566, D02.640.743
cd4-cd8 ratio: E01.370.225.500.195.107.595.500.150.160, E01.370.225.625.107.595.500.150.160, E05.200.500.195.107.595.500.150.160, E05.200.625.107.595.500.150.160, E05.242.195.107.595.500.150.160, G04.170.107.595.500.150.160, G09.188.105.595.500.150.160, G12.248
zea mays: B01.650.940.800.575.100.822.966, J02.500.200.909, J02.500.300.100.977
vibrissae: A13.950
models, animal: E05.598
castration: E04.270.282, E04.950.165
anthracenes: D02.455.426.559.847.117, D04.615.117
glutarates: D02.241.081.337.351
in situ hybridization: E01.370.225.500.620.670.325, E01.370.225.750.600.670.325, E05.200.500.620.670.325, E05.200.750.600.670.325, E05.393.661.475
neomycin: D09.408.051.623
oxidopamine: D02.092.311.342.478.650
paclitaxel: D02.455.426.392.368.242.888.777, D02.455.849.291.850.777
bone marrow cells: A11.148, A15.378.316
plant preparations: D20.215.784
pacific ocean: Z01.756.700
biliary tract: A03.159
injections: E02.319.267.530
molecular imaging: E01.370.350.557, E05.601.567
multipotent stem cells: A11.872.590
nose: A01.456.505.733, A04.531, A09.531
fructokinases: D08.811.913.696.620.225
glucose transporter type 2: D12.776.157.530.500.500.750, D12.776.543.585.500.500.750
glucose transporter type 5: D12.776.157.530.500.500.968, D12.776.543.585.500.500.968
chemistry, pharmaceutical: H01.158.703.007, H01.181.466
rheum: B01.650.940.800.575.100.825.700, J02.500.850.700
anal canal: A03.556.124.526.070, A03.556.249.249.070
dna (cytosine-5-)-methyltransferase: D08.811.913.555.500.350.100.500
prostatitis: C12.294.565.750
gonadotropins: D06.472.699.322
bacterial toxins: D23.946.123
protein precursors: D12.776.811
fushi tarazu transcription factors: D12.776.260.400.155, D12.776.930.318
homeodomain proteins: D12.776.260.400
rana catesbeiana: B01.050.150.900.090.180.708.180
steroidogenic factor 1: D12.776.260.698.925, D12.776.826.925, D12.776.930.669.925
coturnix: B01.050.150.900.248.350.650.350
immunoglobulin m: D12.776.124.486.485.114.619.574, D12.776.124.790.651.114.619.574, D12.776.377.715.548.114.619.574
falkland islands: Z01.639.040.695
spheniscidae: B01.050.150.900.248.860
inheritance patterns: G05.420
embryo implantation, delayed: G08.686.785.760.170.104.500.100
genetic diseases, inborn: C16.320
corpus luteum: A05.360.319.114.630.278, A06.407.312.497.278
proestrus: G08.686.195.875
3-hydroxysteroid dehydrogenases: D08.811.682.047.436.350
glucuronidase: D08.811.277.450.426
hypothalamo-hypophyseal system: A06.688.357, A08.186.211.730.317.357.352.435, A08.713.357
amputation: E04.555.080
animal identification systems: E05.035
mercury compounds: D01.538
toes: A01.378.610.250.300.792
intra-abdominal fat: A10.165.114.830.500.500
triallate: D02.241.081.251.869.820, D02.886.706.850
trifluralin: D02.092.146.859.717, D02.455.426.559.389.832.767
silage: J02.500.300.100.800
malnutrition: C18.654.521
cocos: B01.650.940.800.575.100.093.211
basal ganglia: A08.186.211.730.885.287.249
dopamine and camp-regulated phosphoprotein 32: D12.776.641.249, D12.776.744.459
neural stem cells: A11.872.653
observer variation: E01.354.753, N02.421.450.600, N05.715.350.150.675, N06.850.490.500.250, N06.850.490.750
androgen-binding protein: D12.776.157.065
inhibins: D06.472.334.968, D06.472.699.337, D12.644.548.387, D12.776.395.439
polyethylene glycols: D02.033.455.250.700, D05.750.741, D25.720.741, J01.637.051.720.741
egg yolk: A16.690.325, J02.500.470.800
tocopherols: D03.438.150.909.750, D03.830.219.909.750
vitamin a: D02.455.326.271.665.202.495.818, D02.455.426.392.368.367.379.249.700.860, D02.455.849.131.495.818, D23.767.261.700.860
transcriptome: G02.111.087.847.750, G02.149.115.847.750, G05.355.310.700.750, G05.360.920
alkylation: G02.111.087.029, G02.149.115.029, G02.149.465.040, G02.607.750.040, G03.495.130
particle accelerators: E07.710.680
protamines: D12.776.660.750, D12.776.664.750
sperm head: A05.360.490.890.820, A11.497.760.400
apoptosis regulatory proteins: D12.644.360.075, D12.776.476.075
glycogen: D05.750.078.562.388, D09.698.365.388
estrone: D04.808.365.415.414, D04.808.578.502.497, D06.472.040.502.497, D06.472.334.851.437.996
uridine diphosphate glucuronic acid: D03.383.742.686.850.600.677.375, D09.408.620.569.727.375, D13.695.740.850.600.677.375, D13.695.827.708.727.375, D13.695.827.919.600.677.375
retina: A09.371.729
protoporphyrins: D03.383.129.578.840.500.725, D03.549.909.500.725, D04.345.783.500.725, D23.767.727.725
anti-obesity agents: D27.505.954.427.140
diet, high-fat: G07.610.240.267
obesity, abdominal: C18.654.726.500.697, E01.370.600.115.100.160.120.699.500.249, G07.100.100.160.120.699.500.249
ventricular remodeling: C23.300.985, G09.330.190.962.975
guanine: D03.438.759.758.399.454
anxiety: F01.470.132
nonlinear dynamics: E05.599.850, H01.548.675
swimming: G11.427.590.530.568.800, G11.427.590.530.698.277.875, I03.450.642.845.869
dopaminergic neurons: A08.663.278, A11.671.270
receptor, serotonin, 5-ht2a: D12.776.543.750.070.800.200.100, D12.776.543.750.100.800.200.100, D12.776.543.750.720.300.800.200.100
receptors, dopamine d2: D12.776.543.750.070.300.400.500, D12.776.543.750.100.150.400.500, D12.776.543.750.720.300.300.400.500
serotonergic neurons: A08.663.895, A11.671.895
diuron: D02.455.426.559.389.703.397, D02.948.681.397
liver cirrhosis, experimental: C06.552.630.467, E05.598.500.468
thioacetamide: D02.065.064.786, D02.065.900.890, D02.241.081.018.110.786, D02.886.685.800
protein multimerization: G02.111.087.697, G02.149.115.697
cholesterol ester transfer proteins: D09.400.430.750, D12.776.124.197, D12.776.157.165, D12.776.395.199
dyslipidemias: C18.452.584.500
acetyl-coa carboxylase: D08.811.464.257.050, D08.811.641.249
phosphoenolpyruvate carboxykinase (gtp): D08.811.520.224.125.550
phytosterols: D04.808.247.808.756
rats, zucker: B01.050.150.900.649.865.635.505.700.550.700
potassium channels: D12.776.157.530.400.600, D12.776.543.550.425.750, D12.776.543.585.400.750
primary cell culture: E01.370.225.500.223.500, E05.200.500.223.500, E05.240.249.500, E05.242.223.500
acute-phase proteins: D12.776.124.050
glucose transport proteins, facilitative: D12.776.157.530.500.500, D12.776.543.585.500.500
kidney tubules: A05.810.453.736.560
lipocalins: D12.776.157.469
mice, inbred dba: B01.050.050.157.520.500, B01.050.050.199.520.520.500, B01.050.150.900.649.865.635.505.500.400.500
receptors, ccr2: D12.776.543.750.100.160.150.200, D12.776.543.750.705.852.125.150.200, D23.050.301.264.035.605.150.200, D23.101.100.110.605.150.200
animal migration: F01.145.113.069.500
antarctic regions: Z01.158, Z01.639.019
succinate dehydrogenase: D05.500.562.750.249.500, D08.811.600.250.500.750.500, D08.811.600.250.875.249.500, D08.811.682.660.385.500, D08.811.682.660.750, D08.811.682.830.249.500, D12.776.157.427.374.375.909.500, D12.776.331.199.750.500, D12.776.543.277.500.750.500, D12.776.543.277.875.249.500, D12.776.556.579.374.375.141.500
gene knockout techniques: E05.393.335.750
gene expression regulation, enzymologic: G05.355.315.320
peroxidases: D08.811.682.732
in situ hybridization, fluorescence: E01.370.225.500.620.670.325.350, E01.370.225.750.600.670.325.350, E05.200.500.620.670.325.350, E05.200.750.600.670.325.350, E05.393.285.350, E05.393.661.475.350
plant roots: A18.400
proanthocyanidins: D03.438.150.266.450.700, D03.830.219.266.450.700, D05.750.078.937.429
technology, pharmaceutical: E05.916, H02.646.500, J01.897.836
drug carriers: D26.255.260, D27.720.280.260, E02.319.300.380
discrimination learning: F02.463.425.280
finasteride: D04.808.054.079.500, D04.808.925.100.250
ccaat-enhancer-binding protein-alpha: D12.776.260.108.124.500, D12.776.660.167.500, D12.776.930.127.124.500
lipogenesis: G02.111.087.525, G02.149.115.525, G03.495.520.249
ppar gamma: D12.776.260.698.239.588, D12.776.826.239.588, D12.776.930.669.239.588
sterol regulatory element binding protein 1: D12.776.260.103.500.750.500, D12.776.260.108.092.750.500, D12.776.930.125.500.750.500, D12.776.930.127.092.750.500
weaning: G07.610.220.500.750, G07.610.593.762, G07.700.620.762
hematopoietic stem cells: A11.148.378, A11.872.378, A15.378.316.378
nadph oxidase: D08.811.682.608.575, D12.776.331.894
bayes theorem: E05.318.740.600.200, N05.715.360.750.625.150, N06.850.520.830.600.200
markov chains: E05.318.740.600.500, E05.318.740.996.500, G17.830.500, N05.715.360.750.625.500, N05.715.360.750.770.500, N06.850.520.830.600.500, N06.850.520.830.996.500
cichlids: B01.050.150.900.493.602.200
atlantic ocean: Z01.756.092
recovery of function: G16.757
gonadotropin-releasing hormone: D06.472.699.327.740.320, D12.644.400.400.740.320, D12.644.456.460, D12.644.548.365.740.320, D12.776.641.650.405.740.320
neurosecretory systems: A06.688, A08.713
fertilization: G08.686.785.760.277
dna mutational analysis: E05.393.760.700.300
expressed sequence tags: G05.360.340.024.340.137.275
p-glycoproteins: D12.776.157.530.100.652, D12.776.157.530.450.074.500.500.875, D12.776.395.550.020.610, D12.776.543.550.192.610, D12.776.543.585.100.610, D12.776.543.585.450.074.500.500.875
blood urea nitrogen: E01.370.225.124.100.115, E01.370.390.400.100, E05.200.124.100.115
ethylene dichlorides: D02.455.326.146.379.350, D02.455.526.439.458
hydrolysis: G02.111.087.505, G02.149.115.505, G02.149.395, G03.495.508
rumen: A13.869.804
adrenocorticotropic hormone: D06.472.699.327.935.059, D06.472.699.327.935.531.500, D06.472.699.631.525.600.059, D06.472.699.631.525.600.531.500, D12.644.400.400.935.059, D12.644.400.400.935.531.500, D12.644.548.365.935.059, D12.644.548.365.935.531.500, D12.644.548.691.525.690.059, D12.644.548.691.525.690.531.500, D12.776.641.650.405.935.059, D12.776.641.650.405.935.531.500
cell adhesion molecules, neuronal: D12.776.395.550.200.250, D12.776.543.550.200.250, D23.050.301.350.250
extracellular matrix proteins: D12.776.860.300
myelin-associated glycoprotein: D12.776.395.550.570, D12.776.503.921.049, D12.776.543.550.555, D12.776.543.620.530, D12.776.641.580.500, D23.050.301.264.035.913.049, D23.101.100.110.929.049
oligodendroglia: A08.637.600, A11.650.600
serine endopeptidases: D08.811.277.656.300.760, D08.811.277.656.959.350
cryopreservation: E01.370.225.500.620.760.160, E01.370.225.750.600.760.160, E02.792.156, E05.200.500.620.760.160, E05.200.750.600.760.160, E05.760.156
semen preservation: E02.792.833.890, E05.760.833.890
antigens, cd95: D12.776.543.750.073.500, D12.776.543.750.705.852.760.195, D23.050.301.264.035.195, D23.101.100.110.195
fas ligand protein: D12.644.276.374.750.249, D12.644.276.972.249, D12.776.395.550.312, D12.776.467.374.750.249, D12.776.467.972.249, D12.776.543.550.312, D23.050.301.264.035.284, D23.101.100.110.283, D23.529.374.750.249, D23.529.972.249
spermatocytes: A05.360.490.890.880, A11.497.760.700
bcl-x protein: D12.644.360.075.718.937, D12.776.476.075.718.875
fresh water: G16.500.275.280, N06.230.232
arctic regions: Z01.208
beluga whale: B01.050.150.900.649.189.865.110
sperm immobilizing agents: D27.505.696.138.379, D27.505.696.875.360.276.727, D27.505.954.705.360.276.727, D27.888.569.071.379
zinc compounds: D01.975
fenitrothion: D02.705.400.625.300, D02.705.539.345.300, D02.886.300.692.300
peroxidase: D08.811.682.732.700
acrosome reaction: G08.686.785.760.277.800.100
dihydrotestosterone: D04.808.054.040.248, D06.472.334.851.968.964
cladocera: B01.050.500.131.365.150
3-oxo-5-alpha-steroid 4-dehydrogenase: D08.811.682.660.465
receptors, estradiol: D12.776.260.698.750.350.350, D12.776.826.750.350.350, D12.776.930.669.750.350.350
glyceraldehyde-3-phosphate dehydrogenases: D08.811.682.657.163.750
baroreflex: G09.330.190.400.090, G11.561.600.765.063
leptin: D06.472.699.042.500, D12.644.276.024.500, D12.644.548.011.500, D12.776.467.024.500, D23.529.024.500
thyroid hormone receptors beta: D12.776.260.698.850.750, D12.776.624.664.700.830.750, D12.776.826.850.750, D12.776.930.669.850.750
georgia (republic): Z01.542.900.420, Z01.586.200.420, Z01.586.950.420
autophagy: G04.299.139.399, G04.299.482.350.091
tauopathies: C10.574.945
alpha-synuclein: D12.776.641.860.500
hypothermia, induced: E02.258.750
injections, intraventricular: E02.319.267.530.550
pest control, biological: N06.850.780.200.650.650
vitis: B01.650.940.800.575.100.965.500
carboxylic acids: D02.241
north sea: Z01.756.092.650
phocoena: B01.050.150.900.649.189.566.600
sulfonamides: D02.065.884, D02.886.590.700
atmosphere: G16.500.275.063, N06.230.300.100
feathers: A13.370
freezing: G01.595.680.500, G01.906.595.272.437, G02.149.767.680.466, G02.842.750.680.466
ice cover: G01.311.400, G16.500.275.410.500, N06.230.291.500
lakes: G01.311.580, G16.500.275.280.500, N06.230.232.500
snow: G16.500.240.135.867, G16.500.275.063.725.480, G16.500.750.775.480, N06.230.300.100.725.480
salmonella: B03.440.450.425.800, B03.660.250.150.710
receptors, gaba-a: D12.776.157.530.400.175.562, D12.776.157.530.400.400.100.100, D12.776.543.550.425.175.562, D12.776.543.550.425.500.100.100, D12.776.543.585.400.175.562, D12.776.543.585.400.500.100.100, D12.776.543.750.051.500, D12.776.543.750.720.200.300.300
cloning, molecular: E05.393.220
conserved sequence: G02.111.570.580
gastritis: C06.405.205.697, C06.405.748.398
mucins: D12.776.395.560.631
stem cells: A11.872
blood proteins: D12.776.124
cadmium chloride: D01.142.175, D01.210.450.150.125
phagosomes: A11.284.430.214.190.875.190.700
liposomes: D25.479.517, D26.255.260.517, D27.720.280.260.517, J01.637.051.479.517, J01.637.087.500.517
rotarod performance test: E05.017.449
spinal cord injuries: C10.228.854.770, C10.900.850, C26.819
pituitary-adrenal system: A06.407.691
restraint, physical: E02.085.700, E05.472.760
stress, psychological: F01.145.126.990, F02.830.900
aluminum silicates: D01.056.050.075, D01.578.725.025, D01.650.550.050.075, D01.837.725.700.760.050
bronchoalveolar lavage: E05.927.100
chemotaxis: G04.299.283.424
magnesium silicates: D01.524.500, D01.578.725.500, D01.837.725.700.760.535
encephalitis: C02.182.500, C10.228.140.430, C10.228.228.210.150, C10.228.228.245
lipopolysaccharides: D09.400.500, D09.698.718.450, D10.494, D23.050.161.616.525, D23.946.123.329.500
microglia: A08.637.400, A11.650.400
sepsis: C01.539.757, C23.550.470.790.500
cpg islands: G02.111.570.080.380.160, G05.360.080.380.160, G05.360.340.024.159
genomic imprinting: G05.355.315.203.500
kruppel-like transcription factors: D12.776.260.522, D12.776.930.375
rna, long untranslated: 
snrnp core proteins: D12.776.157.725.500.875.700, D12.776.660.625.750, D12.776.664.962.500.875.700, D23.050.290.875, D23.050.422.750
nova scotia: Z01.107.567.176.589
otters: B01.050.150.900.649.147.550.600
fructans: D09.698.350
hypertriglyceridemia: C18.452.584.500.500.851
inulin: D05.750.078.562.855.750, D09.698.350.500, D09.698.365.855.750
oligosaccharides: D09.698.629
agglutination: G02.111.087.026, G02.149.115.026, G12.425.143.100
cerebrospinal fluid: A12.207.270.210
dyskinesia, drug-induced: C10.228.662.262.500, C10.720.312, C25.100.750, C25.723.705.200
electron transport: G02.111.087.240, G02.149.115.240, G03.495.335.531.403, G03.495.553.350
glucocorticoids: D06.472.040.543, D27.505.696.399.472.488
animals, domestic: B01.050.050.116
great lakes region: Z01.107.567.875.350
cervix uteri: A05.360.319.679.256
beetles: B01.050.500.131.617.069
sexual dysfunction, physiological: C12.294.644, C13.351.500.665
phosphoproteins: D12.776.744
acridine orange: D03.494.046.250.150
adenosine triphosphatases: D08.811.277.040.025
captan: D03.438.513.124
glycosaminoglycans: D09.698.373
calcium-binding proteins: D12.776.157.125
estrogen receptor modulators: D06.347.360, D27.505.696.399.450.360
oviposition: G08.686.785.760.480
catechin: D03.438.150.240.190, D03.438.150.266.450.206, D03.830.219.240.190, D03.830.219.266.450.206
quercetin: D03.438.150.266.450.284.777, D03.830.219.266.450.284.777
haplorhini: B01.050.150.900.649.801.400
nutrition disorders: C18.654
ascaris suum: B01.050.500.500.294.700.100.100.108.700
morphogenesis: G07.700.320.500
parasite egg count: E01.370.225.932.600, E05.200.932.600
parasitology: H01.158.273.688
chemokines, cxc: D12.644.276.374.200.120, D12.776.467.374.200.120, D23.125.300.120, D23.469.200.120, D23.529.374.200.120
aluminum hydroxide: D01.045.250.050, D01.056.037, D01.455.150
interleukins: D12.644.276.374.465, D12.776.467.374.465, D23.529.374.465
ovalbumin: D12.644.861.560, D12.776.034.614, D12.776.256.317.663, D12.776.290.663, D12.776.872.560
aminobenzoates: D02.241.223.100.050, D02.455.426.559.389.127.020
craniofacial abnormalities: C05.660.207, C16.131.621.207
gaba antagonists: D27.505.519.625.240.300, D27.505.696.577.240.300
sodium channel blockers: D27.505.519.562.750, D27.505.954.411.720
spasm: C10.597.613.750, C23.888.592.608.750
catheterization: E02.148, E05.157
kidney cortex necrosis: C12.777.419.393, C13.351.968.419.393
renal artery: A07.231.114.745
animals, genetically modified: B01.050.050.136, B05.620.136
green fluorescent proteins: D12.776.532.265
airway remodeling: C23.300.017, G09.772.029
extracellular matrix: A11.284.295.310
administration, topical: E02.319.267.120
lymph nodes: A10.549.400, A15.382.520.604.412
3,4-dihydroxyphenylacetic acid: D02.241.223.601.220
microdialysis: E05.196.353.500
phylogeny: G05.697, G16.100.178.605, L01.100.697
zebrafish proteins: D12.776.325.500
alkaloids: D03.132
chemokine cxcl2: D12.644.276.374.200.120.100, D12.644.276.374.200.600.940, D12.776.467.374.200.120.100, D12.776.467.374.200.600.940, D23.125.300.120.100, D23.125.300.600.940, D23.469.200.120.100, D23.469.200.600.940, D23.529.374.200.120.100, D23.529.374.200.600.940
isocoumarins: D03.438.150.446.598, D03.830.219.446.598
isoquinolines: D03.438.531
mycophenolic acid: D02.241.081.193.678, D10.251.618
piperazines: D03.383.606
sterigmatocystin: D03.494.953.852.777, D23.946.587.850
colony-forming units assay: E01.370.225.500.383, E05.200.500.383, E05.242.383
fetal stem cells: A11.872.220
glutathione disulfide: D12.644.456.448.500
i-kappa b proteins: D12.644.360.378, D12.776.260.420, D12.776.476.381, D12.776.930.326
proto-oncogene proteins c-kit: D08.811.913.696.620.682.725.400.050, D12.776.543.750.060.124, D12.776.543.750.705.852.150.100, D12.776.543.750.750.400.200.170, D12.776.624.664.700.183, D23.050.301.264.035.590, D23.101.100.110.590
laboratories: N02.278.487
apolipoproteins: D10.532.091, D12.776.070.400, D12.776.521.120
fish proteins: D12.776.325
hepatocyte nuclear factor 4: D12.776.260.262.968, D12.776.260.698.119, D12.776.660.352.968, D12.776.826.119, D12.776.930.323.968, D12.776.930.669.119
sequence homology: G02.111.810, G05.810
diffusion chambers, culture: E07.241
egg shell: A13.316
anesthetics, intravenous: D27.505.696.277.100.035.075, D27.505.954.427.210.100.035.075
eagles: B01.050.150.900.248.250.200, B01.050.150.900.248.815.350.200
public-private sector partnerships: J01.219.843, N03.540.706
societies, scientific: N03.540.828.838
methyl parathion: D02.705.400.625.600.500, D02.705.539.345.600.500, D02.886.300.692.600.500
monocrotophos: D02.705.400.550
embryo transfer: E02.875.800.500, E05.820.800.500
czech republic: Z01.542.248.395, Z01.586.250.395
angiogenesis inhibitors: D27.505.696.377.077.099, D27.505.696.377.450.100, D27.505.954.248.025
plasma membrane neurotransmitter transport proteins: D12.776.157.530.562.374, D12.776.543.585.562.374
symporters: D12.776.157.530.450.625, D12.776.543.585.450.625
cnidaria: B01.050.500.308
taurine: D02.455.326.146.100.850, D02.886.645.600.055.850
receptors, aryl hydrocarbon: D12.776.260.698.209.715, D12.776.826.209.715, D12.776.930.662, D12.776.930.669.209.715
beta-naphthoflavone: D03.438.150.266.450.175.100, D03.830.219.266.450.175.100
abdominal cavity: A01.923.047.025
immunosuppression: E02.095.465.425.450, E05.478.610
monoamine oxidase: D08.811.682.664.750
muscle proteins: D12.776.210.500
receptors, g-protein-coupled: D12.776.543.750.100
spectrometry, mass, matrix-assisted laser desorption-ionization: E05.196.566.755
glomerular filtration rate: E01.370.390.400.300, G08.852.357
bacteria: B03
soot: D20.633.937.339
phoca: B01.050.150.900.649.147.600.700.600
metabolomics: H01.158.201.586, H01.158.273.180.599, H01.181.122.638
benzazepines: D03.438.079
dopamine agonists: D27.505.519.625.150.151, D27.505.696.577.150.151
dopamine antagonists: D27.505.519.625.150.175, D27.505.696.577.150.175
fenoldopam: D03.438.079.300
receptors, dopamine d1: D12.776.543.750.070.300.400.400, D12.776.543.750.100.150.400.400, D12.776.543.750.720.300.300.400.400
receptors, dopamine d5: D12.776.543.750.070.300.400.400.500, D12.776.543.750.100.150.400.400.500, D12.776.543.750.720.300.300.400.400.500
apocynaceae: B01.650.940.800.575.100.081
diabetes mellitus, experimental: C18.452.394.750.074, C19.246.240, E05.598.500.374
glyburide: D02.886.590.795.575, D02.948.828.575
hyperglycemia: C18.452.394.952
seeds: A18.024.500.750, J02.500.775
mice, inbred akr: B01.050.050.157.520.318, B01.050.050.199.520.520.318, B01.050.150.900.649.865.635.505.500.400.318
columbiformes: B01.050.150.900.248.165
passeriformes: B01.050.150.900.248.620
raptors: B01.050.150.900.248.815
regional blood flow: G09.330.190.163.780
reperfusion injury: C14.907.725, C23.550.767.877
avian proteins: D12.776.093
cardiac myosins: D05.750.078.730.475.475.124, D08.811.277.040.025.193.750.750.124, D12.776.210.500.600.470.249, D12.776.220.525.475.475.124
cardiotoxins: D27.888.569.142
myofibrils: A10.690.552.875, A11.284.430.214.190.750.620, A11.620.249.850, A11.620.500.500
stroke volume: E01.370.370.380.150.700, G09.330.380.124.882
fibroblast growth factor 8: D12.644.276.624.180, D12.776.467.624.180, D23.529.624.180
hypospadias: C12.294.494.400, C12.706.516, C13.351.875.466, C16.131.939.516
prealbumin: D12.776.034.841.450, D12.776.124.727.450
anguilla: B01.050.150.900.493.338.282
respiratory rate: E01.370.600.875.875, G09.772.770.755.730
tidal volume: E01.370.386.700.485.750.900.350.750, G09.772.850.970.500.700
cd4-positive t-lymphocytes: A11.118.637.555.567.569.200, A15.145.229.637.555.567.569.200, A15.382.490.555.567.569.200
immune system: A15.382
guanosine triphosphate: D03.438.759.646.454.504, D13.695.667.454.504, D13.695.827.426.504
mitochondrial proton-translocating atpases: D08.811.277.040.025.325.750, D08.811.913.696.650.150.500.750, D12.776.157.530.450.250.875.500.750, D12.776.543.585.450.250.875.500.750, D12.776.543.585.475.625, D12.776.575.750.625
neuropeptides: D12.644.400, D12.776.641.650
oxidative phosphorylation coupling factors: D12.776.691
ventricular dysfunction, left: C14.280.945.900
rac gtp-binding proteins: D08.811.277.040.330.300.400.700.100, D12.644.360.525.700.100, D12.776.157.325.515.700.100, D12.776.476.525.700.100
core binding factor alpha 1 subunit: D12.776.930.155.200.100
osteopontin: D12.644.276.374.625, D12.776.395.700.837, D12.776.467.374.625, D12.776.860.300.762, D23.529.374.625
spatial behavior: F01.145.875, I01.880.894
chromones: D03.438.150.266, D03.830.219.266
intracellular signaling peptides and proteins: D12.644.360, D12.776.476
stat3 transcription factor: D12.644.360.024.342.300, D12.776.157.057.186.300, D12.776.476.024.421.300, D12.776.930.840.300
gene regulatory networks: G05.360.080.689.360
drosophila: B01.050.500.131.617.289.310.250
drug delivery systems: E02.319.300
scavenger receptors, class b: D12.776.543.750.705.940.625, D12.776.543.750.710.450.750.625
desoxycorticosterone: D04.808.745.745.654.339, D06.472.040.585.611
mollusca: B01.050.500.644
nevada: Z01.107.567.875.760.550
songbirds: B01.050.150.900.248.620.750
swallows: B01.050.150.900.248.620.750.725
fluoroimmunoassay: E05.478.412.341, E05.478.566.159
placentation: G08.686.785.760.769.491
clusterin: D12.776.395.207, D12.776.580.215
glycoproteins: D09.400.430, D12.776.395
molecular chaperones: D12.776.580
dimethyl sulfoxide: D02.886.640.150
hydrocortisone: D04.808.745.745.654.600, D06.472.040.585.353.476, D06.472.040.585.478.392
oogenesis: G04.299.151.650.249, G08.686.785.760.310.500
ethane: D02.455.326.146.379
ferritins: D12.776.157.427.249, D12.776.556.579.249
magnesium chloride: D01.210.450.150.500, D01.524.475
hepatocyte growth factor: D12.644.276.374.420, D12.776.467.374.420, D23.529.374.420
hypophysectomy: E04.270.532, E04.525.400
calcium-transporting atpases: D08.811.277.040.025.125, D12.776.157.530.450.250.500, D12.776.543.585.450.250.500
diabetic nephropathies: C12.777.419.192, C13.351.968.419.192, C19.246.099.875
hyperalgesia: C10.597.751.791.400, C23.888.592.763.770.400
pain threshold: F02.463.593.710.560, F02.830.816.444.700, G11.561.600.810.444.700
rats, inbred oletf: B01.050.050.157.760.290, B01.050.050.199.520.760.290, B01.050.150.900.649.865.635.505.700.400.290
peromyscus: B01.050.150.900.649.865.635.680.510
survival: I03.784
tert-butyl alcohol: D02.033.415.110.855, D10.289.110.855
genes, recessive: G05.360.340.024.340.415, G05.420.325
anseriformes: B01.050.150.900.248.050
ambystoma: B01.050.150.900.090.608.080.068
virology: H01.158.273.540.859
iridovirus: B04.280.410.400, B04.525.400
2,4-dinitrophenol: D02.455.426.559.389.657.566.304.500, D02.640.743.304.250
lordosis: C05.116.900.800.750
phosphocreatine: D12.125.373.603, D12.125.740.675
salmon: B01.050.150.900.493.817.750.705
femur: A02.835.232.043.650.247
south carolina: Z01.107.567.875.075.662, Z01.107.567.875.750.700
17-hydroxysteroid dehydrogenases: D08.811.682.047.436.375
steroid 17-alpha-hydroxylase: D08.244.453.915.748, D08.811.682.690.708.170.915.748, D08.811.682.690.708.783.745, D12.776.422.220.453.915.748
antifungal agents: D27.505.954.122.136
humerus: A02.835.232.087.090.400
indoles: D03.438.473
radius: A02.835.232.087.090.700
ribs: A02.835.232.904.567
thalidomide: D02.241.223.805.810.800, D03.383.621.808.800, D03.438.513.750.750
ulna: A02.835.232.087.090.850
gonadotropins, pituitary: D06.472.699.322.576, D06.472.699.631.525.343, D12.644.548.691.525.343
cyclin d2: D12.644.360.262.150.200, D12.776.167.218.150.200, D12.776.476.262.150.200
abnormalities, radiation-induced: C16.131.080, C26.733.031, N06.850.810.300.360.031
fetal diseases: C13.703.277, C16.300
snails: B01.050.500.644.400.750
argentina: Z01.107.757.077
incubators: E07.461
golgi apparatus: A11.284.430.214.190.875.336
penile erection: G08.686.785.760.717
follistatin: D12.776.157.247
ion channels: D12.776.157.530.400, D12.776.543.550.425, D12.776.543.585.400
mitochondrial proteins: D12.776.575
plasminogen activator inhibitor 1: D12.644.822.750.695.500, D12.644.861.695.500, D12.776.124.125.640, D12.776.645.750.695.500, D12.776.872.695.500, D23.119.832.500
gravidity: G08.686.340, G08.686.785.760.769.213, N06.850.490.812.250
sea bream: B01.050.150.900.493.602.750
acetaminophen: D02.065.199.092.040
histological techniques: E01.370.225.750, E05.200.750
malathion: D02.705.400.625.500, D02.705.539.345.500, D02.886.300.692.500
norethynodrel: D04.808.668.651.693.706
glutamate decarboxylase: D08.811.520.224.125.250
glutamate-ammonia ligase: D08.811.464.259.200.600
paraoxon: D02.705.400.650
cell aggregation: G04.299.283.251
drug tolerance: G07.690.812.260, G07.700.680.260
carcinoma: C04.557.470.200
prostaglandin-endoperoxide synthases: D08.811.600.720, D08.811.682.690.708.715
mifepristone: D04.808.365.415.580
seminiferous epithelium: A05.360.444.849.700.700, A10.272.700
activating transcription factor 3: D12.776.260.108.061.875, D12.776.930.127.061.875
cyclin d: D12.644.360.262.150, D12.776.167.218.150, D12.776.476.262.150
fetal weight: C23.888.144.300, E01.370.600.115.100.160.120.300, E05.041.124.160.750.300, G07.100.100.160.120.300, G07.700.320.249.314.120.300, G07.700.320.500.325.235.937, G08.686.280
transplantation: E04.936
stem cell transplantation: E04.936.225.687
codon: D13.444.735.544.355, G05.360.335.355, G05.360.340.024.340.137.190
genes, ras: G05.360.340.024.340.375.500.791.550
infusion pumps: E07.505, E07.858.082.505
calcium-calmodulin-dependent protein kinase type 4: D08.811.913.696.620.682.700.125.350, D12.644.360.100.350, D12.776.476.100.350
cyclic amp-dependent protein kinases: D08.811.913.696.620.682.700.150.125, D12.644.360.200.125, D12.776.476.200.125
early growth response protein 1: D12.776.260.158.500, D12.776.460.525.500, D12.776.930.313.500
proto-oncogene proteins c-fos: D12.776.260.108.765, D12.776.624.664.700.179, D12.776.660.760, D12.776.930.127.765
central nervous system agents: D27.505.954.427
nucleus accumbens: A08.186.211.730.885.287.249.683
scattering, small angle: E05.196.822.830, G01.595.861.755
electrical equipment and supplies: E07.305
gastropoda: B01.050.500.644.400
waste products: D20.944, N06.850.460.710
galliformes: B01.050.150.900.248.350
fisheries: J01.040.168.300
bronchiolitis: C08.127.446.135, C08.381.495.146.135, C08.730.099.135
larynx: A04.329
pentanones: D02.522.720
phenylphosphonothioic acid, 2-ethyl 2-(4-nitrophenyl) ester: D02.705.429.812.750, D02.705.539.692.750, D02.886.300.846.750
propoxur: D02.241.081.251.583.788
endoplasmic reticulum: A11.284.430.214.190.875.248
hydrophobic and hydrophilic interactions: G02.842.312
time: G01.910
brain injuries: C10.228.140.199, C10.900.300.087, C26.260.118, C26.915.300.200
mitochondrial diseases: C18.452.660
toxicogenetics: H01.158.273.343.750.850, H01.158.703.052.850, H01.158.703.795.850, H02.628.479.850, H02.628.795.850
nissl bodies: A08.663.712, A11.284.430.214.190.500.610, A11.284.430.214.190.875.248.300.610, A11.284.430.214.190.875.811.740.300.610, A11.671.693
skin transplantation: E04.680.275.850, E04.936.580.700
transplantation, heterologous: E04.936.764
hsp90 heat-shock proteins: D12.776.580.216.380
oxidants, photochemical: D27.720.642.631, D27.888.569.540.631
body patterning: G07.700.320.500.100
proto-oncogene proteins c-myb: D12.776.260.675, D12.776.624.664.700.188, D12.776.930.653
oceans and seas: G01.311.625, G16.500.275.810.650, Z01.756
mice, nude: B01.050.150.900.649.865.635.505.500.550.500
epiglottis: A02.165.257.625.411, A02.165.407.500.411, A04.329.591.411
polycythemia: C15.378.738
halogenation: G02.111.087.485, G02.149.115.485, G03.495.496
maternal deprivation: F01.829.263.370.240
adiposity: E01.370.600.115.100.062.500, G02.111.097.134.500, G03.180.134.500, G07.100.049.134.500
adrenergic antagonists: D27.505.519.625.050.200, D27.505.696.577.050.200
carbazoles: D03.438.473.144, D03.494.148
propanolamines: D02.033.100.624, D02.033.755.624, D02.092.063.624
adrenergic alpha-1 receptor agonists: D27.505.519.625.050.100.100.100, D27.505.696.577.050.100.100.100
receptors, adrenergic, alpha-1: D12.776.543.750.070.300.300.300.700, D12.776.543.750.100.150.300.300.700, D12.776.543.750.720.300.300.300.300.100
receptors, angiotensin: D12.776.543.750.100.047, D12.776.543.750.720.600.150, D12.776.543.750.750.130, D12.776.543.750.750.555.150
germ-line mutation: G05.365.590.350
pregnancy rate: E05.318.308.985.775, G08.686.705, L01.280.975.775, N01.224.935.849, N06.850.505.400.975.775, N06.850.520.308.985.775
ejaculation: G08.686.785.760.084
drosophila melanogaster: B01.050.500.131.617.289.310.250.500
microscopy, atomic force: E01.370.350.515.666.400, E05.595.666.400
alkylating agents: D27.505.519.124, D27.888.569.035
crustacea: B01.050.500.131.365
insect hormones: D06.472.445.573
phenylcarbamates: D02.241.081.251.583
arthropods: B01.050.500.131
gametogenesis: G04.299.151.650, G08.686.785.760.310
genes, helminth: G05.360.340.024.340.310, G05.360.340.337.500
infusion pumps, implantable: E07.505.254, E07.858.082.505.254
purkinje cells: A08.186.211.132.810.428.200.212.600, A08.186.211.865.428.200.212.600, A08.663.784, A11.671.784
hypothyroidism: C19.874.482
b-lymphocytes: A11.063.438, A11.118.637.555.567.562, A15.145.229.637.555.567.562, A15.382.032.438, A15.382.490.555.567.562
immunologic factors: D27.505.696.477
t-lymphocytes, cytotoxic: A11.118.637.555.283.875, A11.118.637.555.567.550.500.200, A11.118.637.555.567.569.220.200, A11.118.637.555.567.569.500.200, A15.145.229.637.555.283.875, A15.145.229.637.555.567.550.500.200, A15.145.229.637.555.567.569.220.200, A15.145.229.637.555.567.569.500.200, A15.382.490.555.283.875, A15.382.490.555.567.550.500.200, A15.382.490.555.567.569.220.200, A15.382.490.555.567.569.500.200
scopolamine hydrobromide: D02.145.074.722.822.775, D03.132.760.180.848, D03.132.889.601.775, D03.605.869.822.775, D04.075.080.875.099.722.822.775
growth inhibitors: D27.505.696.377.450
chlorodiphenyl (54% chlorine): D02.455.526.439.773.292.077, D02.455.526.439.785.292.077
insulin-like growth factor i: D12.644.276.937.400, D12.776.124.862.400, D12.776.467.937.400, D23.529.937.400
microvilli: A11.284.180.565
insulin-secreting cells: A03.734.414.131, A06.390.131, A06.407.414.087, A11.382.625.092, A11.436.294.092
choroid plexus: A08.186.211.276.298
diaphyses: A02.835.232.169
epiphyses: A02.835.232.251
chemotaxis, leukocyte: G04.299.283.424.233
hla-d antigens: D12.776.395.550.509.400, D12.776.543.550.423.400, D23.050.301.500.400.400, D23.050.301.500.450.400, D23.050.705.552.410.400, D23.050.705.552.450.400
metabolic networks and pathways: G03.495.553
lung injury: C08.381.520, C26.891.554
intubation, gastrointestinal: E02.585.412, E05.497.412
pregnenolone: D04.808.745.745.725, D06.472.040.585.745, D06.472.334.851.687.500
shrews: B01.050.150.900.649.473.751
growth disorders: C23.550.393
blotting, southern: E05.196.401.114, E05.301.300.087, E05.393.525.150, E05.601.150
fundulidae: B01.050.150.900.493.850.280.214
poecilia: B01.050.150.900.493.850.280.680
zooplankton: B05.080.500.980
nesting behavior: F01.145.113.252.478
smegmamorpha: B01.050.150.900.493.850
isoflavones: D03.438.150.266.450.400, D03.830.219.266.450.400
phytoestrogens: D27.505.696.399.472.277.540.500
stilbenes: D02.455.426.559.389.150.700
pituitary adenylate cyclase-activating polypeptide: D12.644.276.860.887, D12.644.400.625, D12.776.467.860.887, D12.776.641.600.887, D12.776.641.650.625, D23.529.850.887
fallopian tubes: A05.360.319.114.373, A13.706.500
stromal cells: A11.329.830
beta vulgaris: B01.650.940.800.575.100.200.399
ethers, cyclic: D02.355.291, D04.345.241
cyclooxygenase 2: D08.811.600.720.750
cyclooxygenase inhibitors: D27.505.519.389.310, D27.505.696.663.850.014.040.500.500, D27.505.954.158.030.500, D27.505.954.329.030.500
ibuprofen: D02.241.223.701.430
gingiva: A14.549.167.646.480
bottle-nosed dolphin: B01.050.150.900.649.189.267.100
bromine compounds: D01.139
invertebrates: B01.050.500
prostatic intraepithelial neoplasia: C04.557.470.200.240.500
space perception: F02.463.593.778, F02.463.593.932.869
models, anatomic: J01.897.280.500.545.129, L01.178.820.090.545.129
synchrotrons: E07.710.680.700
prostaglandins: D10.251.355.255.100.637, D10.251.355.255.550, D23.469.050.175.725
amlodipine: D03.383.725.203.065
collagen type iv: D12.776.860.300.250.400.100
glucose transporter type 1: D12.776.157.530.500.500.500, D12.776.543.585.500.500.500
monosaccharide transport proteins: D12.776.157.530.500, D12.776.543.585.500
cyclic nucleotide-gated cation channels: D12.776.157.530.400.337, D12.776.543.550.425.452, D12.776.543.585.400.452
cholinergic agents: D27.505.519.625.120, D27.505.696.577.120
imprinting (psychology): F02.463.425.448
narcotics: D27.505.696.277.600, D27.505.696.663.850.014.760, D27.505.954.427.040.550, D27.505.954.427.210.600
malate dehydrogenase: D08.811.682.047.820.496
collagen type iii: D05.750.078.280.300.300, D12.776.860.300.250.300.300
habituation, psychophysiologic: F02.463.425.393, F02.830.422, G11.561.600.360
physical stimulation: E05.723
electric conductivity: G01.358.500.249.277
meiotic prophase i: G04.299.134.220.220.687.444, G04.299.134.220.220.875.500, G05.355.105.220.687.500, G05.355.105.220.875.500
autoimmune diseases: C20.111
autoimmunity: G12.450.192
interleukin-17: D12.644.276.374.465.517, D12.776.467.374.465.517, D23.529.374.465.517
mice, inbred mrl lpr: B01.050.050.157.520.555, B01.050.050.199.520.520.555, B01.050.150.900.649.865.635.505.500.400.555
nitric oxide synthase type iii: D08.811.682.664.500.772.750
kaplan-meier estimate: E05.318.740.998.650, N05.715.360.750.795.650, N06.850.520.830.998.650
lipase: D08.811.277.352.100.400
mice, 129 strain: B01.050.150.900.649.865.635.505.500.400.025, B01.050.150.900.649.865.635.505.500.550.025, B01.050.150.900.649.865.635.505.500.800.500.025
goldfish: B01.050.150.900.493.200.244.248.480
lipid peroxides: D02.389.338.450, D02.737.450, D10.440
dehydration: C18.452.950.179, C23.550.274
hemolysis: C23.550.403, G12.425.143.545
animals, inbred strains: B01.050.050.157, B01.050.050.199.520
embryo culture techniques: E05.240.468
in vitro oocyte maturation techniques: E02.875.800.906, E05.820.800.906
oviparity: G08.686.650
south australia: Z01.338.600
cervical vertebrae: A02.835.232.834.151
piloerection: F02.830.702.607, G11.561.600.765.482, G13.750.829.690
thoracic vertebrae: A02.835.232.834.892
transcription factor chop: D12.776.260.108.124.875, D12.776.660.167.875, D12.776.930.127.124.875
superovulation: E02.875.800.984.500, E05.820.800.984.500, G08.686.785.760.690.768
placenta diseases: C13.703.590
androgen receptor antagonists: D06.347.065.249, D27.505.696.399.450.065.249
calcium channels, t-type: D12.776.157.530.400.150.720, D12.776.543.550.425.150.720, D12.776.543.585.400.150.720
adrenalectomy: E04.270.115
glucose-6-phosphate isomerase: D08.811.399.475.200.350
selection, genetic: G05.355.800
vinblastine: D03.132.436.681.827.650, D03.438.473.402.681.827.650
turtles: B01.050.150.900.833.848
prostatic diseases: C12.294.565
prostatic secretory proteins: D12.776.866.249
receptors, tumor necrosis factor: D12.776.543.750.705.852.760
sex determination processes: G05.355.865, G07.700.320.500.325.377.812, G07.700.320.750.437, G08.686.785.880.437
wnt proteins: D12.776.467.984, D23.529.984
dogfish: B01.050.150.900.493.370.853.392
dna, complementary: D13.444.308.497.220, D13.444.600.223.500, D27.720.470.530.600.223.260
lymnaea: B01.050.500.644.400.750.645
alpha-crystallin b chain: D12.776.306.366.100.300, D12.776.580.157.300
alpha-crystallins: D12.776.306.366.100, D12.776.580.157
immunity: G12.450
nanocomposites: J01.637.512.150
serum albumin, bovine: D12.776.034.841.540, D12.776.124.727.540
nanomedicine: H01.603.600, J01.897.115.625, J01.897.520.600.600
hydroxyeicosatetraenoic acids: D10.251.355.096.450, D10.251.355.255.100.300
microscopy, video: E01.370.350.515.690, E05.595.690, J01.897.280.500.898.475, L01.178.820.090.898.475, L01.178.847.823.475
vascular resistance: G09.330.380.921
mice, hairless: B01.050.050.157.520.200, B01.050.050.199.520.520.200, B01.050.150.900.649.865.635.505.500.400.200, B01.050.150.900.649.865.635.505.500.550.230
sunlight: G01.358.500.505.650.836, G01.750.250.650.836, G01.750.770.578.836, G16.500.275.063.725.525, G16.500.750.775.525, N06.230.300.100.725.525
musculoskeletal abnormalities: C05.660, C16.131.621
amphibians: B01.050.150.900.090
fluorine: D01.268.380.300
chemoreceptor cells: A08.663.650.915.500, A08.800.950.500, A11.671.650.915.500
ictaluridae: B01.050.150.900.493.080.148
pulmonary ventilation: E01.370.386.700.660, G09.772.650
cardiac output: E01.370.370.380.150, G09.330.380.124
anemia: C15.378.071
niacinamide: D03.066.515.530, D03.383.725.547.530
kidney tubules, distal: A05.810.453.736.560.540
spectroscopy, fourier transform infrared: E05.196.712.726.676.700, E05.196.867.826.676.700
lysosomes: A11.284.430.214.190.875.190.550
organelles: A11.284.430.214.190.875
baltic states: Z01.542.248.136, Z01.586.950.140
cell growth processes: G04.299.233, G07.700.320.249.410
th1 cells: A11.118.637.555.567.550.500.400.900, A11.118.637.555.567.569.200.400.900, A11.118.637.555.567.569.500.400.900, A15.145.229.637.555.567.550.500.400.500, A15.145.229.637.555.567.569.200.400.500, A15.145.229.637.555.567.569.500.400.500, A15.382.490.555.567.550.500.400.900, A15.382.490.555.567.569.200.400.900, A15.382.490.555.567.569.500.400.900
th2 cells: A11.118.637.555.567.550.500.400.905, A11.118.637.555.567.569.200.400.905, A11.118.637.555.567.569.500.400.905, A15.145.229.637.555.567.550.500.400.750, A15.145.229.637.555.567.569.200.400.750, A15.145.229.637.555.567.569.500.400.750, A15.382.490.555.567.550.500.400.905, A15.382.490.555.567.569.200.400.905, A15.382.490.555.567.569.500.400.905
dna nucleotidylexotransferase: D08.811.913.696.445.308.325
tumor necrosis factors: D12.644.276.374.750, D12.644.276.972, D12.776.467.374.750, D12.776.467.972, D23.529.374.750, D23.529.972
splenomegaly: C23.300.775.750
adipose tissue, white: A10.165.114.830
oxazines: D03.383.533
quail: B01.050.150.900.248.350.650
brassica rapa: B01.650.940.800.575.100.157.200.277
germination: G07.700.320.625.249, G15.744.300
isopoda: B01.050.500.131.365.400
florida: Z01.107.567.875.750.350
cyclin-dependent kinase inhibitor p27: D12.644.360.225.600, D12.776.167.187.600, D12.776.476.225.600, D12.776.624.776.355.600
sheep, domestic: B01.050.150.900.649.077.380.791.150
colloids: D20.280, D26.255.165, D27.720.280.165
mediterranean sea: Z01.756.592
neostriatum: A08.186.211.730.885.287.249.487.550
food supply: J01.576.423.750
toxicity tests, subacute: E05.940.850
veterinary medicine: H02.956
blastula: A16.331.099
mating preference, animal: F01.145.113.252.748.300
taste: F02.830.816.724, G11.561.600.810.724
amp-activated protein kinases: D08.811.913.696.620.682.700.085, D12.644.360.062, D12.776.476.062
electroacupuncture: E02.186.250, E02.190.044.244, E02.342.543, E02.779.468.399, E03.091.823.500, E03.155.519
glucose transporter type 4: D12.776.157.530.500.500.937, D12.776.543.585.500.500.937
cloaca: A13.223, A16.178
photic stimulation: E05.723.729
social behavior: F01.145.813
infusions, intravenous: E02.319.267.082.500, E02.319.267.510.590
goats: B01.050.150.900.649.077.380.513
selenium compounds: D01.810
peroxiredoxin vi: D08.811.277.352.100.680.750.937.300.500, D08.811.277.352.100.680.750.937.625.624, D08.811.641.773, D08.811.682.732.850.500
pyridostigmine bromide: D03.383.725.762.740
glutethimide: D03.383.621.808.425
escape reaction: F01.145.113.448, F01.145.367
ostreidae: B01.050.500.644.080.643
extracellular space: A10.082.500, A11.284.295
retinal ganglion cells: A08.663.650.850.875, A09.371.729.831.875, A11.671.650.850.875
oregon: Z01.107.567.875.560.550, Z01.107.567.875.580.550
hydroxyproline: D12.125.072.401.623.478
cardiolipins: D10.570.755.375.760.400.885.185, D23.050.550.480.330
follicular phase: G08.686.605.310
luteal phase: G08.686.605.410
coproporphyrinogen oxidase: D08.811.682.660.250
digitonin: D04.808.155.580.130.500.236, D09.408.180.261.236
trypsin: D08.811.277.656.300.760.895, D08.811.277.656.959.350.895
gene expression regulation, leukemic: G05.355.315.370.500
fetal growth retardation: C13.703.277.370, C16.300.390, C23.550.393.450
columbidae: B01.050.150.900.248.165.150
calcitonin gene-related peptide: D12.644.400.097, D12.776.641.650.097
psoas muscles: A02.633.567.825
spinal nerves: A08.800.800.720
methyltestosterone: D04.808.054.079.429.824.664
tetrahydronaphthalenes: D02.455.426.559.847.638.960, D04.615.638.960
international agencies: N03.540.514
international cooperation: I01.615.500
lactoferrin: D08.811.277.656.300.760.471, D08.811.277.656.959.350.471, D12.776.157.427.750.249, D12.776.256.626.632.507, D12.776.377.457.507, D12.776.395.507, D12.776.556.579.750.249
zeranol: D02.455.426.559.389.657.852.900.975, D02.540.950.975
adrenal gland neoplasms: C04.588.322.078, C19.053.347, C19.344.078
heptachlor: D02.455.526.439.516
indenes: D02.455.426.559.847.486, D04.615.486
piperidines: D03.383.621
dihydrolipoamide dehydrogenase: D05.500.562.452.150, D05.500.562.468.500, D05.500.562.625.500, D08.811.600.391.150, D08.811.600.465.500, D08.811.600.741.525, D08.811.682.657.350.750.500, D08.811.682.667.061, D12.776.331.192
pituitary hormones: D06.472.699.631, D12.644.548.691
higher nervous activity: F02.463.247, G11.561.600.370
airway resistance: E01.370.386.700.050, G09.772.060
alginates: D09.698.068
chitin: D05.750.078.139, D09.698.211
chlorophyllides: D03.383.129.578.840.374.180, D03.383.129.578.840.500.640.220.180, D03.549.909.374.180, D03.549.909.500.640.220.180, D04.345.783.374.180, D04.345.783.500.640.220.180, D23.767.727.220.180, D23.767.727.640.220.180
glucuronic acid: D02.241.081.844.915.162.249, D02.241.152.811.162.500, D02.241.511.902.915.162.500, D09.811.922.162.500
hexuronic acids: D02.241.081.844.915.400, D02.241.152.811.400, D02.241.511.902.915.400, D09.811.922.400
mannans: D09.698.550
polysaccharides: D09.698
x-rays: G01.358.500.505.970, G01.750.250.970, G01.750.750.918
diabetic angiopathies: C14.907.320, C19.246.099.500
diet, atherogenic: E05.263, G07.610.240.242
swine, miniature: B01.050.150.900.649.077.880.399.800
cimetidine: D02.078.370.200, D03.383.129.308.130
diphenhydramine: D02.092.471.320, D02.455.426.559.389.115.250
histamine antagonists: D27.505.519.625.375.425, D27.505.696.577.375.425
histamine h1 antagonists: D27.505.519.625.375.425.400, D27.505.696.577.375.425.400
histamine h2 antagonists: D27.505.519.625.375.425.425, D27.505.696.577.375.425.425
propylene glycols: D02.033.455.706
thiadiazines: D02.886.665.785, D03.383.855.785
mytilus edulis: B01.050.500.644.080.537.500.500
neuroendocrine cells: A11.382.944
mitochondria, muscle: A11.284.430.214.190.875.564.627, A11.284.835.626.627
trichlorfon: D02.705.429.937
chromosome breakage: C23.550.210.170, G05.355.180.210.170, G05.365.590.175.175
gene rearrangement: G05.355.330
metaphase: G04.299.134.220.220.750, G04.299.134.220.220.781.625, G05.355.105.220.750, G05.355.105.220.781.625
mosaicism: G05.365.590.175.595
hematopoiesis: G04.299.151.825, G09.188.124.544
dicofol: D02.455.426.559.389.261.220, D02.455.526.439.202.190
amylases: D08.811.277.450.066
animal husbandry: J01.040.090
fatty acids, omega-3: D10.212.302.380.410, D10.251.355.337, D10.627.430.450
food, organic: J02.500.519
acute kidney injury: C12.777.419.780.050, C13.351.968.419.780.050
capillaries: A07.231.461.165
cyclosporine: D04.345.566.235.300, D12.644.641.235.300
antimutagenic agents: D27.505.696.706.080, D27.720.799.042
cyclooxygenase 1: D08.811.600.720.500
azure stains: D02.886.369.080, D03.494.741.080
oxidoreductases, n-demethylating: D08.811.682.662.582
azacitidine: D02.145.150, D03.383.742.680.245.217, D13.570.685.245.217, D13.570.800.286.300
deoxycytidine: D03.383.742.680.245.500, D13.570.230.329, D13.570.685.245.500
vitamin e deficiency: C18.654.521.500.133.841
follicular atresia: G08.686.785.280
ganglionic blockers: D27.505.696.663.050.340
pentolinium tartrate: D03.383.773.700
sympathectomy, chemical: E04.525.210.080.800.800
mitomycin: D02.806.400.249.350, D03.383.097.500.350, D03.438.473.412.249.350
pharmaceutical preparations: D26
phenylethyl alcohol: D02.033.375.650
2-acetylaminofluorene: D02.065.064.150, D02.241.081.018.110.080, D02.455.426.559.847.389.050, D04.615.389.050
isoflurophate: D02.705.429.750.249
acetogenins: D02.033.415.054, D02.455.326.146.049, D02.540.205, D03.383.312.200, D10.289.054
annona: B01.650.940.800.575.100.065.500
argemone: B01.650.940.800.575.100.795.124
fatty alcohols: D02.033.415, D10.289
isoindoles: D03.438.513
lactones: D02.540
molluscacides: D27.720.031.700.596, D27.720.723.596, D27.888.723.596
norbornanes: D02.455.849.575.781
new england: Z01.107.567.875.550
hsp40 heat-shock proteins: D12.776.580.216.292
mouth abnormalities: C07.465.525, C07.650.525, C16.131.850.525
spine: A02.835.232.834
tunisia: Z01.058.266.887
biomarkers, pharmacological: D23.101.137
butyric acid: D02.241.081.114.750, D10.251.400.143.500
ubiquitin: D12.776.947.500
dolphins: B01.050.150.900.649.189.267
erythrocyte deformability: G09.188.370.249
endothelins: D12.644.276.400, D12.776.467.400, D23.529.400
receptors, endothelin: D12.776.543.750.100.220, D12.776.543.750.750.320
chemokines: D12.644.276.374.200, D12.776.467.374.200, D23.125.300, D23.469.200, D23.529.374.200
fibrinogen: D12.776.124.050.250, D12.776.124.125.500, D12.776.811.300, D23.119.490
protein c: D08.622.705, D12.776.124.650, D12.776.395.635, D23.113.700
fatty acids, monounsaturated: D10.251.355.325
butylated hydroxytoluene: D02.455.426.559.389.657.239.216
cresols: D02.455.426.559.389.657.239
ecdysterone: D04.808.247.222.265.165.750, D06.472.445.573.271.750
memantine: D02.455.426.100.050.035.500
aflatoxin b1: D03.438.150.119.075, D03.830.219.119.075, D23.946.587.142.075
acrosome: A05.360.490.890.820.100, A11.284.430.214.190.875.190.550.040, A11.497.760.400.100
triterpenes: D02.455.849.919
hydroxyindoleacetic acid: D03.066.288.478, D03.438.473.404.478
aneugens: D27.888.569.468.060
glucosides: D09.408.348
macrophages, peritoneal: A11.329.372.630, A11.627.482.630, A11.733.397.630, A15.382.680.397.630, A15.382.812.522.630
mesentery: A01.923.047.025.600.451
nucleosides: D09.408.595, D13.570
thyrotropin-releasing hormone: D06.472.699.327.740.880, D12.644.400.400.740.880, D12.644.456.837, D12.644.548.365.740.880, D12.776.641.650.405.740.880, D12.776.641.650.810
isoproterenol: D02.033.100.291.439, D02.092.063.291.439, D02.092.311.649
receptors, adrenergic, beta: D12.776.543.750.070.300.300.340, D12.776.543.750.100.150.300.340, D12.776.543.750.720.300.300.300.340
cyclic n-oxides: D03.661.243
spin labels: D02.389.678
hedgehog proteins: D12.644.276.671, D12.776.467.671, D23.529.671
intubation, intratracheal: E02.041.500, E02.585.578, E05.497.578
trypan blue: D02.172.975, D02.455.426.559.847.638.555.875, D02.886.645.600.080.050.650.875, D04.615.638.555.875
cerebral ventricles: A08.186.211.276
jejunum: A03.556.124.684.500, A03.556.249.750
phlorhizin: D09.408.702
sodium-glucose transporter 1: D12.776.157.530.450.625.437.500, D12.776.157.530.500.750.500, D12.776.543.585.450.625.562.500, D12.776.543.585.500.750.500
adipokines: D06.472.699.042, D12.644.276.024, D12.644.548.011, D12.776.467.024, D23.529.024
resistin: D06.472.699.042.750, D12.644.276.024.750, D12.644.548.011.750, D12.776.467.024.750, D23.529.024.750
wine: J02.200.100.900
mononuclear phagocyte system: A15.382.812
enoyl-coa hydratase: D08.811.520.241.300.250
sternum: A02.835.232.904.766
sodium nitrite: D01.625.600.600.800, D01.857.775
anemia, hemolytic: C15.378.071.141
cats: B01.050.150.900.649.147.354.250.125
erythrocyte count: E01.370.225.500.195.107.330, E01.370.225.625.107.330, E05.200.500.195.107.330, E05.200.625.107.330, E05.242.195.107.330, G04.170.107.330, G09.188.105.330
glycolates: D02.241.081.018.386, D02.241.511.316
papio: B01.050.150.900.649.801.400.112.199.120.610
abdomen: A01.923.047
contractile proteins: D12.776.210
papillary muscles: A02.633.580.680, A07.541.510.619, A07.541.704.750, A07.541.749
sarcolemma: A11.284.149.707
pulmonary gas exchange: E01.370.386.700.650, G03.495.166.775.602, G09.772.770.755.760.602
fourier analysis: E05.377, G17.226, L01.224.800.625
peptide mapping: E05.196.181.400.454.720, E05.196.401.319.720, E05.196.700, E05.393.760.705.685
nephrectomy: E04.950.774.435
matrix metalloproteinase inhibitors: D27.505.519.389.745.610
synaptophysin: D12.776.543.488.875, D12.776.543.990.840, D12.776.641.800, D23.101.840.800
tau proteins: D12.776.220.600.450.510, D12.776.641.560.510
immunophenotyping: E01.370.225.812.447, E05.200.812.447, E05.478.594.450
sperm capacitation: G08.686.785.760.277.760
abdominal neoplasms: C04.588.033
peritoneal cavity: A01.923.047.025.600.678
darkness: G01.590.540.233
elasticity: G01.374.590
proline: D12.125.072.401.623
dichlorvos: D02.705.400.130
soman: D02.705.429.750.750
osseointegration: G11.427.590.195.140.570, G16.100.856.150.150.570
erythrocyte indices: E01.370.225.625.230, E05.200.625.230, G09.188.260
peripheral nerves: A08.800.800
genes, fos: G05.360.340.024.340.375.500.791.330
crest syndrome: C06.405.117.119.500.204, C14.907.617.812.500, C14.907.823.225, C17.300.799.801.500, C17.800.784.801.500, C18.452.174.130.204
chromosome deletion: C23.550.210.050.500.500, G05.355.600.800.180, G05.365.590.029.530.175, G05.365.590.175.050.500.500, G05.365.590.762.180, G05.700.131.500.500
chromosome disorders: C16.131.260, C16.320.180
choline: D02.033.100.291.211, D02.092.063.291.211, D02.092.877.883.333, D02.675.276.232
galactans: D09.698.360
plant gums: D05.750.078.739, D09.698.700, D20.215.721.249
oncorhynchus kisutch: B01.050.150.900.493.817.750.705.580.410
receptors, odorant: D12.776.543.750.100.600, D12.776.543.750.735
borates: D01.132.250.075, D01.248.497.158.076, D02.203.130.075
dental pulp: A14.549.167.900.260
dental pulp necrosis: C07.793.237.315, C23.550.717.182
incisor: A14.549.167.860.425
molar: A14.549.167.860.525
odontoblasts: A11.329.522
periodontal ligament: A14.549.167.646.771
tongue: A03.556.500.885, A14.549.885
potassium channel blockers: D27.505.519.562.500, D27.505.954.411.645
chlorambucil: D02.455.526.728.650.156
gene conversion: G05.355.760.615.475
lac operon: G05.360.340.024.686.545, G05.360.340.358.207.500.545
genital diseases, male: C12.294
housing, animal: N06.230.150.360.250
appetite: F02.830.071, G07.610.390.070, G10.261.390.070
urogenital abnormalities: C12.706, C13.351.875, C16.131.939
pituitary neoplasms: C04.588.322.609, C04.588.614.250.195.885.500.600, C10.228.140.211.885.500.600, C10.228.140.617.477.600, C10.228.140.617.738.675, C10.551.240.250.700.500.500, C19.344.609, C19.700.734
sitosterols: D04.808.247.222.857, D04.808.247.808.756.669
hymenoptera: B01.050.500.131.617.479
pollination: G08.686.785.760.743, G15.744.800
pinnipedia: B01.050.150.900.649.147.600
mercury isotopes: D01.496.532
perches: B01.050.150.900.493.602.600
cerebrum: A08.186.211.730.885.287
trout: B01.050.150.900.493.817.750.825
trematoda: B01.050.500.500.736.715
sexual development: G07.700.320.750, G08.686.785.880
hydrazines: D02.442
hyperkinesis: C10.597.350.350, C23.888.592.350.350
reversal learning: F02.463.425.798
kisspeptins: D12.644.276.836, D12.644.400.430, D12.776.624.776.546
1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine: D03.383.725.450
dopamine agents: D27.505.519.625.150, D27.505.696.577.150
mptp poisoning: C10.228.140.079.862.800.300, C10.228.662.600.700.250, C10.720.606, C25.723.705.400
aorta, thoracic: A07.231.114.056.372
cell adhesion molecules: D12.776.395.550.200, D12.776.543.550.200, D23.050.301.350
guanosine monophosphate: D03.438.759.646.454.525, D13.695.667.454.525, D13.695.827.426.525
nitrites: D01.248.497.158.635, D01.625.600.600, D02.633
sorbus: B01.650.940.800.575.100.842.500.793
tunica intima: A07.231.330.800, A07.231.700, A10.272.491.355.800
tunica media: A02.633.570.491.800, A07.231.491.800, A10.690.467.491.800
apolipoproteins e: D10.532.091.500, D12.776.070.400.500, D12.776.521.120.500
brachiocephalic trunk: A07.231.114.145
blood-air barrier: A04.411.715.025, A07.025
cytogenetics: H01.158.273.343.180
methionine sulfoximine: D02.886.030.676.620, D12.125.166.676.620
photoperiod: G01.910.675
estrogens, conjugated (usp): D06.472.334.851.437.988
haloperidol: D02.522.352.506
propranolol: D02.033.100.624.698.711, D02.033.755.624.698.711, D02.092.063.624.698.711, D02.455.426.559.847.638.945, D04.615.638.945
dehydroepiandrosterone: D04.808.054.079.429.625, D04.808.578.502.400, D06.472.040.502.400, D06.472.334.851.968.952
hybridization, genetic: E05.820.150.390, G05.355.090.390
pentose phosphate pathway: G02.111.087.160.875, G02.149.115.160.875, G03.495.256.875, G03.495.335.693, G03.495.553.695
amyloid precursor protein secretases: D08.811.277.656.300.032
calcium-calmodulin-dependent protein kinase type 2: D08.811.913.696.620.682.700.125.200, D12.644.360.100.200, D12.776.476.100.200
gap-43 protein: D12.776.395.550.400, D12.776.543.550.400, D12.776.641.400
histone acetyltransferases: D08.811.913.050.134.407
nuclear receptor coactivator 1: D08.811.913.050.134.407.100, D12.644.360.024.308.100, D12.776.157.057.080.100, D12.776.476.024.394.100, D12.776.660.675.100, D12.776.930.617.100
hyalin: A12.580
receptors, metabotropic glutamate: D12.776.543.750.100.450, D12.776.543.750.720.200.450.500
ectoderm: A16.504.273
endoderm: A16.504.407
nodal protein: D12.644.276.954.550.650, D12.776.467.942.550.650, D23.529.942.550.650
mitochondria, heart: A11.284.430.214.190.875.564.627.603, A11.284.835.626.627.603
comb and wattles: A13.242
4-aminopyridine: D02.092.080.060, D03.383.725.050.060
antithyroid agents: D06.347.100, D27.505.696.399.450.100
receptors, thyroid hormone: D12.776.260.698.850, D12.776.624.664.700.830, D12.776.826.850, D12.776.930.669.850
clodronic acid: D02.705.429.500.200
immunotherapy, adoptive: E02.095.465.425.400.330.050.400, E05.478.550.520.050.400
rats, inbred bn: B01.050.050.157.760.110, B01.050.050.199.520.760.110, B01.050.150.900.649.865.635.505.700.400.110
angiotensin ii type 1 receptor blockers: D27.505.519.162.500
glucose clamp technique: E01.370.225.124.100.350, E05.196.500, E05.200.124.100.350
losartan: D02.455.426.559.389.185.475, D03.383.129.308.507, D03.383.129.617.467
oligopeptides: D12.644.456
lysine: D12.125.068.555, D12.125.095.647, D12.125.142.497
paraffin: D02.455.612
soil microbiology: H01.158.273.540.274.555, N06.850.425.300
trifolium: B01.650.940.800.575.100.401.906
electron transport complex iv: D05.500.562.374, D08.811.600.250.687, D08.811.682.285, D12.776.157.530.450.250.875.304, D12.776.543.277.687, D12.776.543.585.450.250.875.484
oxidative phosphorylation: G02.111.087.677.550, G02.149.115.677.550, G03.495.335.631, G03.495.790.550
blood flow velocity: E01.370.370.130, G09.330.380.630.080
bursa of fabricius: A10.549.175, A13.163, A15.382.520.604.114
enzyme precursors: D08.622
stereotyped behavior: F01.145.896
serum albumin: D12.776.034.841, D12.776.124.050.700, D12.776.124.727
prothrombin time: E01.370.225.625.115.610, E05.200.625.115.610, G09.188.680
starfish: B01.050.500.408.765
malaria: C03.752.530
luteinizing hormone, beta subunit: D06.472.699.322.576.463.500, D06.472.699.631.525.343.463.500, D12.644.548.691.525.343.463.500
ovarian cysts: C04.182.612, C13.351.500.056.630.580, C19.391.630.580
swine diseases: C22.905
glomerulonephritis: C12.777.419.570.363, C13.351.968.419.570.363
receptors, tumor necrosis factor, type ii: D12.776.543.750.705.852.760.798, D23.050.301.264.035.910, D23.101.100.110.916
anesthetics, general: D27.505.696.277.100.035, D27.505.954.427.210.100.035
angiotensin i: D06.472.699.094.075, D12.644.400.070.075, D12.644.456.073.021, D12.644.548.058.075, D12.776.641.650.070.075, D23.469.050.050.025
petrolatum: D02.455.699
rana temporaria: B01.050.150.900.090.180.708.420
phosphamidon: D02.705.400.700
distemper: C02.782.580.600.500.285, C22.268.265
distemper virus, phocine: B04.820.455.600.650.500.320, B04.909.777.455.600.650.500.320
radioligand assay: E01.370.225.985, E01.370.374.650, E01.370.384.720, E05.200.985
cerebellar cortex: A08.186.211.132.810.428.200.212, A08.186.211.865.428.200.212
chemistry, clinical: H01.181.341
environment, controlled: N06.230.150
sense organs: A09
acute lung injury: C08.381.520.500
characiformes: B01.050.150.900.493.130
british columbia: Z01.107.567.176.160
salts: D01.786
acids, acyclic: D02.241.081
aquatic organisms: B05.080, G16.500.275.810.650.075
bays: G01.311.625.080
matrix metalloproteinases: D08.811.277.656.300.480.525, D08.811.277.656.675.374.525
mice, inbred a: B01.050.050.157.520.300, B01.050.050.199.520.520.300, B01.050.150.900.649.865.635.505.500.400.300
granuloma, respiratory tract: C08.280, C23.550.382.968
plethysmography, whole body: E01.370.386.700.615, E01.370.610.615
docosahexaenoic acids: D10.212.302.380.410.210, D10.251.355.337.250, D10.627.430.450.375
ppar-beta: D12.776.260.698.239.530, D12.776.826.239.530, D12.776.930.669.239.530
nociceptors: A08.663.650.915.875, A08.800.950.875, A11.671.650.915.875
noxae: D27.888.569
vocalization, animal: F01.145.113.055.800
iodine: D01.268.380.400
avena sativa: B01.650.940.800.575.100.822.060, J02.500.200.066, J02.500.300.100.088
dieldrin: D02.455.526.439.371
chromatography, ion exchange: E05.196.181.400.383
porpoises: B01.050.150.900.649.189.566
genome: G05.360.340
major histocompatibility complex: G05.360.340.024.340.610, G05.360.340.024.380.500, G12.500.500
interleukin-13: D12.644.276.374.465.513, D12.776.467.374.465.513, D23.529.374.465.513
hematopoietic system: A15.378
fluorometry: E05.196.712.516.600
oligospermia: C12.294.365.700.508
spermatogenesis-blocking agents: D27.505.696.138.760, D27.505.696.875.360.443.068.760, D27.505.954.705.360.443.068.760, D27.888.569.071.760
cyproterone: D04.808.745.432.219, D04.808.883.419
hermaphroditic organisms: B05.275
animals, outbred strains: B01.050.050.284
ear, inner: A09.246.631
evoked potentials, auditory, brain stem: G07.265.500.370.300, G11.561.270.370.300
antigens, cd3: D23.050.301.264.035.103, D23.050.301.264.894.095, D23.101.100.110.103, D23.101.100.894.095
antigens, cd4: D12.776.543.750.705.852.420.810.500, D12.776.543.750.925.700.025, D23.050.301.264.035.104, D23.050.301.264.894.100, D23.101.100.110.104, D23.101.100.894.100
phosphotyrosine: D12.125.072.050.875.750, D12.125.740.740
lactose: D09.698.629.305.340
methylcellulose: D09.698.365.180.663
picloram: D03.066.707.523, D03.383.725.705.523
picolinic acids: D03.066.707, D03.383.725.705
gata4 transcription factor: D12.776.260.257.400, D12.776.930.321.400
cobalt radioisotopes: D01.496.239.354, D01.496.749.256
seals, earless: B01.050.150.900.649.147.600.700
geese: B01.050.150.900.248.050.350, B01.050.150.900.248.617.492
alternative splicing: G02.111.087.750.700.100, G02.149.115.750.700.100, G03.495.839.700.100, G05.355.315.700.700.100
phosphofructokinase-2: D08.811.277.352.650.622, D08.811.641.843, D08.811.913.696.620.225.850.750
local lymph node assay: E01.370.225.812.871.450, E05.200.812.871.450, E05.478.594.890.450
cardiotonic agents: D27.505.954.411.222, D27.720.799.080
infusions, subcutaneous: E02.319.267.510.795
carbon isotopes: D01.496.123
nitrogen isotopes: D01.496.586
erythropoietin: D12.644.276.374.410.240.150, D12.776.395.240.150, D12.776.467.374.410.240.150, D23.529.374.410.240.150
interleukin-4: D12.644.276.374.465.504, D12.776.467.374.465.504, D23.529.374.465.504
hydralazine: D03.383.710.605.500
capillary permeability: G03.495.166.330, G09.330.165
neuromuscular junction: A08.800.550.550.550, A08.850.550.550, A11.284.149.165.420.780.550.550
sensory receptor cells: A08.663.650.915, A08.800.950, A11.671.650.915
drug administration routes: E02.319.267
electrolytes: D01.248
bile ducts: A03.159.183
drug contamination: N06.850.360
membrane lipids: D10.570
dendritic cells: A11.066.270, A11.436.270, A15.382.066.270, A15.382.812.260
blood coagulation factors: D12.776.124.125, D23.119
benomyl: D02.241.081.251.125, D03.438.103.140
plankton: B05.080.500
toxicity tests, subchronic: E05.940.900
sunburn: C17.800.600.725, C26.200.855
dendrites: A08.663.256, A11.284.180.225, A11.671.240
peroxides: D01.248.497.158.685.750, D01.339.431.374, D01.650.550.750, D02.389.338, D02.737
mediastinum: A01.923.761.800.500
nanowires: J01.637.512.925
pleural cavity: A01.923.761.800.650
fat body: A13.365
ileum: A03.556.124.684.249, A03.556.249.124
silver compounds: D01.847
ca1 region, hippocampal: A08.186.211.464.405.099, A08.186.211.730.885.287.500.345.099
blood vessels: A07.231
pulmonary surfactants: D27.505.954.796.600
mytilus: B01.050.500.644.080.537.500
human umbilical vein endothelial cells: A11.436.275.682
ca3 region, hippocampal: A08.186.211.464.405.174, A08.186.211.730.885.287.500.345.174
dendritic spines: A08.663.256.200, A11.284.180.225.169, A11.671.240.169
sequence homology, amino acid: G02.111.810.200, G05.810.200
intestine, large: A03.556.124.526, A03.556.249.249
hemocytes: A11.118.480, A15.145.229.480
immunomodulation: E02.095.465, G12.425.746
gastric acid: A12.200.307.603
extracellular fluid: A11.284.295.260, A12.207.270
therapeutic irrigation: E02.533.500, E05.927
salinity: G02.640.500, G02.842.640.500
chlorophyll: D03.383.129.578.840.374, D03.383.129.578.840.500.640.220, D03.549.909.374, D03.549.909.500.640.220, D04.345.783.374, D04.345.783.500.640.220, D23.767.727.220, D23.767.727.640.220
plant lectins: D12.776.503.499, D12.776.765.678
tilapia: B01.050.150.900.493.602.200.800
bone substitutes: D25.130.325, J01.637.051.130.325
otoacoustic emissions, spontaneous: G11.561.600.810.263.570
presbycusis: C09.218.458.341.887.772, C10.597.751.418.341.887.772, C23.888.592.763.393.341.887.772
spiral ganglion: A08.340.390.800, A08.800.350.800, A08.800.800.120.910.120.800, A09.246.631.246.900
testosterone propionate: D04.808.054.079.429.824.832, D06.472.334.851.968.984.750
cystathionine gamma-lyase: D08.811.520.300.250
sulfur: D01.268.185.900
sulfurtransferases: D08.811.913.817.500
thiosulfate sulfurtransferase: D08.811.913.817.500.500
8-bromo cyclic adenosine monophosphate: D03.438.759.646.138.395.225, D13.695.462.200.225, D13.695.667.138.395.225, D13.695.827.068.395.225
reproductive control agents: D27.505.696.875, D27.505.954.705
zambia: Z01.058.290.175.920
point mutation: G05.365.590.675
dicumarol: D03.438.150.446.520.203, D03.830.219.446.520.203
substrate specificity: G02.111.835
adenylate cyclase: D08.811.520.650.200, D12.644.360.050, D12.776.476.050
chromosome mapping: E05.393.183
genetic linkage: G05.540
quantitative trait loci: G05.360.340.024.380.937
immersion: E05.466
microcirculation: G09.330.190.163.645
propylene glycol: D02.033.455.706.725
chlorzoxazone: D03.438.221.346
selenomethionine: D02.712.700, D02.886.030.676.900, D12.125.166.676.900
fusarium: B01.300.381.366
synapsins: D12.776.641.750, D12.776.744.840
heat stroke: C26.522.500
thyroid hormone receptors alpha: D12.776.260.698.850.500, D12.776.624.664.700.830.500, D12.776.826.850.500, D12.776.930.669.850.500
hoof and claw: A13.491
mya: B01.050.500.644.080.535
rna, ribosomal, 18s: D13.444.735.686.675
insulin receptor substrate proteins: D12.644.360.024.301, D12.776.157.057.039, D12.776.476.024.382
receptor, insulin: D08.811.913.696.620.682.725.400.200, D12.776.543.750.060.484, D12.776.543.750.750.580.300
north america: Z01.107.567
pinocytosis: G04.299.482.370
maternal behavior: F01.829.263.370.215
splenic diseases: C15.604.744
conservation of natural resources: J01.256, N06.230.080
diarrhea: C23.888.821.214
fur seals: B01.050.150.900.649.147.600.288
neuropil: A08.637.500, A08.663.703, A11.650.500, A11.671.685
pten phosphohydrolase: D08.811.277.352.650.850, D12.776.476.590, D12.776.624.776.695
hair cells, auditory: A08.663.650.250, A08.663.650.915.750.600.350, A08.800.950.750.600.350, A09.246.631.246.577.325, A11.671.650.250, A11.671.650.915.750.600.350
calcineurin: D08.811.277.352.650.625.150, D12.644.360.087, D12.776.476.087
saponins: D09.408.782
antigens, cd36: D12.776.157.530.300.500, D12.776.395.550.625.136, D12.776.543.550.625.136, D12.776.543.585.300.500, D12.776.543.750.011, D12.776.543.750.705.675.136, D12.776.543.750.705.940.625.249, D12.776.543.750.710.450.750.625.249, D23.050.301.264.035.136, D23.101.100.110.136
polyphenols: D02.455.426.559.389.657.715, D03.438.150.266.450.260.777
paralysis: C10.597.622, C23.888.592.636
startle reaction: E01.370.376.550.650.800, E01.370.600.550.650.800, F02.830.702.807, G11.561.600.765.869
alkanesulfonates: D02.455.326.146.100.050, D02.886.645.600.055.050
computational biology: H01.158.273.180
lasers: E07.632.490, E07.710.520
microdissection: E01.370.225.500.620.520, E01.370.225.750.600.520, E01.370.225.998.221.580, E04.221.580, E05.200.750.600.520, E05.200.998.221.580, E05.591.560
caustics: D27.720.185, D27.888.569.185
p-aminohippuric acid: D02.065.277.431.192.100, D02.241.223.100.050.500.650, D02.241.223.100.100.100.100, D02.241.755.360.192.100, D02.455.426.559.389.127.020.937.650, D02.455.426.559.389.127.085.067.100
escherichia coli: B03.440.450.425.325.300, B03.660.250.150.180.100
methoprene: D06.472.445.573.666.500
tachycardia, ventricular: C14.280.067.845.940, C23.550.073.845.940
paraffin embedding: E01.370.225.500.620.720.610, E01.370.225.750.600.720.610, E05.200.500.620.720.610, E05.200.750.600.720.610
quinone reductases: D08.811.682.608.800
receptors, cholinergic: D12.776.543.750.720.360
impulsive behavior: F01.145.527
head: A01.456
axonal transport: G03.495.166.355.040, G04.299.418.040, G11.561.600.085
decidua: A05.360.319.679.490.373, A16.710.289
play and playthings: I03.450.642.693
aggression: F01.145.126.125, F01.145.813.045
sexual behavior: F01.145.802
receptors, somatostatin: D12.776.543.750.100.850, D12.776.543.750.720.600.760, D12.776.543.750.750.555.760, D12.776.543.750.750.580.720, D12.776.543.750.750.700.800
cyclin-dependent kinase inhibitor p21: D12.644.360.225.500, D12.776.167.187.500, D12.776.476.225.500, D12.776.624.776.355.500
epidermal growth factor: D06.472.317.350, D12.644.276.561, D12.776.467.561, D23.529.561
arecoline: D03.066.515.292, D03.132.080, D03.383.725.547.292
churg-strauss syndrome: C14.907.940.897.249.249, C15.604.515.292.015, C20.111.193.500
pulmonary eosinophilia: C08.381.750, C15.378.553.231.549.750
bromobenzenes: D02.455.426.559.389.220, D02.455.526.368.150
punctures: E02.800, E04.665
somatosensory disorders: C10.597.751.791, C23.888.592.763.770
cerebrovascular circulation: G09.330.190.163.159
deoxyglucose: D09.254.229
hydrogen: D01.268.406, D01.362.340, D01.435
panax: B01.650.940.800.575.100.087.500
plant structures: A18
multidrug resistance-associated proteins: D12.776.157.530.100.304, D12.776.157.530.450.074.500.500.500, D12.776.543.585.100.304, D12.776.543.585.450.074.500.500.500
spinal diseases: C05.116.900
bile acids and salts: D04.808.105
organic anion transporters: D12.776.157.530.450.074.500, D12.776.543.585.450.074.500
organic anion transporters, sodium-dependent: D12.776.157.530.450.074.500.687, D12.776.543.585.450.074.500.812
organic anion transporters, sodium-independent: D12.776.157.530.450.074.500.781, D12.776.543.585.450.074.500.875
ketone bodies: D02.522.585
acetophenones: D02.522.120
epithelial sodium channels: D12.776.157.530.400.875.200, D12.776.543.550.425.875.200, D12.776.543.585.400.875.200
mineralocorticoid receptor antagonists: D06.347.700, D27.505.696.399.450.600, D27.505.696.560.500.726.249
receptors, mineralocorticoid: D12.776.260.698.750.530, D12.776.826.750.530, D12.776.930.669.750.530
spironolactone: D02.540.679, D04.808.745.745.855
electron spin resonance spectroscopy: E05.196.867.519.274
carnitine: D02.092.877.883.099
cadherins: D12.776.395.550.200.200, D12.776.543.550.200.200, D23.050.301.350.200
tribulus: B01.650.940.800.575.100.987.849
antigen-antibody complex: D12.776.124.486.485.114.257, D12.776.124.790.651.114.257, D12.776.377.715.548.114.257, D23.050.101
dinitrochlorobenzene: D02.455.426.559.389.261.250, D02.455.426.559.389.565.250, D02.455.526.439.202.200, D02.640.529.240.250, D23.050.550.480.350
haptens: D23.050.550.480
phthalic anhydrides: D02.113.600, D02.241.223.805.800
1-butanol: D02.033.415.110.175, D10.289.110.175
butanols: D02.033.415.110, D10.289.110
hearing loss, functional: C09.218.458.341.750, C10.597.751.418.341.750, C23.888.592.763.393.341.750, F01.145.126.875
cholelithiasis: C06.130.409
ethers: D02.355
gallbladder: A03.159.439
dog diseases: C22.268
whales: B01.050.150.900.649.189.865
blood coagulation: G09.188.124.560.150
calcifediol: D04.808.247.222.159.478.250, D04.808.247.808.146.478.250, D04.808.812.768.196.478.250, D10.570.938.146.478.250
calcitonin: D06.472.699.150, D12.644.400.095, D12.644.548.150, D12.776.641.650.095
calcitriol: D04.808.247.222.159.478.387.300, D04.808.247.808.146.478.387.300, D04.808.812.768.196.478.387.300, D10.570.938.146.478.387.300
urodela: B01.050.150.900.090.608
hearing tests: E01.370.382.375
gravity sensing: G11.561.600.810.255, G15.744.450
orientation: F01.058.577, F02.830.606
dopamine uptake inhibitors: D27.505.519.625.150.800, D27.505.519.625.600.220, D27.505.696.577.150.800, D27.505.696.577.600.220
mazindol: D03.438.513.500
azoles: D03.383.129
crops, agricultural: B01.650.510.344, J02.500.300
macrolides: D02.540.505, D02.540.576.500, D04.345.674.500
pacific states: Z01.107.567.875.580
prunus: B01.650.940.800.575.100.842.500.625
x-ray microtomography: E01.370.350.700.810.810.900, E01.370.350.825.810.810.900
wnt4 protein: D12.776.467.984.400, D23.529.984.400
immunoassay: E05.478.566, E05.601.495
neural tube defects: C10.500.680, C16.131.666.680
amphipoda: B01.050.500.131.365.055
respiratory physiological phenomena: G09.772
azocines: D03.383.113
bungarotoxins: D20.888.850.325.139, D23.946.833.850.325.139
pirenzepine: D03.438.079.080.070.750
quinolizines: D03.438.834
urochordata: B01.050.150.200.727, B01.050.500.272.727
amphetamine: D02.092.471.683.152.110
cholinergic agonists: D27.505.519.625.120.140, D27.505.696.577.120.140
clozapine: D03.494.240.220
serotonin antagonists: D27.505.519.625.850.850, D27.505.696.577.850.850
anesthetics, inhalation: D27.505.696.277.100.035.060, D27.505.954.427.210.100.035.060
central nervous system depressants: D27.505.696.277, D27.505.954.427.210
dextroamphetamine: D02.092.471.683.152.110.200
signal detection, psychological: E01.370.685.814, F02.463.593.257.800, F02.463.593.710.725, F04.096.753.814, F04.669.908
stress, mechanical: G01.374.676.830, G01.595.540.830
exfoliation syndrome: C11.941.375.285
biomechanics: 
spinal fractures: C26.117.500.500, C26.404.812, C26.831.600
body weights and measures: E01.370.600.115.100, E05.041.124, G07.100.100
cardiac output, low: C14.280.148, C23.888.192
memory, short-term: F02.463.425.540.407
inferior colliculi: A08.186.211.132.659.727.407, A08.186.211.653.727.249
acetyl coenzyme a: D03.438.759.646.138.382.300.020, D08.211.211.300.075, D13.695.667.138.382.300.020, D13.695.827.068.382.300.020
neurotransmitter uptake inhibitors: D27.505.519.625.600, D27.505.696.577.600
food deprivation: F01.658.433
olfactory pathways: A08.186.211.464.699, A08.186.211.730.885.600, A08.612.220.640
cathepsin d: D08.811.277.656.074.500.180, D08.811.277.656.224.187, D08.811.277.656.300.048.180
lysophospholipase: D08.811.277.352.100.680.510
adrenergic alpha-1 receptor antagonists: D27.505.519.625.050.200.100.100, D27.505.696.577.050.200.100.100
clonidine: D03.383.129.308.436.500
hydroxylamines: D02.092.570
respiratory burst: G03.495.278.620, G04.299.305.620
enterocytes: A03.556.124.369.290, A10.615.550.444.290, A11.436.290
portal vein: A07.231.908.670.567
substance p: D12.644.276.812.900.866, D12.644.400.800.750, D12.644.456.800.866, D12.776.467.812.900.866, D12.776.641.650.800.750, D23.469.050.375.850.890, D23.529.812.900.866
hyperlipidemias: C18.452.584.500.500
bile: A12.200.087
acids: D01.029
n-methylaspartate: D12.125.067.500.400, D12.125.119.170.400
presynaptic terminals: A08.663.542.145.750, A08.850.700, A11.284.149.165.420.780.700, A11.671.137.750
inclusion bodies: A11.284.420
benz(a)anthracenes: D02.455.426.559.847.149, D04.615.149
serotonin plasma membrane transport proteins: D12.776.157.530.450.625.311, D12.776.157.530.562.374.875, D12.776.543.585.450.625.374, D12.776.543.585.562.374.875
cytoplasmic granules: A11.284.430.214.190.500, A11.284.430.214.190.875.190.190
vitamin e: D03.438.150.909, D03.830.219.909
biological specimen banks: N02.278.065
risk management: N03.219.463.800, N04.452.871
secretory vesicles: A11.284.430.214.190.875.190.880.810
muscle fibers, fast-twitch: A10.690.552.500.500.600, A11.620.249.400
secondary: 
cortisone: D04.808.745.745.183, D06.472.040.585.478.195
fetal viability: G07.280, G07.700.320.500.325.235.875, G08.686.220
umbilical arteries: A07.231.114.929, A16.378.693.641
ganglia, sympathetic: A08.340.315.350, A08.800.050.300.300, A08.800.050.800.300
hypoglossal nerve: A08.800.800.120.330
hippurates: D02.065.277.431, D02.241.223.100.100.400, D02.241.755.360, D02.455.426.559.389.127.085.460
receptor, endothelin b: D12.776.543.750.100.220.200, D12.776.543.750.750.320.200
sequence deletion: G05.355.600.800, G05.365.590.762
saccharin: D02.886.675.687, D03.383.129.708.089.708, D03.438.185.708
amphetamine-related disorders: C25.775.225, F03.900.225
gtp-binding proteins: D08.811.277.040.330.300, D12.776.157.325
methamphetamine: D02.092.471.683.152.619
sulpiride: D02.065.277.866, D02.241.223.100.100.866, D02.455.426.559.389.127.085.866
myelin basic protein: D12.776.543.620.540, D12.776.641.580.510
antigens, neoplasm: D23.050.285
hydroxyl radical: D01.248.497.158.459.300, D01.339.431.249, D01.455.432
iron chelating agents: D27.505.519.914.500.410, D27.720.832.500.410
phenanthrolines: D03.494.669
receptor, platelet-derived growth factor alpha: D08.811.913.696.620.682.725.400.900.500, D12.776.543.750.060.625.300, D12.776.543.750.750.400.630.300
receptor, platelet-derived growth factor beta: D08.811.913.696.620.682.725.400.900.750, D12.776.543.750.060.625.400, D12.776.543.750.750.400.630.400
receptors, lh: D12.776.543.750.100.400, D12.776.543.750.720.600.450, D12.776.543.750.750.555.450, D12.776.543.750.750.660.350.450
blastoderm: A16.331.024
carboxy-lyases: D08.811.520.224.125
niacin: D03.066.515.475, D03.383.725.547.475
quinolinic acid: D03.383.725.822.700
tryptophan: D12.125.072.050.850, D12.125.142.875
zymosan: D09.698.365.089.750
ethylenebis(dithiocarbamates): D02.241.081.251.869.265, D02.886.706.250
loperamide: D03.383.621.440
polyploidy: C23.550.210.702, G05.365.590.175.677, G05.700.740
carbamoyl-phosphate synthase (ammonia): D08.811.464.259.350
common dolphins: B01.050.150.900.649.189.267.150
minke whale: B01.050.150.900.649.189.865.100.500
ganglia, sensory: A08.340.390, A08.800.350
tritolyl phosphates: D02.455.426.559.389.657.239.900, D02.705.400.875
diatoms: B01.750.875
reactive nitrogen species: D01.625.700, D02.654.846
tocotrienols: D03.438.150.909.875, D03.830.219.909.875
insect proteins: D12.776.092.500
hematologic tests: E01.370.225.625, E05.200.625
physicochemical processes: G02.149.767, G02.842.750
caseins: D12.776.256.626.207, D12.776.744.150
polycystic kidney diseases: C12.777.419.403.875, C13.351.968.419.403.875
soybean proteins: D12.776.765.741, J02.500.850.500.700.500.750
nephritis, interstitial: C12.777.419.570.643, C13.351.968.419.570.643
hematologic diseases: C15.378
endothelial growth factors: D12.644.276.390, D12.776.467.390, D23.529.390
lymphokines: D12.644.276.374.480, D12.776.467.374.480, D23.529.374.480
vascular endothelial growth factors: D12.644.276.100.800, D12.776.467.100.800, D23.529.100.800
nitro compounds: D02.640
hepatectomy: E04.210.556
extinction, biological: G16.100.280
lauric acids: D10.251.500
bulbourethral glands: A05.360.444.123, A10.336.197
endothelium-dependent relaxing factors: D27.505.954.411.918.500
nitric oxide donors: D27.505.519.656, D27.505.954.411.590
nitroprusside: D01.248.497.158.291.350.550, D01.490.100.300.550, D01.625.400.100.325.550
bees: B01.050.500.131.617.479.387
fatty acids, omega-6: D10.251.355.343
safflower oil: D10.212.302.380.750, D10.212.507.750, D10.627.700.840, D20.215.784.750.840, J02.500.375.400.700
perceptual distortion: F02.463.593.603
receptors, serotonin: D12.776.543.750.070.800, D12.776.543.750.100.800, D12.776.543.750.720.300.800
morphine: D03.132.577.249.562.571, D03.549.686.607.587, D03.605.497.607.587, D04.615.723.795.576.571
receptors, opioid, mu: D12.776.543.750.100.620.550, D12.776.543.750.720.600.610.550, D12.776.543.750.750.555.610.550
reward: F02.463.425.770.836
ornithine decarboxylase: D08.811.520.224.125.425
regeneration: G16.100.856
animal communication: F01.145.113.055
sulfonylurea compounds: D02.886.590.795, D02.948.828
adrenergic alpha-agonists: D27.505.519.625.050.100.100, D27.505.696.577.050.100.100
placental insufficiency: C13.703.590.800
p-selectin: D12.776.395.550.200.700.775, D12.776.395.550.625.905, D12.776.503.843.775, D12.776.543.550.200.700.775, D12.776.543.550.625.905, D23.050.301.264.035.912.775, D23.050.301.350.700.775, D23.101.100.110.918.775
hematuria: C12.777.934.442, C13.351.968.934.442, C23.550.414.849
captopril: D12.125.072.401.623.270
sulfinic acids: D01.029.260.877.700, D01.875.800.700, D02.886.645.585
epoprostenol: D10.251.355.255.100.637.550.500, D10.251.355.255.550.550.500, D23.469.050.175.725.895.500
isoprostanes: D10.251.355.255.100.375, D10.251.355.411
diabetes mellitus, type 1: C18.452.394.750.124, C19.246.267, C20.111.327
membranes: A10.615
presenilins: D12.776.543.696
receptors, notch: D12.776.543.750.725, D12.776.930.670
surface plasmon resonance: E05.196.890, E05.601.123.700
gluconeogenesis: G02.111.087.160.500, G02.149.115.160.500, G03.495.256.500
glucose metabolism disorders: C18.452.394
adrenal gland diseases: C19.053
ascites: C23.550.081
carboxymethylcellulose sodium: D09.698.365.180.663.329
scrotum: A05.360.444.661
tissue adhesions: C23.550.355.274.840
protein array analysis: E05.196.630.570.700, E05.393.525.680, E05.588.570.700, E05.601.680
listeria monocytogenes: B03.510.100.500.500, B03.510.460.400.410.485.500
receptors, retinoic acid: D12.776.260.698.701, D12.776.826.701, D12.776.930.669.701
mevalonic acid: D02.241.511.579
hexoses: D09.546.359
keratins: D05.750.078.593.450, D12.776.220.475.450, D12.776.860.607
dipeptidyl peptidase 4: D08.811.277.656.350.350.126, D08.811.277.656.959.250, D23.050.301.264.035.283, D23.050.301.264.894.160, D23.101.100.110.282, D23.101.100.894.160
colorimetry: E05.196.922.250
brachyura: B01.050.500.131.365.190.110
ecdysteroids: D04.808.247.222.265.165, D04.808.247.808.756.143, D06.472.445.573.271
juvenile hormones: D06.472.445.573.666
phytol: D02.455.849.291.523
attention deficit and disruptive behavior disorders: F03.550.150
propylthiouracil: D03.383.742.698.875.842.708
discrimination (psychology): F02.463.593.257
estriol: D04.808.365.415.331, D06.472.334.851.437.750
history, ancient: K01.400.470
bromides: D01.139.300.050, D01.248.497.158.125
alpha 1-antitrypsin: D12.644.822.750.035, D12.644.861.035, D12.776.124.050.070, D12.776.124.790.106.085, D12.776.377.715.085.085, D12.776.395.068, D12.776.645.750.035, D12.776.872.035
encephalomalacia: C10.228.140.461
amnesia: C10.597.606.525.100, C23.888.592.604.529.100, F01.700.625.100, F03.087.200
cytomegalovirus infections: C02.256.466.245
models, immunological: E05.599.395.500
viral plaque assay: E01.370.225.875.970.790, E05.200.875.970.790
blood platelets: A11.118.188, A15.145.229.188
deuterium oxide: D01.435.256.250, D01.455.900.200
hypercalcemia: C18.452.174.451, C18.452.950.340
cholinergic fibers: A08.663.542.234
receptors, nerve growth factor: D12.776.543.750.750.400.550
allopurinol: D03.438.759.160
gout suppressants: D27.505.954.329.337
hydrochlorothiazide: D02.886.590.700.135.261.476, D02.886.655.500.261.476, D03.438.174.261.476
hyperuricemia: C23.550.449
aldehyde dehydrogenase: D08.811.682.657.163.249
erythropoiesis: G04.299.151.825.414, G09.188.124.544.414
phenylhydrazines: D02.442.726
antiparasitic agents: D27.505.954.122.250
veterinary drugs: D26.939
adrenergic uptake inhibitors: D27.505.519.625.050.601, D27.505.519.625.600.050, D27.505.696.577.050.601, D27.505.696.577.600.050
reserpine: D03.132.436.681.933.500, D03.438.473.402.681.933.500
ammonia: D01.362.075, D01.625.050
cardiomyopathy, hypertrophic: C14.280.238.100, C14.280.484.150.070.160
rna probes: D13.444.600.723, D27.505.259.750.600.825, D27.720.470.530.600.825
receptors, prolactin: D12.776.543.750.720.600.710, D12.776.543.750.750.555.710, D12.776.543.750.750.660.350.725
citrulline: D12.125.095.226
laminin: D12.776.395.550.530, D12.776.543.550.500, D12.776.860.300.675
histidine: D12.125.072.329, D12.125.142.308
carcinoma in situ: C04.557.470.200.240
immunochemistry: H01.158.201.486, H01.181.122.605, H02.403.044.500
porifera: B01.050.500.802
alopecia: C17.800.329.937.122, C23.300.035
diestrus: G08.686.195.374
fluorine compounds: D01.303
cyclooxygenase 2 inhibitors: D27.505.519.389.310.500, D27.505.696.663.850.014.040.500.500.500, D27.505.954.158.030.500.500, D27.505.954.329.030.500.500
tetrazoles: D03.383.129.617
benzopyrans: D03.438.150, D03.830.219
acyl-coa dehydrogenase: D08.811.682.660.150.100, D12.776.331.099
fatty acid desaturases: D08.811.682.690.708.392
weight loss: C23.888.144.243.963, G07.700.320.249.314.120.200.963
cochlear diseases: C09.218.568.120
atenolol: D02.033.100.624.698.070, D02.033.755.624.698.070, D02.092.063.624.698.070
ethanolamines: D02.033.100.291, D02.033.375.291, D02.092.063.291
cyclobutanes: D02.455.426.392.368.201
fumonisins: D02.455.326.146.432, D23.946.587.385
datura stramonium: B01.650.940.800.575.100.905.188.800
pentylenetetrazole: D03.383.066.600
lameness, animal: C22.510
developmental biology: H01.158.273.200
mammals: B01.050.150.900.649
monokines: D12.644.276.374.500, D12.776.467.374.500, D23.529.374.500
indocyanine green: D03.438.473.400
veins: A07.231.908
gpi-linked proteins: D12.776.395.550.448, D12.776.543.484.500, D12.776.543.550.418
helium: D01.268.613.350, D01.362.641.352
heart atria: A07.541.358
plant components, aerial: A18.024
protein tyrosine phosphatase, non-receptor type 1: D08.811.277.352.650.775.300.100, D12.644.360.585.100, D12.776.476.564.100
sapindaceae: B01.650.940.800.575.100.885
cd8-positive t-lymphocytes: A11.118.637.555.567.569.220, A15.145.229.637.555.567.569.220, A15.382.490.555.567.569.220
immunity, innate: G12.450.564
ultrasonics: H01.671.031.849
iron, dietary: D01.490.600, D02.691.550.600
arginase: D08.811.277.913.292
pituitary hormones, anterior: D06.472.699.631.525, D12.644.548.691.525
tropolone: D02.455.426.392.368.284.900
hair color: G13.500, G16.690.490
cochlear microphonic potentials: G07.265.500.370.223, G11.561.270.370.223
deoxyribonuclease bamhi: D08.811.150.280.260.240, D08.811.277.352.335.350.300.260.240, D08.811.277.352.355.325.300.260.240
deoxyribonucleases, type ii site-specific: D08.811.150.280.260, D08.811.277.352.335.350.300.260, D08.811.277.352.355.325.300.260
transgenes: G05.360.340.024.340.825
ethmoid sinus: A04.531.621.267
cucurbitaceae: B01.650.940.800.575.100.300
nondisjunction, genetic: C23.550.210.645, G05.355.105.220.625.620, G05.355.600.620
vesicular acetylcholine transport proteins: D12.776.157.530.450.162.887.500.249, D12.776.157.530.562.750.500.249, D12.776.543.585.450.162.887.500.249, D12.776.543.585.562.750.500.249
vesicular transport proteins: D12.776.543.990
organothiophosphates: D02.705.400.625, D02.705.539.345, D02.886.300.692
osteonecrosis: C05.116.852, C23.550.717.732
bromocriptine: D03.132.327.412.100, D03.549.439.131, D03.549.562.100
congenital hypothyroidism: C05.116.099.343.347, C05.116.132.256, C16.320.240.625, C19.297.155, C19.874.482.281
methionine: D02.886.030.676, D12.125.142.557, D12.125.154.549, D12.125.166.676
ginkgo biloba: B01.650.940.800.575.400.300
cardiovascular agents: D27.505.954.411
methylhydrazines: D02.442.600
vitamin b complex: D27.505.696.377.605.600.708
osmotic pressure: G01.374.715.578, G02.640.249, G02.685.661, G02.842.640.249, G02.842.700.661
vasopressins: D06.472.699.631.692.781, D12.644.400.900, D12.644.456.925, D12.644.548.691.692.781, D12.776.641.650.937
ras proteins: D08.811.277.040.330.300.400.500, D12.644.360.525.500, D12.776.157.325.515.500, D12.776.476.525.500
achilles tendon: A02.880.176
tendon injuries: C26.874
liver glycogen: D05.750.078.562.388.518, D09.698.365.388.518
alpha-fetoproteins: D12.776.124.790.106.092, D12.776.320.525.500, D12.776.377.228.500, D12.776.377.715.085.092, D23.101.840.050
dendrimers: D05.750.327, E02.319.300.380.200, J01.637.512.600.200
ferumoxytol: 
retinoids: D02.455.326.271.665.202.495, D02.455.426.392.368.367.379.249.700, D02.455.849.131.495, D23.767.261.700
acrylonitrile: D02.626.095
reflex, righting: E01.370.376.550.650.695, E01.370.600.550.650.695, G11.561.600.765.745
endosomal sorting complexes required for transport: D05.500.199, D12.776.543.990.493
zinc isotopes: D01.496.966
methimazole: D02.886.489.600, D03.383.129.308.535
bowhead whale: B01.050.150.900.649.189.865.130
adrenergic neurons: A08.663.100, A11.671.050
sheep diseases: C22.836
compressive strength: G01.374.180
weight-bearing: G01.374.676.965, G01.595.540.965
eels: B01.050.150.900.493.338
adrenergic beta-agonists: D27.505.519.625.050.100.200, D27.505.696.577.050.100.200
critical period (psychology): F02.463.425.209
terbutaline: D02.033.100.291.905, D02.092.063.291.905
adenosine monophosphate: D03.438.759.646.138.180, D13.695.667.138.180, D13.695.827.068.180
sodium dodecyl sulfate: D02.033.415.220.720, D02.886.645.600.055.050.632, D10.289.220.720
myeloproliferative disorders: C15.378.190.636
macaca radiata: B01.050.150.900.649.801.400.112.199.120.510.570
transplantation, homologous: E04.936.864
macrophage colony-stimulating factor: D12.644.276.374.410.240.500, D12.776.395.240.500, D12.776.467.374.410.240.500, D23.529.374.410.240.500
sodium salicylate: D02.241.223.100.300.595.608.500, D02.241.511.390.595.608.500, D02.455.426.559.389.127.281.595.608.500, D02.455.426.559.389.657.410.595.608.500
carboxyhemoglobin: D12.776.124.400.141, D12.776.422.316.762.149
polarography: E05.196.749, E05.301.700
uranium: D01.268.033.950, D01.268.271.100.950, D01.268.556.900, D01.552.020.940, D01.552.544.900
convulsants: D27.505.696.282.224, D27.505.954.427.220.224
oncogene proteins v-fos: D12.776.624.664.520.750.887, D12.776.964.700.750.887, D12.776.964.775.750.887
paraventricular hypothalamic nucleus: A08.186.211.730.317.357.342.400
receptors, lhrh: D12.776.543.750.100.410, D12.776.543.750.720.600.460, D12.776.543.750.750.555.460, D12.776.543.750.750.700.460
octamer transcription factor-2: D12.776.260.655.500.200, D12.776.930.632.500.200
thioctic acid: D02.241.803, D02.886.778.827, D08.211.906, D10.251.941
brain ischemia: C10.228.140.300.150, C14.907.253.092
kininogens: D12.644.276.812.654, D12.776.124.125.635, D12.776.467.812.654, D12.776.811.420, D23.119.630, D23.469.050.375.425, D23.529.812.654
isocitrate dehydrogenase: D08.811.682.047.820.475
san francisco: Z01.107.567.875.580.200.700, Z01.107.567.875.760.200.700, Z01.433.875
information systems: L01.700.508.300
urethane: D02.241.081.251.944
trenbolone acetate: D04.808.365.415.930
hypothalamus, anterior: A08.186.211.730.317.357.342
receptors, adrenergic, alpha-2: D12.776.543.750.070.300.300.300.725, D12.776.543.750.100.150.300.300.725, D12.776.543.750.720.300.300.300.300.200
streptozocin: D02.654.692.768, D02.948.594.768, D09.408.051.900
disaccharides: D09.698.629.305
calcium-calmodulin-dependent protein kinases: D08.811.913.696.620.682.700.125, D12.644.360.100, D12.776.476.100
cholera toxin: D08.811.913.400.725.115.180, D23.946.123.194, D23.946.330.150
gtp-binding protein alpha subunits, gs: D08.811.277.040.330.300.200.100.400, D12.644.360.375.100.400, D12.776.157.325.332.100.400, D12.776.476.375.100.400, D12.776.543.325.100.400
iloprost: D10.251.355.255.550.700.125, D23.469.700.275
middle cerebral artery: A07.231.114.228.550
picolines: D03.383.725.676
prostaglandins f: D10.251.355.255.100.637.400, D10.251.355.255.550.400, D23.469.050.175.725.790
pyrans: D03.383.663, D03.830
body fluids: A12.207
sp1 transcription factor: D12.776.260.522.750.249, D12.776.930.375.750.249
sp3 transcription factor: D12.776.260.522.750.750, D12.776.930.375.750.750
starvation: C18.654.521.750
antigens, fungal: D23.050.202
silver staining: E01.370.225.500.620.670.780, E01.370.225.750.600.670.780, E05.200.500.620.670.780, E05.200.750.600.670.780
homing behavior: F01.145.113.646
phagocytes: A11.733, A15.382.680
lectins: D12.776.503
retroviridae: B04.820.650, B04.909.574.807, B04.909.777.731
2,4,5-trichlorophenoxyacetic acid: D02.241.081.018.386.682.800, D02.241.511.316.682.800
chlorphenamidine: D02.078.200
nitrobenzoates: D02.241.223.100.600, D02.455.426.559.389.127.650
x chromosome: A11.284.187.865.982, G05.360.162.865.982
3-hydroxyacyl coa dehydrogenases: D08.811.682.047.820.150
acetyl-coa c-acyltransferase: D08.811.913.050.080
isomerases: D08.811.399
multienzyme complexes: D05.500.562, D08.811.600
wing: A13.395.823
radiographic image enhancement: E01.370.350.600.350.700, E01.370.350.700.700, L01.224.308.380.600
lymphoid tissue: A10.549, A15.382.520.604
alcian blue: D03.438.473.050
erythrocyte aggregation: E01.370.225.625.225, E05.200.625.225, G09.188.124.552.249
metabolome: G03.500
methylcholanthrene: D02.455.426.559.847.149.500, D04.615.149.500
premedication: E02.319.703
glucose-6-phosphatase: D08.811.277.352.650.225
coal ash: D20.633.110
elastic tissue: A10.165.400
pheochromocytoma: C04.557.465.625.650.700.725, C04.557.580.625.650.700.725
neural cell adhesion molecule l1: D12.776.395.550.200.250.520.578, D12.776.543.550.200.250.520.578, D23.050.301.350.250.520.578
neural cell adhesion molecules: D12.776.395.550.200.250.520, D12.776.543.550.200.250.520, D23.050.301.350.250.520
shiga toxin: D08.811.277.450.430.700.750.750.100, D23.946.123.794.095, D23.946.330.575.100
sialic acids: D02.241.081.844.562.668, D02.241.511.902.562.668, D09.067.687.668, D09.811.589.668
sialyltransferases: D08.811.913.400.800
activin receptors, type ii: D08.811.913.696.620.682.700.062.750, D12.776.543.750.750.400.820.500.750
bone morphogenetic protein 7: D12.644.276.954.200.700, D12.776.467.942.200.700, D23.529.942.200.700
adrenal medulla: A06.407.071.265
skin physiological phenomena: G13.750
electric countershock: E02.342.287
neurophysiology: H01.158.610.268, H01.158.782.562
agonistic behavior: F01.145.126.125.100
aminobiphenyl compounds: D02.455.426.559.389.185.060
membrane microdomains: A11.284.149.165.570
receptors, neurotransmitter: D12.776.543.750.720
ossification, heterotopic: C23.550.751
yolk sac: A10.615.284.981, A16.254.750.981, A16.331.800
interleukin-2 receptor alpha subunit: D12.776.543.750.705.852.420.320.500, D23.050.301.264.035.401, D23.101.100.110.401
leishmania major: B01.268.475.868.488.405
apoptotic protease-activating factor 1: D12.644.360.024.131.124, D12.644.360.075.358.124, D12.776.157.057.004.124, D12.776.476.024.139.124, D12.776.476.075.358.124
infusions, parenteral: E02.319.267.510
polymyxin b: D04.345.566.780.750, D10.477.750.750, D12.644.050.600.750, D12.644.641.780.750, D12.776.543.695.054.600.750
aedes: B01.050.500.131.617.289.275.100
helminths: B01.050.500.500
hernia, abdominal: C23.300.707.374
polydactyly: C05.660.585.600, C16.131.621.585.600
growth plate: A02.835.232.251.352
cytophotometry: E01.370.225.500.386, E05.196.712.516.600.240, E05.200.500.386, E05.242.386
fatty acids, volatile: D10.251.400
fermentation: G02.111.087.160.249, G02.149.115.160.249, G03.495.256.249
isothiocyanates: D02.500.375, D02.886.250
fetal heart: A07.541.278, A16.378.303
mullerian ducts: A16.623
receptor, muscarinic m2: D12.776.543.750.100.475.200, D12.776.543.750.720.360.500.200
sulfadimethoxine: D02.065.884.725.760, D02.092.146.807.760, D02.886.590.700.725.760
cardiomyopathies: C14.280.238
tetrahydroisoquinolines: D03.438.531.820
phosphorus isotopes: D01.496.669
sphingosine: D02.033.100.700, D02.033.455.843, D02.092.063.700
bird diseases: C22.131
crop, avian: A13.265
gastrointestinal contents: A12.519
erythroid precursor cells: A11.148.378.590.837.250, A11.443.240.497, A11.872.378.590.817.250, A15.378.316.378.590.837.250
affinity labels: D27.720.470.410.080
eicosapentaenoic acid: D10.212.302.380.410.385, D10.251.355.255.200, D10.251.355.337.290, D10.627.430.450.390
thioinosine: D02.886.759.800, D03.438.759.590.616.900, D13.570.583.616.900, D13.570.800.573.900, D13.570.900.800
thermogenesis: G07.110.232.778, G07.700.345.421.778, G16.100.057.500.535.778
angiotensin receptor antagonists: D27.505.519.162
neprilysin: D08.811.277.656.300.480.600, D08.811.277.656.675.374.600, D23.050.285.550, D23.050.301.264.035.550, D23.101.100.110.550, D23.101.840.500
valine: D12.125.070.950, D12.125.142.930
viper venoms: D20.888.850.960, D23.946.833.850.960
body fluid compartments: A10.082, A12.207.180
cholinergic antagonists: D27.505.519.625.120.200, D27.505.696.577.120.200
antigens, nuclear: D12.776.660.625, D23.050.290
nad: D03.438.759.646.138.694, D08.211.589, D13.695.667.138.694, D13.695.827.068.694
diquat: D03.383.725.762.352
hepatopancreas: A13.463
hexobarbital: D03.383.742.698.253.317
pentobarbital: D03.383.742.698.253.593
siberia: Z01.252.122.500.500, Z01.542.248.775.800, Z01.586.200.775.800, Z01.586.950.775.800
benzoxepins: D03.438.245
spiro compounds: D02.455.426.559.847.885, D04.615.885
partial pressure: G01.374.715.714
anthelmintics: D27.505.954.122.250.075
postmortem changes: C23.550.260.224.617
chlorpromazine: D02.886.369.198, D03.494.741.198
biogenic amines: D02.092.211
injections, intra-arterial: E02.319.267.530.370
self stimulation: F01.145.775, F02.830.784
water deprivation: F01.658.938
gestonorone caproate: D04.808.668.651.693.362, D04.808.745.745.654.527
adrenal cortex: A06.407.071.140
urinary tract: A05.810
carbonates: D01.045.125, D01.200.275.150, D01.248.497.158.165
dental high-speed technique: E06.216
coxsackievirus infections: C02.782.687.359.213
enterovirus b, human: B04.820.565.284.182, B04.909.777.618.284.182
hair cells, auditory, inner: A08.663.650.250.250, A08.663.650.915.750.600.350.350, A08.800.950.750.600.350.350, A09.246.631.246.577.325.315, A11.671.650.250.250, A11.671.650.915.750.600.350.350
cathepsins: D08.811.277.656.224
endopeptidases: D08.811.277.656.300
anthozoa: B01.050.500.308.237
intercellular junctions: A11.284.149.165.420
zonula occludens-1 protein: D12.776.543.984.900.500
karyometry: E01.370.225.500.384.617, E05.200.500.384.467, E05.242.384.467
acyl coenzyme a: D03.438.759.646.138.382.300, D08.211.211.300, D13.695.667.138.382.300, D13.695.827.068.382.300
cholecystokinin: D06.472.317.152, D12.644.120, D12.644.400.105, D12.776.641.650.105
deer: B01.050.150.900.649.077.380.373
y chromosome: A11.284.187.865.983, G05.360.162.865.983
nerve crush: E04.525.210.560
sciatic neuropathy: C10.668.829.500.675
anions: D01.248.497.158
anticholesteremic agents: D27.505.519.186.071.202, D27.505.954.557.500.202
carnitine o-acetyltransferase: D08.811.913.050.134.150, D08.811.913.050.350.170
macaca nemestrina: B01.050.150.900.649.801.400.112.199.120.510.560
2-methyl-4-chlorophenoxyacetic acid: D02.241.081.018.386.682.500, D02.241.511.316.682.224
electronystagmography: E01.370.380.230.280, E01.370.382.900.280, E01.370.405.260
labyrinth diseases: C09.218.568
cations, divalent: D01.248.497.300.333
galactosamine: D09.067.342.356
neoplasm metastasis: C04.697.650, C23.550.727.650
histiocytosis: C15.604.250
drosophila proteins: D12.776.092.500.462
myosins: D05.750.078.730.475, D08.811.277.040.025.193.750, D12.776.210.500.600, D12.776.220.525.475
multigene family: G05.360.340.024.340.645
receptors, glucocorticoid: D12.776.260.698.750.430, D12.776.826.750.430, D12.776.930.669.750.430
biomphalaria: B01.050.500.644.400.750.185
phospholipases a: D08.811.277.352.100.680.750
phospholipases a2: D08.811.277.352.100.680.750.937
prostaglandins e: D10.251.355.255.100.637.250, D10.251.355.255.550.250, D23.469.050.175.725.780
antibiotics, antineoplastic: D27.505.954.248.106
ethylamines: D02.092.471
puromycin aminonucleoside: D02.241.223.200.380.650, D03.438.759.590.138.325.800, D03.438.759.590.138.711.650, D09.408.051.788.650, D13.570.230.229.650, D13.570.583.138.325.800, D13.570.583.138.711.650
transfer (psychology): F02.463.425.910
toluidines: D02.092.146.859, D02.455.426.559.389.832.559
anti-mullerian hormone: D06.472.334.984.500
testicular hormones: D06.472.334.984
carbocyanines: D02.455.326.397.300
thalamus: A08.186.211.730.317.826
angiotensins: D06.472.699.094, D12.644.400.070, D12.644.456.073, D12.644.548.058, D12.776.641.650.070, D23.469.050.050
hexamethonium: D02.092.877.250.592.400, D02.675.276.558.592.500
hepatic veins: A07.231.908.380
validation studies as topic: E05.337.925, N05.715.360.335.500
ethylnitrosourea: D02.654.692.300, D02.948.594.310
oligodeoxyribonucleotides: D13.695.578.424.450
hypertrophy, right ventricular: C14.280.195.410, C23.300.775.250.401
poultry diseases: C22.131.728
electrocoagulation: E02.154.402, E04.014.170.402
adenine nucleotides: D03.438.759.646.138, D13.695.667.138, D13.695.827.068
diaphragm: A02.633.567.900.300
ibotenic acid: D03.383.129.385.231, D23.946.587.475
alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid: D03.383.129.385.025
cathepsin l: D08.811.277.656.224.407, D08.811.277.656.262.500.157, D08.811.277.656.300.200.157
pneumonectomy: E04.928.600.600
hemolytic plaque technique: E01.370.225.812.375, E05.200.812.375, E05.478.594.375
drug stability: E05.916.330
nucleotidases: D08.811.277.352.650.600
porphobilinogen synthase: D08.811.520.241.300.550
genes, erba: G05.360.340.024.340.375.500.791.290
aeromonas: B03.440.450.019.025, B03.660.250.017.025
bacterial infections: C01.252
melanins: D12.125.072.050.875.379, D23.767.620
arousal: F02.830.104, G11.561.600.042
social environment: I01.880.656
pupil: A09.371.060.450.780, A09.371.894.513.780
radiation-protective agents: D27.505.696.706.776, D27.720.799.763
apamin: D20.888.065.115.060, D23.946.833.065.115.060
charybdotoxin: D12.644.115, D20.888.065.830.150, D23.946.833.065.830.150
genes, jun: G05.360.340.024.340.375.500.791.365
aldicarb: D02.241.081.251.046
autonomic pathways: A08.800.050.050, A08.800.800.060
diabetic neuropathies: C10.668.829.300, C19.246.099.937
vasoactive intestinal peptide: D06.472.317.950, D06.472.699.952, D12.644.400.875, D12.644.548.952, D12.776.641.650.875
kallikrein-kinin system: G02.111.635.500.500, G03.495.553.485, G03.615.500.500, G07.700.345.810.500.500, G09.330.190.400.500
hypertension, renovascular: C12.777.419.331.490, C13.351.968.419.331.490, C14.907.489.631.485
models, cardiovascular: E05.599.395.161
oxadiazoles: D03.383.129.462.580
quinoxalines: D03.438.857
1-acylglycerophosphocholine o-acyltransferase: D08.811.913.050.175
endocardium: A07.541.207
heart septal defects: C14.240.400.560, C14.280.400.560, C16.131.240.400.560
heart valve diseases: C14.280.484
gangliosides: D09.400.410.420.025.475, D10.390.470.025.475, D10.570.877.360.025.475
glucosamine: D09.067.342.531
sulfur radioisotopes: D01.496.749.858, D01.496.868.690
tissue extracts: D20.777
anesthesia, inhalation: E03.155.197.197
germ-free life: G06.320
cyclopropanes: D02.455.426.392.368.533
cobalt isotopes: D01.496.239
alcoholic beverages: J02.200.100
efficiency: F02.784.692.351
meprobamate: D02.241.081.251.510
hydroxybutyrate dehydrogenase: D08.811.682.047.820.350
injections, intramuscular: E02.319.267.530.460
thoracic diseases: C08.846
anophthalmos: C11.250.080, C16.131.384.159
cleft lip: C07.465.409.225, C07.465.525.164, C07.650.525.164, C16.131.850.525.164
microphthalmos: C11.250.566, C16.131.384.666
syndactyly: C05.116.099.370.894.819, C05.660.585.800, C05.660.906.819, C16.131.621.585.800, C16.131.621.906.819
phenytoin: D03.383.129.308.432.555.730
cottonseed oil: D10.212.302.380.380, D10.212.507.350, D10.627.700.263, D20.215.784.750.263, J02.500.375.400.300
retinoid x receptor alpha: D12.776.260.698.701.500.500, D12.776.826.701.500.500, D12.776.930.669.701.500.500
receptors, serotonin, 5-ht1: D12.776.543.750.070.800.100, D12.776.543.750.100.800.100, D12.776.543.750.720.300.800.100
receptors, serotonin, 5-ht2: D12.776.543.750.070.800.200, D12.776.543.750.100.800.200, D12.776.543.750.720.300.800.200
tocolytic agents: D27.505.696.875.825, D27.505.954.705.825
basal metabolism: E01.370.374.750.100, G03.495.335.154
body temperature regulation: G07.110.232, G07.700.345.421, G16.100.057.500.535
sigmodontinae: B01.050.150.900.649.865.635.680
anemia, hypochromic: C15.378.071.196
anemia, macrocytic: C15.378.071.252
infarction: C23.550.513.355, C23.550.717.489
tooth: A14.549.167.860
ciona intestinalis: B01.050.150.200.727.300, B01.050.500.272.727.300
ecology: H01.158.273.248, H01.277.249
amygdala: A08.186.211.464.090, A08.186.211.730.885.287.249.152
kindling, neurologic: G11.561.600.480
oligonucleotide probes: D13.444.600.601, D27.505.259.750.600.650, D27.720.470.530.600.650
chorda tympani nerve: A08.800.800.120.250.120
primate diseases: C22.735
kidney tubular necrosis, acute: C12.777.419.780.050.500, C13.351.968.419.780.050.500
extremities: A01.378
retinal diseases: C11.768
ribosomes: A11.284.430.214.190.875.811
ethambutol: D02.092.782.258.368.265
geniculate bodies: A08.186.211.730.317.826.701.444
visual pathways: A08.612.220.860
deuterium: D01.435.256, D01.496.289
specific gravity: G02.842.810
epididymitis: C12.294.199
lymphatic system: A15.382.520
hexanones: D02.522.520
acetylglucosamine: D09.067.342.531.050
methylmalonic acid: D02.241.081.337.540.500
receptor activity-modifying protein 1: D12.776.476.024.412.100, D12.776.543.725.100
receptor activity-modifying protein 2: D12.776.476.024.412.200, D12.776.543.725.200
receptor activity-modifying protein 3: D12.776.476.024.412.300, D12.776.543.725.300
receptor activity-modifying proteins: D12.776.476.024.412, D12.776.543.725
phosphoenolpyruvate carboxylase: D08.811.520.224.125.650
pyruvate carboxylase: D08.811.464.257.500
pyruvate kinase: D08.811.913.696.620.695
dopamine beta-hydroxylase: D08.811.682.690.708.292
blood-testis barrier: A05.360.444.849.700.349, A07.045
busulfan: D02.033.455.125.125, D02.455.326.146.100.050.500.100, D02.886.645.600.055.050.510.100
harmaline: D03.132.436.444, D03.438.473.402.444, D03.494.154.333
olivary nucleus: A08.186.211.132.810.406.574, A08.186.211.865.467.500.574
picrotoxin: D02.455.426.392.368.367.800, D02.540.552
passive cutaneous anaphylaxis: E01.370.225.812.871.600, E05.200.812.871.600, E05.478.594.890.600, G12.425.143.754
endarterectomy, carotid: E04.100.814.456.250
methylenetetrahydrofolate reductase (nadph2): D08.811.682.662.290, D12.776.331.775
oxidoreductases acting on ch-nh group donors: D08.811.682.662
common bile duct: A03.159.183.079.300
hyperbilirubinemia, hereditary: C16.320.565.300, C18.452.648.300
ganglia, invertebrate: A08.340.352, A13.408
chaetomium: B01.300.107.800.150
oncogenes: G05.360.340.024.340.375.500
dermatomycoses: C01.539.800.200, C01.703.295, C17.800.838.208
gastrointestinal hemorrhage: C06.405.227, C23.550.414.788
anesthesia: E03.155
cardiovascular physiological phenomena: G09.330
endomyocardial fibrosis: C14.280.238.406
tacrolimus: D02.540.505.810
centrifugation, density gradient: E05.181.724.336, E05.196.941.336
inositol: D02.033.800.519, D09.853.519
urinary bladder: A05.810.890
phencyclidine: D03.383.621.699
troleandomycin: D02.540.505.600.800
diptera: B01.050.500.131.617.289
ivermectin: D02.540.505.330
pupa: B05.500.700, G07.700.320.500.550.500.700
cesium isotopes: D01.496.180
radiation-sensitizing agents: D27.505.954.600
tetraethylammonium compounds: D02.092.877.787, D02.675.276.787
sweat glands: A10.336.899, A17.815.830
auditory pathways: A08.612.220.110
appetitive behavior: F01.145.113.111
elements: D01.268
tellurium: D01.268.185.950, D01.268.513.968
cholesterol, dietary: D10.212.302.347, D10.570.938.208.222
prodrugs: D26.675
atrioventricular node: A07.541.409.147
insulin-like growth factor binding protein 2: D12.776.157.420.260
insulin-like growth factor binding protein 3: D12.776.157.420.270
insulin-like growth factor binding protein 4: D12.776.157.420.280
crassostrea: B01.050.500.644.080.643.150
hemangiosarcoma: C04.557.450.795.390, C04.557.645.390
adenofibroma: C04.557.450.565.590.595.050, C04.557.470.625.050
acetylene: D02.455.326.397.259
myelin p0 protein: D12.776.395.550.200.250.500, D12.776.395.570, D12.776.543.550.200.250.500, D12.776.543.620.570, D12.776.641.580.550, D23.050.301.350.250.500
labetalol: D02.033.100.291.460, D02.065.793.324, D02.092.063.291.460
pindolol: D02.033.100.624.698.699, D02.033.755.624.698.699, D02.092.063.624.698.699
interferons: D12.644.276.374.440, D12.644.276.718, D12.776.467.374.440, D12.776.467.718, D23.529.374.440, D23.529.718
visual cortex: A08.186.211.730.885.287.500.571.735
asteraceae: B01.650.940.800.575.100.100
medicine, african traditional: E02.190.488.505, E02.190.901.433, I01.076.201.450.654.505
vibrio: B03.440.450.900.859, B03.660.250.830.830
vibrio infections: C01.252.400.959
1,2-dimethylhydrazine: D02.442.600.400.200
dimethylhydrazines: D02.442.600.400
ethoxyquin: D03.438.810.200
propyl gallate: D02.241.223.100.300.200.600, D02.241.511.390.200.600, D02.455.426.559.389.127.281.200.600, D02.455.426.559.389.657.410.200.600
eosine yellowish-(ys): D02.455.426.559.847.885.347.325, D03.494.953.275.325, D04.615.885.347.325
phenoxyacetates: D02.241.081.018.386.682, D02.241.511.316.682
heart neoplasms: C04.588.894.309, C14.280.459
duodenal neoplasms: C04.588.274.476.411.445, C06.301.371.411.445, C06.405.249.411.445, C06.405.469.275.270, C06.405.469.491.445
walking: G11.427.590.530.568.900, G11.427.590.530.698.277.937, I03.450.642.845.940
acyltransferases: D08.811.913.050
serine c-palmitoyltransferase: D08.811.913.050.668
sphingomyelin phosphodiesterase: D08.811.277.352.640.750
oleic acid: D10.251.355.325.600.525
trans fatty acids: D10.251.355.920
escherichia coli proteins: D12.776.097.275
adaptation, biological: G16.100.057
amitrole: D03.383.129.799.100
hemosiderin: D12.776.556.526
mossy fibers, hippocampal: A08.186.211.464.405.200.500, A08.186.211.730.885.287.500.345.200.500, A08.663.542.145.750.500, A08.850.700.500, A11.671.137.560
phorbol esters: D02.455.849.291.500.510
polytetrafluoroethylene: D05.750.395.616, D25.720.395.616, J01.637.051.720.395.616
biological clocks: G07.180.562.094
baculoviridae: B04.280.065, B04.525.100
cytochrome b group: D08.244.187, D12.776.422.220.187
viscosity: G02.842.925
somatosensory cortex: A08.186.211.730.885.287.500.670.675
body water: A12.207.200
isoelectric focusing: E05.196.401.663, E05.301.300.663
pituitary gland, posterior: A06.407.747.875, A06.688.357.750.875, A08.186.211.730.317.357.352.435.500.875, A08.713.357.750.875
trigeminal nuclei: A08.186.211.132.931
macaca: B01.050.150.900.649.801.400.112.199.120.510
culex: B01.050.500.131.617.289.275.225
heterocyclic compounds: D03
dark adaptation: G14.640.154.371
saimiri: B01.050.150.900.649.801.400.600.150.710.710
immunoglobulin fab fragments: D12.644.541.500.650, D12.776.124.486.485.680.650, D12.776.124.790.651.680.650, D12.776.377.715.548.680.650
metalloproteins: D12.776.556
aerobiosis: G02.111.087.024, G02.149.115.024, G03.495.112
beak: A13.114
fructosephosphates: D09.894.417.313
rose bengal: D02.455.426.559.847.885.347.700, D03.494.953.275.700, D04.615.885.347.700
nephrosis: C12.777.419.630, C13.351.968.419.630
muscle spindles: A08.663.650.915.750.500, A08.800.950.750.500, A10.690.552.500.750, A11.671.650.915.750.500
cardiovascular abnormalities: C14.240, C16.131.240
killifishes: B01.050.150.900.493.850.280.500
botulinum toxins: D08.811.277.656.300.480.153, D08.811.277.656.675.374.153, D12.776.097.156, D23.946.123.179
ethylmaleimide: D02.241.081.337.502.524.418, D02.478.440.418, D03.383.129.578.399.418
motor endplate: A08.800.550.550.550.500, A08.850.550.550.500, A11.284.149.165.420.780.550.550.500
osmium: D01.268.556.660, D01.268.956.702, D01.552.544.660
osmium tetroxide: D01.640.500, D01.650.550.600
efferent pathways: A08.612.380
barbital: D03.383.742.698.253.150
nasal septum: A04.531.591
aflatoxins: D03.438.150.119, D03.830.219.119, D23.946.587.142
griseofulvin: D03.438.127.275
rats, inbred buf: B01.050.050.157.760.130, B01.050.050.199.520.760.130, B01.050.150.900.649.865.635.505.700.400.130
kidney papillary necrosis: C12.777.419.493, C13.351.968.419.493
nerve endings: A08.800.550
glutamate dehydrogenase: D08.811.682.664.500.398
sugar alcohol dehydrogenases: D08.811.682.047.150.700
quinolines: D03.438.810
quipazine: D03.383.606.827, D03.438.810.850
leucyl aminopeptidase: D08.811.277.656.350.100.511, D08.811.277.656.350.555.700, D08.811.277.656.675.555.700
electroshock: E05.723.402.403, F04.669.224
quinolinic acids: D03.383.725.822
cardiac volume: G09.330.380.249
history, medieval: K01.400.500
history, modern 1601-: K01.400.504
apnea: C08.618.085, C23.888.852.130
vagus nerve: A08.800.050.050.925, A08.800.050.600.825, A08.800.800.060.920, A08.800.800.120.900
chromatophores: A11.436.265
digestive system abnormalities: C06.198, C16.131.314
ear: A01.456.313, A09.246
thiopental: D03.383.742.698.253.800.810
aziridines: D03.383.097.217
oxygenases: D08.811.682.690
isoxazoles: D03.383.129.385
gentamicins: D09.408.051.374
alcohol dehydrogenase: D08.811.682.047.820.250
cyanamide: D01.625.400.100.150, D02.491.203.362
audiometry, evoked response: E01.370.382.375.060.050
corn oil: D10.212.302.380.370, D10.212.507.340, D10.627.700.240, D20.215.784.750.240, J02.500.375.400.250
5-aminolevulinate synthetase: D08.811.913.050.276
deferoxamine: D02.092.570.394.265, D02.241.511.372.265
heme: D03.383.129.578.840.500.640.587, D03.549.909.500.640.587, D04.345.783.500.640.587, D23.767.727.640.587
thromboxane a2: D10.251.355.255.100.825.800, D23.469.050.175.800.800
defecation: G10.261.326.210
immunoelectrophoresis: E01.370.225.812.735.645.350.350, E05.196.401.568, E05.200.812.735.645.350.350, E05.301.300.568, E05.478.594.760.645.350.350, E05.478.605.492.350.350
abortion, veterinary: C13.703.039.422, C22.021
pressure: G01.374.715
choline deficiency: C18.654.521.500.133.699.160
reflex, monosynaptic: G11.561.600.765.643
enalapril: D12.644.456.345.360
coenzymes: D08.211
ubiquinone: D02.806.250.900, D08.211.935
agammaglobulinemia: C15.378.147.142, C15.604.515.032, C20.673.088
blood protein disorders: C15.378.147
calcimycin: D03.438.221.173
ionophores: D27.505.519.562.374, D27.720.395
2,2'-dipyridyl: D03.383.725.220
health: N01.400
palmitates: D10.251.694.600
chlorofluorocarbons: D02.455.526.439.220, D02.455.526.510.140
platelet count: E01.370.225.500.195.107.740, E01.370.225.625.107.700, E01.370.225.625.625.625, E05.200.500.195.107.740, E05.200.625.107.700, E05.200.625.625.625, E05.242.195.107.740, G04.170.107.740, G09.188.105.700
nephrocalcinosis: C12.777.419.590, C13.351.968.419.590, C18.452.174.130.560
blood-retinal barrier: A07.040, A09.371.729.055
cytochrome p-450 cyp1a2: D08.244.453.040.777, D08.811.682.690.708.170.040.443, D12.776.422.220.453.040.555
veratrine: D03.132.920.256.815, D03.549.256.815
stomach diseases: C06.405.748
stomach ulcer: C06.405.608.849, C06.405.748.586.849
parathyroid glands: A06.407.560
acatalasia: C16.320.565.663.025, C18.452.648.663.025
cerebral arteries: A07.231.114.228
cerebral infarction: C10.228.140.300.150.477.200, C10.228.140.300.775.200.200, C14.907.253.092.477.200, C14.907.253.855.200.200
constriction: E05.225
choroid: A09.371.894.223
optic disk: A08.800.800.120.680.660, A09.371.729.690
polymethacrylic acids: D02.241.081.069.800, D05.750.716.822.111.650, D25.720.716.822.111.650, J01.637.051.720.716.822.111.650
hyperphagia: C23.888.821.645
association learning: F02.463.425.069.296
bloodletting: E02.800.558.500
breast implants: E07.695.140
glucose transporter type 3: D12.776.157.530.500.500.875, D12.776.543.585.500.500.875, D12.776.641.480
protein carbonylation: G02.111.087.682, G02.149.115.682, G03.495.710.690
alpha-chlorohydrin: D02.033.260.100, D02.033.455.706.100
insemination, artificial: E02.875.540, E02.875.800.937, E05.820.800.937, G08.686.785.760.363.492
mesylates: D02.455.326.146.100.050.500, D02.886.645.600.055.050.510
oxalic acid: D02.241.081.337.593.750
turbinates: A02.835.232.781.324.948, A04.531.898
alkynes: D02.455.326.397
pargyline: D02.092.200.650, D02.455.426.559.389.140.210.650
calmodulin: D12.644.360.381.249, D12.776.157.125.412.249, D12.776.476.387.249
nucleotides, cyclic: D13.695.462
phosphoric diester hydrolases: D08.811.277.352.640
capsaicin: D02.065.160.500, D02.455.326.271.060.222, D02.455.426.559.389.657.166.099, D03.132.760.200, D10.251.355.325.190
urethra: A05.360.444.492.726, A05.810.876
urinary retention: C12.777.934.880, C13.351.968.934.880
schwann cells: A08.637.800, A08.800.800.690, A11.650.800
apomorphine: D03.132.098.038.290, D03.438.531.085.030.290, D03.549.095.290
receptors, adrenergic: D12.776.543.750.070.300.300, D12.776.543.750.100.150.300, D12.776.543.750.720.300.300.300
thrombocythemia, essential: C15.378.100.832, C15.378.140.860.800, C15.378.190.636.860.800, C15.378.463.825
solitary nucleus: A08.186.211.132.810.406.750, A08.186.211.865.467.500.750
peptide hormones: D06.472.699, D12.644.548
molluginaceae: B01.650.940.800.575.100.740
dna mismatch repair: G02.111.087.219.220, G02.149.115.219.220, G05.355.195.220
microsatellite instability: C23.550.362.590, G05.365.590.335.590, G05.370.590
relaxin: D06.472.334.734.769, D06.472.699.715, D12.644.548.762
splanchnic nerves: A08.800.050.050.800, A08.800.050.800.800, A08.800.800.060.800
polyuria: C12.777.934.616, C13.351.968.934.616, C23.888.942.600
flavins: D03.438.733.315, D03.494.507, D08.211.474, D23.767.405
silymarin: D03.438.150.266.450.268.777, D03.830.219.266.450.268.777
bis(chloromethyl) ether: D02.355.601.250
ligation: E04.426
radioactive pollutants: D20.693
thiocyanates: D02.262.775, D02.886.728
nitrosomethylurethane: D02.241.081.251.944.500, D02.654.585
disulfiram: D02.241.081.251.869.220.250, D02.886.520.150.175, D02.886.706.200.200
glycerolphosphate dehydrogenase: D08.811.682.047.150.700.400
palmitoyl-coa hydrolase: D08.811.277.352.897.700
amiodarone: D03.438.127.075
antimalarials: D27.505.954.122.250.100.085
antipsychotic agents: D27.505.696.277.950.040, D27.505.954.427.210.950.040, D27.505.954.427.700.872.331
leukemia p388: C04.557.337.372.782, C04.619.531.782
aminopyrine n-demethylase: D08.811.682.662.582.276
lac repressors: D12.776.097.521, D12.776.260.703.600, D12.776.930.700.781
nitroso compounds: D02.654
tartrates: D02.241.081.337.864, D02.241.081.844.759, D02.241.511.902.759, D09.811.779
mineral oil: D02.455.699.500
ecotoxicology: H01.158.273.248.500, H01.158.703.795.211, H01.277.249.500, H02.628.795.211
iris: A09.371.060.450, A09.371.894.513
glossopharyngeal nerve: A08.800.050.050.337, A08.800.050.600.387, A08.800.800.060.337, A08.800.800.120.290
vagotomy: E04.525.210.080.600.850, E04.525.210.850
spiperone: D02.455.426.559.847.885.800, D02.522.352.800, D04.615.885.800
flurothyl: D02.355.417.515
vitamin d deficiency: C18.654.521.500.133.770
valinomycin: D04.345.566.297.500, D12.644.641.297.500
nasal polyps: C08.460.572, C09.603.557, C23.300.825.557
biota: G16.500.275.157.049.100, N06.230.124.049.100
corbicula: B01.050.500.644.080.175
tibial fractures: C26.404.875, C26.558.857
neurokinin a: D12.644.276.812.900.500, D12.644.400.800.500, D12.644.456.800.500, D12.776.467.812.900.500, D12.776.641.650.800.500, D23.469.050.375.850.550, D23.529.812.900.500
receptors, neurokinin-1: D12.776.543.750.100.862.500, D12.776.543.750.720.600.830.500, D12.776.543.750.750.555.830.500
receptors, neurokinin-2: D12.776.543.750.100.862.540, D12.776.543.750.720.600.830.540, D12.776.543.750.750.555.830.540
wound healing: G16.100.856.891
adoptive transfer: E02.095.465.425.400.330.050, E05.478.550.520.050
eosinophil peroxidase: D08.811.682.732.440, D12.776.124.486.379.600
cues: F02.463.425.234
retention (psychology): F02.463.425.540.772
harderian gland: A13.445
shock: C23.550.835
granulocytes: A11.118.637.415, A11.148.350, A11.627.340, A15.145.229.637.415, A15.378.316.340, A15.382.490.315
endothelium, corneal: A09.371.060.067.318, A09.371.060.217.318, A10.272.491.318
triethylenemelamine: D03.383.097.217.924, D03.383.931.915
sperm retrieval: E02.875.800.988, E04.936.537.750, E05.820.800.988
marsupialia: B01.050.150.900.649.573
spermatic cord: A05.360.444.777
haversian system: A10.165.265.507
phthalimides: D02.241.223.805.810, D02.478.600, D03.438.513.750
micrognathism: C05.500.460.457, C05.660.207.540.460.457, C07.320.440.457, C07.650.500.460.457, C16.131.621.207.540.460.457, C16.131.850.500.460.457
intraocular pressure: G14.440
sympathomimetics: D27.505.696.663.050.870
leg: A01.378.610.500
thermography: E01.370.350.800, E05.933.500
lumbosacral region: A01.923.176.519
counseling: F02.784.176, F04.408.413, N02.421.143.303, N02.421.461.363
microcephaly: C05.660.207.620, C10.500.507.500, C16.131.621.207.620, C16.131.666.507.500
radiotherapy: E02.815
aniline hydroxylase: D08.244.453.040.050, D08.811.682.690.708.170.040.050, D12.776.422.220.453.040.050
psychophysiology: E02.190.525.812, F02.830, F04.096.795, H01.158.782.795
rhabdomyosarcoma: C04.557.450.590.550.660, C04.557.450.795.550.660
sarcoma, experimental: C04.557.450.795.830, C04.619.857, E05.598.500.496.968
interneurons: A08.663.358, A11.671.358
narcotic antagonists: D27.505.696.543, D27.505.696.663.850.512, D27.505.954.427.550
proprioception: F02.830.816.541, G11.561.600.810.541
feedback: L01.143.283.425
loop of henle: A05.810.453.736.560.610
plasma volume: G09.188.130.610, G09.330.380.092.610
nikethamide: D03.066.515.530.500, D03.383.725.547.530.500
intracranial aneurysm: C10.228.140.300.510.600, C14.907.055.635, C14.907.253.560.300
oximes: D02.092.570.665
thiosemicarbazones: D02.845.746.703, D02.886.803
unfolded protein response: G02.111.087.675.871.790.600.962, G02.111.087.693.600.850, G02.149.115.675.871.790.600.850, G02.149.115.693.600.925, G03.495.770.871.790.600.850, G05.355.315.670.600.850
organoselenium compounds: D02.712
pentoses: D09.546.627
nervous system physiological phenomena: G11.561
deoxy sugars: D09.254
cornea: A09.371.060.217
ancylostoma: B01.050.500.500.294.700.775.100.100
diethylcarbamazine: D02.241.081.251.240, D03.383.606.380
morantel: D02.886.778.440, D03.383.742.440, D03.383.903.440
thyroidectomy: E04.270.856
rac1 gtp-binding protein: D08.811.277.040.330.300.400.700.100.500, D12.644.360.525.700.100.100, D12.776.157.325.515.700.100.100, D12.776.476.525.700.100.100
phenylpropionates: D02.241.223.701
pyridazines: D03.383.710
receptor, endothelin a: D12.776.543.750.100.220.100, D12.776.543.750.750.320.100
amiloride: D03.383.679.149
liddle syndrome: C12.777.419.815.683, C13.351.968.419.815.683, C16.320.565.861.698, C18.452.648.861.698
urbanization: I01.880.526.726
fluorine radioisotopes: D01.496.749.340
neutrons: G01.249.645
arvicolinae: B01.050.150.900.649.865.635.070
lipolysis: G02.111.087.530, G02.149.115.530, G03.495.520.500
hyaluronic acid: D09.698.373.475
kidney pelvis: A05.810.453.537
lymph: A12.207.270.606, A15.382.520.150
pulmonary circulation: G09.330.190.163.770, G09.772.770.690
smoke inhalation injury: C26.200.322.800
glucose solution, hypertonic: D26.776.314.420
glycerol kinase: D08.811.913.696.620.275
ferrochelatase: D08.811.520.500, D12.776.157.427.374.375.957, D12.776.556.579.374.375.617, D12.776.575.562
hydroxymethylbilane synthase: D08.811.913.225.575
hemolymph: A13.453
conalbumin: D12.776.034.180, D12.776.157.427.750.124, D12.776.256.317.180, D12.776.290.180, D12.776.556.579.750.124
thiobarbiturates: D03.383.742.698.253.800
tongue neoplasms: C04.588.443.591.925, C07.465.565.925, C07.465.910.874
myocarditis: C14.280.238.625
stearic acids: D10.251.882
iodoproteins: D12.776.486
thyroglobulin: D12.776.377.856, D12.776.395.768, D12.776.486.706
coenzyme a: D03.438.759.646.138.382, D08.211.211, D13.695.667.138.382, D13.695.827.068.382
palmitic acids: D10.251.694
skeleton: A02.835
carboxypeptidases: D08.811.277.656.350.245
conductometry: E05.196.922.500, E05.301.160
6-ketoprostaglandin f1 alpha: D10.251.355.255.100.637.400.350, D10.251.355.255.550.400.350, D10.251.355.325.450, D23.469.050.175.725.790.450
thromboxanes: D10.251.355.255.100.825, D10.251.355.255.775, D23.469.050.175.800
uracil: D03.383.742.698.875
chlordiazepoxide: D03.438.079.080.150
keratosis: C17.800.428
sialorrhea: C07.465.815.815
laminectomy: E04.525.450
oscillometry: E05.654
s100 proteins: D12.776.157.125.750, D12.776.641.655
carcinoma, basal cell: C04.557.470.200.165, C04.557.470.565.165
hydrothorax: C08.528.476
amyloid: D05.500.049, D12.776.049
vestibular nerve: A08.800.800.120.910.900
vestibulocochlear nerve diseases: C09.218.807.800, C10.292.910
pets: B01.050.050.116.600
virilism: C23.888.971
methyl n-butyl ketone: D02.522.520.500
dna, viral: D13.444.308.568
leukemia virus, murine: B04.820.650.375.525, B04.909.574.807.375.525, B04.909.777.731.375.525
proviruses: B04.725
tumor virus infections: C02.928, C04.619.935, C04.925
rubidium radioisotopes: D01.496.749.740
endrin: D02.455.526.439.416
tetanus toxin: D12.776.097.872, D23.946.123.893
aldrin: D02.455.526.439.042
benzidines: D02.455.426.559.389.185.100
acrylic resins: D05.750.716.822.111, D25.720.716.822.111, J01.637.051.720.716.822.111
central venous pressure: G09.330.380.076.732.336
liver circulation: G09.330.190.163.881.552
anuria: C12.777.419.078, C12.777.934.141, C13.351.968.419.078, C13.351.968.934.070
dilatation: E05.284
juxtaglomerular apparatus: A05.810.453.324.359.520, A05.810.453.736.520.520
starlings: B01.050.150.900.248.620.750.712
monkey diseases: C22.735.500
decanoates: D10.251.175.200
nandrolone: D04.808.365.415.638, D06.472.334.851.968.976
hydra: B01.050.500.308.485.400
reproduction, asexual: G08.686.785.760.830
receptors, adrenergic, alpha: D12.776.543.750.070.300.300.300, D12.776.543.750.100.150.300.300, D12.776.543.750.720.300.300.300.300
heat-shock response: G07.700.830.500
bone screws: E07.695.130, E07.858.442.660.115, E07.858.690.650.115
ranvier's nodes: A08.637.800.500.700, A08.663.542.512.560.700, A08.800.800.690.500.700, A10.755.503.700, A11.284.149.165.760, A11.650.800.500.700, A11.671.514.553.640
ionomycin: D10.251.355.391
secretory rate: G03.495.873
exocrine glands: A10.336
carnitine acyltransferases: D08.811.913.050.350
lipidoses: C16.320.565.398.641, C18.452.584.687, C18.452.648.398.641
muscular diseases: C05.651, C10.668.491
2-aminopurine: D03.438.759.138.050
mitomycins: D02.806.400.249, D03.383.097.500, D03.438.473.412.249
malates: D02.241.081.337.463, D02.241.511.505
reflex, acoustic: E01.370.376.550.650.670, E01.370.600.550.650.670, G11.561.600.765.594
coronary circulation: G09.330.190.163.324
magnetic resonance angiography: E01.370.350.500.500, E01.370.350.825.500.500, E01.370.370.050.500
map kinase kinase kinase 5: D08.811.913.696.620.682.700.559.500, D12.644.360.400.500, D12.776.476.400.500
achlorhydria: C06.405.748.045, C18.452.076.087
h(+)-k(+)-exchanging atpase: D08.811.277.040.025.325.625, D12.776.157.530.450.250.875.500.625, D12.776.543.585.450.250.875.500.625
pyridinium compounds: D03.383.725.762
diencephalon: A08.186.211.730.317
leptophos: D02.705.429.812.500, D02.705.539.692.500, D02.886.300.846.500
monoamine oxidase inhibitors: D27.505.519.389.616
tetrachlorvinphos: D02.705.400.750
blood protein electrophoresis: E01.370.225.124.100.110, E05.196.401.076, E05.200.124.100.110, E05.301.300.049
anti-anxiety agents: D27.505.696.277.950.015, D27.505.954.427.210.950.015, D27.505.954.427.700.872.015
benzodiazepines: D03.438.079.080
extinction, psychological: F02.463.425.770.232
psychotropic drugs: D27.505.954.427.700
punishment: F02.463.425.770.571, I01.880.630.716
reinforcement (psychology): F02.463.425.770
mechanotransduction, cellular: G01.154.100.440, G01.595.100.440, G02.111.087.800.580, G02.149.115.800.580, G04.299.880.580
methylamines: D02.092.668
synaptic vesicles: A08.850.840, A11.284.430.214.190.875.190.880.830
asbestos, crocidolite: D01.578.725.050.050.100, D01.837.725.700.760.070.050.090
asbestos, serpentine: D01.524.500.050, D01.578.725.050.075, D01.578.725.500.050, D01.837.725.700.760.070.110, D01.837.725.700.760.535.400
lymphocytes: A11.118.637.555.567, A15.145.229.637.555.567, A15.382.490.555.567
anthraquinones: D02.455.426.559.847.117.159, D02.806.100, D04.615.117.159
tumor cells, cultured: A11.251.860
urokinase-type plasminogen activator: D08.811.277.656.300.760.910, D08.811.277.656.959.350.910, D12.776.124.125.662.884
cell survival: G04.299.316
opossums: B01.050.150.900.649.573.575
cell cycle: G04.299.134
enzyme activation: G02.111.087.245, G02.149.115.245, G03.495.368
models, biological: E05.599.395
carrier proteins: D12.776.157
drug implants: D26.255.210.315, D27.720.280.210.315
osteogenesis: G07.700.320.500.325.377.625.100.729, G11.427.590.560.100.729
solubility: G02.842.800
gap junctions: A11.284.149.165.420.471
binding, competitive: E05.196.080, G02.111.087.090, G02.111.570.120.309, G02.149.115.090
sewage: D20.944.932.500
cell adhesion: G04.299.117
cell line: A11.251.210
monocytes: A11.118.637.555.652, A11.148.580, A11.627.624, A11.733.547, A15.145.229.637.555.652, A15.378.316.580, A15.382.490.555.652, A15.382.680.547, A15.382.812.547
recombinant fusion proteins: D12.776.828.300
saccharomyces cerevisiae: B01.300.107.795.785.800, B01.300.930.705.655
transcriptional activation: G05.355.315.800
transfection: E05.393.350.810, G05.355.760.860
two-hybrid system techniques: E05.393.220.870, E05.393.525.870, E05.601.690.650
cell culture techniques: E01.370.225.500.223, E05.200.500.223, E05.240.249, E05.242.223
waste disposal, fluid: N06.850.780.200.800.800.890, N06.850.860.510.900.600.900, N06.850.860.510.900.800
water purification: N06.850.780.200.800.800.900.900, N06.850.860.510.900.900
glycosylation: G02.111.087.160.812, G02.149.115.160.812, G02.149.465.350, G02.607.750.350, G03.495.256.812
pyruvic acid: D02.241.755.812.800
schiff bases: D02.491.784
chromosomes: A11.284.187, A11.284.430.106.279.345.190, G05.360.162
cricetulus: B01.050.150.900.649.865.635.150.250
microtubules: A11.284.430.214.190.750.602
mitotic spindle apparatus: 
alcohol oxidoreductases: D08.811.682.047
cell movement: G04.299.283, G07.700.560.500.180
fluorescent antibody technique, indirect: E01.370.225.500.607.512.240.310, E01.370.225.750.551.512.240.310, E05.200.500.607.512.240.310, E05.200.750.551.512.240.310, E05.478.412.310, E05.478.583.375.310
heart valves: A07.541.510
microfilament proteins: D05.750.078.730, D12.776.220.525
computer systems: L01.224.230
physiological phenomena: G07
lactalbumin: D12.776.034.398, D12.776.256.626.506
tetrazolium salts: D03.383.129.617.700
thiazoles: D02.886.675, D03.383.129.708
aldehyde oxidoreductases: D08.811.682.657.163
dna, bacterial: D13.444.308.212
genes, bacterial: G05.360.340.024.340.364.249, G05.360.340.358.024.249, G05.360.340.358.207.249
membrane potentials: G01.154.535, G04.580, G07.265.750, G11.561.570
patch-clamp techniques: E05.242.800
pyramidal cells: A08.186.211.464.405.700, A08.186.211.730.885.287.500.345.700, A08.186.211.730.885.287.500.766, A08.663.790, A11.671.790
ethidium: D03.494.633.416
inflammation mediators: D23.469
tumor necrosis factor-alpha: D12.644.276.374.500.800, D12.644.276.374.750.626, D12.644.276.972.626, D12.776.124.900, D12.776.395.930, D12.776.467.374.500.800, D12.776.467.374.750.626, D12.776.467.972.626, D23.529.374.500.800, D23.529.374.750.626, D23.529.972.626
cytochrome c group: D08.244.286, D12.776.422.220.286
hl-60 cells: A11.251.210.190.465, A11.251.860.180.465, A11.627.340.360.500
k562 cells: A11.251.210.190.510, A11.251.860.180.510, A11.443.240.497.480
nerve growth factor: D12.644.276.860.437, D12.776.467.860.437, D12.776.641.600.437, D23.529.850.437
neurites: A08.663.256.500, A08.663.542.145.500, A11.284.180.610, A11.671.543
pc12 cells: A11.251.210.190.750, A11.251.860.180.750, A11.299.500
computer simulation: L01.224.160
mucociliary clearance: E01.370.386.520, G09.772.770.580
catalysis: G02.149.170, G02.149.767.500, G02.842.750.500
antimony potassium tartrate: D02.691.075
chaperonin 60: D08.811.277.040.025.142.500.500, D12.776.580.216.210.590.750
cycloheximide: D03.383.621.808.240
hsp70 heat-shock proteins: D12.776.580.216.375
heat-shock proteins: D12.776.580.216
heme oxygenase (decyclizing): D08.811.682.690.708.410
lyases: D08.811.520
fluorescent dyes: D27.720.233.348, D27.720.470.330.348, D27.720.470.410.505.500
carnitine o-palmitoyltransferase: D08.811.913.050.350.200
nuclear proteins: D12.776.660
inhibitory concentration 50: E05.940.350, G07.690.420
eukaryota: B01
carbon: D01.268.150
cell membrane permeability: G03.495.166.335, G04.175
protein kinase c: D08.811.913.696.620.682.700.725
cytoskeletal proteins: D12.776.220
antineoplastic agents: D27.505.954.248
neuroblastoma: C04.557.465.625.600.590.650.550, C04.557.470.670.590.650.550, C04.557.580.625.600.590.650.550
emodin: D02.455.426.559.847.117.159.205.400, D02.806.100.205.400, D04.615.117.159.205.400
leukemia l5178: C04.557.337.372.602, C04.619.531.602
topoisomerase ii inhibitors: D27.505.519.389.892.750, D27.505.954.248.794.750
breast: A01.236
genes, myc: G05.360.340.024.340.375.500.791.420
receptor, erbb-2: D08.811.913.696.620.682.725.400.150, D12.776.543.750.060.374, D12.776.543.750.750.400.350, D12.776.624.664.700.642, D23.101.840.642
rna stability: G02.111.780
cell line, tumor: A11.251.210.190, A11.251.860.180
choriocarcinoma: C04.557.465.955.207, C04.557.465.955.416.202, C04.557.470.200.025.455, C04.850.908.416.186, C13.703.720.949.416.218
gene silencing: G05.355.315.203.374
rna, small interfering: D13.150.650.700, D13.444.735.150.700, D13.444.735.790.552.875
trophoblasts: A11.382.992, A16.254.500.766, A16.710.802
drug screening assays, antitumor: E01.370.225.500.388, E05.200.500.388, E05.242.388, E05.337.550.200
hydroxyestrones: D02.455.426.559.389.657.166.350.350, D04.808.365.415.414.400, D04.808.578.502.497.400, D06.472.334.851.437.984.350
steroid 16-alpha-hydroxylase: D08.244.453.915.737, D08.811.682.690.708.170.915.737, D08.811.682.690.708.783.737, D12.776.422.220.453.915.737
astrocytes: A08.637.200, A11.650.200
diffusion: G01.595.200, G02.149.767.560, G02.842.750.560
dna repair: G02.111.087.219, G02.149.115.219, G05.355.195
models, chemical: E05.599.495
dexamethasone: D04.808.745.432.769.344, D04.808.908.238
thiourea: D02.886.904, D02.948.898
fibroblasts: A11.329.228
bone resorption: C05.116.264, G11.427.590.195.150
carbonic anhydrases: D08.811.520.241.300.150
organ culture techniques: E05.240.484
protein synthesis inhibitors: D27.505.519.389.760
skull: A02.835.232.781
horses: B01.050.150.900.649.709.235.472
fenofibrate: D02.241.081.114.968.500.625, D02.355.726.305.625, D02.455.426.559.389.115.124.750, D02.455.426.559.389.657.654.305.625, D02.522.223.750
adipocytes: A11.329.114
apolipoprotein b-48: D10.532.091.300.240, D12.776.070.400.300.240, D12.776.521.120.300.240
apolipoproteins b: D10.532.091.300, D12.776.070.400.300, D12.776.521.120.300
lipoproteins, vldl: D10.532.599, D12.776.521.622
melphalan: D02.455.526.728.650.594, D12.125.072.050.685.500
molecular weight: G02.842.580
octoxynol: D02.033.455.250.700.660, D05.750.741.610, D25.720.741.610, J01.637.051.720.741.610
erythrocyte membrane: A11.118.290.270, A11.284.149.356, A15.145.229.334.270
cell line, transformed: A11.251.210.172
cyclin-dependent kinases: D08.811.913.696.620.682.700.200, D08.811.913.696.620.682.700.646.500, D12.644.360.250, D12.776.167.200, D12.776.476.250
cyclins: D12.644.360.262, D12.776.167.218, D12.776.476.262
granulosa cells: A05.360.319.114.630.535.200, A06.407.312.497.535.300, A11.382.812, A11.436.329
receptors, fsh: D12.776.543.750.100.250, D12.776.543.750.720.600.370, D12.776.543.750.750.555.370, D12.776.543.750.750.660.350.300
ccaat-enhancer-binding proteins: D12.776.260.108.124, D12.776.660.167, D12.776.930.127.124
coculture techniques: E05.240.374
promoter regions, genetic: G02.111.570.080.689.675, G05.360.080.689.675, G05.360.340.024.340.137.750.680
tissue inhibitor of metalloproteinase-2: D12.776.645.875.500
calcium channels: D12.776.157.530.400.150, D12.776.543.550.425.150, D12.776.543.585.400.150
calcium channels, l-type: D12.776.157.530.400.150.400, D12.776.543.550.425.150.400, D12.776.543.585.400.150.400
coronary vessels: A07.231.114.269, A07.231.908.194
glucuronates: D02.241.081.844.915.162, D02.241.152.811.162, D02.241.511.902.915.162, D09.811.922.162
microscopy, phase-contrast: E01.370.350.515.513.569, E05.490.630.569, E05.595.513.569
cell death: G04.299.139
hydroquinones: D02.455.426.559.389.657.393
nadh, nadph oxidoreductases: D08.811.682.608
food analysis: E05.362, J01.576.423.850.100
intestinal mucosa: A03.556.124.369, A10.615.550.444
drug inverse agonism: G07.690.812.240.393, G07.700.680.240.393
nuclear receptor subfamily 1, group f, member 3: D12.776.260.698.209.182, D12.776.826.209.182, D12.776.930.669.209.182
plasma: A12.207.152.693, A12.207.270.695, A15.145.693
manganese compounds: D01.530
adenocarcinoma, follicular: C04.557.470.200.025.060
comet assay: E05.196.401.153.150, E05.301.300.100.150, E05.393.560.150, E05.940.560.150
arteries: A07.231.114
silver nitrate: D01.625.525.550.850, D01.847.900
osteoblasts: A11.329.629
prostheses and implants: E07.695
scattering, radiation: E05.196.822, G01.595.861
atp-binding cassette transporters: D12.776.157.530.100, D12.776.395.550.020, D12.776.543.550.192, D12.776.543.585.100
cation transport proteins: D12.776.157.530.450.250, D12.776.543.585.450.250
cell polarity: G04.310
protein transport: G03.495.166.700
glutamate-cysteine ligase: D08.811.464.259.850.400
heme oxygenase-1: D08.811.682.690.708.410.500
endocytosis: G04.299.482
progestins: D27.505.696.399.472.858
phosmet: D02.705.400.625.670, D02.705.539.345.670, D02.886.300.692.670, D03.438.513.750.625
hep g2 cells: A11.251.860.180.432, A11.436.348.500
interleukin-8: D12.644.276.374.200.120.800, D12.644.276.374.465.508, D12.776.467.374.200.120.800, D12.776.467.374.465.508, D23.125.300.120.800, D23.469.200.120.800, D23.529.374.200.120.800, D23.529.374.465.508
dna breaks: G05.355.180.210
fatty acid-binding proteins: D12.776.157.170
hela cells: A11.251.210.190.400, A11.251.860.180.400, A11.436.340
amyloid beta-peptides: D12.644.024, D12.776.049.407.249.500, D12.776.543.039.500
caspases: D08.811.277.656.262.500.126, D08.811.277.656.300.200.126, D12.644.360.075.405, D12.776.476.075.405
cytochromes c: D08.244.286.100, D12.776.422.220.286.100
peptide fragments: D12.644.541
sarcoplasmic reticulum calcium-transporting atpases: D08.811.277.040.025.125.500, D12.776.157.530.450.250.500.500, D12.776.543.585.450.250.500.500
chemokine ccl2: D12.644.276.374.200.110.990.600, D12.776.467.374.200.110.990.600, D23.125.300.110.990.600, D23.469.200.110.990.600, D23.529.374.200.110.990.500
respiratory mucosa: A04.760, A10.615.550.760
colony count, microbial: E01.370.225.875.220, E05.200.875.220
recombinant proteins: D12.776.828
caspase 9: D08.811.277.656.262.500.126.550.900, D08.811.277.656.300.200.126.550.900, D12.644.360.075.405.550.900, D12.776.476.075.405.550.900
chondrogenesis: G07.700.320.500.325.377.625.180, G11.427.590.560.180
limb buds: A16.567
proteoglycans: D09.698.735, D12.776.395.650
theca cells: A05.360.319.114.630.535.400, A06.407.312.497.535.600, A11.329.850
bh3 interacting domain death agonist protein: D12.644.360.075.718.968, D12.776.476.075.718.937
caspase 8: D08.811.277.656.262.500.126.550.800, D08.811.277.656.300.200.126.550.800, D12.644.360.075.405.550.800, D12.776.476.075.405.550.800
epidermis: A10.272.497, A17.815.250
mitochondrial membranes: A11.284.149.450.349, A11.284.835.514.349
poly(adp-ribose) polymerases: D08.811.913.400.725.115.690
proto-oncogene proteins c-bcl-2: D12.644.360.075.718, D12.776.476.075.718, D12.776.624.664.700.169
bcl-2-associated x protein: D12.644.360.075.718.400, D12.776.476.075.718.400
dna-binding proteins: D12.776.260
luteal cells: A05.360.319.114.630.278.400, A06.407.312.497.278.400, A11.382.921, A11.436.566
progesterone reductase: D08.811.682.047.436.350.700, D08.811.682.047.820.500
adenylate kinase: D08.811.913.696.650.025
caspase 7: D08.811.277.656.262.500.126.350.700, D08.811.277.656.300.200.126.350.700, D12.644.360.075.405.350.700, D12.776.476.075.405.350.700
candida glabrata: B01.300.381.147.400, B01.300.930.176.400
fungal proteins: D12.776.354
gene expression regulation, fungal: G05.355.315.330
ovotesticular disorders of sex development: C12.706.316.343, C13.351.875.253.343, C16.131.939.316.343, C19.391.119.343
beta-galactosidase: D08.811.277.450.410.100
cell cycle proteins: D12.776.167
dna repair enzymes: D08.811.074
tumor suppressor proteins: D12.776.624.776
map kinase signaling system: G02.111.087.800.560, G02.149.115.800.560, G03.495.553.560, G04.299.880.560
phosphorylation: G02.111.087.677, G02.149.115.677, G02.149.465.700, G02.607.750.700, G03.495.790
proto-oncogene proteins c-akt: D08.811.913.696.620.682.700.755, D12.776.476.565, D12.776.624.664.700.168
cell cycle checkpoints: G04.299.134.109
gene expression regulation, neoplastic: G05.355.315.370
micrornas: D13.150.650.319, D13.444.735.150.319, D13.444.735.790.552.500
spectrophotometry, ultraviolet: E05.196.712.726.802, E05.196.867.826.802
tumor suppressor protein p53: D12.776.260.820, D12.776.624.776.775, D12.776.660.825, D12.776.744.845
models, molecular: E05.599.595
molecular conformation: G02.111.570.790, G02.575.500, G02.842.575.500
photochemotherapy: E02.186.500, E02.319.685, E02.774.722
caveolae: A11.284.149.165.175.160, A11.284.149.165.570.160, A11.284.430.214.190.875.190.880.180.160
clathrin: D12.776.543.990.200
nitric oxide synthase type ii: D08.811.682.664.500.772.500
acetaldehyde: D02.047.064
guanylate cyclase: D08.811.520.650.600, D12.644.360.350, D12.776.476.350
calcium signaling: G02.111.087.800.800.100, G02.149.115.800.800.100, G03.495.166.500.100, G04.299.880.800.100
cytoprotection: G07.690.812.195, G07.700.680.195
sulfones: D02.886.590
oncogene proteins: D12.776.624.664
endothelial cells: A11.436.275
bacterial proteins: D12.776.097
hek293 cells: A11.251.210.172.750, A11.436.334
neovascularization, physiologic: G09.330.190.751
precursor t-cell lymphoblastic leukemia-lymphoma: C04.557.337.428.600.620, C15.604.515.560.600.620, C20.683.515.528.600.620
map kinase kinase 4: D08.811.913.696.620.682.700.565.400, D08.811.913.696.620.682.725.200.400, D12.644.360.440.400, D12.776.476.440.400
mitogen-activated protein kinases: D08.811.913.696.620.682.700.567, D08.811.913.696.620.682.700.646.750, D12.644.360.450, D12.776.476.450
p38 mitogen-activated protein kinases: D08.811.913.696.620.682.700.567.878, D08.811.913.696.620.682.700.646.750.843, D12.644.360.450.835, D12.776.476.450.835
materials testing: E05.570
adipogenesis: G04.299.151.149
food, preserved: J02.500.521
3t3 cells: A11.251.210.100, A11.329.228.100
cathepsin k: D08.811.277.656.224.405, D08.811.277.656.262.500.156, D08.811.277.656.300.200.156
cell hypoxia: G03.495.278.300, G04.299.305.300
chemokine cxcl12: D12.644.276.374.200.120.600, D12.776.467.374.200.120.600, D23.125.300.120.600, D23.469.200.120.600, D23.529.374.200.120.600
hematopoietic stem cell mobilization: E02.095.410
hypoxia-inducible factor 1, alpha subunit: D12.776.260.103.625.750, D12.776.930.125.625.750
matrix metalloproteinase 9: D08.811.277.656.300.480.205.360, D08.811.277.656.300.480.252.445, D08.811.277.656.300.480.525.700.350, D08.811.277.656.675.374.205.360, D08.811.277.656.675.374.252.445, D08.811.277.656.675.374.525.700.350
osteoclasts: A11.329.372.700, A11.627.482.700
receptors, cxcr4: D12.776.543.750.100.160.500.400, D12.776.543.750.705.852.125.500.400, D12.776.543.750.925.700.650, D23.050.301.264.035.605.500.400, D23.101.100.110.605.500.400
lactic acid: D02.241.511.459.450
antineoplastic agents, phytogenic: D27.505.954.248.179
chromatography, supercritical fluid: E05.196.181.750
keratinocytes: A11.436.397
interleukin-10: D12.644.276.374.465.510, D12.776.467.374.465.510, D23.529.374.465.510
interleukin-12: D12.644.276.374.465.512, D12.776.467.374.465.512, D23.529.374.465.512
anaerobiosis: G02.111.087.050, G02.149.115.050, G03.495.146
plants: B01.650
4-nitroquinoline-1-oxide: D02.640.820.600, D03.438.810.470.450, D03.661.243.500
cho cells: A11.251.210.200, A11.436.155
tamoxifen: D02.455.426.559.389.150.700.900
cell shape: G04.320
fast foods: J02.500.477
food: J02.500
food labeling: J01.576.423.850.600.400, J01.576.761.400.450
nutrition policy: I01.655.500.608.400.650, I01.880.604.825.608.400.650, N03.623.500.608.428.650
biological availability: G03.787.151, G07.690.725.129
gastrointestinal tract: A03.556
diving: I03.450.642.845.869.110, N06.230.150.150
amino acid substitution: E05.393.420.601.035, G05.355.600.109
codeine: D03.132.577.249.562.149, D03.549.686.607.204, D03.605.497.607.204, D04.615.723.795.576.149
guaiacol: D02.355.601.536, D02.355.726.453, D02.455.426.559.389.657.166.453, D02.455.426.559.389.657.654.453
hydrogen bonding: G02.149.767.620, G02.842.750.620
mutagenesis, site-directed: E05.393.420.601.575
protein structure, secondary: G02.111.570.790.709.600
proteasome endopeptidase complex: D05.500.562.500, D08.811.277.656.918, D08.811.600.730
alkenes: D02.455.326.271
leukocytes, mononuclear: A11.118.637.555, A15.145.229.637.555, A15.382.490.555
balb 3t3 cells: A11.251.210.100.080, A11.329.228.100.080
dental materials: D25.339, D27.720.102.339, J01.637.051.339
photosynthesis: G02.111.087.160.937, G02.111.087.678.700, G02.149.115.160.937, G02.149.115.678.700, G02.149.767.690.921, G02.842.750.690.921, G03.495.256.937, G03.495.553.700, G03.495.795.700, G15.744.700
scenedesmus: B01.650.940.150.800
triazines: D03.383.931
connexin 43: D12.776.543.585.250.200
fas-associated death domain protein: D12.644.360.024.296.200, D12.644.360.024.500.124, D12.644.360.075.421.200, D12.776.157.057.024.200, D12.776.157.057.500.124, D12.776.476.024.375.550, D12.776.476.024.500.124, D12.776.476.075.421.200
fluorouracil: D03.383.742.698.875.404
tnf receptor-associated death domain protein: D12.644.360.024.296.600, D12.644.360.024.500.249, D12.644.360.075.421.600, D12.776.157.057.024.600, D12.776.157.057.500.249, D12.776.476.024.375.775, D12.776.476.024.500.249, D12.776.476.075.421.600
centromere: A11.284.430.106.279.345.190.160.165, G05.360.160.165
repressor proteins: D12.776.260.703, D12.776.930.700
cortodoxone: D04.808.745.745.654.252, D06.472.040.585.478.225
formazans: D02.172.600
uncertainty: E05.318.740.600.900, F02.463.785.373.820, G17.680.875, N05.715.360.750.625.850, N06.850.520.830.600.900
pulmonary surfactant-associated proteins: D12.776.823
surface tension: G02.842.850.816
pokeweed mitogens: D12.776.503.499.875, D12.776.765.678.875
fatty acid transport proteins: D12.776.157.530.300, D12.776.543.585.300
protein isoforms: D12.776.800
nih 3t3 cells: A11.251.210.100.550, A11.329.228.100.550
melanoma, experimental: C04.557.465.625.650.510.525, C04.557.580.625.650.510.525, C04.557.665.510.525, C04.619.600, E05.598.500.496.937
neoplasm transplantation: E05.624
catechol o-methyltransferase: D08.811.913.555.500.250
glutathione synthase: D08.811.464.259.850.500
thioredoxin reductase 1: D08.811.682.667.750.500
ubiquitin-protein ligases: D08.811.464.938.750
vesicular monoamine transport proteins: D12.776.157.530.450.162.887.500.500, D12.776.157.530.562.750.500.500, D12.776.543.585.450.162.887.500.500, D12.776.543.585.562.750.500.500
chromosomal instability: C23.550.210.110, C23.550.362.180, G05.365.590.175.165, G05.370.180
morpholines: D03.383.533.640
phosphatidylinositol 3-kinases: D08.811.913.696.620.500
prostaglandin d2: D10.251.355.255.100.637.200.200, D10.251.355.255.550.200.200, D23.469.050.175.725.770.720
bismuth: D01.268.556.100, D01.552.544.100
indium: D01.268.556.381, D01.552.544.381
mitogen-activated protein kinase 1: D08.811.913.696.620.682.700.567.342.500, D08.811.913.696.620.682.700.646.750.249.500, D12.644.360.450.169.500, D12.776.476.450.169.500
mitogen-activated protein kinase 3: D08.811.913.696.620.682.700.567.342.750, D08.811.913.696.620.682.700.646.750.249.750, D12.644.360.450.169.750, D12.776.476.450.169.750
ligands: D27.720.470.480
software: L01.224.900
protein kinases: D08.811.913.696.620.682
aconitate hydratase: D08.811.520.241.300.050
intracellular fluid: A11.284.430.429, A11.284.835.450, A12.207.515
iron regulatory protein 1: D08.811.520.241.300.050.500, D12.776.157.427.374.375.960, D12.776.157.725.374, D12.776.494.500, D12.776.556.579.374.375.960, D12.776.664.962.374
iron regulatory protein 2: D08.811.520.241.300.050.750, D12.776.157.427.374.375.961, D12.776.157.725.437, D12.776.494.750, D12.776.556.579.374.375.962, D12.776.664.962.437
receptors, transferrin: D12.776.157.905.500, D12.776.543.750.850
butter: D10.212.302.199, J02.500.350.100, J02.500.375.200
aromatase inhibitors: D27.505.519.389.099
chromatids: A11.284.430.106.279.345.190.160.175, G05.360.160.175
electric impedance: G01.358.500.249.277.350
mesencephalon: A08.186.211.132.659, A08.186.211.653
fadrozole: D02.626.400, D03.383.129.308.270
mammary glands, human: A01.236.249, A10.336.532
automation: J01.897.104
carcinoma, non-small-cell lung: C04.588.894.797.520.109.220.249, C08.381.540.140.500, C08.785.520.100.220.500
cytotoxins: D27.888.569.213
adsorption: G02.149.047, G02.149.767.029, G02.842.750.029
methacrylates: D02.241.081.069.600
molecular imprinting: E05.196.655
embryonic stem cells: A11.872.190
refuse disposal: N06.850.780.200.800.800.700, N06.850.860.510.900.600
rotenone: D03.438.150.266.450.400.843, D03.549.825, D03.830.219.266.450.400.843
rho gtp-binding proteins: D08.811.277.040.330.300.400.700, D12.644.360.525.700, D12.776.157.325.515.700, D12.776.476.525.700
ammonium sulfate: D01.625.062.374, D01.875.800.800.850.050
chemical fractionation: E05.196.155
ionic liquids: D27.720.844.500
phenylurea compounds: D02.455.426.559.389.703, D02.948.681
yogurt: J02.500.350.525.221.888
oxidants: D27.720.642, D27.888.569.540
rna splicing: G02.111.087.750.700, G02.149.115.750.700, G03.495.839.700, G05.355.315.700.700
calcification, physiologic: G07.700.320.186, G07.700.320.500.325.377.625.100.175, G11.427.590.560.100.175
adjuvants, pharmaceutic: D26.650.064, D27.720.744.064
mesenchymal stromal cells: A11.329.830.500, A11.872.590.500
melanocytes: A11.436.613
mice, scid: B01.050.150.900.649.865.635.505.500.550.780
hsp27 heat-shock proteins: D12.776.580.216.270.625
mitogen-activated protein kinase kinases: D08.811.913.696.620.682.700.565, D08.811.913.696.620.682.725.200, D12.644.360.440, D12.776.476.440
neoplasm proteins: D12.776.624
protein-tyrosine kinases: D08.811.913.696.620.682.725
fluorocarbon polymers: D05.750.395, D25.720.395, J01.637.051.720.395
electrophoresis, capillary: E05.196.401.190, E05.301.300.190
xenograft model antitumor assays: E05.337.550.200.900, E05.624.850
tissue inhibitor of metalloproteinase-1: D12.776.645.875.450
intracellular space: A10.082.750, A11.284.430
membrane fluidity: G01.154.500, G02.111.550, G04.570
culture media: D27.720.470.305, E07.206
insect repellents: D27.505.696.706.434, D27.720.031.700.441, D27.720.723.441, D27.888.723.441
cisplatin: D01.210.375, D01.625.125, D01.710.100
camptothecin: D03.132.151
deet: D02.065.277.194, D02.241.223.100.100.230, D02.455.426.559.389.127.085.230
membranes, artificial: D25.479, J01.637.051.479, J01.637.087.500
crystallography: E05.196.309, H01.181.529.240
rosette formation: E01.370.225.812.706, E05.200.812.706, E05.478.594.730
androstenedione: D04.808.054.079.329, D04.808.578.502.112, D06.472.040.502.112, D06.472.334.851.968.875
hydroxycholesterols: D04.808.247.222.284.478, D04.808.247.808.197.561, D10.570.938.208.603
arthroplasty: E04.555.110
annexin a5: D12.776.157.125.050.100
orthodontic appliance design: E05.320.274, E06.658.450, E06.912.675
tooth movement: E06.658.578.836
isometric contraction: G11.427.590.540.472
bleomycin: D09.400.420.110, D12.644.233.110
sodium channels: D12.776.157.530.400.875, D12.776.543.550.425.875, D12.776.543.585.400.875
collagen type v: D05.750.078.280.300.400, D12.776.860.300.250.300.400
g0 phase: G04.299.134.500.300
g1 phase: G04.299.134.500.320
riluzole: D02.886.675.651, D03.383.129.708.089.611, D03.438.185.611
fluorescence polarization: E05.196.712.516.600.390
lipid bilayers: D10.570.510, J01.637.087.500.510
membrane transport modulators: D27.505.519.562
microarray analysis: E05.196.630.570, E05.588.570
microelectrodes: E07.305.250.500
nerve net: A08.511
veratridine: D03.132.920.256.679, D03.549.256.679
omega-conotoxins: D20.888.590.162.720, D23.946.580.590.162.720, D23.946.833.590.162.720
1-methyl-4-phenylpyridinium: D03.383.725.762.550
uncoupling agents: D27.505.519.389.936
pigment epithelium of eye: A09.371.670, A10.272.640
cytokinesis: G04.299.134.220.250
jurkat cells: A11.251.210.190.495, A11.251.860.180.495, A15.382.490.555.567.569.440
amides: D02.065
retinoid x receptors: D12.776.260.698.701.500, D12.776.826.701.500, D12.776.930.669.701.500
chromosomes, mammalian: A11.284.187.520, G05.360.162.520
selective estrogen receptor modulators: D06.347.360.827, D27.505.696.399.450.360.827
cytoplasm: A11.284.430.214
dimethylpolysiloxanes: D02.715.650.700.150, D05.750.900.850.150, D25.720.900.850.150, J01.637.051.720.900.850.150
endoplasmic reticulum stress: G03.495.710.344, G04.299.486, G04.434
quantitative structure-activity relationship: G02.111.830.500, G07.690.830.500
annexin a7: D12.776.157.125.050.120
phosphatidylethanolamine binding protein: D12.644.360.562, D12.776.157.661, D12.776.476.555
protein disulfide-isomerases: D08.811.399.475.800.550
buffaloes: B01.050.150.900.649.077.380.135
ion channel gating: G02.111.087.800.400, G02.149.115.800.400, G04.299.500, G04.299.880.400, G07.265.337.500, G07.700.240.500
tissue culture techniques: E05.240.617
adenoviridae: B04.280.030, B04.909.204.097
osteocytes: A11.329.629.500
vitallium: D01.220.175.950, D01.552.033.182.900, D25.058.224.735, D25.339.208.224.959, J01.637.051.058.224.735, J01.637.051.339.208.224.959
animal testing alternatives: E05.017.080.100
gene deletion: G05.355.600.800.320, G05.365.590.762.320
electrophoresis, cellulose acetate: E05.196.401.200, E05.301.300.200
antigens, bacterial: D23.050.161
gene expression regulation, bacterial: G05.355.315.300
granulocyte-macrophage colony-stimulating factor: D12.644.276.374.410.240.375, D12.776.395.240.300, D12.776.467.374.410.240.375, D23.529.374.410.240.375
carmustine: D02.654.692.247, D02.948.594.247
interinstitutional relations: N04.452.822.400
intracellular membranes: A11.284.149.450, A11.284.835.514
gaba-a receptor antagonists: D27.505.519.625.240.300.500, D27.505.696.577.240.300.500
phosphines: D01.695.525, D02.705.621
bottle feeding: E02.421.150, F01.145.407.099
food packaging: J01.576.423.200.375, J01.576.423.850.600, J01.576.761.400
infant formula: J02.200.700.249, J02.200.712.249, J02.500.350.525.332, J02.500.525.350.500, J02.500.525.500.500
polycarboxylate cement: D25.339.291.700, J01.637.051.339.291.700
plasmids: G05.360.600
excitatory amino acid antagonists: D27.505.519.625.190.300, D27.505.696.577.190.300
arsenites: D01.075.050, D01.248.497.158.055, D02.691.088.047
chymotrypsin: D08.811.277.656.300.760.176, D08.811.277.656.959.350.176
hsp30 heat-shock proteins: D12.776.580.216.270.750
leupeptins: D12.644.456.580
proteasome inhibitors: D27.505.519.389.745.705
pyrrolidinones: D03.383.773.812
ubiquitinated proteins: D12.776.938
ubiquitination: G02.111.087.675.871.790.600.925, G02.111.087.693.600.775, G02.149.115.675.871.790.600.831, G02.149.115.693.600.850, G03.495.770.871.790.600.831, G05.355.315.670.600.831
xenopus proteins: D12.776.045.500
review literature as topic: L01.178.682.759
astragalus plant: B01.650.940.800.575.100.401.087
cyclin d1: D12.644.360.262.150.100, D12.776.167.218.150.100, D12.776.476.262.150.100, D12.776.624.664.700.100
cyclooctanes: D02.455.426.392.368.408
medicine, chinese traditional: E02.190.488.585.520, I01.076.201.450.654.558.520
waste management: N06.850.780.200.800.800.900, N06.850.860.510.900
cell lineage: G04.172, G07.700.320.500.325.180.500, G08.686.155, G08.686.785.760.170.104.249
trpm cation channels: D12.776.157.530.400.901.555, D12.776.543.585.400.901.555
extracellular signal-regulated map kinases: D08.811.913.696.620.682.700.567.342, D08.811.913.696.620.682.700.646.750.249, D12.644.360.450.169, D12.776.476.450.169
connexins: D12.776.543.585.250
g2 phase: G04.299.134.500.340
jnk mitogen-activated protein kinases: D08.811.913.696.620.682.700.567.513, D08.811.913.696.620.682.700.646.750.374, D12.644.360.450.340, D12.776.476.450.340
benzoquinones: D02.806.250
indolequinones: D02.806.400, D03.438.473.412
carbachol: D02.092.877.883.333.115, D02.675.276.232.115
inositol phosphates: D02.033.800.519.400, D09.853.519.400, D09.894.480
phosphorus radioisotopes: D01.496.669.604, D01.496.749.658
aroclors: D02.455.526.439.773.292, D02.455.526.439.785.292
astacoidea: B01.050.500.131.365.190.070
dose-response relationship, immunologic: G12.300
minerals: D01.578
interferon regulatory factor-1: D12.644.360.024.302.124, D12.776.157.057.050.124, D12.776.260.108.374, D12.776.260.504.124, D12.776.476.024.385.124, D12.776.930.127.374, D12.776.930.332.124
potassium channels, inwardly rectifying: D12.776.157.530.400.600.450, D12.776.543.550.425.750.450, D12.776.543.585.400.750.450
tetraethylammonium: D02.092.877.787.500, D02.675.276.787.500
recombination, genetic: G05.355.760
1-phosphatidylinositol 4-kinase: D08.811.913.696.620.550
phosphatidylinositols: D10.570.755.375.760.400.942
infant food: J02.500.525.500
neoplastic stem cells: A11.872.650
phenolsulfonphthalein: D02.455.426.559.389.657.625.560
response elements: G02.111.570.080.689.330.700, G02.111.570.080.689.675.700, G05.360.080.689.330.700, G05.360.080.689.675.700, G05.360.340.024.340.137.750.249.765, G05.360.340.024.340.137.750.680.765
spheroids, cellular: A11.251.800
microscopy, immunoelectron: E01.370.350.515.402.625, E05.595.402.625
genome, human: G05.360.340.350
adam proteins: D08.811.277.656.675.374.102, D09.400.430.500, D12.776.395.033
amyloid beta-protein precursor: D12.776.049.407.249, D12.776.543.039, D12.776.645.468.500, D12.776.811.050
aspartic acid endopeptidases: D08.811.277.656.074.500, D08.811.277.656.300.048
muscarinic agonists: D27.505.519.625.120.140.500, D27.505.696.577.120.140.500
dna-(apurinic or apyrimidinic site) lyase: D08.811.074.750, D08.811.520.241.225
mitochondrial membrane transport proteins: D12.776.543.585.475, D12.776.575.750
mitochondrial swelling: G04.299.580
succinate cytochrome c oxidoreductase: D05.500.562.750, D08.811.600.250.875, D08.811.682.830, D12.776.543.277.875
chromosomes, human, pair 21: A11.284.187.520.300.505.510, G05.360.162.520.300.505.510
6-cyano-7-nitroquinoxaline-2,3-dione: D03.438.857.160
receptors, glutamate: D12.776.543.750.720.200.450
electroporation: E05.242.448, E05.301.500
aluminum oxide: D01.056.050, D01.650.550.050
solutions: D26.776
amnion: A10.615.284.277, A16.254.750.277
butterflies: B01.050.500.131.617.561.200
plant development: G07.700.320.625, G15.744.723
sorghum: B01.650.940.800.575.100.822.894
triticum: B01.650.940.800.575.100.822.918, J02.500.200.875
histones: D12.776.660.470, D12.776.664.469
neoplasms, mesothelial: C04.557.470.660
transcription factor ap-1: D12.776.260.108.875, D12.776.930.127.875
carbanilides: D02.065.199.326, D02.455.426.559.389.703.202, D02.948.681.202
cyclin-dependent kinase inhibitor p16: D12.644.360.225.200, D12.776.167.187.200, D12.776.476.225.200, D12.776.624.776.355.200
microtubule proteins: D05.750.078.734, D12.776.220.600
nephelometry and turbidimetry: E05.196.712.650
protein conformation: G02.111.570.790.709
spectrometry, fluorescence: E05.196.712.516.600.676, E05.196.867.726
hydrocarbons, iodinated: D02.455.526.581
chromans: D03.438.150.240, D03.830.219.240
dermatitis, phototoxic: C17.800.174.255.400.225, C17.800.600.335, C17.800.815.255.400.225
neutral red: D03.494.704.600
microvessels: A07.231.461
glial cell line-derived neurotrophic factor: D12.644.276.860.381.500, D12.776.467.860.381.500, D12.776.641.600.381.500, D23.529.850.381.500
proto-oncogene proteins c-fyn: D08.811.913.696.620.682.725.800.551, D12.776.476.571, D12.776.624.664.700.180
proto-oncogene proteins c-ret: D08.811.913.696.620.682.725.400.087, D12.776.543.750.060.217, D12.776.624.664.700.194
electrophysiological phenomena: G07.265
synaptic potentials: G04.580.887, G07.265.337.900.750, G07.265.750.887, G07.700.240.900.750, G11.561.570.918, G11.561.600.835.750
croatia: Z01.542.248.295, Z01.586.980.295
horseradish peroxidase: D08.811.682.732.512
legislation, food: N03.706.615.412
hydroxylation: G02.111.087.512, G02.149.115.512, G02.149.465.410, G02.607.750.410, G03.495.510
photoelectron spectroscopy: E05.196.867.618
biocatalysis: G02.111.087.095, G02.149.115.095, G02.149.170.500, G02.149.767.500.500, G02.842.750.500.500, G03.495.159
maf transcription factors: D12.776.260.108.500, D12.776.930.127.500
carbonic anhydrase inhibitors: D27.505.519.389.200
genes, erbb: G05.360.340.024.340.375.500.791.295
nucleosomes: A11.284.430.106.279.345.190.160.180.625, D12.776.664.224.550, G05.360.160.180.625
nanotubes: J01.637.512.850
araceae: B01.650.940.800.575.100.085
photosynthetic reaction center complex proteins: D05.500.562.488, D08.811.600.710, D12.776.183.750.750, D12.776.543.983.500, D12.776.765.199.750.750
cell physiological phenomena: G04
cellular structures: A11.284
cytological techniques: E01.370.225.500, E05.200.500, E05.242
mannose-binding lectins: D12.776.503.311
cesium: D01.268.549.125, D01.268.556.165, D01.552.528.160, D01.552.544.165
u937 cells: A11.251.210.190.880, A11.251.860.180.880, A11.627.482.665.500, A11.627.624.249.500, A11.627.635.675.750.500
bisphenol a-glycidyl methacrylate: D02.241.081.069.600.150, D02.455.426.559.389.657.100, D05.750.716.822.308.200, D25.339.816.500.200, D25.720.716.822.308.200, J01.637.051.339.816.500.200, J01.637.051.720.716.822.308.200
microscopy, acoustic: E01.370.350.515.370, E01.370.350.850.565, E05.595.370
quinazolines: D03.438.786
benzoflavones: D03.438.150.266.450.175, D03.830.219.266.450.175
creosote: D02.455.426.559.389.657.239.327
fluorenes: D02.455.426.559.847.389, D04.615.389
culture media, conditioned: D27.720.470.305.250, E07.206.250
paracrine communication: G04.299.122.600
bufanolides: D04.808.155.580.064
microsatellite repeats: G02.111.570.080.708.800.500, G05.360.080.708.800.500, G05.360.340.024.850.500
cumulus cells: A05.360.319.114.630.535.200.500, A06.407.312.497.535.300.500, A11.382.812.500, A11.436.329.500
3-alpha-hydroxysteroid dehydrogenase (b-specific): D08.811.682.047.436.350.100, D08.811.682.047.820.186
sodium selenite: D01.810.900.500, D01.857.850
food handling: J01.576.423.200
17-alpha-hydroxyprogesterone: D04.808.745.745.654.829.395.400, D06.472.334.851.687.750.478.400
comparative genomic hybridization: E05.393.285.240, E05.393.520.500, E05.393.661.187
cyclin-dependent kinase inhibitor p15: D12.644.360.225.100, D12.776.167.187.100, D12.776.476.225.100, D12.776.624.776.355.100
fossil fuels: D20.345, N06.230.132.258
incineration: N06.850.860.510.900.600.500
activating transcription factor 6: D12.644.360.011, D12.776.260.108.061.968, D12.776.476.011, D12.776.930.127.061.968
endoribonucleases: D08.811.277.352.355.350, D08.811.277.352.700.350
eif-2 kinase: D08.811.913.696.620.682.700.300, D12.644.360.275, D12.776.476.275
biodiversity: G16.500.275.157.049, N06.230.124.049
diiodothyronines: D06.472.931.740.180, D12.125.072.050.767.741.180
triiodothyronine, reverse: D06.472.931.740.590, D12.125.072.050.767.741.947
crystallography, x-ray: E05.196.309.742.225
ppar delta: D12.776.260.698.239.555, D12.776.826.239.555, D12.776.930.669.239.555
nfatc transcription factors: D12.776.930.608
sincalide: D06.472.317.152.700, D12.644.120.700
caco-2 cells: A11.251.210.190.160, A11.251.860.180.160, A11.436.140
bisbenzimidazole: D03.438.103.145
etoposide: D02.455.426.559.847.638.960.675.250, D04.615.638.960.675.250, D09.408.348.275
chorionic gonadotropin, beta subunit, human: D06.472.699.322.326.125, D06.472.699.649.367.125, D12.644.548.726.367.125, D12.776.780.400.125, D23.101.175, D23.101.840.325
ventricular function, right: G09.330.190.962.900
radioisotope dilution technique: E01.370.384.710, E05.484.650
potassium channels, voltage-gated: D12.776.157.530.400.600.900, D12.776.543.550.425.750.900, D12.776.543.585.400.750.900
cations: D01.248.497.300
blood gas monitoring, transcutaneous: E01.370.225.124.100.100.600.100, E01.370.370.380.600.100, E01.370.386.700.100.600.100, E05.200.124.100.100.600.100
argininosuccinate synthase: D08.811.464.259.300
bone marrow examination: E01.370.225.625.135, E05.200.625.135
caveolin 1: D12.644.360.024.264, D12.776.157.057.010, D12.776.476.024.280, D12.776.543.990.100.500, D12.776.744.287
embryonic induction: G04.299.122.300, G04.299.151.300, G07.700.320.500.100.250, G07.700.320.500.325.180.750, G08.686.785.760.170.104.750
eye proteins: D12.776.306
paired box transcription factors: D12.776.260.645, D12.776.930.626
dithiothreitol: D02.033.800.196, D02.886.740.224, D09.853.196
mercaptoethanol: D02.033.375.534, D02.886.489.409
chicago: Z01.107.567.875.350.350.200, Z01.107.567.875.510.350.200, Z01.433.305
intercellular signaling peptides and proteins: D12.644.276, D12.776.467, D23.529
protein kinase inhibitors: D27.505.519.389.755
osteoprotegerin: D12.776.543.750.705.852.760.949.249
rank ligand: D12.644.276.374.750.562, D12.644.276.972.562, D12.776.467.374.750.562, D12.776.467.972.562, D23.529.374.750.562, D23.529.972.562
thapsigargin: D02.455.426.392.368.284.500.888, D02.455.849.765.793.888
cereals: B01.650.510.253, J02.500.200
heterogeneous-nuclear ribonucleoprotein group a-b: D12.776.157.725.500.500.100, D12.776.260.735.500, D12.776.660.235.700.500, D12.776.664.962.500.500.100
active transport, cell nucleus: G03.495.166.310.100, G03.495.166.700.100
genes, fungal: G05.360.340.024.340.364.500, G05.360.340.358.024.500, G05.360.340.358.365.500
vacuolar proton-translocating atpases: D08.811.277.040.025.325.875, D08.811.913.696.650.150.500.875, D12.776.157.530.450.250.875.500.875, D12.776.543.585.450.250.875.500.875
tor serine-threonine kinases: D08.811.913.696.620.682.700.931, D12.776.476.925
apigenin: D03.438.150.266.450.260.110, D03.830.219.266.450.260.110
flavones: D03.438.150.266.450.260, D03.830.219.266.450.260
kaempferols: D03.438.150.266.450.284.388, D03.830.219.266.450.284.388
immunity, mucosal: G12.450.573
symbiosis: G06.590.580.800, G16.100.900
eicosanoids: D10.251.355.255, D23.469.050.175
receptor activator of nuclear factor-kappa b: D12.776.543.750.705.852.760.345
ipomoea: B01.650.940.800.575.100.238.500
antibodies, monoclonal: D12.776.124.486.485.114.224, D12.776.124.790.651.114.224, D12.776.377.715.548.114.224
glutathione s-transferase pi: D08.811.913.225.500.500
exocytosis: G04.299.490
glycolysis: G02.111.087.160.750, G02.149.115.160.750, G03.495.256.750, G03.495.335.436, G03.495.553.360
sesquiterpenes: D02.455.849.765
3t3-l1 cells: A11.251.210.100.775.800, A11.329.228.100.775.800
hemoglobinopathies: C15.378.420, C16.320.365
chemistry techniques, analytical: E05.196
environment: G16.500.275, N06.230
nuclear localization signals: D12.644.770.610, G02.111.570.060.670.610
caspase inhibitors: D27.505.519.389.745.325.500
okadaic acid: D02.355.291.705
bucladesine: D03.438.759.646.138.395.250, D13.695.462.200.250, D13.695.667.138.395.250, D13.695.827.068.395.250
receptors, corticotropin: D12.776.543.750.720.600.285, D12.776.543.750.750.555.285, D12.776.543.750.750.660.285
catalytic domain: G02.111.570.120.704, G02.111.570.790.709.610.189
singlet oxygen: D01.339.431.500
sodium azide: D01.625.100.750, D01.857.462
tromethamine: D02.033.455.706.900
gene knockdown techniques: E05.393.335.500
auditory cortex: A08.186.211.730.885.287.500.863.297
hearing loss, central: C09.218.458.341.887.432, C09.218.807.186.432, C10.228.140.068.432, C10.597.751.418.341.887.432, C23.888.592.763.393.341.887.432
health knowledge, attitudes, practice: F01.100.150.500, N05.300.150.410
e-selectin: D12.776.395.550.200.700.300, D12.776.503.843.300, D12.776.543.550.200.700.300, D23.050.301.264.035.912.300, D23.050.301.350.700.300, D23.101.100.110.918.300
extracorporeal circulation: E04.292
interleukin-18: D12.644.276.374.465.518, D12.776.467.374.465.518, D23.529.374.465.518
ameloblasts: A11.436.107
amelogenesis: G07.700.320.500.325.377.750.190
dental enamel: A14.549.167.900.255
dentin: A14.549.167.900.280
dentinogenesis: G07.700.320.500.325.377.186
20-hydroxysteroid dehydrogenases: D08.811.682.047.820.125
hydroxysteroid dehydrogenases: D08.811.682.047.436
injections, spinal: E02.319.267.530.580
physicochemical phenomena: G02.842
indicator dilution techniques: E05.484
polysorbates: D02.033.455.250.700.690, D05.750.741.700, D25.720.741.700, J01.637.051.720.741.700
brassica: B01.650.940.800.575.100.157.200, J02.500.850.150
hordeum: B01.650.940.800.575.100.822.481, J02.500.200.333
lycopersicon esculentum: B01.650.940.800.575.100.905.322, J02.500.850.533
plant shoots: A18.024.875
nitrofurantoin: D02.640.600.566, D03.383.312.649.566
pulmonary surfactant-associated protein a: D12.776.503.280.249.600, D12.776.823.100
pulmonary surfactant-associated protein b: D12.776.543.701, D12.776.823.124
culture media, serum-free: D27.720.470.305.255, E07.206.255
cytodiagnosis: E01.370.225.500.384, E05.200.500.384, E05.242.384
diploidy: G05.700.264
propidium: D03.494.633.700
paris: Z01.433.800, Z01.542.286.588
gliadin: D12.776.765.725.500.500.400
lectins, c-type: D12.776.503.280
receptors, immunologic: D12.776.543.750.705
cyclic gmp-dependent protein kinases: D08.811.913.696.620.682.700.150.150, D12.644.360.200.150, D12.776.476.200.150
glucagon: D06.472.699.587.469.500, D12.644.548.586.469.500
glucagon-secreting cells: A03.734.414.065, A06.390.087, A06.407.414.043, A11.382.625.064, A11.436.294.064
zona fasciculata: A06.407.071.140.950
metyrapone: D03.383.725.463
gliosis: C23.550.369
trimethyltin compounds: D02.691.850.900.950
carbamazepine: D03.494.240.127
diclofenac: D02.241.223.601.210
fluoxetine: D02.092.831.280
phytoplankton: B05.080.500.600
simvastatin: D02.455.426.559.847.638.400.900, D04.615.638.400.900
chemistry, physical: H01.181.529
absidia: B01.300.300.500.030
air microbiology: H01.158.273.540.274.110, N06.850.425.110
eurotiales: B01.300.107.320
micromonosporaceae: B03.300.390.400.500, B03.510.024.049.500, B03.510.415.400.500, B03.510.460.410.500
saccharopolyspora: B03.300.390.400.790, B03.510.024.049.750, B03.510.415.400.790, B03.510.460.410.790
doxorubicin: D02.455.426.559.847.562.050.200.175, D04.615.562.050.200.175, D09.408.051.059.200.175
stochastic processes: E05.318.740.996, G17.830, N05.715.360.750.770, N06.850.520.830.996
rosaniline dyes: D02.092.146.755
xanthenes: D03.494.953
feedback, physiological: G07.700.345.732, L01.143.283.425.311
protein kinase c-delta: D08.811.913.696.620.682.700.725.400
protein subunits: D12.776.813
oligonucleotides: D13.695.578.424
methylene blue: D02.886.369.517, D03.494.741.517
nitroglycerin: D02.033.800.421.560, D02.640.636
consumer satisfaction: N04.452.822.360
toremifene: D02.455.426.559.389.150.700.900.900
amino acid transport systems, basic: D12.776.157.530.200.374, D12.776.543.585.200.374
growth substances: D27.505.696.377
hydroxyurea: D02.948.395
lithium chloride: D01.210.450.150.450, D01.510.500
ischemia: C23.550.513
mefloquine: D03.438.810.410
primaquine: D03.438.810.050.650
archives: K01.400.152, L01.346.208
aminoquinolines: D03.438.810.050
genomic instability: C23.550.362, G05.365.590.335, G05.370
kinetochores: A11.284.430.106.279.345.190.160.165.500, G05.360.160.165.500
raf kinases: D08.811.913.696.620.682.700.559.842, D12.644.360.400.842, D12.776.476.400.842, D12.776.624.664.700.204
src-family kinases: D08.811.913.696.620.682.725.800
ploidies: G05.700
graphite: D01.268.150.300, D01.578.300
silanes: D01.837.700, D02.715.625
bioreactors: E07.115, J01.897.120.115
filtration: E05.196.454, G01.595.280, G02.149.767.600, G02.842.750.600
osmosis: G01.154.100.600, G01.595.100.600, G02.111.087.640, G02.149.115.640, G02.149.535, G02.149.767.645, G02.685.495, G02.842.700.495, G02.842.750.645
kinesin: D08.811.277.040.025.193.500, D12.776.220.600.450.450, D12.776.641.560.450
transformation, bacterial: E05.393.350.810.500, G05.355.760.860.500, G05.355.760.865.820, G06.099.112.805, G06.590.110.805
cyclin-dependent kinase 5: D08.811.913.696.620.682.700.200.067.875, D08.811.913.696.620.682.700.646.500.500.500, D12.644.360.250.067.875, D12.776.167.200.067.875, D12.776.476.250.067.875
aspergillus fumigatus: B01.300.381.081.295
leukemia, promyelocytic, acute: C04.557.337.539.275.700
large-conductance calcium-activated potassium channel alpha subunits: D12.776.157.530.400.600.150.500.500, D12.776.543.550.425.750.150.500.500, D12.776.543.585.400.750.150.500.249
large-conductance calcium-activated potassium channel beta subunits: D12.776.157.530.400.600.150.500.750, D12.776.543.550.425.750.150.500.750, D12.776.543.585.400.750.150.500.500
large-conductance calcium-activated potassium channels: D12.776.157.530.400.600.150.500, D12.776.543.550.425.750.150.500, D12.776.543.585.400.750.150.500
myocytes, smooth muscle: A11.620.520
mannitol: D02.033.800.609, D09.853.609
amino acid transport system asc: D12.776.157.530.200.500.200, D12.776.543.585.200.500.200
amino acid transport systems, neutral: D12.776.157.530.200.500, D12.776.543.585.200.500
biotinylation: E05.393.525.085, G02.111.087.157, G02.149.115.157, G03.495.233
glutamine: D12.125.068.330, D12.125.095.461, D12.125.154.424
immunoprecipitation: E05.196.150.639, E05.478.605
ganglionic stimulants: D27.505.696.663.050.400
cultured milk products: J02.200.700.124, J02.500.350.525.221
probiotics: J02.500.456.500
protein structure, tertiary: G02.111.570.790.709.610
tetraisopropylpyrophosphamide: D02.705.672.750
aryl hydrocarbon receptor nuclear translocator: D12.776.157.530.750.100, D12.776.260.103.625.500, D12.776.543.585.750.100, D12.776.930.125.625.500
basic helix-loop-helix transcription factors: D12.776.260.103, D12.776.930.125
daunorubicin: D02.455.426.559.847.562.050.200, D04.615.562.050.200, D09.408.051.059.200
butyrates: D02.241.081.114, D10.251.400.143
carcinoma, merkel cell: C02.256.721.150, C02.928.216, C04.557.465.625.650.240.325, C04.557.470.200.025.370.325, C04.557.580.625.650.240.325, C04.925.216
activities of daily living: E02.831.067, I03.050, N02.421.784.110
adenocarcinoma, bronchiolo-alveolar: C04.557.470.200.025.030
competitive bidding: N03.219.463.100.110
benzopyrenes: D02.455.426.559.847.799.306, D04.615.799.306
ocimum: B01.650.940.800.575.100.575.647
1-alkyl-2-acetylglycerophosphocholine esterase: D08.811.277.352.100.680.750.937.249
guanine nucleotide exchange factors: D12.644.360.325.300, D12.776.402.300, D12.776.476.325.300
dimethylphenylpiperazinium iodide: D03.383.606.390
mecamylamine: D02.455.849.575.781.500
nicotinic antagonists: D27.505.519.625.120.200.700, D27.505.696.577.120.200.700
dental polishing: E06.298
saliva: A12.200.666
face: A01.456.505
notochord: A16.660
amino acid transport system x-ag: D12.776.157.530.200.249.500, D12.776.543.585.200.249.500
rna interference: G05.355.315.203.374.790
cytoplasmic vesicles: A11.284.430.214.190.875.190
fura-2: D03.383.129.462.285, D03.438.127.250
1,2-dipalmitoylphosphatidylcholine: D10.570.755.375.760.400.800.224
methyl methanesulfonate: D02.455.326.146.100.050.500.500, D02.886.645.600.055.050.510.500
thymidine kinase: D08.811.913.696.620.750
cytochalasin d: D03.438.473.231.450, D23.946.587.370.450
precipitin tests: E01.370.225.812.735.645, E05.196.150.639.500, E05.200.812.735.645, E05.478.594.760.645, E05.478.605.492
photochemistry: H01.181.529.711
sulfatases: D08.811.277.352.827
apoptosis inducing factor: D08.811.682.608.047, D12.644.360.075.311, D12.776.331.161, D12.776.476.075.311
medicago: B01.650.940.800.575.100.401.590
mustard plant: B01.650.940.800.575.100.157.200.500, J02.500.300.100.575, J02.500.850.537
gentian violet: D02.092.146.400
embryonal carcinoma stem cells: A11.251.860.590, A11.872.190.500, A11.872.650.500
ryanodine receptor calcium release channel: D12.776.157.530.400.150.800, D12.776.210.500.800, D12.776.543.550.425.150.800, D12.776.543.585.400.150.800
metabolic detoxication, phase ii: G03.495.244.820.750, G07.690.812.097.600.750, G07.700.680.097.600.750
protein processing, post-translational: G02.111.087.675.871.790.600, G02.111.087.693.600, G02.149.115.675.871.790.600, G02.149.115.693.600, G03.495.770.871.790.600, G05.355.315.670.600
ultrafiltration: E04.292.975, E05.196.454.807, G01.595.280.807, G02.149.767.600.807, G02.842.750.600.807
fluoresceins: D02.455.426.559.847.885.347, D03.494.953.275, D04.615.885.347
p-glycoprotein: D12.776.157.530.100.652.500, D12.776.157.530.450.074.500.500.750, D12.776.395.550.020.610.610, D12.776.543.550.192.610.610, D12.776.543.585.100.610.500, D12.776.543.585.450.074.500.500.750
adaptor proteins, signal transducing: D12.644.360.024, D12.776.157.057, D12.776.476.024
base pair mismatch: G05.365.590.060
caspase 2: D08.811.277.656.262.500.126.550.200, D08.811.277.656.300.200.126.550.200, D12.644.360.075.405.550.200, D12.776.476.075.405.550.200
human growth hormone: D06.472.699.631.525.425.875, D12.644.548.691.525.425.875
hydroxyacetylaminofluorene: D02.065.064.150.400, D02.241.081.018.110.080.400, D02.455.426.559.847.389.050.400, D04.615.389.050.400
fibroblast growth factor 2: D12.644.276.624.120, D12.776.467.624.120, D23.529.624.120
granulocyte colony-stimulating factor: D12.644.276.374.410.240.350, D12.776.395.240.200, D12.776.467.374.410.240.350, D23.529.374.410.240.350
telomerase: D08.811.913.696.445.308.300.750.750, D12.776.157.725.500.921, D12.776.664.962.500.921
cilia: A11.284.180.165
phosphoserine: D12.125.740.700, D12.125.837.800
dactinomycin: D03.494.200, D04.345.566.252, D12.644.641.252
osmotic fragility: E01.370.225.625.550, E05.200.625.550, G09.188.640
sanitary engineering: H02.229.656, J01.293.821, N06.850.780.200.800.800, N06.850.860.510
luminescent proteins: D12.776.532
quantum dots: E07.705, J01.637.512.600.650
hypoxia-inducible factor 1: D12.776.260.103.625, D12.776.930.125.625
ruthenium red: D01.210.837, D01.625.800, D01.765.765
thorium dioxide: D01.650.550.875, D01.930.930
maltose: D09.698.365.450, D09.698.629.305.523
video recording: L01.240.960
epitopes: D23.050.550
buffers: D27.720.470.280
umbelliferones: D03.438.150.446.912, D03.830.219.446.912
feasibility studies: E05.318.760.550, E05.337.675, N05.715.360.775.350, N06.850.520.450.550
deoxyribose: D09.254.330
epoxy resins: D05.750.716.822.461, D25.720.716.822.461, J01.637.051.720.716.822.461
extravasation of diagnostic and therapeutic materials: C23.550.340, C26.371
root canal filling materials: D25.339.859, J01.637.051.339.859
hla-dq antigens: D12.776.395.550.509.400.430, D12.776.543.550.423.400.430, D23.050.301.500.400.400.430, D23.050.301.500.450.400.430, D23.050.705.552.410.400.430, D23.050.705.552.450.400.430
hla-dq alpha-chains: D12.776.395.550.509.400.430.500, D12.776.543.550.423.400.430.500, D23.050.301.500.400.400.430.500, D23.050.301.500.450.400.430.500, D23.050.705.552.410.400.430.500, D23.050.705.552.450.400.430.500
hla-dq beta-chains: D12.776.395.550.509.400.430.750, D12.776.543.550.423.400.430.750, D23.050.301.500.400.400.430.750, D23.050.301.500.450.400.430.750, D23.050.705.552.410.400.430.750, D23.050.705.552.450.400.430.750
liver transplantation: E04.210.650, E04.936.450.490, E04.936.580.490
septal nuclei: A08.186.211.464.750.800, A08.186.211.730.885.750.800
bombyx: B01.050.500.131.617.561.650.100
opium: D20.215.784.500.534
proadifen: D02.241.081.944.550
gastric juice: A12.200.307
cryoprotective agents: D27.505.696.706.320, D27.720.799.180
dioxanes: D03.383.231.388
fuel oils: D20.345.630.500, N06.230.132.258.630.500
ice: D01.455.900.400, D01.650.550.925.400, G16.500.275.410, G16.500.750.775.342, N06.230.291
leukemia l1210: C04.557.337.372.594, C04.619.531.594
xeroderma pigmentosum: C04.834.867, C16.131.831.936, C16.320.850.970, C17.800.600.925, C17.800.621.936, C17.800.804.936, C17.800.827.970, C18.452.284.975
phosphofructokinase-1: D08.811.913.696.620.225.850.500
phosphopyruvate hydratase: D08.811.520.241.300.500
dairy products: J02.500.350
subtraction technique: E01.370.350.760
muscle fibers, skeletal: A10.690.552.500.500, A11.620.249
bacteria, anaerobic: B03.130
pyruvate dehydrogenase complex: D05.500.562.625, D08.811.600.741
schistosomicides: D27.505.954.122.250.075.100.750
automobile driving: I03.125
chromatography, affinity: E05.196.181.400.170
immobilized proteins: D12.776.463
phase transition: G01.595.680, G02.149.767.680, G02.842.750.680
nadp transhydrogenases: D08.811.682.608.540
hemostasis: G09.188.124.560
chromatography, paper: E05.196.181.400.454
intestine, small: A03.556.124.684
sulfoxides: D02.886.640
sulfur isotopes: D01.496.868
cells: A11
benzoyl peroxide: D02.241.223.100.133, D02.455.426.559.389.127.133
deoxyribonuclease (pyrimidine dimer): D08.811.277.352.335.350.137
endodeoxyribonucleases: D08.811.277.352.335.350, D08.811.277.352.355.325
ccn intercellular signaling proteins: D12.644.276.200, D12.776.467.200, D12.776.860.300.200, D23.529.237
enzyme activators: D27.505.519.374
genetic engineering: E05.393.420
insulin-like growth factor ii: D12.644.276.937.420, D12.776.124.862.425, D12.776.467.937.420, D23.529.937.420
serpins: D12.644.822.750, D12.644.861, D12.776.645.750, D12.776.872
viral proteins: D12.776.964
maleates: D02.241.081.337.502
phosphorylases: D08.811.913.400.450.460.400
eosine i bluish: D02.455.426.559.847.885.347.300, D03.494.953.275.300, D04.615.885.347.300
indigo carmine: D03.438.473.396
lissamine green dyes: D02.092.877.475, D02.675.276.475, D02.886.645.600.080.050.550
nucleic acid denaturation: E05.393.640, G02.111.087.615, G02.149.115.615, G05.355.720
nucleic acid renaturation: G02.111.087.625, G02.149.115.625
polynucleotides: D13.695.578
carbon-sulfur lyases: D08.811.520.300
levulinic acids: D02.241.755.547
cholic acid: D04.808.105.225.130, D04.808.221.430.130
cholic acids: D04.808.105.225, D04.808.221.430
sulfobromophthalein: D02.455.426.559.389.657.625.617
neodymium: D01.268.477.625, D01.268.558.362.625, D01.552.550.399.625
crossing over, genetic: G05.355.760.615.200
sulfanilic acids: D02.455.426.559.389.750, D02.886.645.600.080.850
muscle tonus: G11.427.565
dna topoisomerases, type ii: D08.811.399.403.741
honey: J02.500.581
bcl-associated death protein: D12.644.360.075.718.100, D12.776.476.075.718.100, D12.776.744.049
kerosene: D20.345.630.600, N06.230.132.258.630.600
cell migration inhibition: G04.299.283.337
leukocyte migration-inhibitory factors: D12.644.276.374.480.428, D12.776.467.374.480.428, D23.125.477, D23.529.374.480.428
estrogens, catechol: D02.455.426.559.389.657.166.350, D06.472.334.851.437.984
excitatory amino acid transporter 2: D12.776.157.530.200.249.500.500.750, D12.776.157.530.450.625.147.750, D12.776.157.530.562.374.781.750, D12.776.543.585.200.249.500.500.750, D12.776.543.585.450.625.147.750, D12.776.543.585.562.374.781.750
propanols: D02.033.755
klebsiella pneumoniae: B03.440.450.425.425.600, B03.660.250.150.400.590
nafenopin: D02.241.081.751.512
facility regulation and control: N03.706.280, N05.700.300
small business: J01.219.921
gossypium: B01.650.940.800.575.100.700.244
friend murine leukemia virus: B04.820.650.375.525.225, B04.909.574.807.375.525.225, B04.909.777.731.375.525.225
mitoxantrone: D02.455.426.559.847.117.159.500, D02.806.100.500, D04.615.117.159.500
rna, neoplasm: D13.444.735.615
respiratory muscles: A02.633.567.900
hydrazones: D02.442.288
thiophenes: D02.886.778, D03.383.903
hexachlorophene: D02.455.426.559.389.261.190.350, D02.455.426.559.389.657.190.350
indium radioisotopes: D01.496.749.460
cdc2-cdc28 kinases: D08.811.913.696.620.682.700.200.067, D08.811.913.696.620.682.700.646.500.500, D12.644.360.250.067, D12.776.167.200.067, D12.776.476.250.067
cyclin-dependent kinase 2: D08.811.913.696.620.682.700.200.323, D08.811.913.696.620.682.700.646.500.750, D12.644.360.250.323, D12.776.167.200.323, D12.776.476.250.323
parabiosis: E05.660
tolbutamide: D02.886.590.795.896, D02.948.828.896
bone morphogenetic protein 2: D12.644.276.954.200.200, D12.776.467.942.200.200, D23.529.942.200.200
hormesis: G07.700.370
nitrosation: G02.111.087.612, G02.149.115.612, G02.149.465.620, G02.607.750.620, G03.495.655
chlormerodrin: D02.691.750.100.229
levonorgestrel: D04.808.668.651.693.762.450
occludin: D12.776.543.488.500, D12.776.543.984.750
phosphodiesterase inhibitors: D27.505.519.389.735
vitamin k: D02.455.426.559.847.638.721.374, D02.455.849.291.523.500, D04.615.638.721.374
thioguanine: D03.438.759.854
sucrase: D08.811.277.450.329.738
models, genetic: E05.599.395.397
pregnenolone carbonitrile: D02.626.745, D04.808.745.745.725.703
collodion: D25.720.099.500.439, J01.637.051.720.099.500.439
acetamides: D02.065.064, D02.241.081.018.110
lithuania: Z01.542.248.136.580, Z01.586.950.140.580
glycoside hydrolases: D08.811.277.450
sex attractants: D23.641.800
food contamination, radioactive: J01.576.423.850.730.500.249.250, N06.850.460.400.250, N06.850.601.500.249.250, N06.850.810.125
aquaporin 5: D12.776.157.530.400.500.040.484, D12.776.543.550.425.730.040.484, D12.776.543.585.400.730.040.600
protein stability: G02.111.700
phytohemagglutinins: D12.776.395.560.825, D12.776.503.499.750, D12.776.765.678.750
cell compartmentation: G04.299.125
photomicrography: E01.370.350.515.799, E01.370.350.600.635, E05.595.799
cytochrome reductases: D08.811.682.608.191
calcium chloride: D01.146.300, D01.210.450.150.150
eukaryotic initiation factor-2: D12.776.835.725.868.249
mitogen-activated protein kinase 7: D08.811.913.696.620.682.700.567.342.937, D08.811.913.696.620.682.700.646.750.249.937, D12.644.360.450.169.937, D12.776.476.450.169.937
